2015 surveys catalog web, rev. 1/26/15

Table of Contents2015 Surveys and Anatomic Pathology Education Programs

1 New Developments ....................................... 3–8

2 Continuing Education.................................. 9–22Continuing Education Programs .................. 10Competency Assessment Program.............. 17QMEdTM Online Educational Courses ........... 20

3 Quality Management Tools ....................... 23-42Q-PROBESTM...................................................... 26Q-TRACKS®....................................................... 31Q-MONITORS® ................................................. 41

4 Point-of-Care Programs ............................. 43-48

5 General Chemistry and TherapeuticDrug Monitoring ........................................... 49-72

General Chemistry and TherapeuticDrug Monitoring .......................................... 50

Urine Chemistry ............................................... 61Special Chemistry........................................... 64

6 Endocrinology.............................................. 73-80

7 Blood Gas, Critical Care,and Oximetry ............................................... 81-84

8 Toxicology .................................................... 85-96

9 Accuracy-Based Programs..................... 97-102Accuracy-Based Programs ........................... 98Validated Materials...................................... 101

10 Instrumentation Validation Tools .......... 103-122Calibration Verification/Linearity................ 104Instrumentation Quality

Management Programs........................... 118

11 Hematology andClinical Microscopy................................ 123-138

Hematology .................................................. 124Clinical Microscopy...................................... 133

12 Reproductive Medicine ......................... 139-142Andrology and Embryology........................ 140

13 Coagulation ............................................. 143-150

14 Microbiology............................................ 151-178Bacteriology.................................................. 152Mycobacteriology........................................ 163Mycology....................................................... 164Parasitology................................................... 167Virology.......................................................... 171Molecular Microbiology............................... 173Infectious Disease Serology......................... 178

15 Immunology and Flow Cytometry ....... 179-190Immunology .................................................. 180Flow Cytometry............................................. 188

16 Transfusion Medicine, Viral Markers,and Parentage Testing ........................... 191-204

Transfusion Medicine.................................... 192Viral Markers .................................................. 201Parentage Testing ........................................ 204

17 Histocompatibility ................................... 205-210

18 Genetics and Molecular Pathology ...... 211-226Cytogenetics................................................. 212Biochemical and Molecular Genetics....... 215Next-Generation Sequencing..................... 221Molecular Oncology – Solid Tumors ........... 222Molecular Oncology – Hematologic ......... 225

19 Anatomic Pathology ............................... 227-250Surgical Pathology ....................................... 228General Immunohistochemistry.................. 237Predictive Markers ........................................ 239Specialty Anatomic Pathology................... 240Cytopathology ............................................. 242

20 Forensic Sciences ................................... 251-254

21 Analyte/Procedure Index...................... 255-298

22 Program Code Page Index ................... 299-302

You getmore

from thisbox.

1 Prepare staff with the insights and knowledgeof more than 500 pathology experts

2 Gain more than 100 CE credits—five times morethan any other program

3 Access education for every member ofyour team at no additional charge

Deliver excellence and value to your entire team with education by the experts!

Three more reasons to participate inthe CAP Surveys/EXCEL® Programs:

NEW

11 | New Developments

“It’s about building the trust of the clinical staff in thequality of our laboratory results. CAP proficiencytesting is more than what is in the box, it’s being onthe cutting edge of laboratory practices.”

New Developments

4 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs

NEW

1 New Developments

Quality Management ToolsSubsection Name Program Code Page(s)

Q-PROBES Blood Bank Safety Practices QP151 27

Q-PROBES Clinical Test Utilization: Unnecessary Testing QP152 28

Q-PROBES Physician Satisfaction with Anatomic Pathology Services QP153 29

Q-PROBES Identification Errors QP154 30

General ChemistrySection Name Program Code Page(s)

General Chemistry and TherapeuticDrug Monitoring

Quality Cross Check—General Chemistry and TherapeuticDrug Monitoring

CZQ 53


B-Type Natriuretic Peptides, five challenges BNP5 55


Quality Cross Check—B-Type Natriuretic Peptides BNPQ 55


Troponin T, five challenges TNT5 56


Hemoglobin A1c, five challenges GH5 57


Hemoglobin A1c, five challenges, international only GH5I 57

Urine Chemistry Porphobilinogen, Urine UPBG 63

EndocrinologySection Name Program Code Page(s)

Endocrinology 25-OH Vitamin D VITD 76

New Developments

800-323-4040 | 847-832-7000 Option 1 | cap.org 5

NEW

1Blood Gas, Critical Care, and OximetrySection Name Program Code Page(s)

Blood Gas, Critical Care,and Oximetry

Quality Cross Check—Critical Care AqueousBlood Gas Series

AQQ, AQ2Q,AQ3Q, AQ4Q

83

Blood Gas, Critical Care,and Oximetry

Quality Cross Check—Blood Oximetry SOQ 84

Hematology and Clinical MicroscopySubsection Name Program Code Page(s)

Hematology Automated Hematology Differential for Mindray BC-5000 FH11 125

Hematology Automated Hematology Differential for Mindray BC-6000 FH12 125

Hematology Quality Cross Check—Automated Hematology SeriesFH3Q, FH4Q,FH6Q, FH9Q

126

Hematology Hematopathology Online Education HPATH/HPATH1 132

Clinical Microscopy Hemocytometer Fluid Count, international only HFCI 136

MicrobiologySubsection Name Program Code Page(s)

BacteriologyGram-Negative Blood Culture Panel for Molecular

Multiplex TestingGNBC 158

Bacteriology Stool Pathogen, without Shiga Toxin SPN 161

Mycobacteriology Molecular MTB Detection and Resistance MTBR 163

Molecular MicrobiologyC. trachomatis and N. gonorrhoeae DNA by Nucleic

Acid AmplificationHC7 174

Molecular Microbiology Bacterial Strain Typing, Gram-Negative Organisms BSTN 175

Molecular Microbiology Nucleic Acid Amplification, Organisms without MTB IDN 175

New Developments


NEW

1 Immunology and Flow CytometrySubsection Name Program Code Page(s)

Immunology Antichromatin Antibody ACA 182

Immunology Antiribosomal-P Antibody ARP 183

Immunology Heavy Chain/Light Chain Analysis HCA 185

Transfusion Medicine, Viral Markers, and Parentage TestingSubsection Name Program Code Page(s)

Transfusion Medicine Transfusion Medicine Competency Assessment—Eluate Test TMCAE 194

Transfusion Medicine Antibody Titer ABT3 196

Transfusion Medicine Red Blood Cell Antigen Typing RBCAT 200

HistocompatibilitySection Name Program Code Page(s)

Histocompatibility HLA Disease Association, Drug Risk DADR1, DADR2 209

New Developments

800-323-4040 | 847-832-7000 Option 1 | cap.org 7

NEW

1Genetics and Molecular PathologySubsection Name Program Code Page(s)

Next-Generation Sequencing Next-Generation Sequencing NGS 221

No CAP program for a test your laboratory performs?We’ve got you covered with this unique, complimentary program—only from the CAP!Sign up for this unique and complimentary service for those rare analytes for whichproficiency testing is not yet available. This service now includes all clinicallaboratory disciplines.• The CAP connects labs performing testing for which no formal

proficiency testing is available.• There is no charge for this service.• Participate at any time, no contract required.• A minimum of three labs performing the same analyte must participate

before the CAP can facilitate the sample exchange.• Each individual laboratory will receive its own results along with an anonymized summary

report for all participants.

Visit cap.org and choose the Laboratory Improvement Programs tab to register today!

Your Choice.Gain the expertise of your peers usingthe convenience of your mobile device.

Customize your reading experiencewith font control, brightness, margins,and quick navigation.

Enhance your learning by adding notes,highlights, and bookmarks.

See for yourself at ebooks.cap.org.

Available now—your favorite CAP Press booksin ebook format!

Continuing

Education

2

Continuing EducationContinuing Education Programs .........................................................................................................10Competency Assessment Program ......................................................................................................17QMEd™ Online Educational Courses..................................................................................................20

2 | Continuing Education

“The educational part comes when you get theresults and review them with the staff, especiallyif you have had issues—true issues. When eachCAP Survey comes back, we go over it with thewhole staff for their continuing education. Wesee if, and where, we went wrong or if we havemore to learn. The educational part is when youget the results back…CAP encourages people tobe current on their education and knowledge.”

Continuing Education Programs


Con

tinui

ngEd

ucat

ion

2


Your laboratory demonstrates its commitment to quality by choosingCAP Surveys programs. You’ll find the same level of quality in the CAPContinuing Education Programs.Legend

This activity is eligible for continuing medical education (CME) credit.

This activity is eligible for continuing education (CE) credit.

This activity is eligible for continuing medical education (CME) credit or continuing education (CE) credit.

Information for Courses Bearing the CME Icon

AccreditationThe College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME)to provide continuing medical education for physicians.

CME Category 1The College of American Pathologists designates these enduring materials educational activities for a maximum of the statednumber of AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of theirparticipation in the activity.

Note to CME participants of enduring* materials courses:An AMA requirement mandates that all physicians wishing to claim CME credits must pass a scored assessment. All CAPenduring materials CME courses require participants to pass a scored assessment prior to claiming credit.

* Enduring courses are those courses that endure over time such as print or Internet courses.

CE (Continuing Education for Nonphysicians) for Courses Bearing the CE IconThe College of American Pathologists designates these educational activities for a maximum of the stated number of credits ofcontinuing education. Participants should claim only the credit commensurate with the extent of their participation in the activity.

The American Society for Clinical Pathology (ASCP) Board of Certification (BOC) Certification Maintenance Program (CMP)accepts this activity to meet its continuing education requirements. The states of California and Florida also approve these activitiesfor continuing education credit.

Cytotechnologists may apply the credits from the PAPCE/PAPJE/PAPKE/PAPLE/PAPME Series 1 or 2, PAP PT, and NGCprograms toward the required educational activities for the American Society of Cytopathology (ASC) Continuing Education CreditProgram (CECC) and the International Academy of Cytology (IAC).


800-323-4040 | 847-832-7000 Option 1 | cap.org 11

Continuing

Education

2

Surveys Continuing Education ActivitiesWhen your laboratory participates in CAP Surveys, every member of your team can enroll in education activities and earncontinuing education (CE) credit at no additional charge. Simply follow these steps:

1. Establish a free Web account.2. Complete a reading provided in the Participant Summary or Final Critique.3. Answer online learning assessment questions.

Each member of your staff can access the Surveys education activities for a maximum of 12 months.

Surveys Education ActivitiesProgram Name Program Code Source Catalog

Page(s)

General Chemistry and Therapeutic DrugsC1/C3/C3X,

CZ/CZX/CZ2X, C7Participant Summary 50

Toxicology T Participant Summary 86

Urine Toxicology UT Participant Summary 86

Urine Drug Testing, Screening UDS, UDS6 Participant Summary 88

CAP/AACC Forensic Urine Drug Testing, Confirmatory UDC Participant Summary 89

Drug Monitoring for Pain Management DMPM Participant Summary 95

Basic Hematology HE, HEP Participant Summary 124

Blood Cell Identification BCP Participant Summary 124

Hematology Automated Differentials FH Series FH1-FH12, FH1P-FH12P Participant Summary 125

Bone Marrow Cell Differential BMD Participant Summary 128

Virtual Body Fluid VBF Participant Summary 134

Coagulation, Limited CGL, CGDF Participant Summary 144

Bacteriology D Final Critique 152

Mycology F Final Critique 164

Electrophoresis SPE Participant Summary 68

Transfusion Medicine, Comprehensive, Limited J, J1 Participant Summary 192

Transfusion Medicine, Educational Challenges JE1, JATE1 Participant Summary 192, 193

Transfusion Medicine, Electronic Crossmatch EXM, EXM2 Participant Summary 195

Transfusion Medicine, Automated Testing JAT Participant Summary 192

CAP/NSH HistoQIP HQIP Final Critique 234



Con

tinui

ngEd

ucat

ion

2

Surveys Self-Reported Training OpportunitiesWhen your laboratory participates in CAP Surveys, every member of your team can receive self-reported training opportunities.

Self-Reported Training Opportunities*Program Name Program Code Source Catalog

Page(s)

Hematology and Clinical Microscopy

Blood Cell Identification BCP Participant Summary 124

Bone Marrow Cell Differential BMD Participant Summary 128

Hematology Automated Differentials FH Series FH1-FH12, FH1P-FH12P Participant Summary 125

Basic Hematology HE, HEP Participant Summary 124

Hemoglobinopathy HG Participant Summary 128

Virtual Peripheral Blood Smear VPBS Participant Summary 130

Clinical Microscopy CMP, CMMP Participant Summary 133

Microbiology

Blood Parasite BP Participant Summary 168

Expanded Bacteriology DEX Participant Summary/Final Critique 153

Mycobacteriology E Participant Summary/Final Critique 163

Yeast F1 Participant Summary/Final Critique 164

Parasitology P Participant Summary/Final Critique 167

Ticks, Mites, and Other Arthropods TMO Participant Summary 169

Genetics and Molecular Pathology

CAP/ACMG Cytogenetics CY Participant Summary 212

CAP/ACMG FISH for Constitutional/HematologicDisorders

CYF Participant Summary 212

CAP/ACMG FISH for Paraffin-Embedded Tissue CYJ, CYK, CYL Participant Summary 213

CAP/ACMG Cytogenomic Microarray Analysis CYCGH Participant Summary 213

*Notes:

• CAP Self-Reported Training opportunities do not offer CE credit, but can be used towards fulfilling requirements for certificationmaintenance by agencies such as the American Society for Clinical Pathology (ASCP). Please verify with your certifying agency todetermine your education requirements.

• These opportunities are subject to change. Refer to the Participant Summary/Final Critique for availability.


800-323-4040 | 847-832-7000 Option 1 | cap.org 13

Continuing

Education

2

Maintenance of Certification (MOC)Maintenance of Certification (MOC) is the board certification program that involves continuous professional development andensures that an American Board of Pathology (ABP) board-certified pathologist is committed to lifelong learning and competencyin a specialty and/or subspecialty.

There are six competency categories defined by the American Board of Medical Specialties (ABMS) and endorsed by the ABP tofulfill specific MOC requirements. They are listed below with their descriptions.

All CAP education activities providing CME credits meet the MOC Part II: Lifelong Learning requirements. Some programs willmeet the requirements for Self-Assessment Module (SAM) and/or MOC Part IV at the laboratory or the individual levels. Programsthat meet Part IV are identified within the description of the program. Visit the CAP website for the current list of programs thatmeet the requirements for MOC Part II and Part IV.

Interpersonal and Communication SkillsDemonstrate interpersonal and communication skills that result in effective information exchange and teaming with patients,patients’ families, and professional associates.

Medical KnowledgeDemonstrate knowledge of established and evolving biomedical, clinical, and cognate sciences and the application of thisknowledge to pathology.

Practice-Based Learning and ImprovementDemonstrate ability to investigate and evaluate diagnostic and laboratory practices in your own lab, appraise and assimilatescientific evidence, and improve laboratory practices and patient care.

Patient CareDemonstrate a satisfactory level of diagnostic competence and provide appropriate and effective consultation in the context ofpathology services.

ProfessionalismDemonstrate a commitment to carrying out professional responsibilities, adherence to ethical principles, and sensitivity to diversepatient population.

Systems-Based PracticeDemonstrate understanding of and contribution to local, regional, and national health care systems, and support health care insystems-based practice definition.

This activity fulfills the SAM credit requirements for MOC and is therefore eligible for SAM credit. Participants whosuccessfully complete an online assessment may apply their earned credit(s) to the ABP’s SAM requirements.

Note to CME/CE participants: The AMA mandates that all education providers (such as the CAP) require participantspass assessment questions in an enduring* program in order to earn and claim CME credits. All participants inany activity granting CME/CE will be required to complete and pass assessment questions before claiming theircredits.

For CME/CE activities: Participants will have unlimited attempts to pass the assessment.

For CME/SAM activities ONLY: Participants will have three attempts to pass the assessment, with feedbackprovided after each attempt. Participants may not claim CME/SAM if they do not pass on the third attempt.

*Enduring programs are those courses that endure over time such as print or online courses.



Con

tinui

ng E

duca

tion

2

Education Programs

Program Name Program CodeMaximum AMA PRA

CME Category 1 Credits™ Annually

Maximum CE Credits Annually

Format Catalog Page

Autopsy Pathology AUCD/AUCD1 12 NA CD-ROM 240

Clinical Pathology Improvement Program*

CPIP/CPIP1 15 NA Online 16

Online Digital Slide Program in Dermatopathology*

DPATH/DPATH1 14**** NA Online (DigitalScope) 231

Online Digital Slide Program in Fine-Needle Aspiration*

FNA/FNA1 10 10 Online (DigitalScope) 249

Fine-Needle Aspiration Glass Slide

FNAG/FNAG1 10 10 Glass Slides 250

Gynecologic Cytopathology – Fields of View

FOVK/FOVK1, FOVM/FOVM1

NA 10 Online 246

Forensic Pathology FR/FR1 12 12 CD-ROM 253

Hematopathology Online Education

HPATH/HPATH1 6 6 Online (DigitalScope) 132

Nongynecologic Cytopathology Education**

NGC/NGC1 25 25Glass Slides

With Online Cases (DigitalScope)

248

Neuropathology Program NP/NP1 10**** NA CD-ROM 241

Gynecologic Cytopathology PAP Education Program***

PAPCE/APAPCEPAPJE/APAPJEPAPKE/APAPKEPAPLE/APAPLE

PAPME/APAPMESeries 1 or 2

8 8 Glass Slides 245

Glass Slide Cytopathology PAP PT Program (with Glass Slide PAP Education)***

PAPCPT/APAPCPTPAPJPT/APAPJPTPAPKPT/APAPKPTPAPLPT/APAPLPT

PAPMPT/APAPMPT

8 8 Glass Slides 243

Practicum in Cancer Surgical Pathology*

PCSP/PCSP1 5**** NA Online (DigitalScope) 233

Online PAP EducationPEDK/APEDK, PEDL/APEDL,

PEDM/APEDM8 8 Online (DigitalScope) 244

Performance Improvement Program in Surgical Pathology

PIP/PIP1 40 NA Glass Slides 228

*Program is available for purchase online. Go to cap.org and choose the Learning tab.**NGC provides up to 20 CME/CE credits for the glass slides and 5 CME/CE credits for the online slide portion of the program.*** PAP provides up to 8 CME/CE credits for glass slides.**** SAM credits are included in CME totals for the appropriate programs.

Discontinued


800-323-4040 | 847-832-7000 Option 1 | cap.org 15

Continuing Education

2

Education Programs

Program Name Program CodeMaximum AMA PRA

CME Category 1 Credits™ Annually

Maximum CE Credits Annually

Format Catalog Page

Online Performance Improvement Program in Surgical Pathology*

PIPW/PIPW1 40 NA Online (DigitalScope) 229

Glass Slide Cytopathology PAP PT Program (with Online PAP Education)

PTGDK/APTGDK PTGDL/APTGDL

PTGDM/APTGDM 8 8

Glass Slides With Online Cases (DigitalScope)

242

Nongynecologic Cytopathology Intraoperative Touch Imprint/Crush Preparation Program*

TICP/TICP1 10**** 10 Online (DigitalScope) 247

Online Virtual Biopsy Program* VBP/VBP1 23**** NA Online (DigitalScope) 230

*Program is available for purchase online. Go to cap.org and choose the Learning tab.**** SAM credits are included in CME totals for the appropriate programs.

System RequirementsMany of our education programs utilize online whole slide images that simulate the use of a microscope. This allows you to scan and use multiple magnifications to view the image.

To best view these programs, we recommend the following.

•OperatingSystem:Windows(XP,Vista,Windows7).MacOSXisnotsupported. •BrowserVersion:InternetExplorer7.xornewer.InIEversions10and11,openin“CompatibilityView.”Goto

http://windows.microsoft.comformoreinformation. •Pop-upblockersmustbeturnedofftoaccesstheactivity.Also,cap.orgmustbeaddedasatrustedwebsite.

Note:Gotocap.orgforthemostup-to-dateinformationonsystemrequirements.

The download speed and the appearance of the activity will vary depending on the type and speed of your Internet connection, computer’s power, and browser. The use of a Macintosh is not recommended regardless of the browser version.

ProgramsusingDigitalScoperequireaone-timedownloadandinstallationoffreesoftware,MicrosoftSilverlight.Foradditionaldetails, go to cap.org and choose the Laboratory Improvement Programs tab.

Discontinued



Con

tinui

ngEd

ucat

ion

2

Clinical Pathology Improvement Program (CPIP)The Clinical Pathology Improvement Program (CPIP) delivers 12 online clinical laboratory cases to study—one per month—and anopportunity to earn up to 15 CME/SAM credits annually. Assess and improve clinical pathology skills and fulfill Maintenance ofCertification (MOC) requirements.

CPIP cases feature real-life case scenarios, including images and clinical background. Participants work through sequentially-revealed information and a series of prompts to arrive at a resolution—just as in the laboratory.

Cases include thought-provoking questions with feedback and a multiple-choice post-test. Participants who earn passing scores onpost-tests may apply their earned credits to the ABP’s MOC SAM requirements.

Clinical Pathology Improvement ProgramCPIP/CPIP1

Program Name Program Code Cases/Year

CPIP/CPIP1

Online cases in clinical pathology z 12

Additional InformationPathologists and residents can use CPIP online to assess and improve their skills inclinical pathology.

• Case topics may originate from the ABP s general listing suggested for MOCincluding laboratory administration and operations, transfusion medicine,chemistry, coagulation, hematology, immunology, microbiology, and moleculargenetic pathology.

• Cases may include patient history, case-related static images, and wholeslide images.

• Monthly individual CPIP cases can also be purchased online. Go to cap.org andchoose the Learning tab. To purchase both CPIP and CPIP1, please call800-323-4040 or 847-832-7000 option 1.

Program Information• One online clinical laboratory

case per month

• CPIP1 - Additionalpathologist (within thesame institution) reportingoption with CME/SAM credit;must order in conjunctionwith CPIP

• Earn a maximum of 15CME/SAM credits (AMA PRACategory 1 Credits™) per year

• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements

• Twelve cases per year; yourCAP shipping contact will benotified via email when theactivity is available

Competency Assessment Program

800-323-4040 | 847-832-7000 Option 1 | cap.org 17

Continuing

Education

2Program Adds Safety & Compliance CoursesOnline Competency Assessment Program helps you meet CAP Laboratory Accreditation Program requirements andCLIA-mandated competency assessment regulations. Also available for 2015 are Safety & Compliance courses specific to theclinical laboratory.

Competency Assessment Program includes:• Competency assessment courses with customized training and CE credit• Reassessment courses• A library of educational training courses (Pro Courses) with CE credit• Instrument-specific observation chec lists for competency and training• Course-building and modifying tools• Management trac ing and reporting• Individual transcripts

Safety & Compliance Courses for the LaboratoryThe package includes all seven courses, which are appropriate for annual laboratory compliance training and for clinicallaboratory science students prior to clinical rotations. Access Safety & Compliance courses throughout the subscription period;the CAP updates these courses when necessary to reflect changes in regulations or best practices.

• OSHA Bloodborne Pathogens• OSHA Chemical Hygiene• OSHA Electrical Safety• OSHA Fire Safety• OSHA Formaldehyde• Tuberculosis Awareness• Medical Errors and Patient Safety

Note: You must purchase the Safety & Compliance course package in conjunction with the Competency Assessment Programsubscription; it is not available for purchase separately.

The Safety & Compliance courses listed above do not offer CE credit.

New for 2015!• Two levels of assessment courses for Blood Ban /Transfusion Medicine and Microbiology modules one for generalists and

one for specialists!• Competency Profiles. This new functionality will allow administrators to create profiles to document the six areas of

competency as defined by CLIA and the CAP Laboratory Accreditation Program. Learn more about Competency Profile atcap.org.

Please see next pages for all course descriptions. For more information, visit cap.org and choose the Learning tab.




Con

tinui

ngEd

ucat

ion

2

Assessment Course ScheduleDiscipline January 2015 Release July 2015 Release

Blood Banking/Transfusion Medicine Antibody screen and identification Transfusion reactions

Chemistry Liver and renal testingChemistry quality control, calibration,

and reportable range

Hematology and Coagulation Common coagulation tests Platelet testing, morphology, and disorders

Histology Safety issues in the histology laboratory Special stains

Immunology Qualitative HIV testingMolecular amplification methods for

detection of infectious diseases

MicrobiologyGram stain: organism detection and

differentiationUrine and body fluid cultures

Phlebotomy/Specimen ProcessingChallenges of phlebotomy: pediatricblood collection, alternate sites, and

difficult draws

Specimen collection for workplace urinedrug testing programs and forensic drug

and alcohol testing

Point-of-Care TestingPoint-of-care whole blood prothrombin

time and INR (PT/INR) testingCardiac biomarkers

Quality Programs/Management Monitoring the quality control program Competency evaluation

Safety Fire and electrical safety Ergonomics

Urinalysis/Body Fluids Cerebrospinal fluid analysis Semen analysis

Pro Course ScheduleDiscipline January 2015 Release July 2015 Release

Blood Banking/Transfusion Medicine Direct antiglobulin test ABO typing discrepancies

Chemistry Clinical toxicology Electrolytes, acid, base, and anion gap

Hematology and Coagulation Erythrocyte morphology White blood cell inclusions

Histology Immunohistochemistry part 2 Histology specimen handling

ImmunologyMonitoring the testing process

in immunologyHuman chorionic gonadotropin and

fetal fibronectin

Microbiology Genital cultures The microbiology of wounds

Phlebotomy/Specimen Processing Phlebotomy professionalism and ethics Routine venipuncture performance

Point-of-Care Testing Provider performed testing Point-of-care urine reagent strip testing

Quality Programs/Management Document control New instrument method validation

Safety Hazardous chemicals Laboratory waste and spill management

Urinalysis/Body Fluids Microscopic urinalysis part 2 Serous and synovial fluids


800-323-4040 | 847-832-7000 Option 1 | cap.org 19

Continuing

Education

2

Safety & Compliance CoursesOSHA Bloodborne Pathogens Addresses the OSHA Bloodborne Pathogens standard as it applies to clinical and medicallaboratories. Covers major bloodborne pathogens, including hepatitis B and HIV. Focuses on proper handling of sharps, personalprotective equipment (PPE), engineering controls such as microbiological safety cabinets, and proper work practices like hand-washing.

OSHA Chemical Hygiene Describes the OSHA Chemical Hygiene Standard and helps satisfy OSHA requirements for annualtraining. Explains Haz-Com, the National Fire Protection Agency diamond, the Safety Data Sheet, and common-sense laboratorysafety rules applied to clinical laboratory practice.

OSHA Electrical Safety Addresses electrical safety and electrical hazards commonly found in the clinical laboratory. Coversprevention and safety measures, fighting electrical fires, and treatment of electrical injuries.

OSHA Fire Safety Teaches the basics of fire safety in the clinical laboratory, including classes of fire and key acronyms such asPASS and RACE. Addresses fire prevention, drills, and firefighting techniques.

OSHA Formaldehyde Covers essentials for any laboratory that uses formaldehyde or formalin. Shares facts aboutformaldehyde, safety risks, proper handling procedure, monitoring, spill clean-up, and personal protective equipment.

Tuberculosis Awareness Provides background information about spread of TB, PPD testing procedures, CDC guidelines, andmethods of control.

Medical Errors and Patient Safety Includes potential causes of medical errors in the clinical laboratory, important legislationand definitions, and steps laboratory professionals can take to reduce the impact of medical errors in their workplace. Servesas an ideal part of an effective medical error reduction program and is appropriate for both experienced and newer laboratorypersonnel.Note: The Safety & Compliance courses are not available for purchase separately. The courses listed above do not offer CE credit.

CAP QMEd™ online educational courses—make quality yourcompetitive position and patient care advantageThe seven QMEd courses can help you understand how to plan and resource your laboratory’squality management system. Every course is highly interactive and delivered to your desktop. Youcan learn at your own location, on your own time, and at your own pace. Courses are availablefor one year. You may share the login with everyone in your laboratory.

QMEd courses include:1. 15189 Walkthrough2. QMS Implementation Roadmap3. Root Cause Analysis4. Internal Auditing5. Document Control6. Quality Manual Development7. Management Review

Choose CAP QMEd courses on your 2015 Surveys order form.


Con

tinui

ngEd

ucat

ion

2

QMEd™ Online Educational Courses

Learn quality tools and techniques with case examples frommedical laboratories.Program information

• CAP uality Management Educational Resources ( MEd) courses help you improve your processes and eliminate waste.• CAP MEd courses help you build a quality management system—one piece at a time—that sustains your continuous

improvement and Lean efforts.• CAP MEd courses are delivered online via a highly interactive user interface that allows you to learn at your own pace.• All CAP MEd courses are licensed for one year, allow sharing of logins, and include continuing education (CE) credit.

CAP online interactive QMEd courses will help you:• nderstand the concept of a uality management system• Self-assess your current MS against international uality standards• Plan and resource for the development of your MS• Interpret ISO 15189 re uirements• Improve your document control system• Perform internal audits using tracer audit and process audit methods• Implement and refine occurrence management with root cause analysis• rite an effective uality manual• Measure, analyze, and set goals with senior management

About the Courses15189 WalkthroughOrder ISOEDWTDesigned for lab quality managers (along with your medical and administrative decision makers) considering implementation ofan ISO 15189 program. Summarizes each section of the standard, while clarifying its intent and key requirements. Hear directlyfrom CAP 15189SM assessors who offer context and examples of how technical problems relate to more fundamental deficienciesin the quality management system.

2 CE credits available

QMS Implementation RoadmapOrder ISOEDRMOutlines the practical steps necessary to build, implement, and maintain a quality management system that meets the ISO 15189standard. Gain perspective on practices (and pitfalls) straight from CAP 15189 assessors, as well as CAP 15189-accredited labs.Designed for lab quality managers, plus your implementation team members.


Root Cause AnalysisOrder ISOEDRCLearn real-world methodology to conduct a root cause analysis, along with the tools necessary to implement it. Learn from actualexamples of complete root cause analysis based on projects in labs like yours. You will even perform key steps based on aparticipant case study. The course is designed for laboratory quality managers and implementation team members.



800-323-4040 | 847-832-7000 Option 1 | cap.org 21

Continuing

Education

2


Internal AuditingOrder ISOEDIAIncrease your capabilities for internal auditing with a proven methodology for process audits, tracer audits, and laser audits. Learnfrom CAP 15189 assessors how to prepare for interviews, communicate findings to your quality management team, and use auditsto drive process improvements.


Document ControlOrder ISOEDDCThis how-to course on document control systems details how to control documents in a way that meets ISO 15189 re uirements,how to accomplish document control even with minimal resources (such as spreadsheets), and how document control contributes tocost containment. All this from CAP 15189 assessors who give examples and commentary on common pitfalls and issues.


Quality Manual DevelopmentOrder ISOEDQMThis course provides guidance on how to go beyond a quality plan to develop a manual that organizes and communicates yourlaboratory’s quality management system. You will see an example of an effectively structured and written manual so you canorganize and create your own. Plus, CAP 15189 assessors show you approaches to link your quality policy to quality objectivesand metrics.


Management ReviewOrder ISOEDMRThis course interprets the ISO 15189 requirements for management review. The CAP 15189 assessors discuss how to structure thereview meeting, communicate results of quality assessments, and prompt strategic decisions from management—all in the contextof the overall health of your organization.


Make sure your laboratory team is ready to meet the challenges ahead. Sign up now for this comprehensive set of learning tools.

For more information, visit cap.org and choose the Laboratory Improvement Programs tab or call 800-323-4040or 847-832-7000 option 1.

Multitasker.Managing competency for your staff placesdemands on your resources.

Now there is a resource that multitasks for you!

The Competency Assessment Programmakes it easy to:

• Develop and manage all si elements ofcompetency assessment

• Create educational resources for alllaboratory staff

• Provide valuable training for new hires• tay current with laboratory safety and

compliance requirements• Provide management with employee

performance reports• Enhance your continuing education program• Be inspection ready

Competency Assessment Program gives youand your staff more time to focus on betterpatient results.

Quality M

anagement Tools

3

Quality Management ToolsQ-PROBES™ ...................................................................................................................................26Q-TRACKS®.....................................................................................................................................31

Clinical Pathology Monitors ...........................................................................................................33Anatomic Pathology Monitors ........................................................................................................39

Q-MONITORS® ...............................................................................................................................41

New Programs New

Blood Bank Safety Practices (QP151).................................................................................................27Clinical Test Utilization: Unnecessary Testing (QP152) .........................................................................28Physician Satisfaction with Anatomic Pathology Services (QP153) .........................................................29Identification Errors (QP154) .............................................................................................................30

Discontinued ProgramsTechnical Staffing Ratios (QP141)Validating Laboratory Results in Electronic Health Records (QP142)Physician Satisfaction with Clinical Laboratory Services (QP143)Use and Effectiveness of Delta Checks (QP144)Laboratory Management Index Program (LMB)CAP LINKS (IMR1-4, IMRPT, IMRLP, IMRLM)

3 | Quality Management Tools

“I like being associated with the CAP becauseit is an organization with a great reputation forhelping laboratories improve.”


Qua

lity

Man

agem

ent T

ools

3

Quality Management Tools

Quality ManagementToolsUse the CAP’s Quality Management Tools (QMT) to improve the Total Testing Process byidentifying quality improvement opportunities of selected key processes in the clinical and anatomicpathology laboratories, examining preanalytical, analytical and postanalytical phases:

• Establish realistic goals by comparing performance against similar institutions withcomparable demographics

• Monitor progress through unique and robust quality indicators on a periodical basis

• Make effective quality management decisions based on practical and in-depthindividual reports provided to participants

• Improve efficiencies to allow time for more patient-centric activities

• Easily integrate quality management into your daily work processes withpredesigned monitoring tools developed by laboratory professionals and scientists

Q-PROBES™ A One-Time Opportunity to Perform In-Depth Quality Assessment

Q-TRACKS® A Program for Continuous Quality Monitoring

Q-MONITORS® Customized Quality Monitors Program

Q-PROBES, Q-TRACKS, and Q-MONITORS activities meet the American Board of Pathology MOC Part IV PracticePerformance Assessment requirements.

800-323-4040 | 847-832-7000 Option 1 | cap.org 25

Quality M

anagement Tools

3

Quality Management Tools

Q-PROBES, Q-TRACKS, andQ-MONITORSoffer a comprehensive collection of tools tocomplement your quality management program needs.*

Select Q-PROBES, Q-TRACKS, andQ-MONITORS studies to supportyour quality improvement initiatives.

Prea

naly

tic

Ana

lytic

Post

anal

ytic

Ana

tom

icPa

thol

ogy

Clin

ical

Path

olog

y

Turn

arou

ndTim

e

Patie

ntSa

fety

Mic

robi

olog

y

Tran

sfus

ion

Med

icin

e

Che

mist

ry/

Hem

atol

ogy

Cus

tom

erSa

tisfa

ctio

n

Q-PROBES

Blood Bank Safety Practices (QP151) z z z z

Clinical Test Utilization: Unnecessary Testing(QP152)

z z z

Physician Satisfaction with Anatomic Pathology Services(QP153)

z z z z z

Identification Errors (QP154) z z z z z z

Q-TRACKS

Patient Identification Accuracy (QT1) z z z z

Blood Culture Contamination (QT2) z z z z

Laboratory Specimen Acceptability (QT3) z z z

In-Date Blood Product Wastage (QT4) z z z

Gynecologic Cytology Outcomes:Biopsy Correlation Performance (QT5)

z z z z z

Satisfaction With Outpatient Specimen Collection (QT7) z z z

Stat Test Turnaround Time Outliers (QT8) z z z z z

Critical Values Reporting (QT10) z z z z

Turnaround Time of Troponin (QT15) z z z z z z

Corrected Results (QT16) z z z z z z z

Outpatient Order Entry Errors (QT17) z z z

Mislabeled Cases, Specimens, Blocks, and Slides inSurgical Pathology (QT19)

z z z

Q-MONITORS

Monitoring of Troponin Metrics for Suspected MI (QM1) z z z z z z z z

*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includesbenchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requiresaccredited hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor,assess, and correct problems identified in preanalytic, analytic, and postanalytic systems (§493.1249, §493.1289, §493.1299).

Q-PROBES


Qua

lity

Man

agem

ent T

ools

3

Q-PROBES

A One-Time Opportunity to Perform In-Depth QualityAssessment

1 Q-PROBES studies are available only one time annually and may not be repeated in the future.

Pilot quality monitoring—Use Q-PROBES short-term comprehensive quality studies1 to learnhow to start monitoring and measuring key processes that you may not have followed in the pastor that are not commonly monitored in most laboratories. Q-PROBES studies analyze hot topicsand industry trends to keep the laboratory current.

Gain experience in data collection and analysis—Participants will collect data duringpredetermined dates. Based on submitted data, the CAP provides personalized reports with theindividual participant’s performance compared against other participants.

Strengthen your quality assessment expertise—CAP’s pathologist experts providein-depth discussion and identify best practices for laboratories to strive for. In addition,consolidated results of the studies are carefully reviewed and analyzed to be published inthe form of scientific articles. Such articles give participants an extra layer of informationto be utilized for further analysis.

Participants in the Q-PROBES program receive:

• sers guide

• Templates and instructions for data collection

• Individual report, how to interpret the results guide,overall aggregated data

• Data Analysis and Criti ue that includes datadistributions and analysis of laboratory practices and commentaries from pathologist expertson improvement opportunities

• Access to the scientific articles that are published with the results of the studies

Q-PROBES activities meet the American Board of Pathology MOC Part IV Practice PerformanceAssessment requirements.

Q-PROBES

800-323-4040 | 847-832-7000 Option 1 | cap.org 27

Quality M

anagement Tools

3

Blood Bank Safety Practices QP151Transfusion of ABO incompatible red blood cells can be a lethal error and is most commonly due to patient or specimenmisidentification. Since the rate of incompatible ABO transfusions at any single institution is very low, this study will focus onthe frequency of specimen identification errors that can lead to incompatible ABO transfusion.

ObjectivesDetermine the rates of mislabeled specimens submitted for ABO typing and of ABO result discrepancies (wrong-blood-in-tube);compare rates between laboratories.

Data CollectionFrom a 30-day review of all specimens submitted for ABO typing, participants will record the number of mislabeled specimens,the number of ABO typing results with a historical type on record, the number of current specimen results that are discrepantfrom the historical results, and the total number of RBC transfusions.

A mislabeled specimen will be defined as any specimen that does not meet the requirements of the institution’s labeling policy.

For the most recent calendar or fiscal year, the number of RBC units transfused, the total number of specimens submitted forABO typing, and the number of ABO results that were discrepant from the historical results will also be recorded.

Performance Indicators• Primary:

o Percent of mislabeled ABO specimens• Secondary:

o Percent of ABO typing result discrepancieso Percent of correct historical ABO typeso Percent of mislabeled ABO specimens that are rejected

New

This is a one-time study conducted in the first quarter.

Q-PROBES


Qua

lity

Man

agem

ent T

ools

3

Clinical Test Utilization: Unnecessary Testing QP152In spite of well-known concerns and costs associated with inappropriate laboratory testing, implementation of effective solutionsis challenging. Educational interventions tend to be transient while use of automated testing algorithms, menu restrictions,feedback or other strategies that may effectively diminish inappropriate laboratory testing are not in widespread use. Collectinginformation about testing patterns is vital for evaluating inappropriate utilization and developing policies and procedures toimprove testing practices.

ObjectivesAssess laboratory testing utilization by evaluating results from previous tests that indicate additional testing may beunnecessary.

Data CollectionParticipants will retrospectively collect data from the most recent 30 to 40 patients with completed orders for free PSA, factor VLeiden and positive anti-HAV testing. Current testing date and previous testing date and results (as applicable) will be recorded.Participants will also complete a questionnaire about their test utilization practices, policies, and procedures.

Performance Indicators• Percent of inappropriate tests performed• Percent of free PSA tests performed when recently tested total PSA is outside of the range for accurately interpreting free PSA

results• Percent of anti-HAV tests performed when previous test results were positive• Percent of factor V Leiden mutation tests performed when the patient had already been tested

New

This is a one-time study conducted in the second quarter.

Q-PROBES

800-323-4040 | 847-832-7000 Option 1 | cap.org 29

Quality M

anagement Tools

3

Physician Satisfaction with Anatomic Pathology Services QP153Although patients are the principle end-users of anatomic pathology services, clinicians enjoy a preferred customer status andtheir opinions are an essential component in developing a customer-oriented pathology department. Surveying clinicians willprovide valuable information for anatomic pathology quality improvement activities.

ObjectivesAssess clinician satisfaction with anatomic pathology services and correlate it with the laboratory workload, performanceimprovement activities, and customer support services.

Data CollectionClinicians will be asked to complete a standardized questionnaire regarding their perception of anatomic pathology services.Questions on services will include timeliness of reporting, diagnostic accuracy, communication, educational activities,accessibility, responsiveness to problems, and courtesy of staff. Clinical questionnaires will be available by two modes ofaccess: electronic distribution with direct return to the CAP, or by use of hard copy response forms. Data from the first 50returned questionnaires will be submitted for analysis.


o Overall mean satisfaction score

• Secondary:o Mean satisfaction score for anatomic pathology service categories

New

This is a one-time study conducted in the third quarter.

Q-PROBES


Qua

lity

Man

agem

ent T

ools

3

Identification Errors QP154Identification errors in the laboratory have the potential to cause serious patient adverse events. These errors may involvemisidentification of a patient or of a specimen. The laboratory’s ability to recognize these errors before results are releasedcontributes to a culture of patient safety and minimizes the adverse consequences of identification errors.

ObjectivesExamine how well your laboratory prevents identification errors by detecting them before results are released to caregivers.Participants will receive their overall identification error rate and their rates of error detection before and after results arereleased to primary caregivers. These rates will be compared to the error rates from all participating institutions. This study willalso seek to identify institutional processes and factors more likely to be found in laboratories that detect a high proportion ofidentification errors before results are released.

Data CollectionOver five weeks, participants will collect data on all patient and specimen identification errors detected by their laboratorybefore results were released, and also on identification errors that come to their attention after results were released.Participants will record whether they know of any patient harm that resulted from any of the identification errors. In addition,laboratories will have the option of tracking the reason for the identification errors.

This study includes all types of testing, both clinical and anatomic pathology, and tests from all patient locations (eg, inpatient,outpatient, outreach).


o Overall identification error rateo Rate of identification errors detected before release of resultso Rate of identification errors detected after release of results

• Secondary:o Breakdown of identification error detection time (before or after release of results)o Breakdown of reasons for identification error

New

This is a one-time study conducted in the fourth quarter.

Q-TRACKS

800-323-4040 | 847-832-7000 Option 1 | cap.org 31

Quality M

anagement Tools

3

Q-TRACKS

A Program for Continuous Quality MonitoringIdentify and monitor opportunities for quality improvement over timeUse established Q-TRACKS programs to identify opportunities to quantitate your quality improvement measures.

Evaluate quality improvementsMeasure the effectiveness and impact of implemented changes in key processes. The individual reports include performance ofquality indicators over time, benchmarking information, trends, and suggested areas for improvement.

Step 1:Establish realistic benchmarks by comparing yourlaboratory to others like yours.

Step 2:Identify improvement opportunities.

Step 3:Monitor improvement over time toensure accurate results, patient safety,and quality patient care.

Q-TRACKS: QT3 - Laboratory Specimen AcceptabilityTrend Analysis Report: January-March

Q-TRACKS: QT3 - Laboratory Specimen AcceptabilityExternal Comparison Report: January-March

(most like you)

Q-TRACKS


Qua

lity

Man

agem

ent T

ools

3

Q-TRACKS activities meet the American Board of Pathology MOC Part IV Practice PerformanceAssessment requirements.

Participants in the Q-TRACKS program receive:• sers guide

• Templates and instructions for data collection

• uarterly reports that include fingerprint clusters, customer-defined groups, and all institutioncomparisons

• Peer directory

• Annual summary report

Laboratory Administration for PathologistsElizabeth A. Wagar, MD, FCAPRichard E. Horowitz, MD, FCAP, andGene P. Siegal, MD, PhD, FCAP, editorsItem number: PUB312Hardcover; 300 pages; 100+ figures, tables, and photographs; 2011

Quality Management in Anatomic Pathology: Promoting PatientSafety through Systems Improvement and Error ReductionRaouf E. Nakhleh, MD, FCAP, andPatrick L. Fitzgibbons, MD, FCAP, editorsItem number: PUB118Softcover; 198 pages; 70+ exhibits and tables; 2005

Quality Management in Clinical Laboratories: Promoting PatientSafety through Risk Reduction and Continuous ImprovementPaul Valenstein, MD, FCAP, editorItem number: PUB214Softcover; 265 pages; 80+ exhibits and tables; 2005

PRESS

To orderVisit cap.org and choose the Shop tab or call the CAP CustomerContact Center at 800-323-4040 or 847-832-7000 option 1.

Also available as ebooks! Visit ebooks.cap.org

Quality Management Resources from CAP Experts

Q-TRACKS

800-323-4040 | 847-832-7000 Option 1 | cap.org 33

Quality M

anagement Tools

3Patient Identification Accuracy QT1

In order to report accurate laboratory results and meet The Joint Commission National Patient Safety Goal #1: “Identify patientscorrectly,” institutions must properly identify patients. Since most laboratories perform testing away from the patient, patientidentification, and labeling of specimens and coordination with test requisitions must be performed accurately and completely.By continuously monitoring for wristband errors, participants can promptly identify and correct problems that may interfere withpatient care services.

ObjectivesAssess the incidence of wristband errors within individual institutions, compare performance between participating institutions,and identify improvement opportunities.

Data CollectionOn six predetermined days per month, participants will monitor patient wristband identification for all phlebotomies performedat their institution. Phlebotomists will tally the total number of wristbands checked, the number of errors found, and the typesof wristband error. This monitor includes all routinely wristbanded patients. Include emergency department patients only if theemergency department routinely applies wristbands to these patients.

Performance Indicator Performance Breakdown• ristband error rate ( ) • Brea down of wristband error types ( )

Blood Culture Contamination QT2Despite advances in blood culture practices and technology, false-positive blood culture results due to contaminants continue tobe a critical problem. Blood culture contamination rate, the primary indicator of preanalytic performance in microbiology, isassociated with increased length of hospital stay, additional expense, and the administration of unnecessary antibiotics. TheCAP and other accrediting organizations require you to monitor and evaluate key indicators of quality for improvementopportunities. Use this monitor to help meet this requirement.

ObjectiveDetermine the rate of blood culture contamination using standardized criteria for classifying contaminants.

Data CollectionOn a monthly basis, participants will tabulate the total number of blood cultures processed and the total number of contaminatedblood cultures. Blood cultures from neonatal patients are tabulated separately. For the purposes of this study, participantswill consider a blood culture to be contaminated if they find one or more of the following organisms in only one of a seriesof blood culture specimens: Coagulase-negative Staphylococcus; Micrococcus; Alpha-hemolytic viridans group streptococci;Propionibacterium acnes; Corynebacterium sp. (diptheroids); or Bacillus sp. Participants have the option to monitor institution-specific subgroups, for example, a specific department or patient population.

Performance Indicators• Neonatal contamination rate ( )• Other contamination rate ( )• Overall contamination rate ( )

Q-TRACKS Clinical Pathology Monitors

Look for your input forms approximately three weeks prior to the quarter.

Q-TRACKS


Qua

lity

Man

agem

ent T

ools

3

Laboratory Specimen Acceptability QT3A substantial amount of rework, diagnostic and therapeutic delay, and patient inconvenience can result from specimenrejection. Patient redraws may result from unlabeled, mislabeled, and incompletely labeled specimens; clotted and/orhemolyzed specimens; or insufficient specimen quantity. By continuously monitoring specimen acceptability, collection, andtransport, laboratories can promptly identify and correct problems.

ObjectiveIdentify and characterize unacceptable blood specimens that are submitted to the chemistry and hematology/coagulationsections of the clinical laboratory for testing.

Data CollectionThis monitor includes all blood specimens submitted for testing to the chemistry and hematology departments of the clinicallaboratory. On a weekly basis, participants will record the total number of specimens received, the number of rejectedspecimens, and the primary reason each specimen was rejected.

Performance Indicator Performance Breakdown• Specimen rejection rate ( ) • Brea down of reasons for rejection ( )

In-Date Blood Product Wastage QT4Blood for transfusion is a precious resource. At a minimum, wastage of blood that is not out-of-date represents a financial lossto the health care system. More ominously, systemic wastage of blood may reflect an environment of care that is out of controland could pose risks to patient safety.

ObjectiveCompare the rates of blood product wastage (ie, units discarded in-date) in participating hospitals and track rates ofimprovement over time.

Data CollectionOn a monthly basis, participants will use blood bank records to obtain information on the total number of units transfusedfor each type of blood component. Participants will track the number and type of blood units that are wasted in-date and thecircumstances of wastage. This monitor includes the following types of blood components: red blood cells (allogeneic), frozenplasma, platelet concentrates, single donor platelets, and cryoprecipitate.

Performance Indicators Performance Breakdown• Overall blood wastage rate ( ) • Brea down of circumstances of wastage ( )• astage rates by blood component type ( )


Q-TRACKS

800-323-4040 | 847-832-7000 Option 1 | cap.org 35

Quality M

anagement Tools

3

Satisfaction With Outpatient Specimen Collection QT7Specimen collection is one of the few areas of laboratory medicine that involves direct outpatient contact. As a result, patientsatisfaction with this service is a vital indicator of quality laboratory performance. The CAP’s Laboratory AccreditationProgram requires measurement of patient satisfaction with laboratory services (GEN.20335). Use this monitor to help meet thisrequirement.

ObjectiveAssess patient satisfaction with outpatient phlebotomy services by measuring patients’ assessment of waiting time, discomfortlevel, courteous treatment, and overall satisfaction.

Data CollectionOn a monthly basis, participants will provide copies of a standardized questionnaire to a minimum of 25 outpatients (maximumof 99 outpatients) using predetermined data collection criteria. This monitor includes any outpatient undergoing venipuncture.This monitor excludes patients seen in the emergency department, ambulatory surgery area, urgent care facility, chest paincenter, 23-hour short-stay facility, employee health department, outpatient health screening fair/promotion, dialysis center,nursing home, or extended care facility.

Performance Indicators• Overall patient satisfaction score• Patients more than satisfied ( )

Stat Test Turnaround Time Outliers QT8The stat test turnaround time (TAT) outlier rate, expressed as a percentage of tests missing target reporting times, is a measureof outcomes that evaluates how well the laboratory meets patient and clinician needs. This monitor helps meet CAP Checklistrequirement GEN.20316, “The QM program includes monitoring key indicators of quality in the preanalytic, analytic, andpostanalytic phases.”

ObjectiveMonitor the frequency that stat test TAT intervals exceed institutional stat test TAT expectations.

Data CollectionBefore beginning data collection, participants will establish a specimen receipt-to-report deadline for emergency department(ED) stat potassium tests. On six predetermined days per month, participants will monitor the TAT of up to 10 randomlyselected ED stat potassium tests on each of three, eight-hour shifts (up to 180 tests per month) and track the number of ED statpotassium results reported later than the established reporting deadline. This monitor includes stat potassium testsordered as part of a panel and excludes stat potassium levels that are requested on body fluids other than blood, as part oftimed or protocol studies, or after the specimen arrives in the laboratory.

Performance Indicator Performance Breakdowns• Stat test TAT outlier rate ( ) • Brea down of outliers by shift ( )

• Brea down of outliers by day of wee ( )


Q-TRACKS


Qua

lity

Man

agem

ent T

ools

3

Critical Values Reporting QT10Laboratories commonly refer to critical values as results requiring immediate notification to the physician or caregiver fornecessary patient evaluation or treatment. Regulations from agencies and accreditors such as the CMS, The JointCommission, and the CAP (GEN.20316, COM.30000) mandate that laboratories develop and implement an alert systemfor critical values. Use this monitor to document compliance with your laboratory’s alert plan.

ObjectiveEvaluate the documentation of successful critical values reporting in the general laboratory for inpatients (including dischargedinpatients) and outpatients.

Data CollectionOn a monthly basis, participants will evaluate 120 inpatient, 20 discharged inpatient, and 120 outpatient critical values.Data collection will include general chemistry, hematology, and coagulation analytes on the critical values list. Retrospectively,participants will record the total number of critical values monitored and the number with documentation of successfulnotification. In addition, participants will provide the number of critical values that were not communicated within three hours,the number of failed notifications due to laboratory oversight, and the number of successful notifications to licensed caregivers.This monitor will exclude critical values for cardiac markers, drugs of abuse, therapeutic drug levels, urinalysis, blood gases,point-of-care tests, and tests performed at reference laboratories.

Performance Indicators• Total critical values reporting rate ( )• Inpatient critical values reporting rate ( )• Discharged inpatient critical values reporting rate ( )• Outpatient critical values reporting rate ( )• Failed notification (< hours) rate ( )


Q-TRACKS

800-323-4040 | 847-832-7000 Option 1 | cap.org 37

Quality M

anagement Tools

3

Turnaround Time of Troponin QT15The swiftness with which physicians establish diagnoses of acute myocardial infarction (AMI) in patients presenting to theemergency department (ED) with chest pain may determine the type and predict the outcome of therapy those patients willreceive. Included in the total time consumed in establishing diagnoses of AMI are the component intervals required to measurebiochemical markers of myocardial injury. One of the most critical biochemical markers is troponin. Use this monitor to helpmeet CAP Checklist requirement GEN.20316 QM Indicators of Quality.

ObjectiveDetermine the median order-to-report turnaround time (TAT) of troponin (I or T) ordered to rule out myocardial infarction andthe percent of troponin results reported by each institution’s established deadline.

Data CollectionOn six predetermined days per month, participants will record TATs (in minutes) for three randomly selected troponinspecimens obtained from ED patients on each of three traditional shifts, a total of nine measurements. Participants will measureTATs from the time of test order to the time results are available to ED personnel.

Performance Indicators• Median troponin order-to-report TAT (minutes)• Troponin TAT compliance rate ( )

Corrected Results QT16The CAP developed this Q-TRACKS monitor in recognition of the importance of timely detection and correction of erroneouslaboratory results. Accuracy in laboratory results is critical to the effectiveness of a physician’s plan of care for a patient. Anerroneous result can delay or alter patient treatment; therefore, detection of erroneous results should be a priority in everylaboratory and should be monitored as a key quality indicator. Help measure your compliance with CLIA 493.1299,Postanalytic Systems Quality Assessment, with this monitor.

ObjectiveMonitor the number of corrected test results within individual institutions and compare performance with that of all institutionsand those institutions similar to yours.

Data CollectionOn a monthly basis, participants will monitor the number of corrected test results and the total number of billable tests for thatmonth. Include test results for all patients in all care settings with the following exclusions: anatomic pathology tests, narrativephysician-interpreted tests (eg, bone marrow biopsies and peripheral smear reports), and point-of-care tests.

Performance Indicator• Test result correction rate (per 10,000 billable tests)


Q-TRACKS


Qua

lity

Man

agem

ent T

ools

3

Outpatient Order Entry Errors QT17Order accuracy bears an obvious relationship to the quality of laboratory testing. When the laboratory fails to complete arequested test, it delays the diagnostic evaluation, potentially extending a patient’s hospital stay and prolonging therapy.When the laboratory completes a test that was not requested, the cost of care increases, patients may be subjected tounnecessary phlebotomy, and laboratory efficiency declines.

ObjectiveMeasure the incidence of incorrectly interpreted and entered outpatient physician test orders into the laboratory informationsystem, compare performance across institutions, and track performance over time.

Data CollectionOn six preselected weekdays per month, participants will compare eight outpatient requisitions or order sheets to the ordersentered into the laboratory’s information system to determine if any order entry errors occurred. Order entry error categoriesinclude requesting physician errors; incorrect, missing, and extra test errors; test priority errors; and copy or fax result errors.This monitor excludes tests performed in transfusion medicine or anatomic pathology. This monitor also excludes tests from thefollowing patient care settings: inpatient, emergency department, ambulatory surgery, urgent care, chest pain center, 23-hourshort-stay facility, employee health department, outpatient screening fair/promotion, and dialysis center.

Performance Indicators Performance Breakdown• Overall outpatient order entry error rate ( ) • Brea down of error types ( )• Order entry error rates by type ( )


Q-TRACKS

800-323-4040 | 847-832-7000 Option 1 | cap.org 39

Quality M

anagement Tools

3Gynecologic Cytology Outcomes: Biopsy Correlation Performance QT5

The correlation of cervicovaginal cytology (Pap test) findings with cervical biopsy results is a significant part of thecytopathology laboratory’s quality assurance program. By monitoring this correlation, the laboratory can identify and addresspotential problems requiring improvement, thereby ensuring better patient results.

ObjectiveQuantify the correlation between the findings of cervicovaginal cytology and corresponding histologic material.

Data CollectionOn a monthly basis, participants will record the number of true-positive, false-positive, and false-negative cytology-biopsycorrelations. The false-negative correlations will be classified into four error categories: screening errors, interpretive errors,screening and interpretive errors, and adequacy determination errors. Participants will also record the biopsy diagnoses forPap tests with an interpretation of atypical squamous cells (ASC-US and ASC-H) or atypical glandular cells (AGC). This monitorincludes cervical biopsy specimens submitted to the laboratory that have a corresponding satisfactory or satisfactory but limitedPap test within three months of the biopsy.

Performance Indicators• Predictive value of positive cytology ( )• Sensitivity ( )• Screening/interpretation sensitivity ( )• Sampling sensitivity ( )• Percent positive for ASC- S interpretations• Percent positive for ASC-H interpretations• Percent positive for AGC interpretations

Q-TRACKS Anatomic Pathology Monitors


Q-TRACKS


Qua

lity

Man

agem

ent T

ools

3

Mislabeled Cases, Specimens, Blocks, and Slidesin Surgical Pathology QT19

Mislabeling of surgical pathology specimens has potential catastrophic consequences for patient care. By continuouslymonitoring the rate of mislabeled specimens, participants will be able to identify problems and variables associated withmislabeled specimens, blocks, and slides. This Q-TRACKS monitor will also help participating laboratories fulfill The JointCommission National Patient Safety Goal #1: “Identify patients correctly” in the discipline of surgical pathology.

ObjectivesDetermine the rates of mislabeled cases, specimens, blocks, and slides and the rate at which mislabeling errors led to acorrected report and compare performance to other institutions.

Data CollectionProspectively track each time a specimen container, block or slide is relabeled or renumbered due to an identification error;and if, as a result, a corrected report is issued. Participants will also report the number of cases processed each month and thenumber of blocks and slides (including special stains) that are processed during the same time period. Data will be collectedmonthly.

This Q-TRACKS monitor is limited to routine histology processing.

Performance Indicators• Rate of mislabeled events (mislabeled cases, specimens, bloc s, and slides) per case• Percent of errors that resulted in a corrected report• Rate of mislabeled cases• Rate of mislabeled specimens• Rate of mislabeled bloc s• Rate of mislabeled slides


Q-MONITORS

800-323-4040 | 847-832-7000 Option 1 | cap.org 41

Quality M

anagement Tools

3

Q-MONITORS

A Program for a Customized Comprehensive AssessmentEvaluate quality improvements in your laboratoryWith today’s focus on reducing medical errors, achieving and maintaining excellence is key tosuccess. Using continuous monitoring, Q-MONITORS provide a comprehensive assessment of keyprocesses in your institution.

Structure your data collection and analysis for successUse Q-MONITORS to help build and improve data collection and analyze processes thatcontribute to quality of care, patient safety, and outcomes. Observe performance trends overtime to identify and monitor opportunities for quality improvement through quantitative qualitymeasures.

Establish realistic laboratory benchmarks and performance goalsQ-MONITORS are customized programs that address process-, outcome-, and structure-orientedquality assurance issues. Establish benchmarks through external database comparisons andcompare your performance to establish goals for performance improvement.

Q-MONITORS


Qua

lity

Man

agem

ent T

ools

3

Q-MONITORS Customized Quality Monitoring Program

Monitoring of Troponin Metrics for Suspected MI QM1Patients presenting to the emergency department (ED) with chest pain must be evaluated quickly. Rapid serum troponinmeasurement is an important part of ED practice that can provide decisive information for patient management. Reducingdelays in troponin testing has been reported to result in shorter length of stay in the ED and more rapid initiation of anti-ischemictreatment. Emergency departments and chest pain centers should, therefore, have effective procedures for ensuring optimalturnaround time (TAT) for troponin and a process for ongoing monitoring to ensure that performance meets expectations.

ObjectiveDetermine and monitor troponin TATs for patient arrival to result availability and/or up to six time intervals within the totaltesting process for patients presenting to the ED with chest pain.

Data CollectionSix days per month, collect data from nine patients presenting to the ED with chest pain and tested for troponin level. Dataincludes time of patient arrival, troponin test order, specimen collection, laboratory receipt, and result availability. It is notnecessary to provide data from each TAT component. Participants select which TAT metrics to monitor, with the option tomonitor all metrics.

Participants will also complete a questionnaire about clinical and laboratory practices related to troponin testing.

MetricsDepending on the data submitted, the following metrics will be provided. In addition, TAT benchmarking, as compared to allinstitutions, will be provided for both point-of-care and clinical laboratory testing for patient arrival to result availability andspecimen collection to result availability.• Patient arrival to result availability• Specimen collection to result availability• Test order to result availability• Patient arrival to test order• Test order to specimen collection• Specimen collection to laboratory receipt• Laboratory receipt to result availability

Performance indicators• Median TAT for troponin testing intervals (monthly)• Test order to result availability compliance rate (if applicable)• Specimen collection to result availability compliance rate (if applicable)


Point-of-Care

Programs

4

Point-of-Care Programs

Discontinued ProgramsPOC H. pylori Antibody Competency (POC13)

4 | Point-of-Care Programs

“I think the CAP is fantastic and I’m proud to beassociated with an organization that is so interestedin high quality patient care. The CAP is not justa proficiency testing provider—the CAP is somuch more.”



Poin

t-of

-Car

ePr

ogra

ms

4


POC Competency Challenges are designed to improve waived test results. These programs will evaluateinstrument and method performance, troubleshoot, assess staff competency, and provide information totrain staff. Expected results will be provided. These programs are not proficiency testing programs andparticipants will not return results to the CAP.

POC Competency Challenges may have limited availability and stability.

POC Competency ChallengesPOC1, POC2, POC3, POC4

Program Name Program Code Challenges/Shipment

POC1 POC2 POC3 POC4

POC hCG Competency z 10

POC Glucose Competency z 10

POC Urine Dipstick Competency z 10

POC Strep Screen Competency z 10

POC Competency ChallengesPOC5, POC6, POC7, POC8, POC9


POC5 POC6 POC7 POC8 POC9

POC PT/INR, i-STATCompetency

z 10

POC PT/INR, CoaguChek XS PlusCompetency

z 10

POC Waived Chemistry, Glucoseand HgB Competency

z 10

POC Influenza A/B AntigenDetect Competency

z 10

POC Fecal Occult BloodCompetency

z 10

Program Information• POC1 - One positive 10.0-mL

liquid urine specimen

• POC2 - One abnormal2.5-mL whole blood specimen

• POC - One abnormal10.0-mL li uid urinespecimen

• POC - One 1.0-mL positiveliquid specimen

• Each program will providematerial to test up to 10 staff

• Shipments available uponrequest

Program Information• POC5 - Five abnormal 1.0-mL

lyophilized plasma specimens

• POC6 - Five abnormal 0. -mLlyophilized plasma specimensand five correspondingdiluents

• POC7- One abnormal 1.0-mLwhole blood specimen. Foruse with the HemoCue® B,HemoCue 201, and StanbioHemoPoint® H2 instruments

• POC8 - One 1.5-mL vialpositive for influenza A;One 1.5-mL vial positive forinfluenza B

• POC9 - One positive 2.0-mLfecal specimen

• Each program will providematerial to test up to 10 staff



800-323-4040 | 847-832-7000 Option 1 | cap.org 45

Point-of-Care

Programs

4

POC Competency ChallengesPOC10, POC11, POC12


POC10 POC11 POC12

POC Blood Gases Competency z 10

POC Blood Gases, i-STATCompetency

z 10

POC Plasma Cardiac MarkersCompetency

z 10

POC Competency ChallengesPOC14, POC15, POC16


POC14 POC15 POC16

POC Medtronic ACT/ACT,i-STAT Competency

z 5

POC Hemochron r IL GEMACT-LR Competency

z 5

POC Hemochron r Signature ILGEM PCL ACT Competency

z 5

Program Information• POC10 - Ten abnormal

2.5-mL a ueous blood gasspecimens and ten 2.5-mLhematocrit/hemoglobinspecimens

• POC11 - Ten abnormal2.5-mL a ueous specimensfor blood gas andhematocrit/hemoglobintesting

• POC12- One abnormal1.5-mL plasma specimen;compatible with plasmabased tests, such as AlereTriage and i-STAT instruments


Program Information• POC1 - Five abnormal

1.7-mL lyophilized wholeblood specimens with fivecorresponding diluentsand one calcium chloridediluent vial; compatible withMedtronic HemoTec ACT/ACT, Medtronic Hepcon HMS,i-STAT Celite ACT, i-STATKaolin ACT

• POC15 - Five abnormal0.5-mL unitized specimens;compatible with IL GEMPCL Plus ACT-LR and ITCHemochron Jr./SignatureACT-LR

• POC16- Five abnormal0.5-mL unitized specimens;compatible with IL GEM PCLPlus ACT and ITC HemochronJr./Signature ACT+




Poin

t-of

-Car

ePr

ogra

ms

4

In many hospitals today, laboratory testing has shifted from the central main laboratoryto inpatient rooms, emergency departments, and intensive care units. We have developedthis section in response to this shift and the increased use of point-of-care instrumentsin the hospital. This section will help you select the most appropriate proficiency testingprograms for staff members who work near patient and bedside testing in the hospitalsetting. For additional information about selecting the right programs for your institution,contact the CAP at 800- 2 - 0 0 or 8 7-8 2-7000 option 1.

Use the charts to select the proficiency testing programs that meet your testing needs.

Critical Care Aqueous Blood Gas and OximetrySurvey Name Program Code Page Number

Critical Care Aqueous Blood GasA , A 2, A ,

A82

Blood Oximetry SO 8

ChemistrySurvey Name Program Code Page Number

B-Type Natriuretic Peptides BNP, BNP5 55

Hemoglobin A1c GH2, GH5, GH5I 57

Limited Chemistry, aived LC 58

Neonatal Bilirubin NB, NB2 58

Plasma Cardiac Markers PCARM 59

Whole Blood Glucose BG, B2 59

CoagulationSurvey Name Program Code Page Number

Activated Clotting TimeCT, CT1, CT2,

CT , CT51 6

Platelet Function PF1 1 7

Drug-Specific Platelet Aggregation PIA 1 9

Thromboelastogram TEG 1 7

Whole Blood D-Dimer WBDD 1 9

Whole Blood Prothrombin Time/INRP , P , P6,

P9, P101 8


800-323-4040 | 847-832-7000 Option 1 | cap.org 47

Point-of-Care

Programs

4

Hematology and Clinical MicroscopySurvey Name Program Code Page Number

Amniotic Fluid Lea age (Nitrazine test) AFL 1

Blood Cell Counts HE, HEP, FH series 12 , 125

Clinical Microscopy CMP, CMMP 1

Erythrocyte Sedimentation Rate ESR, ESR1 12

Gastric Occult Blood GOCB 1 6

Occult Blood OCB 1 7

Rapid Total White Blood Cell Count RWBC 1 0

Reticulocytes RT, RT2, RT , RT 129

Rupture of Fetal Membranes Testing ROM1 1 7

Waived Combination HCC 59

ImmunologySurvey Name Program Code Page Number

Anti-HCV, Waived RHCVW 202

Anti-HIV-1, Anti-HIV-1/2, aived AHIVW 202

Infectious Mononucleosis, Waived IMW 181

MicrobiologySurvey Name Program Code Page Number

Group A Strep Antigen Detection D6, D9 156

ToxicologySurvey Name Program Code Page Number

Urine Drug Screen DS6 88



Poin

t-of

-Car

ePr

ogra

ms

4

We created the following charts to help you select the most appropriate CAP Surveys to meet your testing needs. These charts arenot intended to be construed as approval or disapproval of any commercial product or instrument. Please contact aCAP Customer Contact representative at 800- 2 - 0 0 or 8 7-8 2-7000 option 1 or your instrument manufacturer for othercompatibility questions. Select the compatible Survey for your instrument and cartridge from the charts.

Abbott Point-of-Care i-STAT®

Recommended CAP Survey

i-STAT Cartridge Survey Name Program Code Page Number

Blood Gas+

G

Critical Care AqueousBlood Gas

A 82

CG A 82

EG6 A 82

EG7 A 82

CG8 A 82

Chemistry+

G

Critical Care AqueousBlood Gas

A 82

Crea A 82

E A 82

EC A 82

6 A 82

EC8 A 82

CHEM8 A 82

Coagulation

Celite ACTActivated Clotting Time

CT5 1 6Kaolin ACT CT5 1 6

PT/INR Whole Blood Coagulation P 1 8

Cardiac Markers

CKMB

Plasma Cardiac Markers

PCARM, PCARMX 59

BNP PCARM, PCARMX 59

cTnl PCARM, PCARMX 59

Alere Triage®

Recommended CAP Survey

Alere Triage Cartridge Survey Name Program Code Page Number

Triage® Cardiac Panel Plasma Cardiac Markers PCARM, PCARMX 59

Triage BNP

B-Type Natriuretic Peptides,Plasma Cardiac Markers

BNP, BNP5, PCARM,PCARMX

55, 59

Triage CardioProfilER® BNP, BNP5, PCARM,PCARMX

55, 59

Triage Profiler Shortness of BreathBNP, BNP5, PCARM,

PCARMX55, 59

Triage TOX Drug ScreenUrine Drug Screen

DS, DS6 88

Triage Drugs of Abuse Panel DS, DS6 88

General C

hemistry and Therapeutic D

rug Monitoring

5

General Chemistry and Therapeutic Drug MonitoringGeneral Chemistry and Therapeutic Drug Monitoring...........................................................................50Urine Chemistry ...............................................................................................................................61Special Chemistry ............................................................................................................................64

New Programs New

Quality Cross Check, General Chemistry and Therapeutic Drug Monitoring (CZQ) ................................ 53B-Type Natriuretic Peptides, five challenges (BNP5) ............................................................................ 55Quality Cross Check, B-Type Natriuretic Peptides (BNPQ) ................................................................... 55Troponin T, five challenges (TNT5).................................................................................................... 56Hemoglobin A1c, five challenges (GH5)............................................................................................. 57Hemoglobin A1c, five challenges, international only (GH5I) ................................................................. 57Porphobilinogen, Urine (UPBG) ........................................................................................................ 63

Program ChangesSecond instrument reporting no longer offered

General Chemistry and Therapeutic Drug Monitoring (CZ2X) ............................................................50B-Type Natriuretic Peptides (BNP)...................................................................................................55See programs CZQ and BNPQ................................................................................................53, 55

Deleted AnalytesLimited Chemistry, Waived (LCW) .....................................................................................................58

Alanine Aminotransferase (ALT)Aspartate Aminotransferase (AST)

Discontinued ProgramsGeneral Chemistry and Therapeutic Drug Monitoring (CZ2)

See Survey CZX .................................................................................................................................. 50Commutable Frozen Serum (CFS)

5 General Chemistry andTherapeutic Drug Monitoring

“The CAP’s proficiency testing quality is everythingto us. The last thing I want is for a clinician to doubtmy results.”

General Chemistry and Therapeutic Drug Monitoring


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

General Chemistry and Therapeutic Drug MonitoringAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

General Chemistry and Therapeutic DrugsC1, C3/C3X, CZ/CZX/CZ2X, Z

Analyte Program Code Challenges/Shipment

C1 C3/C3XCZ/CZX/

CZ2X Z

Alanine aminotransferase(ALT/SGPT) z z z 5

Albumin z z z 5

Alkaline phosphatase z z z 5

Amylase z z z 5

Aspartate aminotransferase(AST/SGOT) z z z 5

Bilirubin, direct z z z 5

Bilirubin, total z z z 5

Calcium z z z 5

Chloride z z z 5

Cholesterol z z z 5

Cortisol z z z 5

Creatine kinase (CK) z z z 5

Creatinine z z z 5

Glucose z z z 5

HDL cholesterol z z z 5

Human chorionic gonadotropin(hCG), quantitative z z z 5

Iron z z z 5

Lactate dehydrogenase (LD) z z z 5

LDL cholesterol z z z 5

Lipoprotein (a) z z z 5

Magnesium z z z 5

Pancreatic amylase z z z 5

Potassium z z z 5

Protein, total z z z 5

Sodium z z z 5

T3, free (triiodothyronine, free) z z z 5

T3, total (triiodothyronine, total) z z z 5

T3, uptake and related tests z z z 5

T4, free (thyroxine, free) z z z 5

Continued on the next pageGeneral Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditationrequirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 58.

Program Information• Five 5.0-mL li uid serum

specimens

• Conventional andInternational System ofUnits (SI) reporting offered

• Three shipments per year

Additional volume optionsC - General Chemistry withten 5.0-mL specimensC - General Chemistry andTDM with ten 5.0-mL specimens

C 2 - General Chemistryand TDM with fifteen 5.0-mLspecimens

For second instrument reportingoptions, see the uality CrossChec program, C , onpage 5 .


800-323-4040 | 847-832-7000 Option 1 | cap.org 51

General C


rug Monitoring

5

General Chemistry and Therapeutic DrugsC1, C3/C3X, CZ/CZX/CZ2X, Z continued


C1 C3/C3XCZ/CZX/

CZ2X Z

T4, total (thyroxine, total) z z z 5

Thyroid-stimulatinghormone (TSH) z z z 5

Triglycerides z z z 5

Urea nitrogen (BUN) z z z 5

Uric acid z z z 5

Acid phosphatase z z 5

Ammonia z z 5

Apolipoprotein A1 z z 5

Apolipoprotein B z z 5

Calcium, ionized z z 5

Carbon dioxide z z 5

Ferritin z z 5

Gamma glutamyl transferase (GGT) z z 5

Iron binding capacity,total (measured)

z z 5

Iron binding capacity, unsaturated(measured)

z z 5

Iron saturation (%) z z 5

Lactate z z 5

Lipase z z 5

Osmolality z z 5

Phosphorus (inorganic) z z 5

Prealbumin z z 5

Transferrin z z 5

Lithium z z z z 5

Acetaminophen z z 5

Ami acin z z 5

Caffeine z z 5

Carbamazepine z z 5

Carbamazepine, free z z 5

Digoxin z z 5

Digoxin, free z z 5

Disopyramide z z 5

Continued on the next pageGeneral Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditationrequirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 58.


specimens



Additional volume optionsC - General Chemistry withten 5.0-mL specimens

C - General Chemistry andTDM with ten 5.0-mL specimens





Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

General Chemistry and Therapeutic DrugsC1, C3/C3X, CZ/CZX/CZ2X, Z continued


C1 C3/C3XCZ/CZX/

CZ2X Z

Ethosuximide z z 5

Gentamicin z z 5

Lidocaine z z 5

Methotrexate z z 5

N-acetylprocainamide (NAPA) z z 5

Phenobarbital z z 5

Phenytoin z z 5

Phenytoin, free z z 5

Primidone z z 5

Procainamide z z 5

Quinidine z z 5

Salicylate z z 5

Theophylline z z 5

Tobramycin z z 5

Valproic acid z z 5

Valproic acid, free z z 5

Vancomycin z z 5

General Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditationrequirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 58.


specimens



Additional volume optionsC - General Chemistry withten 5.0-mL specimens

C - General Chemistry andTDM with ten 5.0-mL specimens




800-323-4040 | 847-832-7000 Option 1 | cap.org 53

General C


rug Monitoring

5

Quality Cross Check—GeneralChemistry and Therapeutic

Drug Monitoring CZQAnalyte Program Code Challenges/Shipment

CZQ

See Survey C analytes onpages 50-52

z 3

This program does not meet regulatory requirements for proficiency testing. See Survey CZon pages 50-52.

Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, nowledge andpeer-based educational coaching to protect your laboratory from regulatory sanctions.

• The CAP uality Cross Chec program complements CAP PT by offering moreopportunities to monitor and proactively identify instrument problems before theyimpact patient test results.

• This new offering will help you improve uality processes, reduce stress, raisecompetency of staff, and verify the performance of your instrument results.

CAP/AACC Immunosuppressive Drugs CSAnalyte Program Code Challenges/Shipment

CS

Cyclosporine z 3

Sirolimus (rapamycin) z 3

Tacrolimus z 3

Everolimus EVAnalyte Program Code Challenges/Shipment

EV

Everolimus z 3

Mycophenolic Acid MPAAnalyte Program Code Challenges/Shipment

MPA

Mycophenolic acid z 3

NewProgram Information• Three 5.0-mL li uid serum

specimens in duplicate

• Report up to three instruments

• Conventional andInternational System of nits(SI) reporting offered

• Two shipments per year

Program Information• Three 5.0-mL whole blood

specimens


AACC


specimens


Program Information• Three 5.0-mL lyophilized

serum specimens




Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Therapeutic Drug Monitoring,Extended ZE


ZE

Clozapine z 3

Gabapentin z 3

Lamotrigine z 3

Levetiracetam z 3

Oxcarbazepine metabolite z 3

Teriflunomide z 3

onisamide z 3

Therapeutic Drug Monitoring, Special ZT, ZZTAnalyte Program Code Challenges/Shipment

ZT, ZZT

Amitriptyline z 3

Desipramine z 3

Imipramine z 3

Nortriptyline z 3

Tricyclics, total ( ualitative/ uantitative) z 3

Accuracy-Based Lipids ABLAnalyte Program Code Challenges/Shipment

ABL

Apolipoprotein A1 z 3

Apolipoprotein B z 3

Cholesterol* z 3

HDL cholesterol* z 3

LDL cholesterol z 3

Lipoprotein (a) z 3

Triglycerides* z 3

*This analyte will be evaluated against the Centers for Disease Control and Prevention (CDC)reference method.

Program Information• Three 5.0-mL serum specimens


Program Information• T - Three 5.0-mL lyophilized

serum specimens

• T - Six 5.0-mL lyophilizedserum specimens


Program Information• Three 1.0-mL human serum

specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 55

General C


rug Monitoring

5

B-Type Natriuretic Peptides BNP, BNP5Analyte Challenges/Shipment

Program Code

BNP BNP5

BNP 2 5

NT-pro BNP 2 5

Additional Information •Beginningwiththe2015proficiencytesting(PT)programyear,theCollege

ofAmericanPathologistsAccreditationProgramwillrequireallaccreditedlaboratoriesperformingnon-waivedtestingforBNPandNT-proBNP tocomplete15PTchallengesperyear.

•Forsecondinstrumentreportingoptions,seetheQualityCrossCheckprogram,BNPQbelow.

Quality Cross Check—B-Type Natriuretic Peptides BNPQ


BNPQ

BNP z 3

NT-pro BNP z 3

This program does not meet regulatory requirements for proficiency testing. See Surveys BNP or BNP5 above.

Additional InformationAsatrustedpartner,youcanrelyontheCAPtoprovidetheinsight,knowledgeand peer-basededucationalcoachingtoprotectyourlaboratoryfromregulatorysanctions. •TheCAPQualityCrossCheckprogramcomplementsCAPPTbyofferingmore

opportunitiestomonitorandproactivelyidentifyinstrumentproblemsbeforetheyimpactpatienttestresults.

•Thisnewofferingwillhelpyouimprovequalityprocesses,reducestress,raisecompetencyofstaff,andverifytheperformanceofyourinstrumentresults.

Program Information•BNP-Two1.0-mLliquid

plasmaspecimens;ConventionalandInternationalSystemofUnits(SI)reportingoffered;twoshipmentsperyear

•BNP5-Five1.0mLliquidplasmaspecimens;ConventionalandInternationalSystemofUnits(SI)reportingoffered;threeshipmentsperyear

Program Information•Threeliquidspecimensin

duplicate

•Reportuptothreeinstruments

•ConventionalandInternationalSystemofUnits(SI)reportingoffered

• Twoshipmentsperyear

New



Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Harmonized Thyroid ABTHAnalyte Program Code Challenges/Shipment

ABTH

T3, free (triiodothyronine, free) z 3

T3, total (triiodothyronine, total) z 3

T , free (thyroxine, free) z 3

T , total (thyroxine, total) z 3

Thyroid-stimulating hormone (TSH) z 3

PRICE (USD)

Additional Information• Analytes will be evaluated using harmonization.• Specimens are collected by a modified application of Clinical Laboratory and

Standards Institute Guideline CLSI C 7-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materials forCholesterol Measurement Procedures; Approved Guideline.

Cardiac Markers CRT, CRTI, TNT, TNT5Analyte Program Code Challenges/

Shipment

CRT CRTI TNT TNT5

CK-MB, immunochemical z z 5

CK isoenzymes (C -BB, CK-MB,C -MM), electrophoretic

z 5

LD1, LD2, LD , LD , LD5,electrophoretic

z 5

LD1/LD2 ratio, calculationand interpretation

z 5

Myoglobin z z 2

Troponin I z z 5

Troponin T, two challenges z 2

Troponin T, five challenges z 5

Beginning with the 2015 proficiency testing (PT) program year, the College of AmericanPathologists Accreditation Program will require all accredited laboratories performingnon-waived testing for Troponin I and Troponin T to complete 15 PT challenges per year.

Program Information• Three 1.0-mL frozen human

specimens


Program Information• CRT - Five 2.0-mL li uid

serum specimens

• CRTI - Ten 2.0-mL li uidserum specimens

• TNT - Two 2.0-mL li uidserum specimens

• TNT5 - Five 2.0-mL li uidserum specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 57

General C


rug Monitoring

5

Hemoglobin A1c GH2, GH5Analyte Challenges/Shipment

Program Code

GH2 GH5

Hemoglobin A1c 3 5

Additional Information •Beginningwiththe2015proficiencytesting(PT)programyear,theCollege

ofAmericanPathologistsAccreditationProgramwillrequireallaccreditedlaboratoriesperformingnon-waivedtestingforHemoglobinA1ctocomplete 15PTchallengesperyear.

•TheseSurveyswillbeevaluatedagainsttheNationalGlycohemoglobinStandardizationProgram(NGSP)referencemethod.

Hemoglobin A1c GH5IAnalyte Program Code Challenges/Shipment

GH5I

Hemoglobin A1c z 5

Additional Information •ThisprogrammeetstheCAP’sAccreditationProgramrequirementsfor

proficencytesting. •ThisSurveywillnotbeevaluatedagainsttheNationalGlycohemoglobin

StandardizationProgram(NGSP)referencemethod.SeeSurveyGH5tobe evaluatedagainsttheNGSPreferencemethod.

Glycated Serum Albumin GSAAnalyte Program Code Challenges/Shipment

GSA

Glycatedserumalbumin z 3

High-Sensitivity/Cardiac C-Reactive Protein HSCRPAnalyte Program Code Challenges/Shipment

HSCRP

High-sensitivity/CardiacC-reactiveprotein

z 3

Program Information•GH2-Three0.8-mL

liquidhumanwholebloodspecimens;twoshipments peryear

•GH5-Five0.8-mLliquidhumanwholebloodspecimens;threeshipmentsperyear

NewProgram Information•Five0.5-mLlyophilized

specimenswitha3.0-mLdropper-tippedvialofdiluent

•Designedforinternationallaboratoriesthathaveexperiencedsignificantshippingandreceiving issuesandrequirelongerspecimenstability

• Threeshipmentsperyear

Program Information•Three1.0-mLliquidserum

specimens


Program Information•Three0.5-mLliquidserum

specimens




Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Homocysteine HMSAnalyte Program Code Challenges/Shipment

HMS

Homocysteine z 3

Ketones KETAnalyte Program Code Challenges/Shipment

KET

Beta-hydroxybutyrate z 2

Total etones z 2

Limited Chemistry, Waived LCWAnalyte Program Code Challenges/Shipment

LCW

Cholesterol z 3

Glucose z 3

HDL cholesterol z 3

LDL cholesterol z 3

Triglycerides z 3

Neonatal Bilirubin NB, NB2Analyte Challenges/Shipment

Program Code

NB NB2

Bilirubin, direct 2 2

Bilirubin, total 5 2

One human-based serum specimen will offer the value assigned using the referencemethod procedure (Clin Chem. 1985;31:1779-1789).

Program Information• Three 1.0-mL serum

specimens


Program Information• Two 2.0-mL serum specimens

• For use with Acetest® andother ualitative/semi-uantitative methods using

the nitroprusside reaction fortotal etones testing


Program Information• Three 2.0-mL li uid serum

specimens

• For use with waived methodssuch as the Cholestech LD ®

and Roche ACC -CHE ®

Instant Plus

• The glucose specimens arenot appropriate for use onother whole blood glucosemeters


Program Information• NB - Five 1.0-mL human

serum specimens; threeshipments per year

• NB2 - Two 1.0-mL humanserum specimens; mustorder in conjunction with afive-challenge total bilirubinproficiency testing program tomeet regulatory re uirements;two shipments per year


800-323-4040 | 847-832-7000 Option 1 | cap.org 59

General C


rug Monitoring

5

Plasma Cardiac Markers PCARM, PCARMXAnalyte Program Code Challenges/Shipment

PCARM PCARMX

BNP z z 5

CK-MB z z 5

D-dimer z z 2

Myoglobin z z 2

Troponin I z z 5

Beginning with the 2015 proficiency testing (PT) program year, the College of American Pathologists Accreditation Program will require all accredited laboratories performing non-waived testing for BNP and Troponin I to complete 15 PT challenges per year.

Waived Combination HCCAnalyte Program Code Challenges/Shipment

HCC

Glucose z 2

Hemoglobin z 2

Whole Blood Glucose WBG, WB2Analyte Challenges/Shipment

Program Code

WBG WB2

Glucose 5 3

Program Information•PCARM-Five1.5-mLliquid

EDTAplasmaspecimens

•PCARMX-AllSurveyPCARMspecimensinduplicate


Program Information•Two1.0-mLwholeblood

specimens

•ForusewiththeHemoCue® B, HemoCue201,HemoCue301,andStanbioHemoPoint® H2 instruments


Program Information•WBG-Five2.5-mLwhole

bloodspecimens;threeshipmentsperyear

•WB2-Three2.5-mLwholebloodspecimens;twoshipmentsperyear

•Reportupto20differentancillarytestingsitesorinstruments



Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Improve the reliability of your patient results with CAP SurveyValidated Materials

se the same material that is sent in the Surveys program to

• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures

Each laboratory receives a Survey Participant Summary, which includes readilyavailable results.

General Chemistry and TDM, Validated MaterialValidated Material Program Code Corresponding Survey Pages

Chemistry/TDM VM C VM C 50-52


specimens

MORE• Time for patient centric activities• Cost savings in staff time• uality assurance• Ability to receive reformat and resend data•Time for managers to spend on

management responsibilities

LESS• Clerical errors• Time spent inputting PT results• Checking and double-checking data entry• Delays between testing and releasing results• Proficiency Testing Compliance Notices• Missed submission deadlines.

Less is MOREWith the CAP’s e-LAB Solutions Connect™ automated proficiency testing (PT) service,

you’ll spend less time doing clerical work, giving you more time to focuson what matters most, accurate patient results.

To order choose e LAB SolutionsConnect Service (3572LM) in theNew Programs section of the2015 PT order form.

Now you can run PT more likea patient specimen.

Available in the US and Canada only.

Urine Chemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 61

General C


rug Monitoring

5

Urine ChemistryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Urine Chemistry, General UAnalyte Program Code Challenges/Shipment

U

Amylase z 3

Calcium z 3

Chloride z 3

Creatinine z 3

Glucose z 3

Magnesium z 3

Nitrogen, total z 3

Osmolality z 3

Phosphorus z 3

Potassium z 3

Protein, total z 3

Sodium z 3

Urea nitrogen z 3

Uric acid z 3

rine albumin ( uantitative) z 3

rine albumin creatinine ratio z 3

Accuracy-Based Urine ABUAnalyte Program Code Challenges/Shipment

ABU

Calcium z 3

Creatinine z 3



Analytes may be evaluated against the reference method or by using harmonization.

Program Information• Six 15.0-mL urine specimens

• One mailing per yearwill include an additionalspecimen for uric acid testingfor a total of seven challengesper year


Program Information• Three 5.0-mL human urine

specimens


Urine Chemistry


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Kidney Stone Risk Assessment KSAAnalyte Program Code Challenges/Shipment

KSA

Citrate z 3

Cystine z 3

Oxalate z 3

Sulfate z 3

Urine Chemistry, Special N, NXAnalyte Program Code Challenges/Shipment

N, NX-methoxytyramines z 3

5-hydroxyindoleacetic acid z 317-hydroxycorticosteroids z 317- etosteroids z 3Aldosterone z 3Coproporphyrins z 3Cortisol, urinary free z 3Dopamine z 3Epinephrine z 3Homovanillic acid z 3Metanephrine z 3Norepinephrine z 3Normetanephrine z 3Uroporphyrin z 3Vanillylmandelic acid z 3

Myoglobin, Urine MYGAnalyte Program Code Challenges/Shipment

MYGMyoglobin, urine ( ualitative anduantitative)

z 2

Program Information• Three 15.0-mL li uid urine

specimens


Program Information• N - Six 10.0-mL lyophilized

urine specimens and three10.0-mL li uid urinespecimens

• N - All lyophilized Survey Nspecimens in duplicate andthree 10.0-mL li uid urinespecimens


Program Information• Two 1.0-mL urine specimens


Urine Chemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 63

General C


rug Monitoring

5

Porphobilinogen, Urine UPBGAnalyte Program Code Challenges/Shipment

UPBG

Porphobilinogen z 3

Improve the reliability of your patient results with CAP Survey Validated Materialsse the same material that is sent in the Surveys program to


Each laboratory receives a Survey Participant Summary, which includes readily available results.

Urine Chemistry, Validated MaterialsValidated Material Program

Code Corresponding Survey Page

rine Chemistry (Special) VM NVM N, N 62

rine Chemistry (General) VM UVM U 61

Program Information• Three 5-mL urine specimens


• For use with ualitative anduantitative methods

New

Program Information• NVM - Six 10.0-mL lyophilized

and three 10.0-mL li uidurine specimens

• VM - Six 15.0-mL urinespecimens

Knowing that I have beenable to solve a customer’sproblem inspires meespecially since they aredoing such vital work.

– Debbie

“ “

CAP Customer Contact Center representativesunderstand the importance of what you do.

Special Chemistry


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Special ChemistryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

1,5-Anhydroglucitol AGAnalyte Program Code Challenges/Shipment

AG

1,5-anhydroglucitol z 3

Aldolase ADLAnalyte Program Code Challenges/Shipment

ADL

Aldolase z 2

Angiotensin-Converting Enzyme ACEAnalyte Program Code Challenges/Shipment

ACE

Angiotensin-converting enzyme( uantitative)

z 2


specimens


Program Information• Two 1.5-mL li uid serum

specimens


Program Information• Two 2.0-mL lyophilized serum

specimens


Special Chemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 65

General C


rug Monitoring

5

Body Fluid Chemistry FLDAnalyte Program Code Challenges/Shipment

FLD

Albumin z 3

Amylase z 3

CA19-9 z 1

CEA z 1

Cholesterol z 3

Creatinine z 3

Glucose z 3

Lactate z 3

Lactate dehydrogenase (LD) z 3

pH z 3

Protein, total z 3

Triglycerides z 3

Urea nitrogen z 1 per year

Body Fluid Chemistry 2 FLD2Analyte Program Code Challenges/Shipment

FLD2

Al aline phosphatase z 3

Bilirubin z 3

Calcium z 3

Chloride z 3

Lipase z 3

Potassium z 3

Sodium z 3

Uric acid z 3

Program Information• Three .0-mL simulated li uid

body fluid specimens


Program Information• Three .0-mL li uid body fluid

specimens


Special Chemistry


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Cadmium CDAnalyte Program Code Challenges/Shipment

CD

Beta-2-microglobulin, urine z 3

Cadmium, urine z 3

Cadmium, whole blood z 3

Creatinine, urine z 3

This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines forproficiency testing (OSHA standard-29 CFR 1910.1027AppF).

Cerebrospinal Fluid Chemistry andOligoclonal Bands M, OLI


M OLI

Albumin, uantitative z z 3

Electrophoresis (albuminand gamma globulin)

z z 3

Glucose z z 3

IgG, uantitative z z 3

Lactate z z 3

Lactate dehydrogenase (LD) z z 3

Protein, total z z 3

Oligoclonal bands z 3

Cystatin C CYSAnalyte Program Code Challenges/Shipment

CYS

Cystatin C z 2


specimens and three 15.0-mLurine specimens

• Conventional and InternationalSystem of nits (SI)reporting offered

• Six shipments per year

Program Information• M - Three 5.0-mL simulated

li uid spinal fluid specimens

• OLI - Three 5.0-mL simulatedli uid spinal fluid specimensand three paired serumspecimens



specimens


Special Chemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 67

General C


rug Monitoring

5

Fecal Fat FCFSAnalyte Program Code Challenges/Shipment

FCFS

Fecal fat, ualitative z 2

Fructosamine FTAnalyte Program Code Challenges/Shipment

FT

Fructosamine z 2

Glucose-6-Phosphate Dehydrogenase G6PDSAnalyte Program Code Challenges/Shipment

G6PDS

G6PD ( ualitative and uantitative) z 2

Lipoprotein-Associated Phospholipase A2 PLAAnalyte Program Code Challenges/Shipment

PLA

Lipoprotein-associated phospholipase(Lp-PLA2)

z 2

Program Information• Two 10.0-g simulated fecal

fat specimens

• For microscopic detectionof neutral fats (triglycerides)and/or split fats (total freefatty acids)



specimens


Program Information• Two 0.5-mL lyophilized

hemolysate samples


Program Information• Two 0.5-mL li uid specimens


Special Chemistry


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Lipoprotein and Protein ElectrophoresisLPE, SPE, UBJP


LPE SPE UBJP

Lipoprotein electrophoresis z 2

IgA, uantitation z 2

IgG, uantitation z 2

IgM, uantitation z 2

M-protein (Paraprotein)identification z 2

Protein, total z 2

Protein electrophoresis z 2

Protein electrophoresis patterninterpretation

z 2

Urine Bence Jones proteins z 2

Lamellar Body Count LBCProcedure Program Code Challenges/Shipment

LBC

Lamellar body count z 3

Lung Maturity LM, LM1Analyte/Procedure Program Code Challenges/Shipment

LM LM1

Bilirubin ( OD 50) z 1

Fluorescent polarization assay z z 3

Lecithin sphingomyelin (L S) ratio z z 3

Phosphatidylglycerol (PG) z z 3

Program Information• LPE - Two 1.0-mL li uid serum

specimens

• SPE - Two 1.0-mL lyophilizedserum specimens

• B P - Two 10.0-mL urinespecimens


Program Information• Three 2.0-mL simulated li uid

amniotic fluid specimens

• For use with LBC methodsperformed on all hematologyanalyzers


Program Information• LM - Three 5.0-mL simulated

li uid aminotic fluidspecimens

• LM1 - Four 5.0-mL simulatedli uid amniotic fluid specimens


Special Chemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 69

General C


rug Monitoring

5

Plasma Hemoglobin PHGAnalyte Program Code Challenges/Shipment

PHG

Plasma hemoglobin z 2

Procalcitonin PCTAnalyte Program Code Challenges/Shipment

PCT

Procalcitonin z 3

Pseudocholinesterase C7Analyte Program Code Challenges/Shipment

C7

Pseudocholinesterase z 1

Salivary Cortisol SALCAnalyte Program Code Challenges/Shipment

SALC

Salivary cortisol z 3




serum specimens


Program Information• One 2.0-mL lyophilized

serum specimen


Program Information• Three 1.0-mL synthetic oral

fluid specimens


Special Chemistry


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Testosterone and Estradiol Accuracy Survey ABSAnalyte Program Code Challenges/Shipment

ABS

Calcium z 4

Cortisol z 4

Estradiol z 4

Testosterone z 4


Additional Information• The Centers for Disease Control and Prevention (CDC) will set target values for

testosterone and estradiol using the established reference methods.• Calcium, cortisol, and TSH data will be provided by peer groups to determine the

degree of harmonization in the field.

Total Bile Acids TBLAAnalyte Program Code Challenges/Shipment

TBLA

Total bile acids z 3

Trace Metals RAnalyte Program Code Challenges/Shipment

R

Aluminum z 3

Chromium z 3

Copper z 3

Manganese z 3

Selenium z 3

inc z 3

Program Information• Four 1.0-mL human serum

specimens

• One shipment per year


specimens



specimens


Special Chemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 71

General C


rug Monitoring

5

Trace Metals, Urine TMUAnalyte Program Code Challenges/Shipment

TMU

Aluminum z 3

Arsenic z 3

Chromium z 3

Cobalt z 3

Copper z 3

Lead z 3

Manganese z 3

Mercury z 3

Selenium z 3

Thallium z 3

inc z 3

Sweat Analysis Series SW1, SW2, SW3, SW4Analyte Program Code Challenges/Shipment

SW1, SW2, SW3, SW4

Chloride z 3

Conductivity z 3

Osmolality z 3

Sodium z 3

For method compatibility, see chart below.

Compatibility Matrix for Sweat Analysis SeriesMethod/Procedure Program Code Materials Included

SW1 SW2 SW3 SW4

Orion direct electrode zPrecut 2-cm diameter

hatman filter papers

escor Macroduct™ &Nanoduct® Systems

z22-gauge blunt-tippedneedles

CF Indicator System® zPolystyrene boats andchloride-free sponges

All other methodologies zNo additionalmaterials provided

Program Information• Three 10.0-mL urine

specimens



human sweat specimens


Special Chemistry


Gen

eral

Che

mist

ry a

nd Th

erap

eutic

Dru

g M

onito

ring

5

Viscosity VAnalyte Program Code Challenges/Shipment

V

Viscosity z 2

Soluble Transferrin Receptor STFRAnalyte Program Code Challenges/Shipment

STFR

Soluble transferrin receptor (sTfR) z 3





Special Chemistry, Validated MaterialsValidated Material Program Code Corresponding Survey Page

Cerebrospinal Fluid VM MVM M 66

Program Information• Two 10.0-mL serum

specimens


Program Information• Three 2.5-mL li uid human

serum specimens



spinal fluid specimens

Endocrinology

6

Endocrinology

New Programs New

B-Type Natriuretic Peptides, five challenges (BNP5) .............................................................................74Quality Cross Check, B-Type Natriuretic Peptides (BNPQ) ....................................................................7525-OH Vitamin D (VITD) ...................................................................................................................76


B-Type Natriuretic Peptides (BNP)See program BNPQ .....................................................................................................................75

6 | Endocrinology

“The CAP proficiency testing allows us as a laboratoryto look at how we compare with our peers and italso builds the trust of the clinical staff that we arereporting good quality results.”

Endocrinology


Endo

crin

olog

y

6

EndocrinologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Ligand Assay, General K, KKAnalyte Program Code Challenges/Shipment

K, KK

Alpha-fetoprotein (AFP) z 5

CEA z 3

Cortisol z 5

Ferritin z 3

Folate, serum z 3

hCG, quantitative z 5

IgE z 5

Prostate-specific antigen (PSA) z 2

Prostate-specific antigen,complexed (cPSA)

z 2

Prostate-specific antigen, free z 2

Prostatic acid phosphatase (PAP) z 3

T3, free (triiodothyronine, free) z 3


T3 uptake and related tests z 5

T4, free (thyroxine, free) z 5

T4, total (thyroxine, total) z 5


Vitamin B12 z 3

B-Type Natriuretic Peptides BNP, BNP5Analyte Challenges/Shipment

Program Code

BNP BNP5

BNP 2 5

NT-pro BNP 2 5

Additional Information• Beginning with the 2015 proficiency testing (PT) program year, the College of

American Pathologists Accreditation Program will re uire all accredited laboratoriesperforming non-waived testing for BNP and NT-pro BNP to enroll in Survey BNP5.

• For second instrument reporting options, see the uality Cross Chec program,BNP , on page 75.

Program Information• - Five 5.0-mL li uid serum

specimens; two 5.0-mLlyophilized serum specimensfor PSA assays

• - All Survey specimensin duplicate



Program Information• BNP - Two 1.0-mL li uid

plasma specimens;Conventional andInternational System of Units(SI) reporting offered; twoshipments per year

• BNP5 - Five 1.0 mLli uid plasma specimens;Conventional andInternational System of Units(SI) reporting offered; threeshipments per year

Endocrinology

800-323-4040 | 847-832-7000 Option 1 | cap.org 75

Endocrinology

6

Quality Cross Check—B-TypeNatriuretic Peptides BNPQ


BNPQ

BNP z 3

NT-pro BNP z 3

This program does not meet regulatory requirements for proficiency testing. See Surveys BNPor BNP5 on page 74.

Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, nowledge andpeer-based educational coaching to protect your laboratory from regulatory sanctions.



Ligand Assay, Special Y, YY, DYAnalyte Program Code Challenges/Shipment

Y, YY DY

11-deoxycortisol z 3

17-hydroxyprogesterone z 3

Androstenedione z 3

DHEA sulfate z 3

Estradiol z 3

Estriol, unconjugated (uE3) z 3

Follicle-stimulating hormone (FSH) z 3

Growth hormone (GH) z 3

IGF-1 (somatomedin C) z 3

Luteinizing hormone (LH) z 3

Progesterone z 3

Prolactin z 3

Testosterone z 3

Testosterone, bioavailable z 3

Testosterone, free z 3

Sex hormone-binding globulin (SHBG) z 3

Program Information• Three li uid specimens in

duplicate


• Conventional andInternational System of Units(SI) reporting offered


New

Program Information• Y - Six 5.0-mL li uid serum

specimens (two duplicate sets)

• YY - Nine 5.0-mL li uidserum specimens (threeduplicate sets)

• DY - Must order in conjunctionwith Survey Y or YY



Endocrinology


Endo

crin

olog

y

6

Antimüllerian Hormone AMHAnalyte Program Code Challenges/Shipment

AMH

Antim llerian hormone (AMH) z 3

25-OH Vitamin D VITDAnalyte Program Code Challenges/Shipment

VITD

25-OH vitamin D, total z 3

Bone and Growth BGSAnalyte Program Code Challenges/Shipment

BGS

IGF-1 (somatomedin C) z 3

Osteocalcin z 3

Accuracy-Based Vitamin D ABVDAnalyte Program Code Challenges/Shipment

ABVD

25-OH vitamin D (D2 and D ) z 3

Additional Information• The Centers for Disease Control and Prevention (CDC) will establish reference targets

using isotope-dilution LC-MS/MS method.• Specimens are collected by a modified application of Clinical Laboratory and

Standards Institute Guideline CLSI C 7-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materialsfor Cholesterol Measurement Procedures; Approved Guideline.


serum specimens



specimens


New


specimens



Program Information• Three 1.0-mL human li uid

serum specimens

• Serum is from multidonorendogenous pools


Endocrinology

800-323-4040 | 847-832-7000 Option 1 | cap.org 77

Endocrinology

6

Bone and Mineral Metabolism, Urine BUAnalyte Program Code Challenges/Shipment

BU

C-telopeptide (CTx) z 2

Creatinine z 2

Deoxypyridinoline (DPD) z 2

N-telopeptide (NTx) z 2

Pyridinoline (PYD) z 2

Bone Markers and VitaminsBMV1, BMV2, BMV3, BMV4, BMV5, BMV6


BMV1 BMV2 BMV3 BMV4 BMV5 BMV6

1,25 dihydroxyvitamin D

z 3

Bone specific al alinephosphatase

z 3

Vitamin A z 3

Vitamin E z 3

C-telopeptide (CTx) z 3

N-telopeptide (NTx) z 3

Erythropoietin EPOAnalyte Program Code Challenges/Shipment

EPO

Erythropoietin z 2

Fetal Fibronectin FFAnalyte Program Code Challenges/Shipment

FF

Fetal fibronectin z 2


human urine specimens



Program Information• BMV1 through BMV -

Three 5.0-mL li uid serumspecimens for each program

• BMV5 and BMV6 - Three1.0-mL li uid serum specimensfor each program




Program Information• Two 1.2-mL specimens


Endocrinology


Endo

crin

olog

y

6

C-Peptide, Gastrin, Insulin, and PTH Assays INGAnalyte Program Code Challenges/Shipment

ING

C-peptide z 3

Gastrin z 3

Insulin z 3

Parathyroid hormone (PTH) z 3

Maternal Screening FP, FPXAnalyte Program Code Challenges/Shipment

FP, FPX

Alpha-fetoprotein (AFP), amniotic fluid z 2

Alpha-fetoprotein (AFP), serum z 5

Dimeric inhibin A (DIA) z 5

Estriol, unconjugated (uE3) z 5

Human chorionic gonadotropin (hCG),quantitiative z 5

The CAP designed this Survey for laboratories using AFP and hCG for prenatal screeningpurposes only. For all other applications, see Survey K or KK on page 74.

First TrimesterMaternal Screening FP1T, FP1B


FP1T FP1B

Total hCG z 5

Free beta hCG z 5

PAPP-A z z 5

The CAP designed these Surveys for laboratories using hCG for prenatal screening purposesonly. For all other applications, see Survey K or KK on page 74.


serum specimens



Program Information• FP - Five 1.0-mL li uid serum

specimens; two 1.0-mLsimulated amniotic fluidspecimens

• FP - All Survey FP serumspecimens in duplicate; two1.0-mL simulated amnioticfluid specimens


Program Information• FP1T - Five 1.0-mL serum

specimens

• FP1B - Five 1.0-mL serumspecimens


Endocrinology

800-323-4040 | 847-832-7000 Option 1 | cap.org 79

Endocrinology

6

Pharmacogenetics PGX, PGX1, PGX2Analyte/Procedure Program Code Challenges/

Shipment

PGX PGX1 PGX2

CYP2C19 z 2

CYP2C9 z 2

CYP2D6 z 2

UGT1A1 z 2

VKORC1 z 2

IL28B (rs12979860) z 3

HLA-B*5701 z 3

Additional InformationSurvey PG 2 is designed for laboratories that provide HLA-B*5701 testing to identify risof hypersensitivity to abacavir. The intended response is ualitative (presence/absenceof the allele). This Survey is not appropriate for laboratories that perform molecular HLAtyping. For HLA typing proficiency testing, please consult the HLA Molecular Typing(ML, DML) Surveys.

RBC Folate FOLAnalyte Program Code Challenges/Shipment

FOL

RBC folate z 2

Renin and Aldosterone RAPAnalyte Program Code Challenges/Shipment

RAP

Aldosterone z 3

Renin z 3

Program Information• PG - Two 25.0- g extracted

DNA specimens

• PG 1, PG 2 - Three 25.0- gextracted DNA specimens

• Includes allele detection(genotyping) and/orinterpretive challenges


Program Information• Two 2.0-mL whole blood

specimens



plasma specimens



Endocrinology


Endo

crin

olog

y

6

Tumor Markers TM, TMXAnalyte Program Code Challenges/Shipment

TM, TMX

Adrenocorticotropic hormone (ACTH) z 3

Beta-2-microglobulin z 3

CA 15-3 z 3

CA 19-9 z 3

CA 27.29 z 3

CA 72- z 3

CA 125 z 3

Calcitonin z 3

Thyroglobulin z 3





Endocrinology, Validated MaterialsValidated Material Program Code Corresponding Survey Page

Ligands (General) VM VM 7

Ligands (Special) VM YVM Y 75

Program Information• TM - Three 2.0-mL li uid

serum specimens

• TM - All Survey TMspecimens in duplicate


Program Information• VM - Five 5.0-mL li uid

serum specimens; two 5.0-mLlyophilized serum specimensfor PSA assays; threeshipments per year

• YVM - Six 5.0-mL li uidserum specimens (twoduplicate sets); two shipmentsper year

BloodG

as, CriticalC

are, andO

ximetry

7

Blood Gas, Critical Care, and Oximetry

New Programs New

Quality Cross Check—Critical Care Aqueous Blood Gas Series (AQQ, AQ2Q, AQ3Q, AQ4Q) .............83Quality Cross Check—Blood Oximetry (SOQ).....................................................................................84


Critical Care Aqueous Blood Gas (AQ, AQ2, AQ3, AQ4)Blood Oximetry (SO)See programs AQQ, AQ2Q, AQ3Q, AQ4Q and SOQ ............................................................83, 84

7 | Blood Gas, Critical Care, and Oximetry

“If you’re talking to a physician, and they’requestioning things, CAP Surveys results are one ofthe tools you have to go to and say, ‘Here’s why wefeel we’re putting out good results, and here’s thedata to back that up.’ Using the CAP Surveys givesme the confidence to have that discussion.”



Bloo

dG

as, C

ritic

alC

are,

and

Oxi

met

ry

7

Blood Gas, Critical Care, and OximetryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Critical Care Aqueous Blood GasAQ, AQ2, AQ3, AQ4


AQ AQ2 AQ3 AQ4

Calcium, ionized z z z z 2

Chloride z z z z 5

Hematocrit z z z z 5

Hemoglobin, estimated z z z z 5

Lactate z z z z 2

Magnesium, ionized z z 2

PCO2 z z z z 5

pH z z z z 5

PO2 z z z z 5

Potassium z z z z 5

Sodium z z z z 5

tCO2 z z z z 5

Creatinine z z 5

Glucose z z 5

Urea nitrogen (BUN) z z 5

For second instrument reporting options, see the Quality Cross Check programs, AQQ, AQ2Q,AQ3Q, and AQ4Q, on page 83.

Program Information• A , A 2 - Ten 2.5-mL

aqueous specimens (twoduplicate sets) and ten2.5-mL specimens forhematocrit testing (twoduplicate sets); appropriatefor all methods except i-STAT®

• A , A - Ten 2.5-mLspecimens (two duplicate sets)for i-STAT methods only


Do you usean i-STAT

instrument?

Yes

No Order Survey AQ or AQ2

Order SurveyAQ3 or AQ4


800-323-4040 | 847-832-7000 Option 1 | cap.org 83

BloodG

as, CriticalC

are, andO

ximetry

7

Quality Cross Check—Critical CareAqueous Blood Gas AQQ, AQ2Q, AQ3Q, AQ4Q


AQQ AQ2Q AQ3Q AQ4Q

Calcium, ionized z z z z 3

Chloride z z z z 3


Hemoglobin, estimated z z z z 3

Lactate z z z z 3

Magnesium, ionized z z 3

PCO2 z z z z 3

pH z z z z 3

PO2 z z z z 3

Potassium z z z z 3

Sodium z z z z 3

tCO2 z z z z 3

Creatinine z z 3

Glucose z z 3

Urea nitrogen (BUN) z z 3

These programs do not meet regulatory requirements for proficiency testing. See Surveys AQ,AQ2, AQ3, or AQ4 on page 82.

Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, knowledge, andpeer-based educational coaching to protect your laboratory from regulatory sanctions.



Program Information• A , A 2 - Nine 2.5-mL

specimens (three duplicatesets) and nine 2.5-mLspecimens for hematocrittesting (three duplicate sets);appropriate for all methodsexcept i-STAT®

• A , A - Nine 1.7-mLspecimens (three duplicatesets) for i-STAT methods only



New



Bloo

dG

as, C

ritic

alC

are,

and

Oxi

met

ry

7

Blood Oximetry SOAnalyte Program Code Challenges/Shipment

SO

Carboxyhemoglobin z 5

Hematocrit, estimated z 5

Hemoglobin, total z 5

Methemoglobin z 5

Oxyhemoglobin z 5

Additional Information• This Survey is not compatible with Oxicom-2000, -2100, or - 000 whole

blood oximeters.• For second instrument reporting options, see the uality Cross Chec program,

SO , on page 8 .

Quality Cross Check—Blood Oximetry SOQ

Analyte/Procedure Program Code Challenges/Shipment

SOQ

Carboxyhemoglobin z 3

Hematocrit, estimated z 3

Hemoglobin, total z 3

Methemoglobin z 3

Oxyhemoglobin z 3

This program does not meet regulatory requirements for proficency testing. See Survey SOabove.

Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, knowledge, andpeer-based educational coaching to protect your laboratory from regulatory sanctions.



Program Information• Five 1.7-mL stabilized

human hemoglobin solutionspecimens


Program Information• Nine li uid specimens (three

duplicate sets)



New

Toxicology

8

Toxicology

New Programs New

Drug-Facilitated Crime (DFC) ...........................................................................................................a95

New Analyte Additions Toxicology (T) and Urine Toxicology (UT)............................................................................................86CAP/AACC Forensic Urine Drug Testing, Confirmatory (UDC) ..............................................................89Oral Fluid for Drugs of Abuse (OFD) ..................................................................................................90Vitreous Fluid, Postmortem (VF) ..........................................................................................................90Trace Metals, Urine (TMU) ................................................................................................................92Forensic Toxicology, Criminalistics (FTC) .............................................................................................93Drug Monitoring for Pain Management (DMPM) ..................................................................................95

8 | Toxicology

“ We use CAP Surveys for continuing education. Why? Because not every staff member works on every proficiency test and it’s a chance to get everybody together to see if we have everything right or wrong—just a chance to stop and take a few minutes to go over what we’re doing.”

Toxicology


Toxi

colo

gy

8

ToxicologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Toxicology TAnalyte Program Code Challenges/Shipment

T

See drug listing on next page z 5

Urine Toxicology UTAnalyte Program Code Challenges/Shipment

UT

See drug listing on next page z 5

Program Information• A total of five specimens

consisting of 20.0-mLlyophilized serum and50.0-mL li uid urinespecimens

• For laboratories performingualitative and uantitative

drug analysis withconfirmation testing


Program Information• Five 50.0-mL li uid urine

specimens

• For laboratories performingualitative drug analysis with

confirmation testing


Toxicology

800-323-4040 | 847-832-7000 Option 1 | cap.org 87

Toxicology

8

6-acetylmorphine (6-AM)

7-aminoclonazepam

7-aminoflunitrazepam

Acetaminophen

Alpha-hydroxyalprazolam

Alprazolam

Amitriptyline

Amphetamine

Amphetamine group

Atenolol

Atropine

Barbiturate group

Benzodiazepinegroup

Benzoylecgonine

Brompheniramine

Buprenorphine

Bupropion

Butalbital

Cannabinoids

Carbamazepine

Carbamazepine-10,11-epoxide

Carisoprodol

Chlordiazepoxide

Chlorpheniramine

Chlorpromazine

Citalopram

Clomipramine

Clonazepam

Clozapine

Cocaethylene

Cocaine

Codeine

Cotinine

Cyclobenzaprine

Delta-9-THC (serum only)

Delta-9-THC-COOH

Desal ylflurazepam

Desipramine

Desmethylclomipramine

Dextromethorphan

Diazepam

Dihydrocodeine

Diltiazem

Diphenhydramine

Doxepin

Doxylamine

Duloxetine

Ecgonine ethyl ester

Ecgonine methyl ester

Ephedrine

Fentanyl

Flunitrazepam

Fluoxetine

Flurazepam

Hydrocodone

Hydromorphone

Hydroxyzine

Ibuprofen

Imipramine

etamine

Lamotrigine

Lidocaine

Lorazepam

Lysergic acid diethylamide(LSD)

Maprotiline

Meperidine

Mephedrone

Meprobamate

Methadone

Methadonemetabolite (EDDP)

Methamphetamine

Methotrimeprazine

Methylenedioxy-amphetamine (MDA)

Methylenedioxy-methamphetamine(MDMA)

Methylenedioxy-pyrovalerone (MDPV)

Methylphenidate

Metoprolol

Mirtazapine

Morphine

N-desmethyltramadol

Naproxen

Nicotine

Norbuprenorphine

Norchlordiazepoxide

Norcodeine

Norcyclobenzaprine

Nordiazepam

Nordoxepin

Norfentanyl

Norfluoxetine

Nor etamine

Normeperidine

Norpropoxyphene

Norsertraline

Nortrimipramine

Nortriptyline

Norverapamil

O-desmethyltramadol

Olanzapine

Opiate group

Oxazepam

Oxycodone

Oxymorphone

Paroxetine

Phencyclidine

Phenethylamine

Pheniramine

Phenobarbital

Phentermine

Phenylephrine

Phenylpropanolamine

Phenytoin

Propoxyphene

Propranolol

Pseudoephedrine

Quetiapine

Quinidine

Quinine

Ranitidine

Salicylates

Sertraline

Strychnine

Temazepam

Tramadol

Trazodone

Tricyclic group

Trimipramine

Valproic acid

Venlafaxine

Verapamil

olpidem

T, UT Drug ListingChallenges will include a mix of drugs from the list below.

Toxicology


Toxi

colo

gy

8

CAP/AACC Urine Drug Testing, Screening UDS, UDS6

Analyte Program Code

Challenges/Shipment

UDS UDS6 Limited

Acetaminophen 5 3

Amphetamine 5 3

Amphetamine/methamphetamine group 5 3

Barbiturate group 5 3

Benzodiazepine group 5 3

Benzoylecgonine/cocaine metabolites 5 3

Buprenorphine 5 3

Delta-9-THC-COOH 5 3

Ethanol 5 3

Fentanyl 5 3

Lysergic acid diethylamide (LSD) 5 3

Methadone 5 3

Methadone metabolite (EDDP) 5 3

Methamphetamine 5 3

Methaqualone 5 3

Methylenedioxymethamphetamine (MDMA) 5 3

Opiate group 5 3

Oxycodone 5 3

Phencyclidine 5 3

Propoxyphene 5 3

Tricyclic group 5 3

Urine Drug Adulterant/Integrity Testing DAIAnalyte Program Code Challenges/Shipment

DAI

Creatinine z 3

Glutaraldehyde z 3

Nitrite z 3

Oxidants z 3

pH z 3

Specific gravity z 3

Program Information•UDS-Five10.0-mLliquid

urine specimens; three shipments per year

•UDS6-Three10.0-mLliquid urine specimens; two shipments per year

•Forlaboratoriesperforming immunoassay or other nonconfirmation methods

•Participantswillhaveaccessto the AACC quarterly newsletter, Clinical & Forensic Toxicology News

AACC

Program Information•Three25.0-mLurine

specimens

•Twoshipmentsperyear

Toxicology

800-323-4040 | 847-832-7000 Option 1 | cap.org 89

Toxicology

8

CAP/AACC Forensic Urine Drug Testing,Confirmatory UDC


UDC

6-acetylmorphine (6-AM) z 10

Alpha-hydroxyalprazolam z 10

Amphetamine z 10

Benzoylecgonine z 10

Buprenorphine z 10

Butalbital z 10

Codeine z 10

Delta-9-THC-COOH z 10

Hydrocodone z 10

Hydromorphone z 10

Lorazepam z 10

Methadone z 10

Methadone metabolite (EDDP) z 10

Methamphetamine z 10

Metha ualone z 10

Methylenedioxyamphetamine (MDA) z 10

Methylenedioxyethylamphetamine(MDEA)

z 10

Methylenedioxymethamphetamine (MDMA) z 10

Morphine z 10

Norbuprenorphine z 10

Nordiazepam z 10

Norpropoxyphene z 10

Oxazepam z 10

Oxycodone z 10

Oxymorphone z 10

Phencyclidine z 10

Phenobarbital z 10

Propoxyphene z 10

Secobarbital z 10

Temazepam z 10

Adulterant/Integrity Indicator

Creatinine z 10

pH z 10

Specific gravity z 10

Program Information• Ten 50.0-mL li uid urine

specimens

• For laboratories performingdrug screening, confirmation,uantitation, and adulteration

testing

• Participants will have accessto the AACC uarterlynewsletter, Clinical & ForensicToxicology News

• Four shipments per year

AACC

Toxicology


Toxi

colo

gy

8

Oral Fluid for Drugs of Abuse OFDAnalyte Program Code Challenges/Shipment

OFD

Amphetamine Group z 5

Amphetamine z 5

Methamphetamine z 5

Methylenedioxyamphetamine (MDA) z 5

Methylenedioxymethamphetamine (MDMA) z 5

Cocaine and/or metabolite z 5

Benzoylecgonine z 5

Cocaine z 5

Cannabinoids z 5

Delta-9-THC z 5

Delta-9-THC-COOH z 5

Methadone z 5

Opiate Group z 5

6-acetylmorphine (6-AM) z 5

Codeine z 5

Hydrocodone z 5

Hydromorphone z 5

Morphine z 5

Oxycodone z 5

Oxymorphone z 5

Phencyclidine (PCP) z 5

Vitreous Fluid, Postmortem VFAnalyte Program Code Challenges/Shipment

VF

Acetone z 3

Chloride z 3

Creatinine z 3

Ethanol z 3

Glucose z 3

Potassium z 3

Sodium z 3

Vitreous urea nitrogen z 3

Program Information• Five 2.0-mL oral fluid

specimens

• For laboratories performingdrug screening, confirmation,and uantitation


Program Information• Three 5.0-mL synthetic

vitreous fluid specimens


Toxicology

800-323-4040 | 847-832-7000 Option 1 | cap.org 91

Toxicology

8

Serum Drug Screening SDSAnalyte Program Code Challenges/Shipment

SDS

Acetaminophen ( uantitative) z 3

Acetone (semi uantitative and ualitative) z 3

Barbiturate group ( ualitative) z 3

Benzodiazepine group ( ualitative) z 3

Salicylate ( uantitative) z 3

Total tricyclic antidepressants ( ualitative) z 3

CAP/AACC Alcohol/Ethylene Glycol/VolatilesAL1*, AL2


AL1*Whole Blood

AL2Serum

Acetone z z 5

Ethanol z z 5

Ethylene glycol z z 5

Isopropanol z z 5

Methanol z z 5

*The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Survey AL1.

Ethanol Biomarkers ETBAnalyte Program Code Challenges/Shipment

ETB

Ethyl glucuronide (EtG) z 3

Ethyl sulfate (EtS) z 3


specimens

• For laboratories performingimmunoassay or othernonconfirmatory methods


Program Information• AL1 - Five 5.0-mL li uid

whole blood specimens;conventional reporting

• AL2 - Five 2.0-mL li uid serumspecimens; conventional andInternational System of nits(SI) reporting offered

• For uantitative methods only


AACC

Program Information• Three 10.0-mL synthetic urine

specimens


Toxicology


Toxi

colo

gy

8

CAP/AACC Blood Lead BLAnalyte Program Code Challenges/Shipment

BL

Lead z 5

This Survey meets the Occupational Safety and Health Administration (OSHA) requirements for proficiency testing [OSHA lead standards-29 CFR 1910.1025(j)(2)(iii)].

Cadmium CDAnalyte Program Code Challenges/Shipment

CD

Beta-2-microglobulin, urine z 3

Cadmium, urine z 3

Cadmium, whole blood z 3

Creatinine, urine z 3

This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines for proficiency testing (OSHA standard-29 CFR 1910.1027AppF).

Trace Metals, Urine TMUAnalyte Program Code Challenges/Shipment

TMU

Aluminum z 3

Arsenic z 3

Chromium z 3

Cobalt z 3

Copper z 3

Lead z 3

Manganese z 3

Mercury z 3

Selenium z 3

Thallium z 3

Zinc z 3

Program Information•Five6.0-mLliquidnonhuman

whole blood specimens

•Conventionaland International System of Units (SI) reporting offered

•Threeshipmentsperyear

AACC

Program Information•Three6.0-mLwholeblood

specimensandthree11.0-mLurine specimens

•ConventionalandInternationalSystem of Units (SI) reporting offered

•Sixshipmentsperyear


specimens


Toxicology

800-323-4040 | 847-832-7000 Option 1 | cap.org 93

Toxicology

8

Forensic Toxicology, Criminalistics FTCAnalyte Program Code Challenges/Shipment

FTC

See drug listing below z 4

The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Survey FTC.


specimens and one 20.0-mLsynthetic urine specimen



7-aminoclonazepam


Acetaminophen


Alprazolam

Amitriptyline

Amphetamine

Benzoylecgonine

Butalbital

Carisoprodol

Chlorpheniramine

Clonazepam

Cocaethylene

Cocaine

Codeine

Cyclobenzaprine*

Delta-9-THC

Delta-9-THC-COOH

Desipramine

Desmethylcyclobenzaprine

Diazepam

Diphenhydramine

Doxepin



Ephedrine

Fentanyl*

Fluoxetine

Flurazepam*

Gamma-hydroxybutyrate (GHB)

Hydrocodone

Hydromorphone

Imipramine

etamine

Lorazepam

Lysergic acid diethylamide (LSD)

Meperidine*

Meprobamate

Methadone

Methadone metabolite (EDDP)

Methamphetamine

Methylenedioxyamphetamine (MDA)

Methylenedioxymethamphetamine(MDMA)

Morphine*

N-desmethyltramadol

Nordiazepam

Nordoxepin

Norfluoxetine

Nor etamine

Norpropoxyphene

Norsertraline

Nortriptyline

Oxazepam

Oxycodone

Oxymorphone

Paroxetine

Phencyclidine

Phenethylamine

Phenobarbital

Phentermine

Phenytoin

Propoxyphene

Pseudoephedrine

Secobarbital

Sertraline

Temazepam

Tramadol*

Trazodone

olpidem

*and/or metabolite(s)

FTC Drug ListingChallenges will include a mix of drugs from the list below.

Toxicology


Toxi

colo

gy

8

Synthetic Cannabinoid/Designer Drugs SCDDAnalyte Program Code Challenges/Shipment

SCDD

Synthetic Cannabinoid/Designer Drugs z 3

PRICE (USD)

Additional InformationSynthetic cannabinoids and designer drug stimulants are widespread and constantly changing in respect to the available chemical moieties. In order to stay contemporary, the CAP has decided to modify the compounds in this program in accordance with the appearance and prevalence of new compounds.

Program Information• Three 10.0-mL urine

specimens

• For laboratories that perform screening and confirmatory testing for the compounds found in this program


4-methylethcathinone (4-MEC)

5F-PB-22 3-carboxyindole metabolite

AB CHMINACA pentanoic acid metabolite

AB FUBINACA oxobutanoic acid metabolite

AB-PINACA N-pentanoic acid metabolite

ADBICA N-pentanoic acid metabolite

ADB-PINACA N-pentanoic acid metabolite

AKB-48 N-pentanoic acid metabolite

Alpha-PVP (α-Pyrrolidinopentiophenone)

AM-2201 N-(4-hydroxypentyl) metabolite

BB-22 3-carboxyindole metabolite

Butylone

Ethylone

JWH-018 N-Pentanoic Acid

MAM 2201 pentanoic acid metabolite

Mephedrone

Methylenedioxypyrovalerone (MDPV)

Methylone

PB-22 3-carboxyindole metabolite

UR-144 N-pentanoic acid metabolite

XLR-11 4-hydroxypentyl metabolite

SCDD Drug ListingChallenges will include a mix of drugs from the list below.

For the most current list of drugs, please go to cap.org and select Laboratory Improvement.

Toxicology

800-323-4040 | 847-832-7000 Option 1 | cap.org 95

Toxicology

8

Drug Monitoring for Pain Management DMPMAnalyte Program Code Challenges/Shipment

DMPM



specimens

• Forlaboratoriesofferingscreeningand/orconfirmatorytestingfor painmanagement

•Includesclinicalcasesandquestionsalongwithdetaileddescriptionsofhowtointerpret test results


AmphetamineGroup

6-acetylmorphine(6-AM)

7-aminoclonazepam


Alprazolam

Amphetamine

BarbiturateGroup

BenzodiazepineGroup

Benzoylecgonine

Buprenorphine

Buprenorphineand/ormetabolites

Butalbital

Cannabinoids

Carisoprodol

Carisoprodoland/ormetabolites

Clonazepam

Cocaine

Cocaineand/ormetabolites

Codeine

Delta-9-THC-COOH

Diazepam

Fentanyl

Fentanyland/ormetabolites

Hydrocodone

Hydromorphone

Lorazepam

Lorazepamglucuronide

Meperidine

Meperidineand/ormetabolites

Meprobamate

Methadone

Methadonemetabolite(EDDP)

Methamphetamine

Methylenedioxyamphetamine(MDA)


Morphine

N-desmethyltramadol

Norbuprenorphine

Nordiazepam

Norfentanyl

Normeperidine

Noroxycodone

Noroxymorphone

Norpropoxyphene

OpiateGroup

Oxazepam

Oxycodone

Oxymorphone

Propoxyphene

Propoxypheneand/ormetabolites

Temazepam

Tramadol

Tramadoland/ormetabolites

DMPM Drug ListingChallengeswillincludeamixofdrugsfromthelistbelow.

Toxicology

800-323-4040 | 847-832-7000 Option 1 | cap.org a95

Toxicology

8 8

Drug-Facilitated Crime DFCAnalyte Program Code Challenges/Shipment

DFC



specimens

•Forlaboratoriesperformingqualitativeurinedruganalysiswithconfirmationtesting

•Designedforlaboratoriesperformingtestingfordrugsassociatedwithdrug-facilitatedcrimes,whichtargetdrugsatmuchlowerconcentrationsthaninothertoxicologySurveys


New

11-carboxy-THC

4-hydroxytriazolam

7-aminoclonazepam

7-aminoflunitazepam

alpha-hydroxyalprazolam

Amitriptyline

Amobarbital

Amphetamine

Benzoylecgonine

Brompheniramine

Butalbital

Carisoprodol

Chlorpheniramine

Citalopram/escitalopram

Clonidine

Codeine

Cyclobenzaprine

Desipramine

Dextromethorphan

Diphenhydramine

Doxepin

Doxylamine

Fentanyl

Fluoxetine

Gammahydroxybutyrate(GHB)

Hydrocodone

Hydromorphone

Imipramine

Ketamine

Lorazepam

Meperidine

Meprobamate

Methadone

MethadoneMetabolite(EDDP)

Methamphetamine

Methylenedioxyamphetamine(MDA)


Morphine

Nordoxepin

Norfluoxetine

Norketamine

Normeperidine

Norpropoxyphene

Norsertraline

Nortriptyline

Oxazepam

Oxycodone

Oxymorphone

Paroxetine

Pentobarbital

Phencyclidine(PCP)

Phenobarbital

Phenytoin

Propoxyphene

Scopolamine

Secobarbital

Sertraline

Temazepam

Tetrahydrozoline

Tramadol

ValproicAcid

Zaleplon

Ziprasidone

Zolpidem

Zopiclone/Eszopiclone

DFC Drug ListingChallengeswillincludeamixofdrugsfromthelistbelow.

Toxicology


Toxi

colo

gy

8




Toxicology, Validated MaterialsValidated Material Program Code Corresponding Survey Page

Serum Alcohol/EthyleneGlycol/Volatiles VM

AL2M AL2 91

Blood Lead VM BLM BL 92

rine Drug Testing (Screening) VM DSM DS 88

Program Information• AL2M - Five 2.0-mL li uid

serum specimens

• BLM - Five 6.0-mL li uidnonhuman whole bloodspecimens

• DSM - Five 10.0-mL li uidurine specimens


Find a practical guide to toxicology laboratory operationswith this resourceClinical Toxicology Testing:A Guide for Laboratory Professionals

Complex issues face the laboratory director or pathologist whooffers toxicology services. This thorough reference book will guideboth experienced physicians and those in training through thepharmacological principles, testing menus, and methodologies fortoxicology testing.

PRESS

To orderVisit cap.org and choose the Shop tab;or call the CAP Customer Contact Centerat 800-323-4040 or 847-832-7000 option 1.

Item number: PUB220ISBN: 978-0-9837068-1-6Softcover; 304 pages; 2012

Also available as an ebook! Visit ebooks.cap.org

Accuracy-Based

Programs

9

Accuracy-Based ProgramsAccuracy-Based Programs.................................................................................................................98Validated Materials........................................................................................................................101

New Programs New

Hemoglobin A1c, five challenges (GH5)............................................................................................100

Discontinued ProgramsCommutable Frozen Serum (CFS)

9 | Accuracy-Based Programs

“What we do is so exact that we want to knowit’s correct. CAP proficiency testing validates ourlaboratory process so we feel confident that we aresending out the correct results.”

Accuracy-Based Programs


Acc

urac

y-Ba

sed

Prog

ram

s

9

Accuracy-Based ProgramsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Accuracy-Based Lipids ABLAnalyte Program Code Challenges/Shipment

ABL

Apolipoprotein A1 z 3

Apolipoprotein B z 3

Cholesterol* z 3

HDL cholesterol* z 3

LDL cholesterol z 3

Lipoprotein (a) z 3

Triglycerides* z 3

*This analyte will be evaluated against the Centers for Disease Control and Prevention (CDC)reference method.

Accuracy-Based Vitamin D ABVDAnalyte Program Code Challenges/Shipment

ABVD

25-OH vitamin D (D2 and D3) z 3

Additional Information• The Centers for Disease Control and Prevention (CDC) will establish reference targets

using isotope-dilution LC-MS/MS method.• Specimens are collected by a modified application of Clinical Laboratory and

Standards Institute Guideline CLSI C37-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materialsfor Cholesterol Measurement Procedures; Approved Guideline.

Program Information• Three 1.0-mL human serum

specimens


Program Information• Three 1.0-mL human li uid

serum specimens

• Serum is from multidonorendogenous pools



800-323-4040 | 847-832-7000 Option 1 | cap.org 99

Accuracy-Based

Programs

9

Testosterone and Estradiol Accuracy Survey ABSAnalyte Program Code Challenges/Shipment

ABS

Calcium z 4

Cortisol z 4

Estradiol z 4

Testosterone z 4


Additional Information• The Centers for Disease Control and Prevention (CDC) will set target values for

testosterone and estradiol using the established reference methods.• Calcium, cortisol, and TSH data will be provided by peer groups to determine the

degree of harmonization in the field.

Accuracy-Based Urine ABUAnalyte Program Code Challenges/Shipment

ABU

Calcium z 3

Creatinine z 3



Analytes may be evaluated against the reference method or by using harmonization.

Creatinine AccuracyCalibration Verification/Linearity LN24


LN24 LN24 Target Range

Creatinine z 0.6 .0 mg/dL

Estimated glomerularfiltration rate (eGFR)

z

LN Express service is available.

Additional InformationThe College of American Pathologists (CAP) and the National idney Disease EducationProgram (N DEP) have an initiative to harmonize clinically reported creatinine values.This initiative is analogous to what the federal health agencies and the clinical laboratorycommunity did to improve the accuracy of cholesterol and glycohemoglobin testing.

Program Information• Four 1.0-mL human serum

specimens


Program Information• Three 5.0-mL human urine

specimens


Program Information• Six 1.0-mL human serum

specimens




Acc

urac

y-Ba

sed

Prog

ram

s

9

Harmonized Thyroid ABTHAnalyte Program Code Challenges/Shipment

ABTH

T , free (triiodothyronine, free) z 3


T , free (thyroxine, free) z 3

T , total (thyroxine, total) z 3


PRICE (USD)

Additional Information• Analytes will be evaluated using harmonization.• Specimens are collected by a modified application of Clinical Laboratory and

Standards Institute Guideline CLSI C37-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materials forCholesterol Measurement Procedures; Approved Guideline.

Hemoglobin A1c AccuracyCalibration Verification/Linearity LN15



Hemoglobin A1c z 5 12

CAP-assigned target values derived from Hemoglobin A1c measurements assayed byNational Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.


Hemoglobin A1c GH2, GH5Analyte Challenges/Shipment

Program Code

GH2 GH5

Hemoglobin A1c 3 5

Additional Information• Beginning with the 2015 proficiency testing (PT) program year, the College of

American Pathologists Accreditation Program will re uire all accredited laboratoriesperforming non-waived testing for Hemoglobin A1c to enroll in Survey GH5.

• These Surveys will be evaluated against the National GlycohemoglobinStandardization Program (NGSP) reference method.

Program Information• Three 1.0-mL frozen human

specimens


Program Information• Six 0.8-mL li uid human



Program Information• GH2 - Three 0.8-mL

li uid human whole bloodspecimens; two shipmentsper year

• GH5 - Five 0.8-mL li uidhuman whole bloodspecimens; three shipmentsper year

Validated Materials

800-323-4040 | 847-832-7000 Option 1 | cap.org 101

Accuracy-Based

Programs

9

Validated MaterialsImprove the reliability of your patient results with CAP Survey Validated Materials




Chemistry, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page

Chemistry/TDM VM CZVM CZ 50

Cerebrospinal Fluid VM MVM M 66

Urine Chemistry (Special) VM NVM N, N 62

Urine Chemistry (General) VM UVM U 61

Coagulation, Validated MaterialValidated Material Validated Material Code Corresponding Survey Page

Coagulation (Limited) VM CGM CGL 144

Calibration Verification/Linearity, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page

Chemistry, Lipid, Enzyme Calibration Verification/Linearity VM LN2VM LN2 106

Chemistry, Lipid, Enzyme Calibration Verification/Linearity;All Bec man (except A ) and Vitros VM

LN2VM1 LN2BV 106

TDM Calibration Verification/Linearity VM LDM LN 107

Ligand Assay Calibration Verification/Linearity VM LLM LN5 108

rine Chemistry Calibration Verification/Linearity VM LUM LN6 108

Validated Materials


Acc

urac

y-Ba

sed

Prog

ram

s

9

Cytogenetics, Validated MaterialValidated Material Validated Material Code Corresponding Survey Page

Cytogenetics VM CYM CY 212

Endocrinology, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page

Ligands (General) VM VM 74

Ligands (Special) VM YVM Y 75

Toxicology, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page

Serum Alcohol/Ethylene Glycol/Volatiles VM AL2M AL2 91

Blood Lead VM BLM BL 92

Urine Drug Testing (Screening) VM UDSM UDS 88

Instrumentation Validation Tools

10

Instrumentation Validation ToolsCalibration Verification/Linearity .....................................................................................................104Instrumentation Quality Management Programs .................................................................................118

Program ChangesInternational System of Units (SI) reporting now available. See specific program for availability

10 | Instrumentation Validation Tools

“The CAP has proficiency testing available for justabout every test we do and I really like using theirlinearity and calibration verification programs.Everything blends well together.”

Calibration Verification/Linearity


Inst

rum

enta

tion

Valid

atio

n To

ols

10

The CAP CVL programOur program will help you meet CLIA regulations and CAP Laboratory Accreditation Program requirements forcalibration verification and analytical measurement range (AMR) validation under 42 CFR493.1255(b)(3) for mostanalytes. In addition, you will receive a linearity assessment to help identify instrument/method performance issuesbefore they can affect your patient results.

With your enrollment in the CAP CVL program you will receive:

• Testing Kito Kit instructions—Contain important information to help you complete testing and accurately report your resultso Result formo Specimens—The majority of CAP CVL programs offer human-based materials to closely mimic your patient results

• Customized Report Packageo Executive Summary—A quick overview of both your calibration verification and linearity results for all reported

analyteso Calibration Verification evaluationo Linearity evaluation

• Receive your linearity evaluations through LN ExpressSM, our expedited delivery service, within two businessdays for select CVL programs by logging in to e-LAB Solutions™

o Linearity Troubleshooting Reporto Participant Summary—A summary of laboratory performance that includes peer group statistics and enhanced

diagnostic information for early insight into potential problems

• Additional Toolso Calibration Verification/Linearity Program User’s Guide—Get assistance in interpreting your evaluations and

reports as well as helpful troubleshooting information with suggested actions. Also available online by logging into e-LAB Solutions

o Calibration Verification Troubleshooting Guide—The guide provides suggested actions if you receive acalibration verification result of Different, or if your evaluation result is Verified over a range that does notinclude all of your reported results

o Calibration Verification/Linearity Surveys Investigation Checklist for Problematic Results—Interpretative checklistsare included to help with troubleshooting and documentation



800-323-4040 | 847-832-7000 Option 1 | cap.org 105


10

Your Total Calibration Verification/Linearity (CVL) SolutionCVL Program Page

No.Corresponding

Proficiency Testing SurveyPageNo. Validated Material Page

No.LN2 - Chemistry, Lipid, Enzyme CVL 106

C1, C3/C3X,CZ/CZX/CZ2X

50LN2VM 121

LN2BV - Chemistry, Lipid, Enzyme all Beckman(except AU), Vitros CVL

106 LN2VM1 121

LN3 - TDM CVL 107 CZ/CZX/CZ2X/Z 50 LDM 121LN5 - Ligand Assay CVL 108

K/KK 74 LLM 121LN5S - Ligand Assay all Siemens ADVIA(Centaur, CP, and XP) CVL

108

LN6 - Urine Chemistry CVL 108 U 61 LUM 121LN7 - Immunology CVL 109 IG/IGX 180LN8 - Reproductive Endocrinology CVL 109 Y/YY 75LN9 - Hematology CVL 110 FH series, HE series 125,124LN11 - Serum Ethanol CVL 110 AL2 91LN12 - C-Reactive Protein CVL 110 CRP 180LN13, LN13C - Blood Gas/Critical Care CVL 111 AQ, AQ2, AQ3, AQ4 82LN14 - Whole Blood Ethanol CVL 111 AL1 91LN15 - Hemoglobin A1c Accuracy CVL 111 GH2 57LN16 - Homocysteine CVL 112 HMS 58LN17 - Whole Blood Glucose CVL 112 WBG, WB2 59LN18 , LN19 Reticulocyte CVL 112 RT, RT2, RT3, RT4 129LN20 - Urine Albumin CVL 112 U 61LN21 - High-Sensitivity C-Reactive Protein CVL 113 HSCRP 57LN22 - Flow Cytometry CVL 113 FL 188LN23 - Prostate-Specific Antigen CVL 113 K/KK 74

LN24 - Creatinine Accuracy CVL 114C1, C3/C3X,

CZ/CZX/CZ2X50

LN25, LN27 - Troponin I and T CVL 114 CRT, CRTI, TNT 56LN30 - B-Type Natriuretic Peptides CVL 114 BNP 55LN31 - Immunosuppressive Drugs CVL 115 CS 53

LN32 - Ammonia CVL 115C1, C3/C3X,

CZ/CZX/CZ2X50

LN33 - Serum Myoglobin CVL 115 CRT, CRTI 56LN34 - Tumor Markers CVL 115 TM/TMX 80LN35 - Thrombophilia CVL 116 CGS2 145LN36 - Heparin CVL 116 CGS4 145LN37 - von Willebrand Factor Antigen CVL 116 CGS3 145LN38 - CMV Viral Load CVL 116 VLS, VLS2 173LN39 - HIV Viral Load CVL 116 HIV, HV2 173LN40 - Vitamin D CVL 116 BGS 76LN41 - Procalcitonin CVL 117 PCT 69LN42 - D-Dimer CVL 117 CGL, CGDF 144

All CVL Surveys provide individual evaluation reports by analytes, an Executive Summary, and graphical plots for linearity andcalibration verification.



Inst

rum

enta

tion

Valid

atio

n To

ols

10

Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.

Chemistry, Lipid, EnzymeCalibration Verification/Linearity LN2, LN2BV

Analyte ProgramCode LN2 LN2BV Units

LN2,LN2BV

(AllInstruments)

All Beckman(except AU) Vitros

Albumin z 1.5–9.0 g/dL

Calcium z 4.0–18.0 mg/dL

Chloride z 60–180 mmol/L

CO2 z 7–40 mmol/L

Creatinine z 0.3–32.0 mg/dL

Glucose z 20–780 mg/dL

Iron z 10–950 µg/dL

Magnesium z 0.3–10.0 mg/dL

Osmolality z 200–600 mOsm/kg H2O

Phosphorus z 0.5–20.0 mg/dL

Potassium z 1.5–13.0 mmol/L

Protein z 1.5–10.0 g/dL

Sodium z 90–215 mmol/L

Urea nitrogen z 3–190 mg/dL

Uric acid z 1–25 mg/dL

Alkaline phosphatase z 25–1,800 25–1,000 25–1,100 U/L

ALT (SGPT) z 10–900 10–650 30–700 U/L

Amylase z 30–1,800 30–900 30–800 U/L

AST (SGOT) z 10–900 10–500 10–700 U/L

Creatine kinase z 25–2,000 25–1,200 25–700 U/L

CK-2 (MB) Mass z 1–250 1–300 1–200 ng/mL

Gamma glutamyltransferase

z 10–1,400 10–900 10–1,100 U/L

Lactatedehydrogenase

z 50–1,800 50–700 185–3,000 U/L

Lipase z 20–1,400 20–190 150–2,500 U/L

Bilirubin, direct z 0.1–10.0 mg/dL

Bilirubin, total z 0.2–25.0 mg/dL

Cholesterol z 35–625 mg/dL

HDL z 7–120 mg/dL

Triglycerides z 20–700 mg/dL


Program Information• Seven 5.0-mL li uid serum

specimens for basic chemistry,six 3.0-mL liquid serumspecimens for direct and totalbilirubin, seven 2.0-mL liquidserum specimens for lipids,and seven 5.0-mL liquidserum specimens for enzymes

• LN2 Appropriate for mostmajor instruments

• LN2BV Appropriate forBeckman (except AU) andVitros instruments only




800-323-4040 | 847-832-7000 Option 1 | cap.org 107


10


Therapeutic Drug MonitoringCalibration Verification/Linearity LN3

Analyte Program CodeLN3 LN3 Target Ranges

Acetaminophen z 20–450 µg/mL

Amikacin z 2–45 µg/mL

Carbamazepine z 2–18 µg/mL

Digoxin z 0.5–4.4 µg/mL

Gentamicin z 1–11 µg/mL

Lidocaine z 1–10 µg/mL

Lithium z 0.3–4.0 mmol/L

N-acetylprocainamide (NAPA) z 2–25 µg/mL

Phenobarbital z 8–70 µg/mL

Phenytoin z 5–35 µg/mL

Primidone z 1–22 µg/mL

Procainamide z 2–18 µg/mL

Quinidine z 0.4–7.0 µg/mL

Salicylates z 7–90 mg/mL

Theophylline z 5–35 µg/mL

Tobramycin z 1–12 µg/mL

Valproic acid z 15–140 µg/mL

Vancomycin z 7–90 µg/mL


Program Information• Six .0-mL li uid serum

specimens

• A seventh .0-mL li uid serumspecimen for acetaminophenand vancomycin





Inst

rum

enta

tion

Valid

atio

n To

ols

10


Ligand Calibration Verification/Linearity LN5, LN5SAnalyte Program Code Target Ranges

LN5, LN5S* LN5 Target Ranges LN5S Target RangesAFP z 0.5–900.0 ng/mL

CEA z 0.5–750.0 ng/mL 0.5–90.0 ng/mL

Cortisol z 1–65 µg/dL

Ferritin z 2–1,000 ng/mL

Folate z 1.3–20 ng/mL

Human chorionicgonadotropin (hCG)

z 5–14,000 mIU/mL

T3, total (triidothyronine) z 0.5–7.0 ng/mL

T4, total (thyroxine) z 1–24 ng/mL

Thyroid-stimulatinghormone (TSH)

z 0.01–100 µU/mL

Vitamin B12 z 100–2,200 pg/mL

*The LN5S CVL will allow Siemens ADVIA Centaur users to report other major instruments if needed.


Urine Chemistry Calibration Verification/LinearityLN6


LN6 LN6 Target Ranges

Amylase z 40–1,500 U/L

Calcium z 5–30 mg/dL


Creatinine z 20–460 mg/dL


Osmolality z 30–1,800 mOsm/kg H20

Phosphorus z 15–200 mg/dL

Potassium z 7–225 mmol/L

Protein, total z 10–235 mg/dL


Urea nitrogen z 20–2,000 mg/dL

Uric acid z 6–150 mg/dL


Program Information• LN5 - Eight .0-mL li uid

serum specimens; appropriatefor most major instrumentsexcept Siemens ADVIACentaur

• LN5S - Thirteen .0-mL li uidserum specimens; appropriatefor Siemens ADVIA Centaur,XP, and CP users



Program Information• Eighteen .0-mL li uid urine

specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 109


10

Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values than the ranges listed.

Immunology Calibration Verification/Linearity LN7



Alpha-1-antitrypsin z 25–616 mg/dL

Complement C3 z 21–420 mg/dL

Complement C4 z 5–100 mg/dL

IgA z 32–650 mg/dL

IgG z 150–3,000 mg/dL

IgM z 25–450 mg/dL

Transferrin z 38–950 mg/dL


Reproductive Endocrinology Calibration Verification/Linearity LN8



Estradiol z 25–4,500 pg/mL

Follicle-stimulating hormone (FSH) z 3–190 mIU/mL

Human chorionic gonadotropin (hCG) z 5–8,000 mIU/mL

Luteinizing hormone (LH) z 2–190 mIU/mL

Progesterone z 1–50 ng/mL

Prolactin z 3–315 ng/mL

Testosterone z 20–1,500 ng/dL


Program Information•Six2.0-mLliquidserum

specimens


Program Information•Seven4.0-mLliquidserum

specimens

•ConventionalandInternational System of Units (SI) reporting offered




Inst

rum

enta

tion

Valid

atio

n To

ols

10


Hematology Calibration Verification/LinearityLN9



Hemoglobin z 1.5–24.0 g/dL

Platelet count z 10–2,500 x 109/L

RBC count z 0.5–8.00 x 1012/L

WBC count z 0.5–350.0 x 109/L


Serum Ethanol Calibration Verification/LinearityLN11



Serum ethanol z 15–550 mg/dL


C-Reactive ProteinCalibration Verification/Linearity LN12



C-reactive protein z 7–280 mg/L


Program Information• Twenty .0-mL li uid

specimens


Program Information• Seven .0-mL li uid serum

specimens




specimens

• Not appropriate for reportinghigh-sensitivity C-reactiveprotein (hsCRP)



800-323-4040 | 847-832-7000 Option 1 | cap.org 111


10


Blood Gas/Critical CareCalibration Verification/Linearity LN13, LN13C

Analyte ProgramCode

ProgramCode

LN13 LN13Target Ranges LN13C LN13C

Target Ranges

PCO2 z 12–91 mm Hg z 12–91 mm Hg

pH z 6.83–7.82 z 6.83–7.82

PO2 z 18–490 mm Hg z 18–490 mm Hg

Calcium, ionized z 0.15–3.3 mmol/L



Lactate z 0.2–18 mmol/L

Magnesium, ionized z 0.1–2.4 mmol/L

Potassium z 0.5–10.7 mmol/L


Whole Blood EthanolCalibration Verification/Linearity LN14



Ethanol z 15–400 mg/dL


Hemoglobin A1c AccuracyCalibration Verification/Linearity LN15



Hemoglobin A1c z 5%–12%

CAP-assigned target values derived from Hemoglobin A1c measurements assayed byNational Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.


Program Information• Ten 2.5-mL ampules of

aqueous specimens

• Single instrument reportingonly


Program Information• Six .0-mL li uid whole blood

specimens


Program Information• Six 0.8-mL li uid human





Inst

rum

enta

tion

Valid

atio

n To

ols

10


Homocysteine Calibration Verification/Linearity LN16



Homocysteine z 5–65 µmol/L


Whole Blood Glucose Calibration Verification/Linearity LN17



Whole blood glucose z 50–400 mg/dL


Reticulocyte Calibration Verification/Linearity LN18, LN19

Instrument/Method Program Code Program Code



Coulter Gen•S™, LH 500, LH 700 series, and UniCel DxH

z 0.3%–27.0%

All other instruments z 0.3%–24.0%

Pierceable caps z z


Urine Albumin Calibration Verification/Linearity LN20



Urine albumin z 10–350 mg/L

Urine creatinine z 20–500 mg/dL

Program Information• Six 1.0-mL liquid serum

specimens


Program Information• Five 2.0-mL liquid whole

blood specimens

• Report up to 10 different ancillary testing sites or instruments


Program Information• LN18 - Five 2.5-mL liquid

whole blood specimens with pierceable caps

• LN19 - Five 1.0-mL liquid whole blood cell specimens with pierceable caps


Program Information• Six 5.0-mL urine specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 113


10


High-Sensitivity C-Reactive ProteinCalibration Verification/Linearity LN21



High-sensitivity C-reactive protein z 0.5–6.0 mg/L


Flow Cytometry Calibration Verification/LinearityLN22



CD3+ z 50%–70% positive

CD3+ T lymphocytes absolute z 350–4,000 cells/µL

CD3+/CD4+ z 1%–40% positive

CD3+/CD4+ T lymphocytes absolute z 6–2,000 cells/µL

CD3+/CD8+ z 25%–40% positive

CD3+/CD8+ T lymphocytes absolute z 250–1,600 cells/µL

Prostate-Specific AntigenCalibration Verification/Linearity LN23



Prostate-specific antigen z 0.1–90.0 ng/mL

Program Information• Six 1.0-mL li uid serum

specimens

• For high-sensitivity methodsonly


Program Information• Seven 1.0-mL li uid whole

blood specimens


Program Information• Twelve 1.0-mL li uid serum

specimens




Inst

rum

enta

tion

Valid

atio

n To

ols

10


Creatinine AccuracyCalibration Verification/Linearity LN24



Creatinine z 0.6–4.0 mg/dL

Estimated glomerularfiltration rate (eGFR)

z


Additional InformationThe College of American Pathologists (CAP) and the National Kidney Disease EducationProgram (NKDEP) have an initiative to harmonize clinically reported creatinine values.This initiative is analogous to what the federal health agencies and the clinical laboratorycommunity did to improve the accuracy of cholesterol and glycohemoglobin testing.

Troponin Calibration Verification/LinearityLN25, LN27

Analyte Program Code Program Code

LN25 LN25 Target Ranges LN27 LN27 Target Ranges

Troponin I z 0.05–60.00 ng/mL

Troponin T z 0.1–27.00 ng/mL

B-Type Natriuretic PeptidesCalibration Verification/Linearity LN30



BNP z 30–3,500 pg/mL

NT-pro BNP z 50–30,000 pg/mL


Program Information• Six 1.0-mL human serum

specimens


Program Information• LN25 - Seven 2.0-mL li uid

serum specimens

• LN27 - Six 2.0-mL li uidserum specimens


Program Information• Six 1.0-mL li uid plasma

specimens for BNP andNT-pro BNP

• A seventh 1.0-mL li uidplasma specimen for NT-proBNP only




800-323-4040 | 847-832-7000 Option 1 | cap.org 115


10


Immunosuppressive DrugsCalibration Verification/Linearity LN31



Cyclosporine z 60–1,200 ng/mL

Tacrolimus z 1.5–30.0 ng/mL

Ammonia Calibration Verification/Linearity LN32Analyte Program Code


Ammonia z 13–900 µmol/L


Serum Myoglobin Calibration Verification/LinearityLN33



Myoglobin z 25–900 ng/mL


Tumor Markers Calibration Verification/LinearityLN34



CA 125 z 1–1,000 U/mL

CA 15-3 z 2–190 U/mL

CA 19-9 z 10–900 U/mL


Program Information• Seven 2.0-mL li uid whole

blood hemolysate specimens



specimens



specimens


Program Information• Seven .0-mL li uid serum

specimens




Inst

rum

enta

tion

Valid

atio

n To

ols

10

Coagulation Calibration Verification/Linearity LN35, LN36, LN37


LN35 LN36 LN37 Target Ranges

Antithrombin activity z 10%–130%

Protein C activity z 10%–100%

Heparin, low molecular weight z 0.1–2.0 U/mL

Heparin, unfractionated z 0.1–1.3 U/mL

von Willebrand factor antigen z 5%–140%

The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirements HEM.38009, 38010, and 38011.


Viral Load Calibration Verification/Linearity LN38, LN39



CMV viral load z 0.3M–1.0M IU/L

HIV viral load z 0–10M copies/L


Vitamin D Calibration Verification/Linearity LN40


LN40 Target Ranges

25-OH vitamin D, total z 4–120 ng/mL


Program Information• LN35,LN37-Six1.0-mL

frozen plasma specimens per mailing

• LN36-Twelve1.0-ml frozen plasma specimens per mailing,whichincludesix for low molecular weight heparinandsixforunfractionated heparin

•Twoshipmentsperyear; ships on dry ice

Program Information• LN38-Six1.5-mLfrozen

plasma specimens

•Twoshipmentsperyear;shipson dry ice

• LN39-Six2.5-mLfrozenplasma specimens


Program Information•Six1.0-mLserumspecimens

•ConventionalandInternationalSystemofUnits(SI)reportingoffered




800-323-4040 | 847-832-7000 Option 1 | cap.org 117


10

Procalcitonin CalibrationVerification/Linearity LN41


LN41 Target Ranges

Procalcitonin z 0.3-200 ng/mL


D-Dimer CalibrationVerification/Linearity LN42


LN42 Target Ranges

D-dimer z 200-4,500 ng/mL FEU


Program Information• Six 1.0-mL frozen plasma

specimens

• Two shipments per year; shipson dry ice

Program Information• Six 1.0-mL plasma specimens


I’m a cancer survivor.I always try to rememberthe person I am assistingis crucial to gettingaccurate patient results.It is that simple.

– Patrick

“

“


Instrumentation Quality Management Programs


Inst

rum

enta

tion

Valid

atio

n To

ols

10


Instrumentation IChallenges Program Code

I

A Shipment B Shipment C Shipment

Adjustable micropipettecalibration verification/linearity

z z

Analytical balance check z z

Gravimetric pipette calibration z z

Microtiter plate linearity z z

Refractometer calibration z z

Spectrophotometer (stray light check) z z

Absorbance check – UV wavelength z

Fluorescent intensity check –fluorescent microscopes

z

Ocular micrometer calibration z

Osmometer study z

Peak absorbance measurement z

pH meter check z

Photometric calibration – visiblewavelength

z

WARNING: The Instrumentation (I) Survey specimens may contain corrosive or toxic substances,environmental hazards, or irritants.

Program Information• Designed to assess

instruments not routinelychallenged during theproficiency testing process

• Includes appropriatematerials to assess importantfunctional parameters,including accuracy andlinearity



800-323-4040 | 847-832-7000 Option 1 | cap.org 119


10

Interfering Substance Survey IFSAnalyte Program Code

IFS

BilirubinInterferent

HemoglobinInterferent Lipid Interferent

Alanine aminotransferase (ALT/SGPT) z z z

Albumin z z z

Alkaline phosphatase z z z

Amylase z z z

Aspartate aminotransferase (AST/SGOT) z z z

Calcium z z z

Chloride z z z

CK2 (MB) mass z z z

Creatine kinase (CK) z z z

Creatinine z z z

Gamma glutamyl transferase (GGT) z z z

Glucose z z z

Iron z z z

Lactate dehydrogenase (LD) z z z

Lipase z z z

Magnesium z z z

Osmolality z z z

Phosphorus z z z

Potassium z z z

Protein, total z z z

Sodium z z z

Urea nitrogen (BUN) z z z

Uric acid z z z

The material expires December 1, 2015.

Program Information• Eighteen 10.0-mL li uid

serum specimens

• Designed for verifiyingmanufacturing interferencespecifications andinvestigating discrepantresults caused by interferingsubstances

• Submit results any time prior tothe material's expiration date




Inst

rum

enta

tion

Valid

atio

n To

ols

10

Serum Carryover SCOAnalyte Program Code

SCO

Creatinine z

hCG z

Lactate dehydrogenase (LD) z

Phenytoin z

The material expires May 1, 2016.

Urine Toxicology Carryover UTCOAnalyte Program Code

UTCO

Benzoylecgonine z

Delta-9-THC-COOH z

Opiates z

Propoxyphene z

The material expires May 1, 2016.

Program Information• One 10.0-mL li uid serum

specimen (low level) and one5.0-mL liquid serum specimen(high level)

• Designed to screen forinstrument sample probecarryover


Program Information• Two 0.0-mL urine specimens

(low and high levels)

• Designed to screen forinstrument sample probecarryover



800-323-4040 | 847-832-7000 Option 1 | cap.org 121


10

Improve the reliability of your patient results with CAP CVL Validated MaterialsUse the same material that is sent in the CVL program to:

• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document corrective actions• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures

Each laboratory receives a Participant Summary, which includes readily available results.

Calibration Verification/Linearity, Validated MaterialsValidated Material Program Code Corresponding Survey Page

Chemistry, Lipid,Enzyme CalibrationVerification/Linearity VM

LN2VM LN2 106

Chemistry, Lipid,Enzyme CalibrationVerification/Linearity;All Beckman (except AU)and Vitros VM

LN2VM1 LN2BV 106

TDM CalibrationVerification/Linearity VM

LDM LN3 107

Ligand Assay CalibrationVerification/Linearity VM

LLM LN5 108

Urine Chemistry CalibrationVerification/Linearity VM

LUM LN6 108

Program Information• LN2VM, LN2VM1 - Seven

5.0-mL liquid serumspecimens for basic chemistry,six 3.0-mL liquid serumspecimens for direct and totalbilirubin, seven 2.0-mL liquidserum specimens for lipids,and seven 5.0-mL liquidserum specimens for enzymes

• LDM - Six .0-mL li uidserum specimens

• LLM - Eight .0-mL li uidserum specimens; appropriatefor most major instrumentsexcept for Siemens ADVIACentaur

• L M - Eighteen .0-mL li uidurine specimens


Also available as ebooks! Visit ebooks.cap.org

Put fast identificationof cells, fungi, andparasites at yourfingertipsThese laminated guides are aquick, easy reference foraccurate, confidentidentification.

• Portable (5" x 6.5" or 6.5" x 7")

• Durable—heavy-duty towithstand years ofbenchtop use

Visit cap.org and choose the Shop tabto view sample pages and order.*

*CAP distributor customers—contactyour distributor to order

Hematology

andC

linicalMicroscopy

11

Hematology and Clinical MicroscopyHematology ..................................................................................................................................124Clinical Microscopy .......................................................................................................................133

New Programs New

Automated Hematology Differential for Mindray BC-5000 (FH11) .......................................................125Automated Hematology Differential for Mindray BC-6000 (FH12) .......................................................125Quality Cross Check, Automated Hematology Series (FH3Q, FH4Q, FH6Q, FH9Q) .............................126Hematopathology Online Education (HPATH/HPATH1) ......................................................................132Hemocytometer Fluid Count, international only (HFCI) ........................................................................136


Automated Hematology Series (FH1/FH1P to FH10/FH10P and HE/HEP)See programs FH3Q, FH4Q, FH6Q, FH9Q ..................................................................................126

11 | Hematology and Clinical Microscopy

“I appreciate that there are so many CAP proficiencytests and we like the quality of the specimens andthe breadth of the specimens that are available. TheCAP has such big peer groups that I feel good aboutseeing what others are doing for the many analytesand many instruments.”

Hematology


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

HematologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Basic Hematology HE, HEPAnalyte/Procedure Program Code Challenges/Shipment

HE HEP

Blood cell identification z 10

Hematocrit z z 5

Hemoglobin z z 5

MCV, MCH, and MCHC z z 5

Platelet count z z 5

RDW z z 5

Red blood cell count z z 5

White blood cell count z z 5

Blood Cell Identification BCPProcedure Program Code Challenges/Shipment

BCP


Erythrocyte Sedimentation RateESR, ESR1, ESR2, ESR3

Procedure Program Code Challenges/Shipment

ESR ESR1 ESR2 ESR3

All methods except the Sedimat 15®,Sedimat 15 Plus, Alifax®,and ALCOR

z 3

Sedimat 15, Sedimat 15 Plus z 3

Alifax z 3

ALCOR iSED z 3

Program Information• Five .0-mL whole blood

specimens

• HEP - Ten images, eachavailable as photographs,images on a CD-ROM, andonline images


Program Information• Ten images, each available

as photographs, images onCD-ROM, and online images


Program Information• ESR, ESR1 - Three 6.0-mL


• ESR2 - Three .0-mL simulatedwhole blood specimens

• ESR - Three .5-mL wholeblood specimens


Hematology

800-323-4040 | 847-832-7000 Option 1 | cap.org 125

Hematology

andC

linicalMicroscopy

11

Hematology Automated Differential SeriesFH1-FH12, FH1P-FH12P


FH1-FH12 FH1P-FH12P


Hematocrit z z 5

Hemoglobin z z 5

Immature granulocyte parameter z z 5 (FH9 only)

Large unstained cell (L C) z z 5 (FH only)

MCV, MCH, and MCHC z z 5

Nucleated red blood cell count (nRBC) z z 5 (FH and FH9)

Platelet count z z 5

RDW z z 5

Red blood cell count z z 5

White blood cell count z z 5

WBC differential z z 5

For second instrument reporting options, see the Quality Cross Check programs, FH3Q, FH4Q,FH6Q, and FH9Q on page 126.

Program Information• Five whole blood specimens

with pierceable caps

• FHP series - Ten images, eachavailable as photographs,images on a CD-ROM, andonline images

• For method compatibility,see instrument matrix onpage 127


Hematology Benchtop Reference Guide (HBRG)• More than 50 different cell identifications, including

common and rare cells• Detailed descriptions for each cell morphology• Six tabbed sections for easy reference

o Erythrocyteso Erythrocyte Inclusionso Granulocytic (Myeloid) and Monocytic Cellso Lymphocytic Cellso Platelets and Megakaryocytic Cellso Microorganisms and Artifacts

• A durable and water-resistant format—5" x 6½" andspiral bound to withstand years of benchtop use

Add code HBRG to your Surveys order form.


Hematology


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Quality Cross Check—Hematology Automated Differential Series

FH3Q, FH4Q, FH6Q, FH9QAnalyte/Procedure Program Code Challenges/

Shipment

FH3Q FH4Q FH6Q FH9Q


Hemoglobin z z z z 3

Immature granulocyte parameter z z z z (FH9 only)

Large unstained cells (L C) z z z z (FH9 only)

MCV, MCH, MCHC z z z z 3

Nucleated red blood cell count(nRBC)

z z z z(FH and

FH9 only)

Platelet count z z z z 3

RDW z z z z 3

Red blood cell count z z z z 3

hite blood cell count z z z z 3

BC differential z z z z 3

These programs do not meet regulatory requirements for proficiency testing. See the FH serieson page 125.

Additional informationAs a trusted partner, you can rely on the CAP to provide the insight, nowledge, andpeer-based educational coaching to protect your laboratory from regulatory sanctions.



NewProgram Information• Three whole blood specimens

with pierceable caps


• For method compatibility,see instrument matrix onpage 127


Hematology

800-323-4040 | 847-832-7000 Option 1 | cap.org 127

Hematology and C

linical Microscopy

11

Hematology Automated Differential Series, Instrument MatrixInstrument FH and FHQ Series

FH1 FH2 FH3/ FH3Q

FH4/ FH4Q

FH6/ FH6Q

FH9/ FH9Q FH10 FH11 FH12

Horiba ABX 9000+, 9018+, 9020+ z

Sysmex K-series, KCP-1, KX-21/21N, poc H-100i, XP-series z

Abbott Cell-Dyn® 1200, 1600, 1700, 1800, Emerald™ z

Horiba ABX Micros z

Siemens ADVIA® 60 z

Coulter® AcT™, MD, ONYX™, S880, S-plus V, ST, STKR, T-series

z

Drew Scientific DC-18, I-1800, Excell 10/16/18 DREW3 z

CDS/Medonic M-Series z

Mindray BC - 2800, 3000/3200 series z

Abbott Cell-Dyn 3000, 3200, 3500, 3700, 4000, Sapphire™, Ruby™

z

Drew Scientific Excell 22, 2280 z

Siemens ADVIA 120, 120 w/SP1, 2120 z

Coulter Gen-S™, HmX, LH500, LH750, LH755, LH780, LH785, MAXM™, MAXM A/L, STKS, VCS™, Unicel DxH

z

Sysmex XE-2100, XE-2100D, XE-2100L, XE-2100C, XE-2100DC, XE-5000, XN-Series, XT-1800i, XT-2000i, XS-800i, XS-1000i, XS-1000iC, XS-1000iAL, XT-4000i

z

Horiba ABX Pentra 60, 80, 120 z

Coulter AcT 5 diff (AL, CP, OV) z

Mindray BC-5000 series z

Mindray BC-6000 series z

Blood Parasite BPProcedure Program Code Challenges/Shipment

BP

Thin/thick blood film sets* z 5

*This Survey will include corresponding thick films when available.

Program Information•FiveGiemsa-stainedblood

film sets, photographs, and/or online images

•Avarietyofbloodparasites,including Plasmodium, Babesia, Trypanosoma, and filarial worms


Hematology


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Bone Marrow Cell Differential BMDProcedure Program Code Challenges/Shipment

BMD

Bone marrow differential, includingmyeloid erythroid ratio

z 1

Bone marrow cell identification z 5

Bone marrow interpretive uestions z 1-

Additional Information• Examine a whole slide image that includes a 500 bone marrow differential count and

annotated cells for identification.• DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image.• Evaluate cell morphology and identify specific cells in bone marrow.• See system re uirements on page 15.

Fetal Red Cell Detection HBFProcedure Program Code Challenges/Shipment

HBF

leihauer-Bet e, flow cytometry z 2

Rosette fetal screen z 2

Hemoglobinopathy HGProcedure Program Code Challenges/Shipment

HG

Hemoglobin identification anduantification

z

Dry lab educational challenges z 2

Hemoglobin A2 uantitation z

Hemoglobin F uantitation z 1

Sic ling test z

Program Information• One online bone marrow

aspirate whole slide imagethat includes five annotatedcells for identification

• Powered by DigitalScopetechnology

• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available

Program Information• Two 1.2-mL li uid whole

blood specimens

• Not designed for F celluantitation


Program Information• Four 0.5-mL stabilized red

blood cell specimens

• Two dry lab educationalchallenges (case histories,electrophoresis patterns, andclinical interpretationuestions)


Hematology

800-323-4040 | 847-832-7000 Option 1 | cap.org 129

Hematology and C

linical Microscopy

11

Reticulocyte RT, RT2, RT3, RT4Instrument/Method Program Code Challenges/Shipment

RT RT2 RT3 RT4

Abbott Cell-Dyn 3200, 3500, 3700, Ruby z 3

Coulter STKS, MAXM, GenS, HmX, LH500, LH700 series, Unicel DxH z 3

Sysmex XE-2100, XE-2100C, XE-5000, XN Series, XT-2000i, XT-4000i z 3

Abbott Cell-Dyn Sapphire, Siemens ADVIA 120/2120 and all other automated and manual methods

z 3

Pierceable caps z z 3

Sickle Cell Screening SCSProcedure Program Code Challenges/Shipment

SCS

Sickling test z 3

Transfusion-Related Cell Count TRCProcedure Program Code Challenges/Shipment

TRC

Platelet count (platelet-rich plasma) z 5

WBC count z 4

Dry challenge z 2

WBC counts must be performed using a Nageotte chamber, fluorescence microscopy or by flow cytometry.

Waived Combination HCCAnalyte Program Code Challenges/Shipment

HCC

Glucose z 2

Hemoglobin z 2

Program Information•RT,RT2-Three1.0-mL

stabilized red blood cell specimens

•RT3,RT4-Three2.0-mLstabilized red blood cell specimens

• Includespercentageandabsolute result reporting


Program Information•Three1.0-mLstabilized

human erythrocyte specimens


Program Information•Five1.2-mLsuspensionsof

platelet-rich plasma

•Two1.0-mLvialsleukocyte- reduced platelet material

•Two1.0-mLvialsleukocyte- reduced red blood cells


Program Information•Two1.0-mLwholeblood

specimens

•ForusewiththeHemoCue® B, HemoCue 201, HemoCue 301, and Stanbio HemoPoint® H2 instruments


Hematology


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Rapid Total White Blood Cell Count RWBCProcedure Program Code Challenges/Shipment

RWBC

Rapid total white blood cell count z 5

Virtual Peripheral Blood Smear VPBSProcedure Program Code Challenges/Shipment

VPBS

WBC differential z 3

Platelet estimate z 3

RBC morphology z 3


Additional Information • Examine whole slide images that include a 100 WBC differential count and annotated

cells for identification. • DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image. • Evaluate and identify red blood cell (RBC) morphology and identify specific white

blood cells (WBC) in peripheral blood. • See system requirements on page 15.

Program Information• Five 2.0-mL whole blood

specimens

• For use with the HemoCue WBC instrument


Program Information• Three online whole slide

images that include 15 annotated cells for identification

• Powered by DigitalScope technology

• Two online activities per year; your CAP shipping contact will be notified via email when the activity is available

Look for your online Surveys programs via emailWhen you order the CAP’s online Surveys programs for 2015, we will notify your CAP shipping contact when they are available for assignment and distribution within your laboratory.

This earth-friendly, paperless approach supports green initiatives, saving paper and energy resources.

Hematology

800-323-4040 | 847-832-7000 Option 1 | cap.org 131

Hematology

andC

linicalMicroscopy

11

Expanded VirtualPeripheral Blood Smear EHE1


EHE1

BC differential z 2

Platelet estimate z 2

RBC morphology z 2

BC morphology z 2


Interpretive uestions z 1-2

Additional Information• More challenging and/or complex testing• Examine of whole slide images that include a 100 BC/differential count and

annotated cells for identification• DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image• Comprehensive case studies• Ability to recognize and integrate problem-solving s ills through the use of

interpretive uestions• Evaluate and identifiy red blood cell (RBC) morphology and identify specific white

blood cells ( BC) in peripheral blood• See system re uirements on page 15.

Program Information• Two online whole slide images

that include 10 annotatedcells for identification



Body Fluids Benchtop Reference Guide (BFBRG)• Thirty-six color images, including common and rare cells,

crystals, and other cell inclusions• Detailed descriptions of each cell including facts,

cell morphology and inclusions• Nine tabbed sections for easy reference

o Erythroid Serieso Lymphoid Serieso Myeloid Serieso Mononuclear Phagocytic Serieso Lining Cellso Miscellaneous Cellso Crystalso Microorganismso Miscellaneous Findings

• A durable and water-resistant format—5" x 6½" andspiral bound to withstand years of benchtop use

Add code BFBRG to your Surveys order form.


Hematology


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Hematopathology Online EducationHPATH/HPATH1

Program Program Code Challenges/Shipment

HPATH/HPATH1

Hematopathology online case review z 5

Additional InformationHPATH educates pathologists and hematologists to assess and improve their diagnostics ills in hematopathology.

• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.

• Cases are peripheral blood and bone marrow whole slide images.• Cases may include results of ancillary studies such as histochemistry, immunology,

immunohistochemistry, and molecular tests, where appropriate.• See system re uirements on page 15.

NewProgram Information• HPATH - Five diagnostic

challenges/whole slideimages with clinicalhistory; for each additionalpathologist/hematologist,purchase HPATH1

• HPATH1 - Reporting optionwith CME/SAM/CE credit foreach additional pathologistand hematologist (withinthe same institution); mustorder in conjunction withSurvey HPATH

• Earn a maximum of 6CME/SAM credits (AMAPRA Category 1 Credits™)per pathologist and amaximum of 6 CE credits perhematologist for completionof an entire year

• This activity meets theABP MOC Part IV PracticePerformance Assessmentre uirements


• One online activity per year;your CAP shipping contactwill be notified via emailwhen the activity is available

Clinical Microscopy

800-323-4040 | 847-832-7000 Option 1 | cap.org 133

Hematology

andC

linicalMicroscopy

11

Clinical MicroscopyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Clinical Microscopy CMP, CMP1Analyte/Procedure Program

CodeProgram

CodeChallenges/

Shipment

CMP CMP1

Bilirubin z z 3

Blood or hemoglobin z z 3

Glucose z z 3

hCG urine ( ualitative) z z 3

etones z z 3

Leu ocyte esterase z z 3

Nitrite z z 3

Osmolality z z 3

pH z z 3

Protein ( ualitative) z z 3

Reducing substances z z 3

Specific gravity z z 3

robilinogen z z 3

rine sediment photographs z z

Body fluid photographs z z 6

Clinical Microscopy Miscellaneous CMMPProcedure Program Code Challenges/Shipment

CMMP

Fern test (vaginal) z 1

OH preparation (s in or vaginal) z 1

Nasal smear z 1

Pinworm preparation z 1

Stool for leu ocytes z 1

Vaginal wet preparation(for spermatozoa, trichomonas,clue cells, and epithelial cells)

z 1

Program Information• CMP - Three 10.0-mL li uid

urine specimens; for use withall instruments except iCHEM

• CMP1 - Three 12.0-mL li uidurine specimens; for use withiCHEM instruments

• CMP, CMP1 - Ten images,each available asphotographs, images onCD-ROM, and online images


Program Information• Six images, each available as

photographs, images onCD-ROM, and online imagesfor evaluating provider-performed microscopy


Clinical Microscopy


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Virtual Body Fluid VBFProcedure Program Code Challenges/Shipment

VBF

Total nucleated cells differential z 2

Body fluid cell identification z 10

Additional Information• Examine whole slide images that include a differential count and annotated

cells for identification.• DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image.• Evaluate cell morphology and identify specific cells in a body fluid.• See system re uirements on page 15.

Amniotic Fluid Leakage AFLProcedure Program Code Challenges/Shipment

AFL

pH interpretation z 3

Automated Body Fluid ABF1, ABF2, ABF3Procedure Program Code Challenges/Shipment

ABF1 ABF2 ABF3

Red blood cell count z z z 2

hite blood cell count z z z 2

For method compatibility, see instrument matrix below.

Automated Body Fluid, Instrument MatrixInstrument ABF Series

ABF1 ABF2 ABF3

Siemens ADVIA120/2120/2120i

z

Coulter LH 700 Series,nicel DxH

z

Sysmex E-2100, N-series,T-1800i, T-2000i, E-5000,T- 000i

z

IRIS i ® 200 z

Program Information• Two online whole slide body

fluid images that inlcude10 annotated cells foridentification



Program Information• Three 2.0-mL li uid

specimens

• For use with nitrazine paperand the Amniotest™


Program Information• Two .0-mL simulated body

fluid specimens


Clinical Microscopy

800-323-4040 | 847-832-7000 Option 1 | cap.org 135

Hematology

andC

linicalMicroscopy

11

Automated Urinalysis UAA, UAA1Analyte Program Code Challenges/Shipment

UAA UAA1

Casts, semi uantitative z z 2

Crystals, semi uantitative z 2

Epithelial cells, semi uantitative z 2

Red blood cells, uantitative z z 2

hite blood cells, uantitative z z 2

Crystals BFC, URC, BCRProcedure Program Code Challenges/Shipment

BFC URC BCR

Body fluid crystal identification z 2

rine crystal identification z 2

Bile crystal identification z 2

Dipstick Confirmatory DSCAnalyte/Procedure Program Code Challenges/Shipment

DSC

Bilirubin z 2

Sulfosalicylic acid (SSA) z 2

Fecal Fat FCFSAnalyte Program Code Challenges/Shipment

FCFS

Fecal fat, ualitative z 2

Program Information• AA Two 10.0-mL li uid

urine specimens for use withIRIS instruments

• AA1 - Two 12.0-mL li uidurine specimens for use withSysmex instruments


Program Information• BFC - Two 1.5-mL simulated

body fluid specimens (eg,synovial fluid)

• RC - Two 1.5-mL urinespecimens

• BCR - Two 1.5-mL bile fluidspecimens


Program Information• Two 12.0-mL li uid urine

specimens

• For use with methods toconfirm positive bilirubin andprotein dipstic results


Program Information• Two 10.0-g simulated fecal

fat specimens

• For microscopic detectionof neutral fats (triglycerides)and/or split fats (total freefatty acids)


Clinical Microscopy


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Fetal Hemoglobin APTAnalyte Program Code Challenges/Shipment

APT

Fetal hemoglobin z 2

Gastric Occult Blood GOCBAnalyte Program Code Challenges/Shipment

GOCB

Gastric occult blood z 3

Gastric pH z 3

Glucose-6-Phosphate Dehydrogenase G6PDSAnalyte Program Code Challenges/Shipment

G6PDS

G6PD ( ualitative and uantitative) z 2

Hemocytometer Fluid Count HFCProcedure Program Code Challenges/Shipment

HFC

Cytopreparation differential z 3

Red blood cell fluid count z 3

hite blood cell fluid count z 3

Hemocytometer Fluid Count HFCIProcedure Program Code Challenges/Shipment

HFCi

Red blood cell fluid count z 3

hite blood cell fluid count z 3

Differential z 3

This program meets the CAP’s Accreditation Program requirements.

Program Information• Two 1.2-mL simulated gastric

fluid specimens


Program Information• Three 2.0-mL simulated

gastric specimens



hemolysate samples


Program Information• Three 1.0-mL simulated body

fluid specimens


Program Information• Three 2.0-mL simulated body

fluid specimens

• Designed for internationallaboratories that haveexperienced significantshipping and receivingissues and need longerprogram stability


New

Clinical Microscopy

800-323-4040 | 847-832-7000 Option 1 | cap.org 137

Hematology

andC

linicalMicroscopy

11

Lamellar Body Count LBCProcedure Program Code Challenges/Shipment

LBC

Lamellar body count z 3

Occult Blood OCBAnalyte Program Code Challenges/Shipment

OCB

Occult blood z 3

Rupture of Fetal Membranes Testing ROM1Procedure Program Code Challenges/Shipment

ROM1

Rupture of fetal membranes z 3

Special Clinical Microscopy SCM1, SCM2Analyte/Procedure Program Code Challenges/Shipment

SCM1 SCM2

rine hemosiderin, Prussian blue z 3

rine eosinophils, right stain z 3

Ticks, Mites, and Other Arthropods TMOProcedure Program Code Challenges/Shipment

TMO

Tic , mite, and arthropod identification z 3


amniotic fluid specimens

• For use with LBC methodsperformed on all hematologyanalyzers


Program Information• Three 2.0-mL simulated fecal

specimens


Program Information• Three 0.5-mL, simulated

vaginal specimens formethods such as Amnisureand Clinical Innovations


Program Information• Three images, each available

as photographs and onlineimages





Clinical Microscopy


Hem

atol

ogy

and

Clin

ical

Mic

rosc

opy

11

Urine Albumin (Microalbumin)/Creatinine UMCAnalyte/Procedure Program Code Challenges/Shipment

UMC

Creatinine z 2

rine albumin (microalbumin)creatinine ratio

z 2

rine albumin (microalbumin),semi uantitative

z 2

For quantitative reporting, refer to Survey U, page 61.

Worm Identification WIDProcedure Program Code Challenges/Shipment

WID

orm identification z 3

Program Information• Two 5.0-mL li uid urine

specimens

• For use with dipstic andsemi uantitative methods only





Put fast identification of cells at your fingertipsUrinalysis Benchtop Reference Guide (UABRG)• Thirty-four different cell identifications, including

common and rare cells• Detailed descriptions for each cell morphology• Eight tabbed sections for easy reference

o Urinary Cellso Urinary Castso Urinary Crystals

At Acid pAt eutral or Acid pAt eutral or Alkaline p

o Organismso Miscellaneous/Exogenous

• A durable and water-resistant format—5" by 6½" andspiral bound to withstand years of benchtop use.

Add code UABRG to your Surveys order form.


ReproductiveM

edicine

12

Reproductive MedicineAndrology and Embryology ............................................................................................................140

12 | Reproductive Medicine

“The CAP covers everything and their Surveys arethorough. They are at the cutting edge and givegood comparative data which we use for ourperformance improvement. I will continue to useCAP PT for our entire test menu—I feel that it is justanother good measure to ensure that we’re turningout quality results for our patients.”

Andrology and Embryology


Repr

oduc

tive

Med

icin

e

12

Andrology and EmbryologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Semen Analysis SC, SC1, PV, SM, SV, ASAProcedure Program Code Challenges/

Shipment

SC SC1 PV SM SV ASA

Sperm count & presence/absence(manual methods and CASA systems)

z 2

Sperm count & presence/absence(automated methods)

z 2

Postvasectomy sperm count &presence/absence

z 2

Sperm morphology z 2

Sperm viability z 2

Antisperm antibody IgG z 2

Sperm Motility, Morphology, and ViabilitySMCD, SM1CD, SM2CD


SMCD SM1CD SM2CD

Sperm count z 2

Sperm motility/forwardprogression

z 2

Sperm morphology z 2

Sperm viability z 2

Additional Information• DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust the magnification of the whole slide image.

Program Information• SC - Two 0. -mL stabilized

human sperm specimens

• SC1- Two 1.0-mL stabilizedhuman sperm specimens

• PV - Two 0. -mL stabilizedhuman sperm specimenswith counts appropriate forpostvasectomy testing

• SM - Two prepared slidesfor staining

• SV - Two eosin-nigrosin-stained slides

• ASA - Two 0. -mL serumspecimens


Program Information• SMCD - One CD-ROM with

video clips

• SM1CD - Two challenges,each available as imageson CD-ROM and onlinewhole slide images poweredby DigitalScope® technology

• SM2CD - Two challenges,each available as imageson CD-ROM and onlinewhole slide images poweredby DigitalScope technology


Andrology and Embryology

800-323-4040 | 847-832-7000 Option 1 | cap.org 141

ReproductiveM

edicine

12

Embryology EMBProcedure Program Code Challenges/Shipment

EMB

Embryo transfer and quality assessment(three- and five-day-old embryos)

z 4

Ligand Assay, Special Y, YY, DYAnalyte Program Code Challenges/Shipment

Y, YY DY

11-deoxycortisol z

17-hydroxyprogesterone z

Androstenedione z

DHEA sulfate z

Estradiol z

Estriol, unconjugated (uE ) z

Follicle-stimulating hormone (FSH) z

Growth hormone (GH) z

IGF-1 (somatomedin C) z

Luteinizing hormone (LH) z

Progesterone z

Prolactin z

Testosterone z

Testosterone, bioavailable z

Testosterone, free z

Sex hormone-binding globulin (SHBG) z

Antimüllerian Hormone AMHAnalyte Program Code Challenges/Shipment

AMH

Antim llerian hormone (AMH) z

Program Information• One CD-ROM with video

clips


Program Information• Y - Six 5.0-mL li uid serum

specimens (two duplicate sets)

• YY - Nine 5.0-mL li uidserum specimens (threeduplicate sets)

• DY - Must order in conjunctionwith Survey Y or YY




serum specimens


Deliver the best in patient care when youintegrate the CAP’s proficiency testing,accreditation, and education programs• Provide comprehensive, scientifically endorsed laboratory

standards, proficiency testing/EQA, and educational programs• Offer a comprehensive view of the laboratory for ongoing

monitoring of quality performance• Educate laboratory staff with a complete offering of programs

supported by peer groups and scientific leaders that provide aunique balance of regulatory and educational coaching

• Take the guesswork out of laboratory compliance• Gain global quality recognition• Reduce the risk of inaccurate and unreliable test results

CAP accreditation programs customized to meet your patient careneeds include:• Laboratory Accreditation• Reproductive Laboratory Accreditation• Forensic Drug Testing Accreditation• Biorepository Accreditation• CAP 15189™ Accreditation

To learn more, visit cap.org and choose the LaboratoryImprovement Programs tab.

“Participating in CAPLaboratory mprovementPrograms, which aredeveloped by leadingexperts, provides confidencethat your laboratory is doingthe right thing. The CAPaccreditation checklistsystem is an incredibleresource for keeping up withdaily management, newCL A and CAP requirementsand ensuring that you’reperforming high qualitytesting. No other proficiencytesting provider developsprograms for the newesttechnologies as rapidly andeffectively as the CAP.”

Elizabeth Wagar, MD, FCAPProfessor & Chair,Department ofLaboratory edicineThe niversity of Te as DAnderson Cancer Center

Accreditation ProficiencyTesting/EQA

CAP Education

Coagulation

13

13 | Coagulation

“As an executive director, it’s important to me tokeep proficiency testing with the CAP to standardizePT throughout all my laboratories—that way I cansee and understand when there are problems inparticular laboratories.”

Coagulation


Coa

gula

tion

13

CoagulationAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Listing 50:50 mixing study, PT and APTT

Activated partial thromboplastin time

Activated protein C resistance

Alpha-2-antiplasmin

Anti-beta-2-glycoprotein (IgG and IgM)

Antiphospholipid antibody (IgG, IgM, and IgA)

Antithrombin activity/antigen

Dilute prothrombin time

Dilute Russell’s viper venom time

Euglobulin test

Factors II, V, VII, VIII, IX, X, XI, XII, and XIII

Factor VIII assay

Fibrin monomer

Fibrinogen activity

Fibrinogen antigen

Heparin-induced thrombocytopenia (HIT)

High molecular weight kininogen

Kaolin-activated APTT

Kaolin clotting time

Lupus anticoagulant

Plasminogen activator inhibitor

Plasminogen activity/antigen

Prekallikrein

Protein C

Protein S

Prothrombin fragment 1.2

Prothrombin time

Reptilase time

Thrombin-antithrombin

Thrombin time

Tissue plasminogen activator

von Willebrand factor activity: - Collagen binding - Glycoprotein Ib binding - Ristocetin cofactor

von Willebrand factor antigen

von Willebrand multimer analysis

Coagulation, Limited CGL, CGDFAnalyte Program Code Challenges/Shipment

CGL CGDF

Activated partial thromboplastin time z 5

Fibrinogen z 5

International normalized ratio (INR)* z 5

Prothrombin time z 5

D-dimer z z 2 per year

Fibrin(ogen) degradation products, plasma

z z 2 per year

Fibrin(ogen) degradation products, serum z z 2 per year

*Participants reporting INR results will receive a special evaluation to assess the INR calculation.

Coagulation, Extended CGE, CGEXAnalyte Program Code Challenges/Shipment

CGE, CGEX

See analyte listing below z 2

Program Information• CGL - Five 1.0-mL lyophilized

plasma specimens; three shipments per year; one 1.0-mL lyophilized plasma specimen; one 1.0-mL serum specimen; two shipments per year

•CGDF-One1.0-mLserumspecimen; one 1.0-mL lyophilized plasma specimen; two shipments per year

Program Information•CGE-Six1.0-mL

lyophilized plasma specimens (three duplicate vials for each challenge)

•CGEX-Ten1.0-mLlyophilized plasma specimens (five duplicate vials for each challenge)


Coagulation

800-323-4040 | 847-832-7000 Option 1 | cap.org 145

Coagulation

13

Coagulation Special Testing Series CGS1, CGS2, CGS3, CGS4, CGS5, CGS6

Module/Analyte Challenges/Shipment

Program Code

CGS1 CGS2 CGS3 CGS4 CGS5 CGS6

Activated partial thromboplastin time*

2 2 3

International normalized ratio (INR)

2 3

Prothrombin time* 2 3

Lupus Anticoagulant and Mixing Studies Module

Dilute Russell’s viper venom time 2

Lupus anticoagulant (confirmation and screen)

2

50:50 mixing studies, PT and APTT 2

Thrombophilia Module

Activated protein C resistance

2

Antithrombin (activity, antigen)

2

Protein C (activity, antigen) 2

Protein S (activity, free antigen, total antigen)

2

von Willebrand Factor Antigen Module

Factor VIII assay 2

von Willebrand factor (antigen, activity, multimers)

2

Heparin Module

Heparin activities using methodologies including Anti Xa (unfractionated low molecular weight, and hybrid curve)

3

Thrombin time 3

Heparin-Induced Thrombocytopenia Module

Appropriate with methods such as Gen-Probe Lifecodes PF4 IgG and Gen-Probe Lifecodes PF4 Enhanced® assays

2

Appropriate with the Akers Biosciences, Inc. PIFA® Heparin/Platelet Factor 4 Rapid Assay

3

*Not appropriate for meeting regulatory requirements, see page 144.

Program Information•CGS1,CGS2,CGS3-Atotal

of two 2.0-mL lyophilized plasma specimens

•CGS4-Three1.0-mL lyophilized plasma specimens

•CGS5-Two60.0-µLserum specimens

•CGS6-Three50.0-µLlyophilized serum specimens


Coagulation


Coa

gula

tion

13

Dabigatran, Fondaparinux,Rivaroxaban Anticoagulant Monitoring

DBGN, FNPX, RVBNAnalyte Program Code Challenges/Shipment

DBGN FNPX RVBN

Activated partial thromboplastin time* z z z 3

Prothrombin time* z z z 3

Thrombin time z 3

Dabigatran z 3

Fondaparinux z 3

Rivaroxaban z 3

*Not appropriate for meeting regulatory requirements, see page 144.

Activated Clotting Time SeriesCT, CT1, CT2, CT3, CT5

Instrument/Cartridge Program Code Challenges/Shipment

CT CT1 CT2 CT3 CT5

Helena Actalyke® z 3

Helena Cascade POC z 3

IL Gem® PCL ACT z 3

IL Gem PCL ACT-LR z 3

IL GEM PCL Plus ACT z 3

IL GEM PCL Plus ACT-LR z 3

ITC Hemochron® CA510/FTCA510 z 3

ITC Hemochron FTK-ACT z 3

ITC Hemochron Jr. Signature/ACT+ z 3

ITC Hemochron Jr. Signature/ACT-LR

z 3

ITC Hemochron P214/P215 z 3

i-STAT® Celite® and Kaolin ACT z 3

Medtronic HemoTecACT/ACTII/ACT Plus HR-ACT

z 3

Medtronic HemoTecACT/ACTII/ACT Plus LR-ACT

z 3

Medtronic HemoTecACT/ACTII/ACT Plus R-ACT

z 3

Medtronic Hepcon HMS, HMS Plus z 3

Sienco Sonoclot® z 3


specimens


Program Information• CT - Three .0-mL lyophilized


• CT1 - Three 1.7-mL lyophilizedwhole blood specimens

• CT2, CT - Three 0.5-mLlyophilized whole bloodspecimens

• CT5 - Three 1.7-mL lyophilizedwhole blood specimens


Coagulation

800-323-4040 | 847-832-7000 Option 1 | cap.org 147

Coagulation

13

Platelet Function* PF, PF1Instrument/Method Program Code Challenges/Shipment

PF PF1

Platelet aggregation z 2

PFA-100 z 2

Helena Plateletworks® z 2

*This Survey requires the draw of a normal donor sample.

Thromboelastogram TEGInstrument/Method Program Code Challenges/Shipment

TEG

Thromboelastogram z 2

Coagulation Calibration Verification/LinearityLN35, LN36, LN37


LN35 LN36 LN37 Target Ranges

Antithrombin activity z 10%–130%

Protein C activity z 10%–100%

Heparin, low molecular weight z 0.1–2.0 U/mL

Heparin, unfractionated z 0.1–1.3 U/mL

von Willebrand factor antigen z 5%–140%

The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirementsHEM.38009, 38010, and 38011.


Program Information• PF - Four .2 sodium citrate

vacuum tubes; two 10.0-mLplastic tubes; two vials ofspecified agonists

• PF1 - Four .2 sodiumcitrate vacuum tubes; two10.0-mL plastic tubes

• Second instrument/methodreporting requires thepurchase of an additional kit


Program Information• Two 1.0-mL lyophilized whole

blood specimens

• For use with the Haemonetics™

Thromboelastograph® andROTEM® delta hemostasisanalyzers


Program Information• Six 1.0-mL frozen plasma

specimens per program

• Two shipments per year; shipson dry ice

Coagulation


Coa

gula

tion

13

D-Dimer CalibrationVerification/Linearity LN42


LN42 Target Ranges

D-dimer z 200-4,500 ng/mL FEU


Whole Blood CoagulationWP3, WP4, WP6, WP9, WP10

Analyte Challenges/Shipment

Program Code

WP3 WP4 WP6 WP9 WP10

International normalized ratio (INR) 5 5 5 5 3

Prothrombin time 5 5 5 5 –

For method compatibility, see instrument matrix below.

Whole Blood Coagulation, Instrument MatrixInstrument Program Code

WP3 WP4 WP6 WP9 WP10

Abbott CoaguSense™ z

Helena Cascade POC Citrated z

Helena Cascade POC Noncitrated z

ITC Hemochron Jr. Signature/Signature +, SignatureElite and Jr. II – Citrated cuvette

z

ITC Hemochron Jr. Signature/Signature +, SignatureElite and Jr. II – Noncitrated cuvette

z

IL GEM PCL, PCL Plus – Citrated z

IL GEM PCL, PCL Plus – Noncitrated z

i-STAT z

Roche CoaguChek XS Plus and XS Pro z

Roche CoaguChek XS System z

Program Information• Six 1.0-mL plasma specimens


Program Information• P - Five 1.0-mL lyophilized

plasma specimens

• P , P6 - Five 0.5-mLlyophilized whole bloodspecimens

• P9 - Five 0. -mL lyophilizedplasma specimens


• P10 - Three 0. -mLlyophilized plasma specimens;two shipments per year

Coagulation

800-323-4040 | 847-832-7000 Option 1 | cap.org 149

Coagulation

13


specimens

• For use with the SimpliRED®

and Clearview® SimplifyD-dimer methods


Program Information• Three lyophilized specimens

with diluents

• For use with the AccumetricsVerifyNow® System

• it includes sufficient materialto perform one assay; multipleassay reporting requires thepurchase of additional kits



urine specimens

• For use with Aspirin or s


Program Information• One .2 sodium citrate and

two heparin vacuum tubes;two 3.5-mL plastic tubes;one vial of 0.2M CaCl2

• For use with the HaemoneticsPlatelet Mapping® assay


Whole Blood D-Dimer WBDDAnalyte Program Code Challenges/Shipment

WBDD

D-dimer, qualitative z 2

Drug-Specific Platelet Aggregation PIAProcedure Program Code Challenges/Shipment

PIA

Aspirin assay z 3

PRU test z 3

llb/llla assay z 3

11-Dehydrothromboxane B2 TBXAnalyte Program Code Challenges/Shipment

TBX

11-dehydrothromboxane B2 z 3

Platelet Mapping* PLTMAnalyte Program Code Challenges/Shipment

PLTM

AA % aggregation/inhibition z 2

ADP % aggregation/inhibition z 2

*This Survey requires the draw of a normal donor sample.

Coagulation


Coa

gula

tion

13

Improve the reliability of your patient results with CAP Survey Validated MaterialsUse the same material that is sent in the Surveys program to:



Coagulation, Validated MaterialValidated Material Program Code Corresponding Survey Page

Coagulation VM CGM CGL 144

Program Information• Five 1.0-mL lyophilized

plasma specimens; threeshipments per year; one1.0-mL lyophilized plasmaspecimen and one 1.0-mLserum specimen; twoshipments per year

Everyday, I’m impressedby our customers’commitment to qualitypatient care.

– Lynne

“ “


Microbiology

14

MicrobiologyBacteriology ..................................................................................................................................152Mycobacteriology ..........................................................................................................................163Mycology......................................................................................................................................164Parasitology ..................................................................................................................................167Virology........................................................................................................................................171Molecular Microbiology..................................................................................................................173Infectious Disease Serology .............................................................................................................178

New Programs New

Gram-Negative Blood Culture Panel for Molecular Multiplex Testing (GNBC) .......................................158Stool Pathogen, without Shiga Toxin (SPN) .......................................................................................161Molecular MTB Detection and Resistance (MTBR)...............................................................................163C. trachomatis and N. gonorrhoeae DNA by Nucleic Acid Amplification (HC7) ...................................174Bacterial Strain Typing, Gram-Negative Organisms (BSTN) ................................................................175Nucleic Acid Amplification, Organisms without MTB (IDN).................................................................175

Discontinued ProgramsBreakpoint Implementation Tool (BIT)

14 | Microbiology

“In my state, especially, we’re very regulated and haveall these regulatory agencies coming in. The CAP isthe recognized laboratory standard and it’s great tobe compared with a large peer group. I’ve been amanager in a laboratory without the CAP and withthe CAP, and I will tell you that it is better to be withthe CAP!”

Bacteriology


Mic

robi

olog

y

14

BacteriologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Guide for Ordering Appropriate Bacteriology SurveysProcedure Program Code

D D4 D2 D7 D3 D1Bacterial identification z z z z z z

Gram stain z z z z z

Antimicrobial susceptibility testing z z z z

Bacterial antigen detection z z

Participants must report five specimens for each mailing to meet CLIA requirements for thesubspecialty of bacteriology. See the following pages for more detailed information abouteach Survey.

Bacteriology DProcedure Program Code Challenges/Shipment

DAntimicrobial susceptibility testing z 1 graded, 1 ungraded

Bacterial antigen detection z 2

Bacterial identification z 5

Gram stain z 1

Additional InformationAntigen detection challenges will be included in the following shipments:

• Shipment A C. difficile antigen/toxin and spinal fluid meningitis panel• Shipment B Spinal fluid meningitis panel and Group A Streptococcus• Shipment C C. difficile antigen/toxin and Group A Streptococcus

Program Information• Five swabs (in duplicate) with

diluents for culture

• Two specimens for bacterialantigen detection from thefollowing:

One swab for Group AStreptococcus

One 1.0-mL lyophilizedspecimen for spinal fluidmeningitis testing

One 0.5-mL lyophilizedspecimen for Clostridiumdifficile, for use with rapidor molecular testing methods


Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.

Bacteriology

800-323-4040 | 847-832-7000 Option 1 | cap.org 153

Microbiology

14


Expanded Bacteriology DEXAnalyte Program Code Challenges/Shipment

DEX

Live organisms z 2

Additional InformationExpanded Bacteriology (DEX) is an educational opportunity that provides:

• Culture and susceptibility testing challenges for microbiology laboratories thatperform complete identification and susceptibility of bacterial isolates including lesscommon or problematic bacteria

• More exposure to emerging bacterial pathogens and novel resistance mechanisms• Ability to recognize and identify organisms that exhibit multiple drug-resistance

patterns• Recovery and identification of mixed pathogens such as yeast, aerobic, and

anaerobic bacteria in cultures containing multiple organisms

Microbiology Bench ToolsCompetency MBT


MBT


Antimicrobial susceptibility testing z 2

Additional InformationMicrobiology Bench Tools for Competency (MBT) is a supplemental module forcompetency assessment and an educational resource for microbiology laboratories.The module:

• Provides organisms that challenge the basic elements of testing at the microbiologybench, including direct observation, monitoring, recording, and reporting of testresults

• Can be used for both competency and educational purposes, including teaching andtraining pathology residents, new employees, medical, and MT/MLT students

• Provides identification and susceptibility results for supervisor use

This is not a proficiency testing program and participants will not return results to the CAP.

Program Information• Two swabs (in duplicate)

with diluents to performbacterial identification andsusceptibility (when directed)


Program Information• Six challenges with diluents

for culture

• Results will be provided withthe kit to assess personnelcompetency


Bacteriology


Mic

robi

olog

y

14

GC, Throat, and Urine Cultures D1, D2, D3, D7Procedure Program Code Challenges/

Shipment

D1 D2 D3 D7

Antimicrobialsusceptibilitytesting

z z 1

Bacterialidentification z z z z 5

Gram stain z z z 1

Culture source: Throat Urine Cervical Throat/Urine

Microbiologiclevel:

Presence orabsence ofGroup A

Streptococ-cus deter-mination

Organismsidentified tothe extentof your

laboratory’sprotocol

Presence orabsence ofNeisseriagonor-rhoeae

determina-tion

Combinationof two throat

and threeurine culturespecimens

Limited Bacteriology D4Procedure Program Code Challenges/Shipment

D4

Antimicrobial susceptibility testing z 1

Bacterial antigen detection z 1


Gram stain z 1

Culture source: Microbiologic level

GC culturePresence or absence ofNeisseria gonorrhoeae

determination

Throat culturePresence or absence ofGroup A Streptococcus

determination

Urine cultureOrganisms identifiedto the extent of yourlaboratory’s protocol

Program Information• Five loop specimens

(in duplicate) with diluents


Program Information• Five loop specimens (in

duplicate) with diluents andone swab specimen

• Two throat culture specimens,two urine culture specimens,one susceptibility specimen,one GC culture specimen,and one bacterial antigendetection specimen for GroupA Streptococcus



Bacteriology

800-323-4040 | 847-832-7000 Option 1 | cap.org 155

Microbiology

14

Gram Stain D5Procedure Program Code Challenges/Shipment

D5

Gram stain z 5

Virtual Gram Stain VGS1, VGS2Procedure Program Code Challenges/Shipment

VGS1 VGS2

Virtual Gram stain basic z 3

Virtual Gram stain advanced z 3

Additional Information• Virtual Gram Stain Basic Competency (VGS1) is for general and new laboratory

technologists/technicians. Participants will assess the quality of specimens and stainsand will report artifacts and detailed gram-positive and gram-negative morphology.Challenges will include specimens such as CSF, body fluids and positive bloodcultures.

• Virtual Gram Stain Advanced Competency (VGS2) is for experienced laboratorytechnologists/technicians and microbiologists. Participants will receive challengingimages of sputum, body fluids, and other specimens to assess the quality, quantity, andtypical morphology of both gram-positive and gram-negative organisms appropriatefor the site.


• See system re uirements on page 15.

Program Information• Five air-dried, methanol-fixed

unstained glass slides



images

• Results included in the it toassess personnel competency




Bacteriology


Mic

robi

olog

y

14

Rapid Strep A Antigen Detection D6Procedure Program Code Challenges/Shipment

D6

Group A Streptococcus antigen detection z 5

Rapid Strep A Antigen Detection, Waived D9Procedure Program Code Challenges/Shipment

D9

Group A Streptococcus antigen detection z 2

Group B Strep Detection D8Procedure Program Code Challenges/Shipment

D8

Group B Streptococcus detection z 5

Program Information• Five swab specimens


Program Information• Two swab specimens


Program Information• Five swab specimens with

diluents

• Compatible with culture andmolecular methods


Check on your PT shipment with CAPTRAKerSM

Our CAPTRAKer electronic shipment tracking program* gives your labthe ability to locate your PT kit in an instant!

• Alerts you that your CAP PT kits have been shipped

• Allows you to track your shipment through a link

• Results in less worries

To begin receiving CAPTRAKer emails, send your name, CAP account number, and email addressto [email protected].

*CAP distributor customers—contact your distributor for your PT shipping information

SM

Bacteriology

800-323-4040 | 847-832-7000 Option 1 | cap.org 157

Microbiology

14

Bacterial Antigen Detection LBAS, SBASProcedure Program Code Challenges/Shipment

LBAS SBAS

Legionella pneumophilaantigen detection

z 2

Streptococcus pneumoniaeantigen detection

z 2

Blood Culture BCSProcedure Program Code Challenges/Shipment

BCS

Blood culture bacterial detection z 2

Blood Culture,Staphylococcus aureus BCS1


BCS1

Staphylococcus aureus z 3

Program Information• Two li uid simulated clinical

specimens


Program Information• Two challenges with diluents

for inoculation of bloodculture bottles


Program Information• Three specimens with diluents

for inoculation of bloodculture bottles

• Compatible with methods forrapid detection of S. aureus/MRSA/MSSA from positiveblood culture bottles



Bacteriology


Mic

robi

olog

y

14

Blood Culture Panels for Molecular Multiplex TestingGNBC, GPBC


GNBC GPBC

Identification of gram-negativeorganisms such as Acinetobacter,Citrobacter, Enterobacter, Proteus,Haemophilus, Klebsiella, Neisseria,Pseudomonas, Serratia, E. coli, andcommon resistance mechanisms isolatedfrom positive blood culture bottles

z 3

Identification of gram-positive organismssuch as Staphylococcus, Streptococcus,Enterococcus, Listeria, and commonresistance mechanisms isolated frompositive blood culture bottles

z 3

These Surveys are not for the inoculation of blood culture bottles.

PNA FISH PNA1, PNA2, PNA3, PNA4Analyte Program Code Challenges/Shipment

PNA1 PNA2 PNA3 PNA4

Staphylococcus z 3

Yeast z 3

Enterococcus z 3

Gram-negative rods z 3

Campylobacter CAMPAnalyte Program Code Challenges/Shipment

CAMP

Campylobacter z 2

Program Information• Three 1.0-mL li uid simulated

blood culture fluid specimens

• For laboratories usingmolecular multiplex panels


Program Information• Three challenges with diluents

for inoculation of blood culturebottles


Program Information• Two swabs with diluents

• For use with rapid antigen,culture-based testing, andmolecular methods



Bacteriology

800-323-4040 | 847-832-7000 Option 1 | cap.org 159

Microbiology

14

Chlamydia trachomatis HC1, HC3Procedure Program Code Challenges/Shipment

HC1 HC3

Antigen detection (DFA) z 5

Antigen detection (EIA) z 5

Fecal Lactoferrin FLACAnalyte Program Code Challenges/Shipment

FLAC

Fecal lactoferrin z 3

Helicobacter pylori Antigen, Stool HPSProcedure Program Code Challenges/Shipment

HPS

Helicobacter pylori antigen detection z 2

Laboratory Preparedness Exercise LPXAnalyte Program Code Challenges/Shipment

LPX

Live organisms z 3

Additional InformationThe Laboratory Preparedness Exercise (LPX) was developed as a collaborative effort betweenthe College of American Pathologists, the Centers for Disease Control and Prevention(CDC), and the Association of Public Health Laboratories (APHL). Laboratories will be sentlive organisms that either exhibit characteristics of bioterrorism agents or demonstrateepidemiologic importance and will be expected to respond following Laboratory ResponseNetwor Sentinel Laboratory Guidelines if a bioterrorism agent is suspected. All agentsprovided are excluded from the CDC’s select agent list. These may include strains ofBacillus anthracis, Yersinia pestis, Francisella tularensis, and Brucella abortus that have beenmodified and are safe for testing in a laboratory that contains a certified Class II BiologicalSafety Cabinet and is capable of handling Category A and B agents.

Program Information• HC1 - Five 5-well slide

specimens; for the detection ofchlamydial elementary bodiesby DFA

• HC - Five 2.0-mL li uidspecimens


Program Information• Three simulated stool

specimens

• For use with rapid methods


Program Information• Two 0.5-mL fecal suspensions


Program Information• Three specimens with diluents

• Not available to internationalcustomers due to UnitedStates export law restrictions



Bacteriology


Mic

robi

olog

y

14

Methicillin-Resistant Staphylococcus aureusScreen MRS


MRS

MRSA detection z 2

Methicillin-Resistant Staphylococcus aureusScreen MRS5


MRS5

MRSA detection z 5

Rapid Urease RURAnalyte Program Code Challenges/Shipment

RUR

Urease z 3

Program Information• Two swab specimens with

diluents

• For use with molecular methodsand culture-based testing


Program Information• Five swab specimens with

diluents

• For use with molecular methodsand culture-based testing


Program Information• Three simulated gastric

biopsy specimens

• For use with methodssuch as CLOTEST®



Bacteriology

800-323-4040 | 847-832-7000 Option 1 | cap.org 161

Microbiology

14

Stool Pathogen SP, SPN, SP1Analyte/Procedure Program Code Challenges/Shipment

SP SPN SP1

Adenovirus 40/41 z z 2

C. difficile z z 2

Rotavirus z z 2

Shiga toxin z 2

Norovirus z 1

Shiga Toxin STAnalyte Program Code Challenges/Shipment

ST

Shiga toxin z 2

Bacterial Vaginosis BVProcedure Program Code Challenges/Shipment

BV

Bacterial vaginosis detection z 3

Program Information• SP - Two 1.0-mL li uid

specimens; for use with rapidor molecular testing methods;not available to internationalcustomers due to UnitedStates export law restrictions

• SPN - Two 1.0-mL li uidspecimens; for use with rapidor molecular testing methods;intended for internationallaboratories

• SP1 - One 1.0-mL li uidspecimen



• For use with direct shiga toxintesting only; not compatiblewith culture methods,cytotoxicity assays, or PCR



Program Information• Three 1.0-mL li uid

challenges

• For OSOM® BVBlue users



Bacteriology


Mic

robi

olog

y

14

Vaginitis Screen VS, VS1Analyte Program Code Challenges/Shipment

VS VS1

Candida sp. z 5

Gardnerella vaginalis z 5

Trichomonas vaginalis z z 5

Vaginitis Screen, Virtual Gram Stain VS2Procedure Program Code Challenges/Shipment

VS2

Interpretation of Gram-stained vaginalsmears

z 3

Additional Information• DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image.


Vancomycin-Resistant Enterococcus VREProcedure Program Code Challenges/Shipment

VRE

Vancomycin-resistant Enterococcus(VRE) detection

z 2

Program Information• VS - Five swabs for DNA

probe technology; BD Affirm™

VP III probe detection method;three shipments per year

• VS1 - Five swabs for DNAprobe technology; SekisuiOSOM Trichomonas RapidTest and Gen-Probe APTIMA®

Trichomonas vaginalismethods; two shipmentsper year


images


• Two activities per year; yourCAP shipping contact will benotified via email when theactivity is available

Program Information• Two swabs with diluents

• For use with molecularmethods and culture-basedtesting



Mycobacteriology

800-323-4040 | 847-832-7000 Option 1 | cap.org 163

Microbiology

14

MycobacteriologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Mycobacteriology EProcedure Program Code Challenges/Shipment

E

Acid-fast smear z 1

Antimycobacterial susceptibility testing z 1 graded, 1 ungraded

Mycobacterial identification* z 5

*This procedure requires identification of Mycobacterium tuberculosis.

Limited Mycobacteriology E1Procedure Program Code Challenges/Shipment

E1

Acid-fast smear z 5

Mycobacterial culture z 5

Molecular MTB Detection and ResistanceMTBR


MTBR

Mycobacterium tuberculosis detection z 3

Rifampin resistance z 3

Program Information• Five simulated clinical

isolates with diluents and onespecimen for performing anacid-fast bacillus smear

• Identification may beperformed by culture ormolecular methods


Program Information• Five simulated specimens

for acid-fast smears and/orfor the determination of thepresence or absence ofacid-fast bacillus by culture


Program Information• Three simulated sputum

specimens for use withmolecular methods

• Not suitable for culture


New


Mycology


Mic

robi

olog

y

14

MycologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Mycology FProcedure Program Code Challenges/Shipment

F

Antifungal susceptibility testing z 1

Cryptococcal antigen detection z 2 per year

Mold and yeast identification z 5

Yeast F1Procedure Program Code Challenges/Shipment

F1

Antifungal susceptibility testing z 1

Cryptococcal antigen detection z 2 per year

Yeast identification z 5

Program Information• Five loops for culture (in

duplicate) with diluentsand one 1.0-mL simulatedcerebrospinal fluid specimen(A and B shipments only)

• Identification of yeast andmold may be performed byculture or molecular methods



duplicate) with diluentsand one 1.0-mL simulatedcerebrospinal fluid specimen(A and B shipments only)

• Identification of yeast maybe performed by culture ormolecular methods



Mycology

800-323-4040 | 847-832-7000 Option 1 | cap.org 165

Microbiology

14

Candida Culture F3Procedure Program Code Challenges/Shipment

F3

Yeast identification z 5

Galactomannan FGALAnalyte Program Code Challenges/Shipment

FGAL

Galactomannan - Aspergillus z 3

Fungal Serology FSERProcedure Program Code Challenges/Shipment

FSER

Serological detection of specificfungal antibodies

z 3

Fungal Smear FSMProcedure Program Code Challenges/Shipment

FSM

KOH preparation/calcofluor white z 3


duplicate) with diluents

• Contains Candida species

• Identification of Candidaspecies may be performed byculture, molecular, and rapidmethods

•Three shipments per year

Program Information• Three li uid specimens

• For use with methods such asBio-Rad Platelia™


Program Information• Three serum specimens

• For use with immunodiffusionmethods

• Designed for the detectionof antibodies to Aspergillus,Blastomyces, Coccidiodes,and Histoplasma


Program Information• Three slides



Mycology


Mic

robi

olog

y

14

India Ink INDProcedure Program Code Challenges/Shipment

IND

India Ink z 2

Pneumocystis jiroveci PCP1, PCP2, PCP3, PCP4


PCP1 PCP2 PCP3 PCP4

PCP – Calcofluor white stain z 3

PCP DFA stain z 3

PCP Giemsa stain z 3

PCP GMS stain z 3

Program Information• Two li uid specimens





Put fast indentification of fungi at your fingertipsMycology Benchtop Reference Guide (MBRG)• More than 70 fungal identifications of yeast and molds

commonly encountered in the clinical laboratory• Detailed descriptions of the most significant morphologic

elements, ecology, and clinical significance• Color images of macroscopic and

microscopic morphologies• Six tabbed sections for easy reference

o Yeast and Yeast-Like Fungio Molds With Narrow, Hyaline Hyphaeo Dimorphic Fungio Dermatophyteso Zygomyceteso Dematiaceous Molds

• A durable and water-resistant format— 6½" x 7" andspiral bound to withstand years of benchtop use

Add code MBRG to your Surveys order form.


Parasitology

800-323-4040 | 847-832-7000 Option 1 | cap.org 167

Microbiology

14

ParasitologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Parasitology P, P3, P4, P5Procedure Program Code

P P3 P4 P5

Fecal suspension (wet mount) z z z

Fecal suspension (Giardia and/orCryptosporidium immunoassay andmodified acid-fast stain)

z z z z

Giemsa-stained blood smear z

Preserved slide (for permanent stain) z z

Additional Information• The proficiency testing materials used for the Parasitology Surveys contain formalin

as a preservative.• Modified acid-fast stain results do not meet CLIA re uirements for parasite identification.

Program Information• P - Five specimens consisting

of thin and thick films forblood and tissue parasiteidentification; preserved slidesfor permanent stain; 0.75-mLfecal suspensions for directwet mount examination,photographs, and/or onlineimages; two 0.75-mL fecalsuspensions for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain

• P - Five 0.75-mL fecalsuspensions for directwet mount examination,photographs, and/or onlineimages; one 0.75-mL fecalsuspension for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain

• P - Five specimens consistingof 0.75-mL fecal suspensionsfor direct wet mountexamination, preservedslides for permanent stain,photographs, and/or onlineimages; one 0.75-mL fecalsuspension for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain

• P5 - Five 0.75-mL fecalsuspensions for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain


Parasitology


Mic

robi

olog

y

14

Blood Parasite BPProcedure Program Code Challenges/Shipment

BP

Thin/thick blood film sets* z 5

*This Survey will include corresponding thick films when available.

Rapid Malaria RMALProcedure Program Code Challenges/Shipment

RMAL

Rapid malaria detection z 3

Program Information• Five Giemsa-stained blood

film sets, photographs,and/or online images

• A variety of blood parasites,including Plasmodium,Babesia, Trypanosoma, andfilarial worms


Program Information• Three antigen specimens


Put fast identification of parasites at your fingertipsParasitology Benchtop Reference Guide (PBRG)• More than 70 identifications for parasites commonly

encountered in the clinical laboratory• Detailed descriptions of the parasite morphology, ecology,

and clinical significance• Color images of microscopic morphologies using routine

parasitology stains and preparations• Color images of macroscopic worms routinely submitted to

the clinical laboratory• Five tabbed sections for easy reference

o Blood Parasiteso Intestinal Protozoao Intestinal Helminthso Miscellaneous Specimenso Macroscopic Worms

A durable and water-resistant format—6½" by 7" and spiral boundto withstand years of benchtop use.

Add code PBRG to your Surveys order form.


Parasitology

800-323-4040 | 847-832-7000 Option 1 | cap.org 169

Microbiology

14

Ticks, Mites, and Other Arthropods TMOProcedure Program Code Challenges/Shipment

TMO

Tick, mite, and arthropod identification z 3

Worm Identification WIDProcedure Program Code Challenges/Shipment

WID

Worm identification z 3







Virology and Molecular Microbiology Testing


Mic

robi

olog

y

14

Do youperformmoleculartesting onChlamydiaor GC only?

Do youperformnucleic acidamplificationother thanGC?

Do youperformviral loadtestingonly?

Do youperformmolecularmultiplexing?

Do you perform any of the followingvirology testing?n virology culturen virology antigen testingn virology antibody testing

Select fromthefollowingSurveys:

n HC6,HC6X,HC7Chlamydia/GCNucleic AcidAmplification

Select fromthefollowingSurveys:n IDO, ID1,

ID1T,ID2, IDNNucleic AcidAmplification

n BSTE,BSTN,BSTSBacterialStrain Typing

Select fromthefollowingSurveys:n HIV,

HV2HIV Viral Load

n HCVN,HCV2,HBVL,HBVL5HepatitisViral Load

n VLS,VLS2Viral Load

Select fromthefollowingSurveys:n IDR

InfectiousDiseaseRespiratoryPanel

n GIPGastro -intestinalPanel

n GNBC,GPBCBlood CulturePanels

SelectVR1

SelectVR2

SelectVR4

SelectHC2

SelectHC4

For Comprehensive VirologyCulture Testing

For Virology AntigenTesting by Immunofluorescence

For Virology Antigen by EIA orLatex Agglutination

For Herpes Simplex VirusAntigen Detection by DFA

For Herpes Simplex VirusCulture Testing

Yes Yes Yes Yes Yes

Virology Molecular Microbiology

Virology and Molecular Microbiology Testingse this flowchart as a guide for ordering the appropriate Virology and Molecular Microbiology Surveys for your laboratory s

testing menu. For the subspecialty of virology, you must test five specimens per mailing. If you have any uestions, please callthe Customer Contact Center at 800-323-4040 or 847-832-7000 option 1.

SelectVR3/VR3M

For Viral Serology Testing

Virology

800-323-4040 | 847-832-7000 Option 1 | cap.org 171

Microbiology

14

VirologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Virology Culture VR1Procedure Program Code Challenges/Shipment

VR1

Chlamydia trachomatis culture z 1

Viral isolation/identification z 5

Educational challenge z 1 per year

Virology Antigen Detection (DFA) VR2Analyte/Procedure Program Code Challenges/Shipment

VR2 A B C

Adenovirus antigen z 1 1

Cytomegalovirus antigen z 1 1

Herpes simplex virus (HSV) antigen z 1 1

Influenza A antigen z 1 1

Influenza B antigen z 1

Parainfluenza antigen z 1 1

Respiratory syncytial virus (RSV)antigen z 1 1

Varicella-zoster antigen z 1 1

Educational challenge z 1

Program Information• Five 0.5-mL specimens for

viral culture and one 0.5-mLspecimen for Chlamydiatrachomatis culture


Program Information• Five 5-well slide specimens




Mic

robi

olog

y

14

Virology

Virology Antigen Detection (Non-DFA) VR4Analyte Program Code Challenges/Shipment

VR4

Adenovirus (Not 40/41) antigen z 5

Influenza A antigen z 5

Influenza B antigen z 5

Respiratory syncytial virus (RSV) antigen z 5

Rotavirus antigen z 5

Herpes Simplex Virus HC2, HC4Procedure Program Code Challenges/Shipment

HC2 HC4*

Antigen detection (DFA) z 5Culture z 5

*The biohazard warning applies to Survey HC4.

Program Information•Five1.5-mLspecimens

• Forusewithenzymeimmunoassayand/orlatexagglutinationmethods


Program Information•HC2-Five5-wellslide

specimens

•HC4-Five2.0-mLlyophilizedspecimens


RefertotheOrderingInformationprovidedforinformationregardingadditionaldangerousgoodsandrelatedfees.

Molecular Microbiology

800-323-4040 | 847-832-7000 Option 1 | cap.org 173

Microbiology

14

Molecular MicrobiologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Hepatitis Viral LoadHCVN, HCV2, HBVL, HBVL5

Analyte/Procedure Challenges/Shipment

Program Code

HCVN, HCV2 HBVL HBVL5

HCV genotyping 1

HCV, qualitative 1

HCV viral load 5

HBV viral load 2 5

HIV Viral Load HIV, HV2, HIVGProcedure Program Code Challenges/Shipment

HIV, HV2 HIVG

HIV-RNA viral load z 5

HIV genotyping z 1

Viral Load VLS, VLS2Analyte/Procedure Program Code Challenges/Shipment

VLS VLS2

BK viral load z z 2

CMV viral load z z 2

EBV viral load z z 2

Adenovirus viral load z 2

HHV6 viral load z 2

Program Information• HCVN - Five 0.5-mL li uid

plasma specimens

• HCV2 - Five 1.5-mL li uidplasma specimens

• HBVL - Two 1.25-mL plasmaspecimens

• HBVL5 - Five 2.0-mL plasmaspecimens


Program Information• HIV - Five 0.5-mL plasma

specimens

• HV2 - Five 2.5-mL plasmaspecimens

• HIVG - One 1.0-mL plasmaspecimen


Program Information• VLS - Six 1.0-mL EDTA

plasma specimens; twoshipments per year

• VLS2 - Ten 2.0-mL EDTAplasma specimens;three shipments per year



Mic

robi

olog

y

14

Viral Load Calibration Verification/Linearity LN38, LN39



CMV viral load z 0.3M–1.0M IU/L

HIV viral load z 0–10M copies/L


C. trachomatis and N. gonorrhoeae HC6, HC6X, HC7


HC6, HC6X HC7

Nucleic acid amplification (NAA) z z 5

Human Papillomavirus HPVAnalyte Program Code Challenges/Shipment

HPV

Human papillomavirus z 2

For laboratories using Digene, SurePath, and/or ThinPrep collection media, see page 246.

Program Information• LN38-Six1.5-mLfrozen

plasma specimens

•Twoshipmentsperyear;shipsondryice

• LN39-Six2.5-mLfrozenplasma specimens

•Twoshipmentsperyear;shipsondryice

Program Information•HC6-Threeswabspecimens

andtwo1.0-mLsimulatedurine specimens

•HC6X-Threeswabspecimens;twosimulatedurine specimens (in duplicate)

•HC7-Fivesimulatedbodyfluidspecimens;designedforCepheid users

•ForSurveysHC6andHC6X,useeachswabtoperformboth C. trachomatis and N. gonorrhoeae testing


Program Information•Twosimulatedcervical

specimens contained in Digene transport media

•ForDigeneHybridCaptureonly




800-323-4040 | 847-832-7000 Option 1 | cap.org 175

Microbiology

14

Bacterial Strain Typing BSTE, BSTN, BSTSAnalyte Program Code Challenges/Shipment

BSTE BSTN BSTS

Enterococcus z 2Gram-negative organisms* z 2Staphylococcus z 2

*Gram-negative organisms include Klebsiella sp., Acinetobacter sp., and Pseudomonas aeruginosa.

Nucleic Acid Amplification, Organisms IDO, IDNAnalyte/Procedure Program Code Challenges/Shipment

IDO IDN

Bordetella pertussis/parapertussis* z z 1

Legionella pneumophila/Chlamydophila pneumoniae*

z z 1

Methicillin-resistant Staphylococcus aureus z z 1

Molecular typing (bacterial isolates) z z 1

Mycobacterium tuberculosis z 1

Mycoplasma pneumoniae z z 1

Vancomycin-resistant Enterococcus z z 1

*Bordetella pertussis/parapertussis and Legionella pneumophila/Chlamydophila pneumoniae will be included in the following shipments: Shipment A: Bordetella pertussis and Chlamydophila pneumoniae Shipment B: Bordetella parapertussis and Legionella pneumophila

Program Information•Twosetsofloopswithdiluents


Program Information•IDO-Sevenliquidorswab

simulated clinical isolate specimens and two diluents

•IDN-Sixliquidorswabsimulated clinical isolate specimens and two diluents; designed for international laboratories that cannot receiveMTB





Mic

robi

olog

y

14

Nucleic Acid Amplification, Viruses ID1, ID1TAnalyte Program Code Challenges/Shipment

ID1 ID1T

Cytomegalovirus z 1

Enterovirus z 1

Epstein-Barr virus z 1

Herpes simplex virus z 1

Human herpesvirus 6 z 1

Human herpesvirus 8 z 1

Parvovirus B19 z 1

Varicella-zoster virus z 1

BK virus z 1

JC virus z 1

Nucleic Acid Amplification, Respiratory ID2Analyte Program Code Challenges/Shipment

ID2

Adenovirus z 1

Coronavirus/Rhinovirus* z 1

Human metapneumovirus z 1

Influenza virus* z 1

Parainfluenza virus z 1

Respiratory syncytial virus z 1

*Coronavirus/Rhinovirus and influenza virus will be included in the following shipments

• Shipment A Coronavirus and Influenza A• Shipment B Rhinovirus and Influenza B

Program Information• ID1- Eight 1.0-mL li uid

specimens

• ID1T - Two 1.0-mL li uidspecimens


Program Information• Six 1.0-mL li uid specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 177

Microbiology

14

Infectious Disease Respiratory Panelfor Molecular Multiplex Testing IDR


IDR

Adenovirus z 5

Human metapneumovirus z 5

Influenza A z 5

Influenza B z 5

Parainfluenza z 5

Respiratory syncytial virus z 5

Rhinovirus/Enterovirus z 5

Educational challenge (Bocavirus,Coronavirus, or Parainfluenza 4)

z 5

Gastrointestinal Panel for MolecularMultiplex Testing GIP


GIP

Campylobacter z 3

Clostridium difficile, toxin A/B z 3

Cryptosporidium z 3

Enterotoxigenic E. coli (ETEC) LT/ST z 3

Escherichia coli 0157 z 3

Giardia z 3

Norovirus GI/GII z 3

Rotavirus A z 3

Salmonella z 3

Shiga-like toxin producingE. coli (STEC) stx1/stx2

z 3

Shigella z 3

Program Information• Six li uid specimens

• Designed for molecularmultiplex panel users


Program Information• Three 1.0-mL simulated stool

specimens

• Designed for molecularmultiplex panel users



Infectious Disease Serology


Mic

robi

olog

y

14

Infectious Disease SerologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Infectious Disease Serology VR3, VR3MAnalyte Program Code Challenges/Shipment

VR3 VR3M

Cytomegalovirus (CMV) IgG, IgM, andtotal antibodies

z 1

Epstein-Barr virus (EBV) VCA IgG, IgMEBNA IgG, IgM, and total antibodiesEA IgG

z 1

Helicobacter pylori IgG, IgA, andtotal antibodies

z 1

Herpes simplex virus (HSV) IgG antibody z 1

Mycoplasma pneumoniae IgG, IgM, andtotal antibodies

z 1

Mumps IgG z 1

Rubeola virus (English measles) IgGantibody

z 1

Toxoplasma gondii IgG, IgM, andtotal antibodies

z 1

Varicella-zoster virus IgG andtotal antibodies

z 1

Tick-Transmitted Diseases TTDAnalyte Program Code Challenges/Shipment

TTD

Antibodies to tick-transmitted diseaseorganisms

z 3

Program Information• VR - Eight 0.5-mL

lyophilized plasma specimens

• VR M - One 0.5-mLlyophilized plasma specimen


Program Information• Three 0. -mL li uid specimens

• Designed for the detectionof antibodies to Borreliaburgdorferi, Babesiamicroti, and Anaplasmaphagocytophilum


Imm

unology and Flow C

ytometry

15Immunology and Flow CytometryImmunology...................................................................................................................................180Flow Cytometry..............................................................................................................................188

New Programs New

Antichromatin Antibody (ACA) ........................................................................................................182Antiribosomal-P Antibody (ARP) .......................................................................................................183Heavy Chain/Light Chain Analysis (HCA) ........................................................................................185

Discontinued ProgramsRare Flow Antigen Validation, CD103 (RFAV2)

15 | Immunology and Flow Cytometry

“The data we receive from CAP often drives changesthat are necessary to improve our performance.”

Immunology


Imm

unol

ogy

and

Flow

Cyt

omet

ry

15

ImmunologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

ImmunologyANA, ASO, CRP, HCG, IM, RF/RFX, RUB/RUBX, IL


ANA ASO CRP HCG IM RF/RFX

RUB/RUBX IL

Antinuclear antibody(ANA)* z z 5

Antistreptolysin O (ASO)* z z 5

C-reactive protein(qualitative/quantitative)

z z 2

hCG, serum (qualitative/quantitative) z z 5

Infectious mononucleosis z z 5

Rheumatoid factor* z z 5

Rubella (IgG)* z z 5

*Antinuclear antibody, Antistreptolysin O, Rheumatoid factor, and Rubella are regulatedanalytes and are graded for both qualitative and quantitative methods. Semiquantitativeand/or titer results for these analytes are ungraded/educational in this Survey and do notmeet regulatory requirements.

Immunology, General IG/IGXAnalyte Program Code Challenges/Shipment

IG/IGX

Alpha1-antitrypsin z 5

Complement C3 z 5

Complement C4 z 5

Haptoglobin z 5

IgA z 5

IgE z 5

IgG z 5

IgM z 5

Total kappa/lambda ratio z 5

Program Information• ANA and R B - Five 0.5-mL

liquid serum specimens

• ASO, HCG, and RF - Five1.0-mL li uid serumspecimens

• CRP - Two 0.5-mL li uidserum specimens; notappropriate for high-sensitivity CRP (hsCRP)methods

• IM - Five 0.6-mL li uid serumspecimens

• RF - All Survey RF specimensin duplicate

• R B - All Survey R Bspecimens in duplicate

• IL - All immunology specimensexcept RF and R B


Program Information• IG - Ten 1.0-mL li uid serum

specimens

• IG - All Survey IG specimensin duplicate


Immunology

800-323-4040 | 847-832-7000 Option 1 | cap.org 181

Imm

unology and Flow C

ytometry

15

Immunology, Special; Immunology Special, Limited;and H. pylori IgG Antibody S2, S4, S5


S2 S4 S5 A B C

Anticentromere antibody z 1 1

Anti-DNA antibody (ds) z z 1 1 1

Antiglomerular basementmembrane (GBM), IgG antibody

z 1 1

Antimitochondrial antibody z 1 1 1

Antineutrophil cytoplasmic antibody(ANCA, anti-MPO, anti-PR )

z 1 1

Anti-RNP antibody z 1 1 1

Anti-Sm antibody z 1 1 1

Anti-Sm/RNP antibody z 1 1 1

Antismooth muscle antibody z 1 1 1

Anti-SSA antibody z 1 1

Anti-SSB antibody z 1 1

Anti-SSA/SSB antibody z 1 1

Antithyroglobulin antibody z z 1 1 1

Antithyroid microsomal antibody z z 1 1 1

Antithyroid peroxidase antibody z z 1 1 1

Ceruloplasmin z z 1 1

Haptoglobin z z 1 1

Helicobacter pylori, IgG antibody z z

z

12

12

IgD z z 1 1 1

IgG z z 1 1

IgG subclass proteins z z 1 1

Prealbumin (transthyretin) z z 1 1

Total kappa/lambda ratio z z 1 1

Transferrin z z 1 1

Infectious Mononucleosis, Waived IMWAnalyte Program Code Challenges/Shipment

IMW

Infectious mononucleosis, waived z

Program Information• S2 - A minimum of seven

(0.5 to 1.0-mL/vial) li uidserum specimens

• S - A minimum of three(0.5 to 1.0-mL/vial) serumspecimens


• S5 - Two 1.0-mL serumspecimens; two shipmentsper year


specimens


Immunology


Imm

unol

ogy

and

Flow

Cyt

omet

ry

15

Antichromatin Antibody ACAAnalyte Program Code Challenges/Shipment

ACA

Antichromatin antibody z

Antifilamentous Actin IgG AntibodyFCN


FCN

Antifilamentous actin (f-actin)IgG antibody

z

Antihistone Antibody AHTAnalyte Program Code Challenges/Shipment

AHT

Antihistone antibody z

Antimitochondrial M2 Antibody HAnalyte Program Code Challenges/Shipment

H

Antimitochondrial M2antibody (AMA-M2)

z 2

Antiparietal Cell Antibody APCAnalyte Program Code Challenges/Shipment

APC

Antiparietal cell antibody z 2


specimens


New


specimens



specimens






Immunology

800-323-4040 | 847-832-7000 Option 1 | cap.org 183

Imm

unology and Flow C

ytometry

15

Antiphospholipid Antibody ACLAnalyte Program Code Challenges/Shipment

ACL

Anticardiolipin antibody(polyclonal, lgG, lgM, and lgA)

z

Beta-2-glycoprotein I(polyclonal, lgG, lgM, and lgA)

z

Antiphosphatidylserine Antibody APSAnalyte Program Code Challenges/Shipment

APS

Anticardiolipin antibody (polyclonal,IgG, IgM, and IgA)

z

Antiphosphatidylserine antibody(IgG, IgM, and IgA)

z

Beta-2-glycoprotein I (polyclonal,IgG, IgM, and IgA)

z

Antiribosomal-P Antibody ARPAnalyte Program Code Challenges/Shipment

ARP

Antiribosomal-P antibody z

Anti-Saccharomyces cerevisiae Antibody ASCAnalyte Program Code Challenges/Shipment

ASC

Anti-Saccharomyces cerevisiae antibody,lgG and lgA

z 2


serum specimens



serum specimens



specimens


New



Immunology


Imm

unol

ogy

and

Flow

Cyt

omet

ry

15

Celiac Serology CESAnalyte Program Code Challenges/Shipment

CES A B

Antiendomysial antibody, IgA and lgG z 2

Antiendomysial antibody screen, lgA and lgG z 2

Antigliadin antibody, lgA and lgG z 2

Antideamidated gliadin peptide antibody,lgA and lgG

z 2

Antideamidated gliadin peptide antibodyscreen, IgA and IgG

z 2

Antitissue transglutaminase antibody,lgA and lgG

z 2

Antideamidated gliadin peptide andantitissue transglutaminase antibody screen,IgA and IgG

z 2

Cyclic-Citrullinated PeptideAntibody (Anti-CCP) CCP


CCP

Anti-CCP z 2

Cytokines CTKNAnalyte Program Code Challenges/Shipment

CTKN

Interferon (IFN)-gamma z

Interleu in (IL)-1 beta z

IL-2 z

IL-6 z

IL-8 z

IL-10 z

Tumor necrosis factor (TNF)-alpha z

Vascular endothelial growth factor (VEGF) z

Program Information• Each shipment will contain the

appropriate number of0. -mL serum specimens




Program Information• Three 2.0- to .0-mL

lyophilized serum specimens


Immunology

800-323-4040 | 847-832-7000 Option 1 | cap.org 185

Imm

unology and Flow C

ytometry

15

Diagnostic Allergy SEAnalyte/Procedure Program Code Challenges/Shipment

SE

IgE, multiallergen screen ( ualitative) z 5

IgE, total z 5

Lateral flow immunoassay z 5

Specific allergens z 25

Educational challenges z 2 per year

Heavy Chain/Light ChainAnalysis HCA


HCA

IgA appa z

IgA lambda z

IgA appa/lambda ratio and ratiointerpretation

z

IgG appa z

IgG lambda z

IgG appa/lambda ratio and ratiointerpretation

z

IgM appa z

IgM lambda z

IgM appa/lambda ratio and ratiointerpretation

z

This program will target uni ue junctional epitopes between the constant regions ofimmunoglobulin heavy and light chains and will allow laboratories to identify the differentlight chain types of each immunoglobulin class.

High-Sensitivity/Cardiac C-Reactive Protein HSCRPAnalyte Program Code Challenges/Shipment

HSCRP

High-sensitivity/Cardiac C-reactive protein z

Program Information• Five 2.0-mL serum specimens

• Includes common allergensfrom North America as wellas less frequently testedallergens

• Also compatible with theImmunoCAP® Rapid InhalantProfile 1 device for allergentesting



specimens

• Two mailings per year

New


specimens


Immunology


Imm

unol

ogy

and

Flow

Cyt

omet

ry

15

Liver-Kidney Microsomal Antibody (Anti-LKM) LKMAnalyte Program Code Challenges/Shipment

LKM

Anti-L M z 2

M. tuberculosis-Stimulated Infection Detection QFAnalyte Program Code Challenges/Shipment

QF

M. tuberculosis z 2

Rheumatic Disease Special Serologies RDSAnalyte Program Code Challenges/Shipment

RDS

Anti- o-1 (antihistidyl t-RNA synthetase) z 1

Anti-Scl-70 (anti-DNA topoisomerase) z 1

Syphilis Serology GAnalyte Program Code Challenges/Shipment

G

Syphilis z 5

Use with VDRL, RPR, MHA-TP/TP-PA/PK-TP, EIA, CMIA, multiplex flow immunoassay,FTA-ABS, and USR methods. Laboratories performing syphilis serology on CSF specimensmay also use this Survey.

Total Hemolytic Complement CH50Analyte Program Code Challenges/Shipment

CH50

Total hemolytic complement, 50 lysis z 2

Total hemolytic complement, 100 lysis z 2




specimens and onelyophilized mitogen control

• For use with theuantiFERON®-TB method

only







serum specimens


Immunology

800-323-4040 | 847-832-7000 Option 1 | cap.org 187

Imm

unology and Flow C

ytometry

15

Viscosity VAnalyte Program Code Challenges/Shipment

V

Viscosity z 2

Serum Free Light Chains SFLCAnalyte Program Code Challenges/Shipment

SFLC

appa serum free light chain z

Lambda serum free light chain z

appa/lambda serum free lightchain ratio and ratio interpretation

z

Program Information• Two 10.0-mL serum

specimens



specimens


Rely on this reference for a rapidly growing fieldFlow Cytometry in Evaluation of Hematopoietic Neoplasms: A Case-Based Approach is a practical, case-based guide to flow cytometricanalysis in the workup of hematopoietic neoplasms presenting inthe peripheral blood, marrow, lymphoid tissue, and extranodal sites.Using multicolor techniques pioneered by Brent Wood, the textdemonstrates a unique approach to diagnosis of hematopoieticmalignancies as well as identification of small abnormal populationsin the posttherapy setting (minimal residual disease testing).

This text provides pathologists, residents, laboratory technologists,and hematologists with both a study guide and an atlas forregular consultation in the clinical flow cytometry laboratory.

To orderVisit cap.org and choose the Shop tabor call the CAP Customer Contact Centerat 800-323-4040 or 847-832-7000 option 1.

Item number: PUB221ISBN: 978-0-9837068-2-3Hardcover; 176 pages; 2012

PRESS


Flow Cytometry


Imm

unol

ogy

and

Flow

Cyt

omet

ry

15

Flow CytometryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Flow Cytometry FL, FL1, FL2Procedure Program Code Challenges/Shipment

FL FL1 FL2

DNA content and cell cycle analysis z z

Lymphocyte immunophenotyping z z

This Survey is not appropriate for hematology analyzers with monoclonal antibody analysis.

Flow Cytometry—ImmunophenotypicCharacterization of Leukemia/Lymphoma

FL3, FL3CDProcedure Program Code Challenges/Shipment

FL3 FL3CD

Leu emia/lymphoma z 2

Leu emia/lymphoma list modechallenge (CD-ROM)

z 2

Additional Information• Becton Dic inson (BD) Cell uest users may need FACSConvert™ software, which

is standard on most operating systems, to view the BD list mode files on theFL CD CD-ROM.

• Survey FL features DigitalScope technology that simulates the use of a microscope byenabling the user to scan and adjust magnification of the whole slide image.


Program Information• FL1 - Three 1.5-mL whole

blood specimens

• FL2 - Three 1.1-mLspecimens; two fixed cell linespecimens and onecalibrator for DNA contentand cell cycle analysis

• FL - All Survey FL1 and FL2specimens


Program Information• FL - Two .5-mL whole

blood specimens and/or celllines simulating leukemia/lymphoma; images of tissuesections, bone marrow, and/or peripheral blood smearswith clinical histories

• Online whole slide imagespowered by DigitalScopetechnology

• FL CD - CD-ROM containingtwo cases of leu emia/lymphoma with clinicalhistories, digital images,and ungated list mode files;allows users to examinegating strategies and interpretantibody staining patterns;the files are in standard FCS2.0 format and wor wellwith Cell uest™, FACSCanto/Diva™, Expo 2, R(C) P,and other software capableof reading the FCS 2.0 files(with the exception ofSystem II and Paint-A-Gate™

software)


Flow Cytometry

800-323-4040 | 847-832-7000 Option 1 | cap.org 189

Imm

unology and Flow C

ytometry

15

Flow Cytometry, CD34+ FL4Analyte Program Code Challenges/Shipment

FL4

CD z 2

Flow Cytometry, Interpretation Only FL5Procedure Program Code Challenges/Shipment

FL5

Flow cytometry, interpretation only z 2

Survey FL5 is for laboratories that receive flow cytometry analyses from referring laboratories toperform the interpretation of patient results.

Flow Cytometry – ImmunophenotypicCharacterization of Paroxysmal Nocturnal

Hemoglobinuria PNHAnalyte/Procedure Program Code Challenges/Shipment

PNH

PNH RBC analysis z 2

PNH BC analysis z 2

Additional InformationThe PNH Survey complies with the recommendations from the Guidelines for theDiagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria and RelatedDisorders by Flow Cytometry for RBC (eg, CD59 and CD2 5a) and BC (eg, CD15,CD2 , CD 5, and FLAER) analysis. Due to the uni ue nature of these human, donor-based materials, the shipping dates are subject to change. If this should occur, the CAPwill provide notification prior to the originally scheduled shipping date.


HBF



Program Information• Two 1.5-mL stabilized human

CD specimens


Program Information• Two cases consisting of gated

dot plots, clinical histories,and pertinent laboratory data,as well as images of tissuesections, bone marrow, and/or peripheral blood smears



specimens for RBC andBC analysis



blood specimens

• Not designed for F cellquantitation


Flow Cytometry


Imm

unol

ogy

and

Flow

Cyt

omet

ry

15

Rare Flow Antigen Validation, CD1a RFAV1Analyte Program Code Challenges/Shipment

RFAV1

CD1a z 1

Survey RFAV1 does not meet the regulatory requirements for proficiency testing.

Additional InformationThis Survey meets the CAP Accreditation Chec list item FLO.2 7 7, which re uiressemiannual testing of antigens.

ZAP-70 Analysis by Flow Cytometry ZAP70Analyte Program Code Challenges/Shipment

ZAP70

eta chain-associated protein inase 70 z

Additional InformationThis Survey tests for intracellular AP-70 staining of cell lines co-stained with panT- and B-cell mar ers. It allows for assessment of the laboratory s staining techni ues andthe antibody clone used for AP-70 detection.

Program Information• One .5-mL cell line

specimen


Program Information• Three .5-mL cell line

specimens


Download My PT Shipping Calendar to access your customizedshipping scheduleAccess your customized shipping calendar* through e-LAB Solutions™.Not enrolled in e-LAB Solutions? Go to cap.org to get started.

*CAP distributor customers—contact your distributor for your PT shipping scheduleS

O L U T IO

NS

. . . . . . . . . . .

..

..

..

..

..

..

...

-LAB TM

TransfusionM

edicine,ViralMarkers,and

ParentageTesting

16

Transfusion Medicine, Viral Markers, and Parentage TestingTransfusion Medicine......................................................................................................................192Viral Markers ................................................................................................................................201Parentage Testing ..........................................................................................................................204

New Programs New

Transfusion Medicine Competency Assessment—Eluate Test (TMCAE) ..................................................194Antibody Titer (ABT3) .....................................................................................................................196Red Blood Cell Antigen Typing (RBCAT) ...........................................................................................200

Discontinued ProgramsParentage/Relationship Testing (PAR)

See Survey PARF ..................................................................................................................................... 204

16 Transfusion Medicine, Viral Markers,and Parentage Testing

“In my state especially, we’re very regulated, andhave all these regulatory agencies coming in. TheCAP is the recognized laboratory standard andit’s great that you are compared to a large peergroup. I’ve been a manager in a laboratory withoutthe CAP and with the CAP, and I will tell you that itis better to be with the CAP!”

Transfusion Medicine


Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16

Transfusion MedicineAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Transfusion Medicine, Comprehensive/Limited J, J1Procedure Program Code Challenges/Shipment

J J1

ABO grouping z z 5

Rh typing z z 5

Antibody detection z 5

Antibody identification z 5

Compatibility testing z 5

Red blood cell antigen typing z 1

Transfusion Medicine Automated Testing JATProcedure Program Code Challenges/Shipment

JAT

ABO grouping z 5




Rh typing z 5

Transfusion Medicine Educational Challenges JE1Analyte/Program Program Code Challenges/Shipment

JE1


Program Information• - Five 2.0-mL red blood

cell suspensions; five .0-mLcorresponding serumspecimens; one 2.0-mL donorred blood cell suspension

• 1 - Five 2.0-mL redblood cell suspensions; five.0-mL corresponding serum

specimens


Program Information• Five bar-coded .0-mL

blood specimens and one.0-mL blood specimen for

compatibility testing


Program Information• One educational challenge,

which may consist of apaper challenge and/or wetspecimen for ABO grouping,Rh typing, antibody detection,antibody identification,compatibility testing, antigentyping, and/or directantiglobulin testing

• Must purchase in conjunctionwith Survey



800-323-4040 | 847-832-7000 Option 1 | cap.org 193

TransfusionM


ParentageTesting

16

Transfusion Medicine Automated,Educational Challenges JATE1

Analyte/Program Program Code Challenges/Shipment

JATE1

Eduational challenge z 1

Expanded TransfusionMedicine Exercises ETME1


ETME1

Expanded challenges z 2

Additional InformationSurvey ETME1 is an educational opportunity that offers

• More challenging and/or complex antibody identification• Comprehensive case studies in transfusion medicine• Simulated collaboration with other professionals, including those within or outside

your institution• A method for determining the laboratory s ability to recognize and integrate problem

solving s ills in transfusion medicineThe wet challenge may consist of specimens for ABO grouping, Rh typing, antibodydetection, antibody identification, compatibility testing, antigen typing, direct antiglobulintesting, antibody titer, and/or antibody elution.

Program Information• One educational challenge,

which may consist of apaper challenge and/or wetspecimen for ABO grouping,Rh typing, antibody detection,antibody identification,and/or compatibility testing

• Must purchase in conjunctionwith Survey AT


Program Information• ETME1 - One paper

challenge and one wetchallenge consisting of aserum specimen(s) and/orred blood cell suspensions




Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16

Transfusion Medicine Competency Assessment—Comprehensive Transfusion Medicine TMCA


TMCA

ABO grouping z 2




Rh typing z 2

Survey TMCA does not meet the regulatory requirements for proficiency testing.

Transfusion Medicine Competency Assessment—Direct Antiglobulin Test TMCAD


TMCAD

Direct antiglobulin testing z 2

Survey TMCAD does not meet the regulatory requirements for proficiency testing.

Transfusion Medicine CompetencyAssessment—Eluate Test TMCAE


TMCAE

Antibody elution z 2

Survey TMCAE does not meet the regulatory requirements for proficiency testing.

Transfusion Medicine Competency Assessment—Fetal Red Cell Quantitation TMCAF


TMCAF



Survey TMCAF does not meet the regulatory requirements for proficiency testing.

Program Information• Two 2.0-mL red blood cell

suspensions

• Two .0-mL correspondingserum specimens

• One 2.0-mL donor redblood cell suspension

• Three shipments per year;order shipments individuallyor for an entire year

Program Information• Two 2.0-mL red

blood cell suspensions

• Two shipments per year;order shipments individuallyor for an entire year

Program Information• Two 2.0-mL 50 red blood

cell suspensions


New


specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 195

TransfusionM


ParentageTesting

16

Transfusion Medicine, Electronic Crossmatch EXMProcedure Program Code Challenges/Shipment

EXM

Electronic crossmatch z

Survey E M assists laboratories in monitoring the performance of their electroniccrossmatching system.

Transfusion Medicine Automated,Electronic Crossmatch EXM2


EXM2

Electronic crossmatch z

Survey E M2 assists laboratories in monitoring the performance of their electroniccrossmatching system.

Program Information• Three simulated, ISBT-128

labeled donor unit challengesand three corresponding redblood cell suspensions

• Must order in conjunction withSurvey


Program Information• Three simulated, ISBT-128

labeled donor unit challengesand three corresponding redblood cell suspensions

• Must purchase in conjunctionwith Survey AT


The guidance I providefor PT ordering and resultsassures my customers thateverything will be okay.

– Tiffani

“ “




Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16

Antibody Titer ABT, ABT1, ABT2, ABT3Analyte/Procedure Program Code Challenges/Shipment

ABT ABT1 ABT2 ABT3

Anti-A titer z z 1

Anti-B titer z 1

Anti-D titer z z 1

Program Information• ABT - One 2.0-mL plasma

specimen for anti-A titerwith one corresponding titercell ( to red bloodcell suspension); one 2.0-mLplasma specimen for anti-Dtiter with one correspondingtiter cell ( to red bloodcell suspension)

• ABT1- One 2.0-mL plasmaspecimen for anti-A titer withone corresponding titer cell( to red blood cellsuspension)

• ABT2 One 2.0-mL plasmaspecimen for anti-D titer withone corresponding titer cell( to red blood cellsuspension)

• ABT - One 2.0-mL plasmaspecimen for anti-B titer withone corresponding titer cell( to red blood cellsuspension)



800-323-4040 | 847-832-7000 Option 1 | cap.org 197

TransfusionM


ParentageTesting

16

Bacterial Detection in Platelets BDP, BDP5Procedure Challenges/Shipment

Program Code

BDP BDP5

Bacterial culture and detection systems 2 5

Additional Information• The Centers for Medicare Medicaid Services (CMS) re uires proficiency testing for

bacterial detection in platelets.• Survey BDP is designed for donor centers/laboratories that are associated with

a CMS-certified microbiology laboratory with the same CLIA number and areparticipating in an approved proficiency testing program for bacterial detection.

• Survey BDP5 is designed for donor centers/laboratories that are performing bacterialdetection for the purposes of platelet unit screening and are not associated with aCMS-certified microbiology laboratory with the same CLIA number.

• See International Shipping information section in the Ordering InformationSupplement regarding additional dangerous goods shipping fees.

Bacterial Detection in Platelets, RapidBDPV, BDPV5

Procedure Challenges/Shipment

Program Code

BDPV BDPV5

Rapid immunoassay 2 5

Additional Information• The Centers for Medicare and Medicaid Services (CMS) re uires proficiency testing

for bacterial detection in platelets.• Survey BDPV is designed for donor centers/laboratories that are associated with

a CMS-certified microbiology laboratory with the same CLIA number and areparticipating in an approved proficiency testing program for bacterial detection.

• Survey BDPV5 is designed for donor centers/laboratories that are performingbacterial detection for the purposes of platelet unit screening and are not associatedwith a CMS-certified microbiology laboratory with the same CLIA number.

• See International Shipping information section in the Ordering InformationSupplement regarding additional dangerous goods shipping fees.

Program Information• BDP - Two lyophilized pellet

specimens with diluents; twoshipments per year

• BDP5 - Five lyophilized pelletspecimens with diluents; threeshipments per year

Program Information• BDPV - Two frozen

specimens; two shipmentsper year

• BDPV5 - Five frozenspecimens; three shipmentsper year

• For use with methods such asVerax Biomedical




Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16

Cord Blood and Stem Cell Processing CBT, SCPProcedure Program Code Challenges/Shipment

CBT SCP

Absolute CD z 2

Absolute CD z z 2

Absolute CD 5 z 2

Bacterial culture z z 2

CD z 2

CD z z 2

CD 5 z z 2

BF -E z z 2

CF -E z z 2

CF -GEMM z z 2

CF -GM z z 2

Total CFC z z 2

Fungal culture z z 2

Hematocrit z z 2

Hemoglobin z z 2

Mononuclear cell count z z 2

Total nucleated cells z z 2

Total nucleated red cells z z 2

Viability z z 2

BC count z z 2

Additional Information• Because these materials are human donor-based, the ship date is subject to change.

If this should occur, notification will be provided prior to the scheduled date. In someinstances, the program may ship in two installments.

• Due to material stability, no replacements will be available.• See International Shipping information section in the Ordering Information

Supplement regarding additional dangerous goods shipping fees.

Direct Antiglobulin Testing DATProcedure Program Code Challenges/Shipment

DAT

Direct antiglobulin testing z

Program Information• CBT - Two 2.5-mL cord blood

specimens; designed forassays re uired for theproduction of umbilical cordblood stem cell programs

• SCP - Two .0-mL peripheralblood specimens; designedfor laboratories that processand assess the suitability ofstem cells


Program Information• Three 2.0-mL red blood

cell suspensions




800-323-4040 | 847-832-7000 Option 1 | cap.org 199

TransfusionM


ParentageTesting

16

Eluate Survey ELUProcedure Program Code Challenges/Shipment

ELU

Antibody elution z 2


HBF



Platelet Serology PSProcedure Program Code Challenges/Shipment

PS

Antibody detection z

Platelet crossmatch z

Platelet antibody identification z

A low concentration of sodium azide may be present in the specimens and may affectlymphocytotoxicity methods.

Red Blood Cell AntigenGenotyping RAG


RAG

Red cell antigen genotype withpredictive phenotype

z

Program Information• Two 2.0-mL 50 red blood

cell suspensions



blood specimens

• Not designed for F celluantitation


Program Information• Three .0-mL plasma

specimens

• For use with solid-phasered cell adherence, flowcytometry, EIA/ELISA, andRIA methods



specimens




Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16

Red Blood Cell Antigen Typing RBCATProcedure Program Code Challenges/Shipment

RBCAT

Red blood cell antigen typing z 2

Additional InformationSurvey RBCAT is for donor centers and transfusion laboratories performing redcell phenotyping for the management of patients with complex serology includingalloimmunization, sic le cell disease and/or warm autoimmune hemolytic anemia.Challenges will include antigens such as Rh, ell, MNSs, Duffy, and idd bloodgroup system.

Transfusion-Related Cell Count TRCProcedure Program Code Challenges/Shipment

TRC

Platelet count (platelet-rich plasma) z 5

BC count z

Dry challenge z 2

WBC counts must be performed using a Nageotte chamber, fluorescence microscopy or byflow cytometry.

Program Information• Two 2.0-mL red blood cell

suspensions


New

Program Information• Five 1.2-mL suspensions of

platelet-rich plasma

• Two 1.0-mL vials leu ocyte-reduced platelet material

• Two 1.0-mL vials leu ocyte-reduced red blood cells


Viral Markers

800-323-4040 | 847-832-7000 Option 1 | cap.org 201

TransfusionM


ParentageTesting

16

Viral MarkersAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Viral Markers—Series 1 VM1Analyte Program Code Challenges/Shipment

VM1

Anti-HAV (total IgM and IgG) z 5

Anti-HAV (IgG) z 5

Anti-HBc (total: IgM and IgG) z 5

Anti-HBs z 5

Anti-HCV z 5

Anti-HIV-1 z 5

Anti-HIV-1/2 z 5

Anti-HIV-2 z 5

HBsAg z 5

Do not use Survey VM1 with rapid anti-HCV, anti-HIV-1, or anti-HIV-1/2 kits. See page 202 forSurveys appropriate for rapid methods.


VM2

Anti-HBe z 5

HBeAg z 5


VM3

Anti-CMV z

Anti-HTLV-I/II z

HIV-1 p2 antigen z

Program Information• Five .5-mL plasma specimens


Program In formation• Five .5-mL plasma specimens


Program Information• Three .5-mL plasma

specimens


Viral Markers


Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16


VM4

Anti-Trypanosoma cruzi (Chagas disease) z 2


VM5

Anti-HAV (IgM) z 5

Anti-HBc (IgM) z 5


VM6

Anti-HIV-1/2, HIV-1 p2 antigen z 5

Rapid Anti-HIV AHIV, AHIVWAnalyte/Procedure Program Code Challenges/Shipment

AHIV AHIVW

Anti-HIV-1, Anti-HIV-2, Anti-HIV-1/2 z 5

Anti-HIV-1, Anti-HIV-1/2,waived methods only

z 2

Anti-HCV, Rapid Methods RHCVWAnalyte/Procedure Program Code Challenges/Shipment

RHCVW

Anti-HCV, waived methods only z

Program Information• Two 1.0-mL plasma

specimens


Program Information• Five 1.5-mL plasma

specimens



• For use with methods such asthe Abbott ARCHITECT HIVCombo and the Bio-Rad GSHIV Combo assays


Program Information• AHIV - Five 0.5-mL plasma

specimens; second methodreporting available; threeshipments per year

• AHIV - Two 0.5-mL plasmaspecimens; report up to fivedifferent locations within yourinstitution; two shipmentsper year

Program Information• Three 0.5-mL plasma

specimens


Viral Markers

800-323-4040 | 847-832-7000 Option 1 | cap.org 203

TransfusionM


ParentageTesting

16

Nucleic Acid Testing NATAnalyte Program Code Challenges/Shipment

NAT

HBV z 5

HCV z 5

HIV z 5

est Nile virus z 5

Program Information• Five 6.0-mL plasma specimens

• Designed for blood donorcenters performing nucleicacid testing on donor units

• Compatible with HIV, HCV,and HBV multiplex assays


Parentage Testing


Tran

sfus

ion

Med

icin

e,Vi

ralM

arke

rs,a

ndPa

rent

age

Test

ing

16

Parentage Testing

Parentage/Relationship Testing PARFAnalyte/Procedure Program Code Challenges/Shipment

PARF

Calculation challenge (paper challenge) z 1

DNA testing (PCR) z

Program Information• Three blood-stained filter

paper paternity triospecimens; two buccal swabsfor a second alleged fatherchallenge

• Reporting for short tandemrepeats (STRs), Y-STRs, as wellas the conclusions provided


Let them know you’ve earned the markThe CAP certification mark recognizes organizations worldwidefor achieving CAP accreditation. Today, this honor is sharedwith more than 7,600 laboratories. The mark is a way to displayto peers, patients, and the public that you’ve attained CAPaccreditation through the most respected and recognizedlaboratory accreditation program in the world.

The CAP certification mark may be displayed on your website, advertisements, laboratory reports,and in patient areas to communicate your CAP accreditation status.

To access and download your CAP certification mark, please log in to your e-LAB Solutions™account, or contact the CAP Customer Contact Center at [email protected].

Histocompatibility

17

New Programs New

Antibody Titer (ABT3) .....................................................................................................................208HLA Disease Association, Drug Risk (DADR1, DADR2) .......................................................................209

17 | Histocompatibility

“We really like the range of programs the CAP offers.Within each area we can see how we can becomemore efficient. It’s always reassuring to the physiciansto say we have never failed a proficiency testingchallenge from the CAP.”

Histocompatibility


Hist

ocom

patib

ility

17

HistocompatibilityAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

For laboratories conducting BOTH Class I and Class II HLA testing, see next page.

HLA Crossmatching, Antibody Screen, and AntibodyIdentification (Class I) MX1B, MX1C, MX1E


MX1B MX1C MX1E

Crossmatching z z 8

Antibody screen z z z 4

Antibody identification z z z 4

HLA Crossmatching, Antibody Screen, and AntibodyIdentification (Class II) MX2B, MX2C, MX2E


MX2B MX2C MX2E

Crossmatching z z 4

Antibody screen z z z 2

Antibody identification z z z 2

Program Information• M 1B - Four 0.25-mL

plasma specimens; two(approximately 1.0 x 106

cells) purified peripheralblood lymphocyte specimens

• M 1C - Four 0.50-mLplasma specimens; two(approximately .0 x 106


• M 1E - Four 0. 0-mL plasmaspecimens; must be orderedin conjunction with SurveyM 1B or M 1C

• Multiple method reportingprovided


Program Information• M 2B - Two 0.25-mL

plasma specimens; two(approximately 7.2 x 106


• M 2C - Two 0.50-mLplasma specimens; two(approximately 9.6 x 106


• M 2E - Two 0. 0-mL plasmaspecimens; must be orderedin conjunction with SurveyM 2B or M 2C

• Multiple method reportingprovided


Histocompatibility

800-323-4040 | 847-832-7000 Option 1 | cap.org 207

Histocompatibility

17

HLA Crossmatching, Antibody Screen, and AntibodyIdentification (Class I/II) Combinations MXB, MXC

Procedure Corresponding Survey Program Code

MXB MXC

Crossmatching, antibody screen, andantibody identification, Class I

M 1B* z

Crossmatching, antibody screen, andantibody identification, Class II

M 2B* z

Crossmatching, antibody screen, andantibody identification, Class I

M 1C* z

Crossmatching, antibody screen, andantibody identification, Class II

M 2C* z

*See page 206 for specimen and analyte information.

HLA Molecular Typing ML, DL, DMLProcedure Program Code Challenges/Shipment

ML DL DML

Molecular HLA-A, -B, and -C typing (Class I) z z 5

Molecular HLA-DR, -D , and -DP typing(Class II)

z z 5

HLA Serologic Typing (Class I/II)ABO, HLAS, HLAS1


ABO HLAS HLAS1

ABO grouping (includes A subtyping) z 5

HLA serologic typing (Class I and Class II) z

HLA serologic typing (Class I only) z

Program Information• M B - Class I four 0.25-mL

plasma specimens, twopurified peripheral bloodlymphocyte specimens; ClassII two 0.25-mL plasmaspecimens, two purifiedperipheral blood lymphocytespecimens

• M C - Class I four 0.50-mLplasma specimens, twopurified peripheral bloodlymphocyte specimens; ClassII two 0.50-mL plasmaspecimens, two purifiedperipheral blood lymphocytespecimens


Program Information• DL, ML - Five 1.5-mL whole

blood specimens in CPD-A

• DML - Ten 1.5-mL wholeblood specimens in CPD-A

• Serologic e uivalentsreporting available


Program Information• ABO - Five 2.0-mL red

blood cell suspensions andfive .0-mL correspondingserum specimens; must beordered in conjunction withSurvey HLAS or HLAS1

• HLAS - Three .0-mLsuspensions of purifiedperipheral blood lymphocytes

• HLAS1 - Three 1.0-mLsuspensions of purifiedperipheral blood lymphocytes


Histocompatibility


Hist

ocom

patib

ility

17

HLA-B27 Typing B27Procedure Program Code Challenges/Shipment

B27

HLA-B27 typing z 5

Antibody Titer ABT, ABT1, ABT2, ABT3Analyte/Procedure Program Code Challenges/Shipment

ABT ABT1 ABT2 ABT3

Anti-A titer z z 1

Anti-B titer z 1

Anti-D titer z z 1

Monitoring Engraftment MEProcedure Program Code Challenges/Shipment

ME

Stem cell monitoring engraftment z 3

Program Information•Five2.0-mLwholeblood

specimens in CPD-A


Program Information•ABT-One2.0-mLplasma

specimen for anti-A titer withonecorrespondingtitercell(3%to4%redbloodcellsuspension);one2.0-mLplasma specimen for anti-D titerwithonecorrespondingtitercell(3%to4%redbloodcell suspension)

• ABT1-One2.0-mLplasmaspecimenforanti-Atiterwithonecorrespondingtitercell(3%to4%redbloodcellsuspension)

•ABT2One2.0-mLplasmaspecimenforanti-Dtiterwithonecorrespondingtitercell(3%to4%redbloodcellsuspension)

• ABT3-One2.0-mLplasmaspecimenforanti-Btiterwithonecorrespondingtitercell(3%to4%redbloodcellsuspension)


Program Information•Five1.5-mLwholeblood

specimens

•Designedforlaboratoriessupporting stem cell transplant andlaboratoriesmonitoringchimerismafterorgantransplantation


Histocompatibility

800-323-4040 | 847-832-7000 Option 1 | cap.org 209

Histocompatibility

17

HLA Disease Association, Drug RiskDADR1, DADR2


DADR1 DADR2

HLA-A* 1 01 z

HLA-B*1 01 z

HLA-B*15 02 z

HLA-B*57 01 z

HLA-B*58 01 z

HLA-A*29 01 z

HLA-A*29 02 z

HLA-D A1*0 01 z

HLA-D A1*05 01 z

HLA-D B1*0 02 z

HLA-DRB1*0 01 z

HLA-DRB1*0 02 z

HLA-DRB1*0 02 z

HLA-DRB1*0 0 z

HLA-DRB1*0 06 z

HLA-DRB1*06 02 z

HLA-DRB1*08 02 z

HLA-DRB1*08 0 z

HLA-DRB1*1 0 z

HLA-DRB1*1 05 z

HLA-DRB1*1 08 z

HLA-DRB1*15 01 z

HLA-DRB1*15 02 z

D A1*0 /D B1*0 02 z

D A1*05/D B1*02 z

PRICE (USD)

Additional InformationThese Surveys will challenge the laboratory to accurately identify the presence or absenceof alleles associated with a variety of disease states (listed below) and/or the adversereactions to specific drugs.

Program Information• Three 0.1-mL specimens, each

containing 200 g/mL ofhuman DNA in media


New

DADR1oCarbamezepine induced Stevens-

ohnson syndrome (CS )oAllopurinol Stevens- ohnson

syndrome (AS )oHypersensitivity to abacavir (HA)o Dapsone hypersensitivity (DH)

DADR2o Celiac disease (CD)o Narcolepsy (N)o Pemphigus vulgaris (PV)o Psoriasis (P)o Antiglomerular basement membrane

disease (ABM)o Birdshot retinochoroidopathy (BR)o Idiopathic myopathy (IM)

Are you ready for yourCAP inspection?The CAP Accreditation Readiness Assessment(CARA®) is an on-site evaluation and educationprogram for laboratories just beginning their pursuitof CAP accreditation. CARA focuses on:• Facilitating an in-depth understanding of

CAP requirements as they apply to your laboratory• Helping you manage the time and resources

necessary for compliance with CAP accreditationrequirements and preparation for your initial inspection

• Delivering on-site education when you’re ready for it

CARA provides a unique educational coachingexperience that leverages the expertise of the world’smost respected pathology organization.

More control. Zero risk. Give your laboratory its best opportunityto be prepared and be successful.

Email us at [email protected] to accelerate your quality journey.

“The Readiness Assessment [CARA] helped our labimmediately spot potential problems before our inspection.Our CAP inspection went like clockwork!”

Laboratory Director

Genetics

andM

olecularPathology

18

Genetics and Molecular PathologyCytogenetics..................................................................................................................................212Biochemical and Molecular Genetics................................................................................................215Next-Generation Sequencing...........................................................................................................221Molecular Oncology – Solid Tumors.................................................................................................222Molecular Oncology – Hematologic.................................................................................................225

New Programs New

Next-Generation Sequencing (NGS).................................................................................................221

New Analyte AdditionsMultigene Tumor Panel (MTP) ..........................................................................................................224

NRASPIK3CA

18 | Genetics and Molecular Pathology

“We want to use one vendor for all our proficiencytesting and the CAP provides the broad range ofSurveys needed. As new molecular testing becomesavailable, the CAP is first to provide proficiency testsso that we can be assured of providing the mostaccurate results for our patients and we do not haveto do alternative assessment.”

Cytogenetics


Gen

etic

san

dM

olec

ular

Path

olog

y

18

CytogeneticsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

CAP/ACMG Cytogenetics CY, CYBKAnalyte/Procedure Program Code Challenges/Shipment

CY CYBK

Chromosome abnormality z z 6

Karyotype z z 6

Educational challenge, ungraded z z 1 per year

Additional InformationEach challenge includes a case history and images of metaphase cells that arerepresentative of each case. Each mailing will include three constitutional and threeneoplastic challenges.

CAP/ACMG Fluorescence In Situ HybridizationCYF, CYI

Disease/Procedure Program Code Challenges/Shipment

CYF CYI A B

Constitutional and HematologicDisorders

FISH for neoplastic disorder z 1 2

FISH for constitutional abnormality z 2 1

Urothelial Carcinoma

FISH for urothelial carcinoma z 2 2

Additional Information• CYF 2015-A

Hematologic disorder 20 deletion (two slides)Constitutional abnormality Prenatal aneuploidy probes (two slides)Constitutional abnormality (photograph)

• CYF 2015-BHematologic disorder – PML/RARA (two slides)Constitutional abnormality – Probes for the enumeration of sex chromosomes(two slides)Neoplastic disorder (photograph)

• CYF is prepared from cell suspension samples. For FISH in paraffin-embedded tissue,see page 213.

Program Information• CY - Online images of

metaphase cells; deliveredtwo times a year; your CAPshipping contact will benotified via email when theactivity is available

• CYB - Prints of metaphasecells; two shipments per year

Program Information• CYF - Four slides and one

photograph

• CYI - Two 250- L cell samplessuspended in ethanol fromtwo different specimens;participants use FISH to detectchromosome abnormalitiesusing probes for thecentromeres for chromosomes, 7, 17, and a locus-specific

probe for 9p21


Cytogenetics

800-323-4040 | 847-832-7000 Option 1 | cap.org 213

Genetics

andM

olecularPathology

18

CAP/ACMG Fluorescence In Situ Hybridizationfor Paraffin-Embedded Tissue CYH, CYJ, CYK, CYLDisease/Procedure Program Code Challenges/

Shipment

CYH CYJ CYK CYL A B

Breast Cancer

HER2 gene amplification z 10 10

Brain/Glioma Tissue

1p/19q z 1 1

Solid Tumor

MYCN (2p2 ) gene amplification z 1

ALK (2p2 ) gene rearrangement z 1

Lymphoma Tissue

ALK (2p2 ) gene rearrangement z 1

IGH/BCL2 (1 2/18 21) generearrangement

z 1

CAP/ACMG Cytogenomic Microarray AnalysisCYCGH


CYCGH

Cytogenomic microarray analysisfor constitutional abnormality

z 2

Educational paper challengefor constitutional or neoplasticabnormality

z 1

Additional InformationParticipants will identify and characterize gains or losses and the cytogenetic location ofany abnormalities detected.

Program Information• CYH - Two unstained, five-

core tissue microarray slidese uivalent to 10 paraffin-embedded breast tissuespecimens; a duplicate set ofH&E stained tissue microarrayslides will also be provided

• CY - Four unstained slides;one H&E stained slide

• CY , CYL - Two unstainedslides; one H&E stained slide

• All specimens will be.0-micron tissue sections

mounted on positivelycharged glass slides


Program Information• Two .0- g DNA specimens;

one educational paperchallenge


Cytogenetics


Gen

etic

san

dM

olec

ular

Path

olog

y

18



Each laboratory receives a Participant Summary, which includes readily available results.

Cytogenetics, Validated MaterialValidated Material Program Code Corresponding Survey Page

Cytogenetics VM CYM CY 212

Program Information• Prints of metaphase cells

Biochemical and Molecular Genetics

800-323-4040 | 847-832-7000 Option 1 | cap.org 215

Genetics

andM

olecularPathology

18

Biochemical and Molecular GeneticsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

CAP/ACMG Biochemical Genetics BGL, BGL1Analyte/Procedure Program Code Challenges/Shipment

BGL BGL1

Acylcarnitines, ualitative anduantitative

z 1

Amino acids, ualitative anduantitative

z 1

Carnitine, ualitative and uantitative z 3

Glycosaminoglycans(mucopolysaccharides), ualitativeand uantitative

z 1

Organic acids, ualitative anduantitative

z 1


Program Information• BGL -

Acylcarnitines One 0.1-mLplasma specimen

Amino acids One 1.0-mLplasma or 2.0-mL urinespecimen

Glycosaminoglycans(mucopolysaccharides)One 2.0-mL urine specimen

Organic acids One 7.5-mLurine specimen

Educational challenge illconsist of any one of theBGL analytes

• BGL1 - Three 0. -mL serumspecimens




Gen

etic

san

dM

olec

ular

Path

olog

y

18

CAP/ACMG Alpha-1 Antitrypsin(SERPINA1) Genotyping AAT


AAT

Alpha-1 antitrypsin genotyping z 3

This Survey will test for the M, S, and alleles.

CAP/ACMG Apolipoprotein EGenotyping APOE


APOE

Apolipoprotein E (APOE) genotyping z 3

This Survey is designed for laboratories utilizing APOE testing for cardiovascular andAlzheimer diseases and will test for various variants (APOE e2, APOE e3, and APOE e ).

CAP/ACMG HemoglobinopathiesGenotyping HGM


HGM

Alpha-thalassemia z 3

Beta-thalassemia z 3

Hemoglobin S/C z 3

Program Information• Three 10.0- g extracted

DNA specimens



DNA specimens



DNA specimens



800-323-4040 | 847-832-7000 Option 1 | cap.org 217

Genetics

andM

olecularPathology

18

CAP/ACMG Molecular GeneticsMGL1, MGL2, MGL3, MGL4, MGL5

Disease/GeneProgram Code Challenges/

ShipmentMGL1 MGL2 MGL3 MGL4 MGL5

Bloom syndrome z 3

BRCA1/2 z 3

Canavan z 3

Connexin 26 z 3

Cystic fibrosis z z /2(MGL5)

DMD/Bec er z 3

Factor V Leiden z 3

Familial dysautonomia z 3

Fanconi anemia complementationgroup C

z 3

Fragile X z 3

Friedreich ataxia z 3

Gaucher z 3

Glycogen storage disease type IA z 3

Hemochromatosis z 3

Hemoglobin S/C z 3

Huntington z 3

Methylene tetrahydrofolatereductase (MTHFR) 677C Tand 1298A C

z 3

Mucolipidosis IV z 3

Multiple endocrine neoplasiatype 2 (MEN2)

z 3

Myotonic dystrophy z 3

Niemann-Pic disease type A z 3

Plasminogen activator inhibitor(PAI)-1

z 3

Prader- illi/Angelman syndrome z 3

Prothrombin z 3

RhD z 3

Spinal muscular atrophy z 3

Spinocerebellar ataxia z 3

Tay-Sachs z 3

Module MGL is designed for laboratories testing for diseases/disorders related toAsh enazi ewish ancestry.

Program Information• MGL1, MGL2, MGL ,

MGL - A minimum ofthree 50.0- g extractedDNA specimens

• MGL5 - Two 50.0- gextracted DNA specimens




Gen

etic

san

dM

olec

ular

Path

olog

y

18

CAP/ACMG Inherited MetabolicDiseases IMD1, IMD2, IMD3


IMD1 IMD2 IMD3

Mitochondrial DNA deletion syndromes z 3

MCAD z 3

Mitochondrial cytopathies* z 3

*Includes disorders/diseases such as Leber hereditary optic neuropathy and myoclonus epilepsywith ragged red fibers (MERRF).

CAP/ACMG Molecular Genetics SequencingSEC, SEC1


SEC SEC1

DNA se uencing interpretation challenge z 3

DNA se uencing z 3

Additional Information• Test your s ill at interpreting and reporting DNA se uence variants for inherited

disease using standard nomenclature.• Receive a summary and discussion of responses, including comments on the mutation

nomenclature, nown or expected outcomes from identified variants, and teachingpoints about genes/disorders represented.

Program Information• IMD1 - Three 50.0- L

DNA specimens (50.0-ng/L DNA PCR product that

encompasses the entiremitochondrial genome)

• IMD2, IMD - Three 50.0- gextracted DNA specimens


Program Information• SEC - One CD-ROM

containing three DNAse uence electropherogramfiles with a range ofvariants, suitable for base-calling and analysis usinga range of commercial orpublic domain softwareprograms; also includescontrol se uences, normalDNA reference se uences,and nomenclature/mutationreferences

• SEC1 - Three 10.0- gextracted DNA specimens;one set of forward andreverse lyophilized primers



800-323-4040 | 847-832-7000 Option 1 | cap.org 219

Genetics

andM

olecularPathology

18

Pharmacogenetics PGX, PGX1, PGX2Analyte/Procedure Program Code Challenges/

Shipment

PGX PGX1 PGX2

CYP2C19 z 2

CYP2C9 z 2

CYP2D6 z 2

UGT1A1 z 2

VKORC1 z 2

IL28B (rs12979860) z 3

HLA-B*5701 z 3

Additional InformationSurvey PG 2 is designed for laboratories that provide HLA-B*5701 testing to identify risof hypersensitivity to abacavir. The intended response is ualitative (presence/absenceof the allele). This Survey is not appropriate for laboratories that perform molecular HLAtyping. For HLA typing proficiency testing, please consult the HLA Molecular Typing(ML, DML) Surveys.

CAP/ACMG Rett Syndrome (MECP2) RETTAnalyte/Procedure Program Code Challenges/Shipment

RETT

MECP2 genotyping z 3

CAP/ACMG ThrombophiliaMutations TPM


TPM

Factor II z 3

Factor V z 3

Additional InformationThis Survey is designed for the Cepheid Gene pert factor II and factor V assays. DNAextraction for other assays/methods is NOT recommended.

Program Information• PG - Two 25.0- g extracted

DNA specimens

• PG 1, PG 2 - Three 25.0- gextracted DNA specimens

• Includes allele detection(genotyping) and/orinterpretive challenges


Program Information• Three 10.0- g extracted DNA

specimens







Gen

etic

san

dM

olec

ular

Path

olog

y

18

Red Blood Cell AntigenGenotyping RAG


RAG

Red cell antigen genotype withpredictive phenotype

z 3


specimens


800-323-4040 | 847-832-7000 Option 1 | cap.org 221

Genetics

andM

olecularPathology

18

Next-Generation Sequencing

Next-Generation SequencingAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Next-Generation Sequencing NGSProcedure Program Code Challenges/Shipment

NGS

Next-generation se uencing z 1

Additional InformationLaboratories will have the ability to test up to 200 variants. For the full list of genes in thisprogram, please go to cap.org and choose the Laboratory Improvement Programs tab.

Program Information• One 10.0- g extracted DNA

specimen

• Methods-based challengefor laboratories using genepanels, exome, and wholegenome se uencing


New

Give the CAP’s complimentary Sample Exchange Registry service a try!Sign up for this unique and complimentary service for those rare analytes for whichproficiency testing is not yet available. This service now includes all clinicallaboratory disciplines.• The CAP connects labs performing testing for which no formal

proficiency testing is available.• There is no charge for this service.• Participate at any time, no contract required.• A minimum of three labs performing the same analyte must participate

before the CAP can facilitate the sample exchange.• Each individual laboratory will receive its own results along with an anonymized summary

report for all participants.

Visit cap.org and choose the Laboratory Improvement Programs tab to register today!

Molecular Oncology – Solid Tumors


Gen

etic

san

dM

olec

ular

Path

olog

y

18

Molecular Oncology – Solid TumorsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Defective DNA Mismatch Repair/HereditaryNonpolyposis Colorectal Cancer (HNPCC)

MSIProcedure Program Code Challenges/Shipment

MSI

Microsatellite instability testing(DNA amplification)

z 3

Laboratories performing DNA mismatch repair assessment by immunohistochemistry methodsshould see Survey MMR on page 237.

In Situ Hybridization ISH, ISH2Analyte/Procedure Program Code Challenges/Shipment

ISH ISH2

Epstein-Barr virus (EBV) z

Human papillomavirus (HPV) z

appa/Lambda (IG /IGL) z

HER2 (ERBB2) gene amplification(brightfield)

z 10

Laboratories performing FISH for interphase chromosomal targets in paraffin sections refer to theCytogenetics Surveys, page 213.

Program Information• Two 10.0-micron unstained

paraffin section slidesand one H&E slide; twophotograph challenges

• For laboratories performingmolecular testing using PCR


Program Information• ISH - EBV, HPV Three -core

tissue microarray slides andone H E slide (each)

appa/Lambda Four -coretissue microarray slides andone H&E slide

• ISH2 - Two sets of 5-coretissue microarray slides



800-323-4040 | 847-832-7000 Option 1 | cap.org 223

Genetics

andM

olecularPathology

18

Neoplastic Cellularity NEOProcedure Program Code Challenges/Shipment

NEO

Online assessment of percentneoplastic cellularity

z 10

Sarcoma Translocation SARCGene Program Code Challenges/Shipment

SARC

Sarcoma translocation* (RT-PCR) z 3

*See translocation listing below.

Laboratories performing FISH for sarcoma translocation refer to the Cytogenetics Surveys,page 213.

Sarcoma Translocation ListingCOL1A1/PDGFB, t(17;22) EWSR1/WT1, t(11;22) PAX3/FOXO1 or PAX7/FOXO1

EWSR1/ATF1, t(12;22) FUS/DDIT3, t(12;16) SS18/SSX1, t( ;18)

EWSR1/ERG, t(21;22) PAX3/FOXO1, t(2;1 ) SS18/SSX2, t( ;18)

EWSR1/FLI1, t(11;22) PAX7/FOXO1, t(1;1 ) SS18/SSX1 or SS18/SSX2

EWSR1/FLI1 or EWSR1/ERG

Program Information• Ten challenges using whole

slide images

• A method-based preanalyticSurvey to assess competencyfor determining percentneoplastic cellularity



Program Information• Snap-frozen cell pellet from

which approximately 5.0- gof RNA can be extracted




Gen

etic

san

dM

olec

ular

Path

olog

y

18

Solid Tumor–Other BRAF, EGFR, KRAS, KITAnalyte Program Code Challenges/Shipment

BRAF EGFR KRAS KIT

BRAF z 3

EGFR z 3

KRAS z 3

KIT z 1

PDGFRA z 1

Multigene Tumor Panel MTPAnalyte Program Code Challenges/Shipment

MTP

BRAF z 3

EGFR z 3

KRAS z 3

NRAS z 3

PIK3CA z 3

Additional InformationSurvey MTP is designed for use with multiplex technologies such as next-generationse uencing where genes will be added as clinical utility and practices evolve. Thechallenges are mixtures and are more li ely to include mutations at lower relativeconcentrations than do the individual gene-specific Surveys. Laboratories using assaytechnologies that do not reliably detect mutations in small allelic fractions ( 25 ), such asmodified Sanger se uencing, should enroll in the gene-specific Surveys RAS, BRAF, andEGFR.

Glioma GLIAnalyte Program Code Challenges/Shipment

GLI

MGMT z 1

IDH1, IDH2 z 1

10 (PTEN) deletion z 1

Program Information• BRAF, EGFR, RAS -

Paraffin-embeddedsections or shavings

• IT/PDGFRA - Four10.0-micron unstainedparaffin section slides andone H&E slide



Program Information• gDNA for laboratories

performing molecular testingon multiple targets


Program Information• Four 10.0-micron unstained

paraffin section slides andone H&E slide



Molecular Oncology – Hematologic

800-323-4040 | 847-832-7000 Option 1 | cap.org 225

Genetics

andM

olecularPathology

18

Molecular Oncology – HematologicAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Molecular Hematologic OncologyMHO, MHO1, MHO2, MHO3, MHO5

Procedure/Gene Program Code Challenges/Shipment

MHO, MHO1 MHO2, MHO3 MHO5

Lymphoid malignancy genotyping

IGH z 3

IGH/BCL2 major z 3

IGH/BCL2 minor z 3

IGH/CCND1 z 3

IGK z 3

TRB z 3

TRG z 3

Myeloid malignancy genotyping

CBFB/MYH11 z 1

FLT3 ITD z 1

FLT3 TKD z 1

JAK2 c.18 9G T(p.V617F) z 1

NPM1 z 1

PML/RARA z 1

RUNX1/RUNX1T1 z 1

DNA extraction andamplification from formalin-fixed, paraffin-embedded(FFPE) tissue

z 1

Minimal Residual Disease MRD, MRD1, MRD2Analyte Program Code Challenges/Shipment

MRD MRD1 MRD2

BCR/ABL1 p190 z 3

BCR/ABL1 p210 z 3

PML/RARA z 3

Program Information• MHO - One sample vial

containing purified DNA(200 g/mL per vial) for eachspecimen

• MHO1 - MHO specimens induplicate for additional DNAtesting

• MHO2 - Two sample vials;one with purified DNAcontaining 200 g/mL andone with purified RNA,containing 00 g/mL

• MHO - MHO2 specimen induplicate for additional DNAand RNA testing

• MHO5 - Five 10.0-micronparaffin sections; extractionand amplification from FFPEtissue will be assessed by amethod-based challenge

• Two shipments per year;ships on dry ice (dry icedoes not apply to MHO5 orinternational shipments)

Program Information• MRD, MRD1, MRD2 - Three

RNA specimens in distilledwater

• For laboratories diagnosingand monitoring leu emiatumor burden by measuringthe uantity of BCR/ABL1 orPML/RARA fusion transcripts

• Two shipments per year;ships on dry ice

Your Choice.Gain the expertise of your peers usingthe convenience of your mobile device.

Customize your reading experiencewith font control, brightness, margins,and quick navigation.

Enhance your learning by adding notes,highlights, and bookmarks.

See for yourself at ebooks.cap.org.

Available now—your favorite CAP Press booksin ebook format!

Anatom

icPathology

19

Anatomic PathologySurgical Pathology .........................................................................................................................228General Immunohistochemistry ........................................................................................................237Predictive Markers .........................................................................................................................239Specialty Anatomic Pathology .........................................................................................................240Cytopathology...............................................................................................................................242

New Programs New

Hematopathology Online Education (HPATH/HPATH1) ......................................................................232

19 | Anatomic Pathology

“The CAP is good about being the leader, doingresearch, and taking a role in developing theseprograms.”

Surgical Pathology


Ana

tom

icPa

thol

ogy

19

Surgical PathologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Performance Improvement Programin Surgical Pathology PIP/PIP1


PIP/PIP1

Surgical pathology case review z 10

Additional InformationPIP educates pathologists in general surgical pathology. This program:

• Provides a practical approach to continuing education• Gives pathologists a method to assess their diagnostic s ills and compare their

performance with that of their peers• Features PIP case selections that include

o A variety of neoplastic and nonneoplastic lesionso Inflammatory and infectious diseaseo Various sites, encompassing a variety of organ systems

Program Information• PIP - Ten diagnostic

challenges/H&E stained glassslides with clinical history;one individual response form

• PIP1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey PIP

• Earn a maximum of 0 CMEcredits (AMA PRA Category1 Credits™) per pathologist forcompletion of an entire year



Surgical Pathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 229

Anatom

icPathology

19

Online Performance Improvement Programin Surgical Pathology PIPW/PIPW1


PIPW/PIPW1

Surgical pathology case review z 10

Additional InformationPIP educates pathologists in general surgical pathology. Features of this onlineeducational program include:


• Pathologists can assess their diagnostic s ills and compare their performance withthat of their peers.

• Included PIP case selections featureo A variety of neoplastic and nonneoplastic lesionso Inflammatory and infectious diseaseo Various sites, encompassing a variety of organ systems


Program Information• PIP - Ten diagnostic

challenges/whole slideH&E images with clinicalhistory; for each additionalpathologist, purchase PIPW1

• PIP 1 - Reporting option withCME credit for each additionalpathologist (within the sameinstitution); must order inconjunction with Survey PIPW

• Earn a maximum of 0 CMEcredits (AMA PRA Category1 Credits™) per pathologist forcompletion of an entire year



• Four online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available

Test Your Diagnostic Skills with Case of the MonthChallenge yourself and your staff with two new cases each monthdrawn from the CAP Online Performance Improvement Program inSurgical Pathology (PIPW) archives. You can also explore the CaseArchives for dozens of additional cases. Case information includes:• Specimen source• Clinical history• Laboratory findings• Representative whole slide image of the surgical specimen

Case of the Month uses DigitalScope® for unparalleled online viewing of whole slide images. CMEis not available for Case of the Month; CME is available with the PIPW program.

To access the Case of the Month, visit cap.org and choose the CAP Foundation tab.

Surgical Pathology


Ana

tom

icPa

thol

ogy

19

Online Virtual Biopsy Program VBP/VBP1Program Program Code Challenges/Shipment

VBP/VBP1

Online biopsy case review z 5

Additional InformationVBP educates pathologists to assess and improve their diagnostic s ills in surgicalpathology. Features of this online educational program include


• Cases may also include gross, radiographic, or endoscopic images.• Cases are from selected organ systems and may include a variety of

specimen types (eg, core biopsies, endoscopic biopsies, curettings, aspiratesmears). Activities with their corresponding topics are:o 2015-A Lung Biopsyo 2015-B Ear, Nose, Throat Biopsyo 2015-C Gynecologic Biopsyo 2015-D Surgical Pathology Biopsy (various sites)


Program Information• VBP - Five diagnostic

challenges/whole slideimages with clinical history;for each additionalpathologist, purchase VBP1

• VBP1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey VBP

• Earn a maximum of23 CME/SAM credits(AMA PRA Category 1Credits™) per pathologist forcompletion of an entire year



• Four online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available

Surgical Pathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 231

Anatom

icPathology

19

Online Digital Slide Program in DermatopathologyDPATH/DPATH1


DPATH/DPATH1

Online dermatopathology case review z 6

Additional InformationDPATH educates pathologists, dermatopathologists, and dermatologists to assessand improve their diagnostic s ills in dermatopathology. Features of this onlineeducational program include:


• Cases include static images.• See system re uirements on page 15.

Program Information• DPATH - Six diagnostic

challenges/whole slideimages with clinicalhistory; for each additionalpathologist, purchase DPATH1

• DPATH1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey DPATH

• Earn a maximum of1 CME/SAM credits(AMA PRA Category 1Credits™) per pathologist forcompletion of an entire year




Surgical Pathology


Ana

tom

icPa

thol

ogy

19

Hematopathology Online EducationHPATH/HPATH1


HPATH/HPATH1

Hematopathology online case review z 5

Additional InformationHPATH educates pathologists and hematologists to assess and improve their diagnostics ills in hematopathology.


• Cases are peripheral blood and bone marrow whole slide images.• Cases may include results of ancillary studies such as histochemistry, immunology,

immunohistochemistry, and molecular tests, where appropriate.• See system re uirements on page 15.

NewProgram Information• HPATH - Five diagnostic

challenges/whole slideimages with clinicalhistory; for each additionalpathologist/hematologist,purchase HPATH1

• HPATH1 - Reporting optionwith CME/SAM/CE credit foreach additional pathologistand hematologist (withinthe same institution); mustorder in conjunction withSurvey HPATH

• Earn a maximum of 6CME/SAM credits (AMAPRA Category 1 Credits™)per pathologist and amaximum of 6 CE credits perhematologist for completionof an entire year




Surgical Pathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 233

Anatom

icPathology

19

Practicum inCancer Surgical Pathology PCSP/PCSP1


PCSP/PCSP1

Online surgical pathology cancercase review

z

Additional InformationPCSP educates pathologists in cancer case review and reporting.


• Cases review challenges in interpretation, staging, and cancer reporting.• Cases represent the following

oT Staging and Margins in Pancreatic Tumors Challenges and RecommendationsoStaging Invasive Breast Cancer Size Determination and Assessment of

Multiple TumorsoAdverse Histologic Parameters in Thyroid Carcinoma Pic ing Out the olf in

Sheep’s Clothingo Staging Cutaneous Melanoma: Impact of Previous Shave Biopsy


Program Information• PCSP - One mailing

containing four diagnosticchallenges/whole slideH&E images with clinicalhistory; for each additionalpathologist purchase PCSP1

• PCSP1 - Reporting option withCME credit for each additionalpathologist (within the sameinstitution); must order inconjunction with Survey PCSP

• Earn a maximum of5 CME/SAM credits (AMAPRA Category 1 Credits™) perpathologist for completion ofan entire year




Surgical Pathology


Ana

tom

icPa

thol

ogy

19

CAP/NSH HistoQIP HQIPStain/Tissue Program Code Challenges/Shipment

HQIP A B

H E - Lung resection z 1

H E - Bone marrow core biopsy, noaspirates or smears

z 1

IHC - Napsin A (Lung adenocarcinoma) z 1

IHC - H. pylori, stomach (Positive tissuecontrol)

z 1

Special stain - Trichrome (Small bowelresection)

z 1

H E - Colon resection z 1

H E - Liver resection z 1

IHC - Smooth muscle myosin heavy chain(Breast resection)

z 1

IHC - CD 2 (Colon resection,adenocarcinoma)

z 1

Special stain - Reticulin (Liver resection) z 1

Additional InformationHistoQIP improves the preparation of histologic slides in all anatomic pathologylaboratories. In this educational program, participants will receive an evaluation specificto their laboratory, an education criti ue, and a Participant Summary that includes peercomparison data, evaluators comments, and performance benchmar ing data. An expertpanel of pathologists, histotechnologists, and histotechnicians will evaluate submittedslides for histologic technique using uniform grading criteria.

Program Information• Participant laboratories may

submit up to five stained andcoverslipped glass slides (onefrom each category) permailing

• Includes photographs andonline learning assessmentquestions


Histologic PreparationsRichard W. Brown, MD, FCAPThis “how to” guide to good slide preparation was developedby the Histotechnology Committee of the College of AmericanPathologists in conjunction with the National Society forHistotechnology. Building on data and images from the NSH/CAPhistology quality assurance program, HistoQIP, the book presentsphotographic examples of well-prepared slides followed bynumerous examples of associated problems and their solutions.

PRESSTo order and see the table of contentsand sample pages:Visit cap.org and choose the Shop tab.

Item number: PUB123Softcover; 168 pages; 300+photomicrographs, figures,and tables; 2009


Surgical Pathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 235

Anatom

icPathology

19

CAP/NSH HistoQIP - IHC HQIHCStain/Tissue Program Code Challenges/Shipment

HQIHC A B

IHC AE1/ (Bladder biopsy) z 1

IHC C 7 (Cervix biopsy) z 1

IHC Melan A (S in, punch biopsy) z 1

IHC i-67 (Stomach biopsy) z 1

IHC C 20 (Colon biopsy) z 1

IHC ER (Endometrium biopsy) z 1

IHC C 5/6 (S in, excisional biopsy) z 1

IHC p6 (Prostate biopsy) z 1

Additional InformationHisto IP - IHC improves the preparation of immunohistochemistry slides in all anatomiclaboratories involved in the handling of gastrointestinal, dermatologic, and urologicaltract biopsies. Participants will receive an evaluation specific to their laboratory anda Participant Summary. An expert panel of pathologists, histotechnologists, andhistotechnicians will evaluate submitted slides for histologic techni ue using uniformgrading criteria.

CAP/NSH HistoQIP Biopsy Series HQIPBXStain/Tissue Program Code Challenges/Shipment

HQIPBX A B

H E Bladder biopsy z 1

H E Cervical biopsy z 1

H E S in punch biopsy z 1

H E Stomach biopsy z 1

H E Colon biopsy z 1

H E Endometrial biopsy z 1

H E Prostate needle biopsy z 1

H E S in excisional biopsy (large excision) z 1

Additional InformationThe HistoQIP Biopsy Series is an additional program to improve the preparation ofhistologic slides in all anatomic pathology laboratories. Participants will receive anevaluation specific to their laboratory and a Participant Summary. An expert panel ofpathologists, histotechnologists, and histotechnicians will evaluate submitted slides forhistologic technique using uniform grading criteria.

Program Information• Participants may submit

up to four IHC stained andcoverslipped glass slides(one from each category) permailing


Program Information• Participant laboratories may

submit up to four H E stainedand coverslipped glass slides(one from each category) permailing


Surgical Pathology


Ana

tom

icPa

thol

ogy

19

CAP/NSH HistoQIP Specialty SeriesHQBX1, HQBX2, HQBX3

Stain/Tissue Program Code Challenges/Shipment

HQBX1 HQBX2 HQBX3 A B

Gastrointestinal Biopsy Module

H E Colon biopsy z 1 1

H E Esophageal biopsy z 1 1

H E Small intestinal biopsy z 1 1

H E Stomach biopsy z 1 1

Dermatologic Biopsy Module

H&E – Alopecia z 1 1

H E S in excisional biopsy(large excision)

z 1 1

H E S in punch biopsy z 1 1

H E S in shave biopsy z 1 1

Urogenital Tract Biopsy Module

H E Bladder biopsy (nonneoplastic) z 1 1

H E Bladder biopsy (with carcinoma) z 1 1

H E Prostate needle biopsy(nonneoplastic)

z 1 1

H E Prostate needle biopsy(with carcinoma)

z 1 1

Additional InformationThe HistoQIP Specialty Series includes modules to improve the preparation of histologicslides in all anatomic pathology laboratories involved in the handling of gastrointestinal,dermatologic and urogenital tract biopsies. Participants will receive an evaluationspecific to their laboratory and a Participant Summary. An expert panel of pathologists,histotechnologists, and histotechnicians will evaluate submitted slides for histologictechnique using uniform grading criteria.

Program Information• H B 1, H B 2, H B -

Participants may submit upto four H&E stained andcoverslipped glass slides(one from each category)per mailing


General Immunohistochemistry

800-323-4040 | 847-832-7000 Option 1 | cap.org 237

Anatom

icPathology

19

General ImmunohistochemistryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Immunohistochemistry MKProcedure Program Code Challenges/Shipment

MK

Immunohistochemistry z 16

The M program allows laboratories to compare their assay methodology and results withall participating laboratories.

DNA Mismatch Repair MMRProcedure Program Code Challenges/Shipment

MMR

DNA mismatch repair byimmunohistochemistry

z 1

If your laboratory performs DNA mismatch repair by molecular methods, see the MSI programon page 222.

CD117, CD20 ImmunohistochemistryTissue Microarray PM1, PM3


PM1 PM3

CD117 z 10

CD20 z 10

For ER/PgR testing, see the PM2 program on page 239.

Program Information• Glass slides with unstained

tissue sections from fourseparate cases; additionalslides provided for an H&Estain and negative control


Program Information• Four .0-micron unstained

paraffin section slidesand one H&E slide for theimmunohistochemical analysisof DNA mismatch repairproteins MLH1, MSH2, MSH6,and PMS2


Program Information• One 10-core tissue

microarray slide perpredictive mar er


General Immunohistochemistry


Ana

tom

icPa

thol

ogy

19

Immunohistochemistry TissueMicroarray Series PM5


PM5

AL z 10

GATA z 10

Additional InformationThis newly designed program will allow immunohistochemistry laboratories to evaluateappropriate assay performance on a wide array of tissues and/or tumor types.

Each year, the PM5 program will offer different immunohistochemistry mar ers to evaluateassay performance on a wide variety of tissues and/or tumor types. See list below.

CDX2CD30D2-40K 20Ki-67PAX 2PAX 8p63

Program Information• Two 10-core tissue microarray

slides, one for AL and onefor GATA


Predictive Markers

800-323-4040 | 847-832-7000 Option 1 | cap.org 239

Anatom

icPathology

19

Predictive MarkersAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

HER2 Immunohistochemistry HER2Analyte Program Code Challenges/Shipment

HER2

HER2 z 28

Additional InformationThe HER2 program fulfills the proficiency testing re uirement stated in the ASCO/CAPHER2 Testing Guideline. Due to the uni ue nature of these human, donor-basedmaterials, the shipping date is subject to change. If this should occur, the CAP willprovide notification prior to the originally scheduled shipping date.

Gastric HER2 GHER2Analyte Program Code Challenges/Shipment

GHER2

HER2 z 10

Additional InformationThe interpretive criteria for HER2 immunohistochemistry performed on gastroesophagealadenocarcinomas differs significantly from breast carcinoma. The GHER2 program willhelp participating laboratories understand these differences.

ER/PgR ImmunohistochemistryTissue Microarray PM2


PM2

Estrogen receptor (ER) z 20

Progesterone receptor (PgR) z 20

Additional InformationThe PM2 program fulfills the proficiency testing requirement stated in theASCO/CAP ER/PgR Testing Guideline. Due to the uni ue nature of these human,donor-based materials, the shipping date is subject to change. If this should occur,the CAP will provide notification prior to the originally scheduled shipping date.

Program Information• Two 1 -core tissue and

cell-line microarray slides


Program Information• One 10-core tissue

microarray slide


Program Information• Four 10-core microarray slides,

two for ER and two for PgR


Specialty Anatomic Pathology


Ana

tom

icPa

thol

ogy

19

Specialty Anatomic PathologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Autopsy Pathology AUCD/AUCD1Procedure Program Code Challenges/Shipment

AUCD/AUCD1

Autopsy case analysis z 6

Each CD-ROM includes case description, gross and/or microscopic images, and casediscussion with sample death certificate, ey teaching points, and current references.

Program Information• One CD-ROM with six

autopsy cases; one individualresponse form

• A CD1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey A CD

• Earn a maximum of 12 CMEcredits (AMA PRA Category 1Credits™) per pathologist

• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements and the CAPAccreditation chec listrequirement for professionalcompetency


Autopsy & Forensic Anthology of Classic Pathology Images (AFA)This CD-ROM offering contains more than 2,000 classicimages from the CAP’s 1992–2010 Autopsy Pathology (AUCD)and the 1990–2010 Forensic Pathology (FR) programs.• View images in three different modes:

o List—Cases listed by program, year, patient age, and diagnosiso Browse—Images filtered by category (eg, cardiovascular,

CNS, external exam) and/or image type (eg, gross, H&E, scene)o Search—Access images based on matching key

words or word fragments• Customize the anthology by adding your own images and categories• Use only a standard Web browser—it runs on any operating

system—with no software to install

Add this valuable tool to your laboratory’s teaching library.Add code AFA to your Surveys order form.

Specialty Anatomic Pathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 241

Anatom

icPathology

19

Neuropathology Program NP/NP1Procedure Program Code Challenges/Shipment

NP/NP1

Neuropathology case review z 8

Additional InformationThe Neuropathology program helps anatomic pathologists, neuropathologists, andtrainees assess and improve their diagnostic s ills and learn about new developmentsin neuropathology. Each shipment of this educational program includes eight casesthat cover the spectrum of neoplastic and nonneoplastic disorders affecting the centraland peripheral nervous systems, including infectious, degenerative, developmental,demyelinating, traumatic, toxic-metabolic, vascular, and neuromuscular diseases. Inaddition, each mailing will include a mini-symposium that focuses on a specific problemarea in neuropathology, which relates to four of the eight cases.

Program Information• One CD-ROM with eight

cases and a mini-symposium

• NP1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey NP

• Earn a maximum of 10CME/SAM credits (AMAPRA Category 1 Credits™)per pathologist



Experience a new level of pathology education with CAP SAMs• Outcomes-based learning at the cutting edge of pathology science• Peer reviewed by at least two subject matter experts• Highly interactive formats with immediate feedback

Visit cap.org and choose the Learning tab to learn more and register.

Cytopathology


Ana

tom

ic P

atho

logy

19

CytopathologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Glass Slide Gynecologic Cytopathology PAP PT Program

with Online Education PTGDSlide Type Program Code Challenges Per Year

PTGDK PTGDM PTGDL Proficiency Testing Education

SurePath™ z z

10 glass slides 10 whole slide images

ThinPrep® z z

Individual Participant Response Form APTGDK APTGDM APTGDL

Ordering InformationYou will receive one shipment for proficiency testing (10 slides) and two additional shipments for your education (5 slides each).

Follow these steps to order your PAP Proficiency Testing and Online Education:1. Choose the Slide Type program code (refer to table above).2. Order one Individual Participant Response Form code for each participating

pathologist/cytotechnologist (eg, APTGDK).3. Select primary testing session option with two alternative date options using the

Gynecologic Cytology Proficiency Testing Order Details Form.4. Order PPTENR only if you are a laboratory possessing a CLIA license to perform

gynecologic cytology where all personnel are performing proficiency testing at another CLIA location.

Additional Information •Individualparticipantsreceiveintendedresponsesandslideannotationsimmediately

after submission of their education results. •DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image. •The PAP Education Laboratory Kit, a tool that lets your staff collaboratively review the

whole slide images to help sharpen their interpretive and diagnostic skills, is included with PTGD.

•Seesystemrequirementsonpage15.

Program Information•PTGD-Tenglassslidesfor

proficiency testing and ten online whole slide images for education

•Earnamaximumof8CMEcredits (AMA PRA Category 1 CreditsTM) per pathologist andamaximumof8CEcredits per cytotechnologist for completing all challenges

•ThisactivitymeetstheABP MOC Part IV Practice Performance Assessment requirements

•Onlinewholeslideimagespowered by DigitalScope technology

•Oneshipmentforproficiencytesting (10 slides) and two online education activities per year (5 slides each); your CAP shipping contact will be notified via email when the online activities are available

Discontinued

Cytopathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 243

Anatom

icPathology

19

Glass Slide Gynecologic Cytopathology PTProgram with Glass Slide PAP Education PAP PT

Slide Type Program Code Challenges Per Year

PAPCPT PAPKPT PAPMPT PAPLPT PAPJPT ProficiencyTesting Education

Conventional z z

10 10

SurePath z z z

ThinPrep z z z

IndividualParticipantResponse Form

APAPCPT APAPKPT APAPMPT APAPLPT APAPJPT

Ordering InformationYou will receive one shipment for proficiency testing (10 slides) and two additionalshipments for your education (5 slides each).

Follow these steps to order your PAP Proficiency Testing and PAP Education:1. Choose the following:

a. Slide Type program code (refer to table above)b. PAP Education series shipment dates (choose one)

• Series 1 o A mailing ships February 2015 o B mailing ships August 2015

• Series 2 o A mailing ships May 2015 o B mailing ships November 2015

Add the PAP Education series number after the Slide Type program code(eg, PAPCPT1).

2.Order one Individual Participant Response Form code for each participatingpathologist/cytotechnologist. Also include the PAP Education Series number after theprogram code (eg, APAPCPT1).

3. Select primary testing session option with two alternative date options using theGynecologic Cytology Proficiency Testing Order Details Form.

.Order PPTENR only if you are a laboratory possessing a CLIA license to performgynecologic cytology where all personnel are performing proficiency testing atanother CLIA location.

Additional Information• Participants can receive laboratory reference interpretations and performance for the

PAP Education slides within 20 minutes by fax.• The PAP Education component meets the CAP Laboratory Accreditation Program

requirement for participation in a peer educational program.

Program Information• Ten glass slides for proficiency

testing and ten glass slides foreducation

• Earn a maximum of 8 CMEcredits (AMA PRA Category1 CreditsTM) per pathologistand a maximum of 8 CEcredits per cytotechnologistfor completing all challenges


• Three shipments per year;one shipment for proficiencytesting (10 slides) and twoshipments for education (5slides each)

Cytopathology


Ana

tom

ic P

atho

logy

19

Online Gynecologic Cytopathology Education Program PED

Slide Type Program Code Challenges Per Year

PEDK PEDM PEDL

10SurePath z z

ThinPrep z z

Individual Participant Response Form APEDK APEDM APEDL

Ordering InformationYou will receive two shipments for your online education (5 slides each).

Follow these steps to order your PED Education: 1. Choose the Slide Type program code (refer to table above).

2. Order one Individual Participant Response Form code for each participating pathologist/cytotechnologist (eg, APEDK).

Additional Information •DigitalScopetechnologysimulatestheuseofamicroscopebyenablingtheuserto

scan and adjust magnification of the whole slide image. •ThePAPEducationLaboratoryKit,atoolthatletsyourstaffcollaborativelyreviewthe

whole slide images to help sharpen their interpretive and diagnostic skills is included with PED.

•Participantsreceiveintendedresponsesandslideannotationsimmediatelyaftersubmission of their education results.

•PEDmeetstheCAPLaboratoryAccreditionProgramrequirementforparticipationina peer educational program.

•Seesystemrequirementsonpage15.

Program Information•Tenonlinewholeslideimages

•Earnamaximumof8CMEcredits (AMA PRA Category 1 CreditsTM) per pathologist andamaximumof8CEcredits per cytotechnologist for completing all challenges

•ThisactivitymeetstheABP MOC Part IV Practice Performance Assessment requirements

• PoweredbyDigitalScopetechnology

•Twoonlineactivitiesperyear (5 slides each); your CAP shipping contact will be notified via email when the activity is available

Discontinued

Cytopathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 245

Anatom

icPathology

19

Cytopathology Glass Slide Education ProgramPAPCE, PAPJE, PAPKE, PAPLE, PAPME Series 1 or 2

Slide Type Program Code EducationChallenges Per Year

PAPCE PAPKE PAPME PAPLE PAPJE

Conventional z z

10

SurePath z z z

ThinPrep z z z

IndividualParticipantResponseForm

APAPCE APAPKE APAPME APAPLE APAPJE

Ordering Information

Follow these steps to order your PAP Education:1. Choose the following:

a. Slide Type program code (refer to table above)b. PAP Education series shipment dates (choose one)

• Series 1 o A mailing ships February 2015 o B mailing ships August 2015

• Series 2 o A mailing ships May 2015 o B mailing ships November 2015

Add the PAP Education series number after the Slide Type program code(eg, PAPCE1).

2.Order one Individual Participant Response Form code for each participatingpathologist/cytotechnologist. Also include the PAP Education series number after theprogram code (eg, APAPCE1).

Additional Information• Participants can receive laboratory reference interpretations and performance for the

PAP Education slides within 20 minutes by fax.• The PAP Education component meets the CAP Laboratory Accreditation Program

requirement for participation in a peer educational program.

Program Information• Ten glass slides for education

• Earn a maximum of 8 CMEcredits (AMA PRA Category1 CreditsTM) per pathologistand a maximum of 8 CEcredits per cytotechnologistfor completing all challenges


• Two shipments (five slideseach)

Cytopathology


Ana

tom

icPa

thol

ogy

19

Gynecologic Cytopathology – Fields of ViewFOVK/FOVK1, FOVM/FOVM1


FOVK/FOVK1 FOVM/FOVM1

Online review of SurePath slides z 5

Online review of ThinPrep slides z 5

Additional Information• The Fields of View online education program helps pathologists and cytotechnologists

assess and improve their s ills in image-assisted screening.• The Fields of View program helps participants understand the processes involved in

image-assisted gynecologic screening technologies.• Participants receive the reference interpretation for each case immediately after

completing the exercise.• See system re uirements on page 15.

Human Papillomavirus (High Risk) for CytologyCHPVD, CHPVM, CHPVK, CHPVJ


CHPVD CHPVM CHPVK CHPVJ

HPV z z z z 5

High-ris HPVgenotyping (optional)

z z 5

Additional Information• Each laboratory should choose the Survey that best reflects the transport media

received in its facility. For Survey CHPV , participants must provide results for all threemedia types. If your laboratory receives two types of media, order the Survey that ismost appropriate for your specific laboratory (CHPVD, CHPVM, or CHPV ).

• For laboratories that perform HPV genotyping using ThinPrep PreservCyt Transportmedium on site, Survey CHPVM and select samples of Survey CHPVJ provide anopportunity to report specific HPV genotypes.

• The CAP does not report genotyping responses to the CMS.

Program Information• FOV - Five diagnostic

challenges/whole slideimages for SurePath users

• FOVM - Five diagnosticchallenges/whole slideimages for ThinPrep users

• FOV 1/FOVM1 - Reportingoption for each additionalpathologist/cytotechnologist(within the same institution);must order in conjunction withSurvey FOV or FOVM


• Earn a maximum of 10 CEcredits per cytotechnologist


Program Information• Five simulated cervical

specimens

• CHPVD - Digene® SpecimenTransport Medium™ (STM)

• CHPVM - ThinPrepPreservCyt® TransportMedium

• CHPV - SurePathPreservative Fluid TransportMedium and correspondingvial of diluent

• CHPV - Combination ofDigene, ThinPrepPreservCyt, and SurePathtransport mediums


Cytopathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 247

Anatom

icPathology

19

Nongynecologic Cytopathology –Intraoperative Touch Imprint/CrushPreparation Program TICP/TICP1


TICP/TICP1

Online slide and image program in rapidassessment case review

z 5

Additional Information• The TICP Program is designed to familiarize surgical pathologists, cytopathologists,

and cytotechnologists with the cytomorphologic features of pathologic processesand tumors in touch-imprints and crush or scrape preparations. These specimensare prepared either for intraoperative consultation (frozen section) or rapid on-siteevaluation (ROSE) of core biopsies for ade uacy and/or interpretation. Participantswill learn to ma e an immediate ade uacy assessment, assign the process toa general category, and triage the specimen to appropriate ancillary studies.Participants will review digital whole-slides of the TICP preparations (hematoxylin

eosin, modified right-Giemsa, and/or Papanicolaou stains), static images ofthe preparation and ancillary studies, and clinical history/radiographic findings toreach a diagnosis. Each case has a complete description of entities in the differentialdiagnosis along with a discussion of the correct interpretation.


• Participants will receive immediate feedbac on interpretations, ancillary studies andcase-related ade uate assessment.

• The 2015 cases will be comprised of an eclectic mix of procedural touch preparationsand intraoperative consultations from various body sites.


Program Information• TICP - Five online

assessment challenges withclinical history; for eachadditional pathologist orcytotechnologist, purchaseTICP1

• TICP1 Reporting option withCME/SAM/CE credit foreach additional pathologist/technologist (within the sameinstitution); must order inconjunction with Survey TICP

• Earn a maximum of 10CME/SAM credits (AMAPRA Category 1 CreditsTM)per pathologist and amaximum of 10 CE creditsper cytotechnologist forcompletion of an entire year




Cytopathology


Ana

tom

icPa

thol

ogy

19

Nongynecologic CytopathologyEducation Program NGC/NGC1


NGC/NGC1

Nongynecologic cytopathologycase review – glass slides

z 5

Nongynecologic cytopathologycase review – online

z 5 per year

Additional Information• The Nongynecologic Cytopathology Education (NGC) program is an interlaboratory

educational opportunity to assess participants screening and interpretive s ills.The NGC program is unsuitable for proficiency testing as these cases are chosen fortheir educational value. Cases may incorporate static online images that incorporateradiology and multiple aspects of pathology to enhance the interpretation.

• Participants can access laboratory reference interpretations and performance for theglass slides within 20 minutes by fax, providing rapid educational feedbac , peercomparison, and additional review time.


• Additional online advanced education cases provide immediate feedbac oninterpretation selection, follow-up recommendations, and case-related educationalquestions.


Program Information• NGC - Five glass slides; five

online advanced educationcases; one laboratoryresponse form and twoindividual response forms

• NGC1 - Reporting optionwith CME/CE credit foreach additional pathologist/cytotechnologist (within thesame institution); must orderin conjunction with SurveyNGC

• Earn a maximum of25 CME credits (AMA PRACategory 1 Credits™)per pathologist and amaximum of 25 CE creditsper cytotechnologist forcompleting the glass slidesand online cases




Cytopathology

800-323-4040 | 847-832-7000 Option 1 | cap.org 249

Anatom

icPathology

19

Online Digital Slide Program inFine-Needle Aspiration FNA/FNA1


FNA/FNA1

Online program in fine-needleaspiration case review

z 5

Additional Information• This program focuses on FNA diagnostic dilemmas in practice. Online cases, which

consist of whole slide images and static images, provide immediate feedbac oninterpretation selection, ancillary studies selection, and case-related educationalquestions.

• Cases will focus on lung and head and nec pathology.• DigitalScope technology simulates the use of a microscope by enabling the user to

scan and adjust magnification of the whole slide image.• See system re uirements on page 15.

Program Information• FNA - Five online diagnostic

challenges; for eachadditional pathologist orcytotechnologist, purchaseFNA1

• FNA1 - Reporting optionwith CME/CE credit foreach additional pathologist/cytotechnologist (within thesame institution); must orderin conjuction with SurveyFNA

• Earn a maximum of 10 CMEcredits (AMA PRA Category1 Credits™) per pathologist anda maximum of 10 CE creditsper cytotechnologist

• This activity meets the ABPMOC Part IV PracticePerformance Assessmentrequirements



Cytopathology


Ana

tom

icPa

thol

ogy

19

Fine-Needle Aspiration Glass SlideEducation Program FNAG/FNAG1


FNAG/FNAG1

Fine-needle aspiration glassslide case review

z 5

Additional Information• The Fine-Needle Aspiration Glass Slide Education program is an interlaboratory

educational opportunity to assess participants screening and interpretive s ills.FNAG cases may include more than one slide of varying stains and/orpreparations used on fine-needle aspirations.

• Cases may include static online images that incorporate radiology and multipleaspects of pathology to support the interpretation.

• Participants can access laboratory reference interpretations and performance for theglass slides within 20 minutes by fax, providing rapid educational feedbac , peercomparison, and additional review time.

Program Information• FNAG - Five cases consisting

of glass slides and selectedonline images, representing avariety of conditions; onelaboratory response form andtwo individual response forms

• FNAG1 - Reporting optionwith CME/CE credit foreach additional pathologist/cytotechnologist (within thesame institution); must order inconjunction with Survey FNAG

• Earn a maximum of 10 CMEcredits (AMA PRA Category1 Credits™) per pathologist/resident and a maximum of 10CE credits per cytotechnologist

• This activity meets the ABPMOC Part IV PracticePerformance Assessmentrequirements


CAP Practical Guide to Gynecologic CytopathologyDavid C. Wilbur, MD, FCAPMichael R. Henry, MD, FCAPThis image-rich guide extensively covers the principles ofgynecologic cytopathology and takes a thorough look atpractical matters such as evaluation of patients and theirspecimens as well as criteria to determine specimen adequacy.Comprehensive reviews of the morphology of the vast majority ofentities both benign and malignant that are routinely identified inPap tests are presented.

PRESSTo order and see the table of contentsand sample pages:Visit cap.org and choose the Shop tabor call the CAP Customer Contact Centerat 800-323-4040 or 847-832-7000 option 1.

Item number: PUB121ISBN: 978-0-930304-94-2Softcover; 270 pages; 700+photomicrographs, figures,and tables; 2008


Forensic Sciences

20

20 | Forensic Sciences

“We use CAP proficiency testing to ensure theaccuracy of our results and the competencyof our staff.”

Program ChangesDNA Database (DNA, DNAF).........................................................................................................252

Discontinued Procedure: Mitochondrial DNA database analysis

Forensic Sciences


Fore

nsic

Sci

ence

s

20

Forensic SciencesAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

DNA Database DNA, DNAFProcedure Program Code Challenges/Shipment

DNA DNAF

Database analysis (whole blood) z 3

Database analysis (filter paper) z 3

The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Surveys DNA and DNAF.

Forensic Identity—Nuclear and MitochondrialDNA Analysis FID, FIDM


FID FIDM

Forensic nuclear DNA analysis z 3

Forensic mitochondrial DNA analysis z 2

The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Surveys FID and FIDM.

Program Information• DNA - Three 0.5-mL whole

blood specimens

• DNAF - Three blood-stainedfilter paper challenges

• Short tandem repeats (Au-STRand Y-STR)


Program Information• FID - Simulated forensic case

work includes referencestandards for all suspects andvictims along with evidentiarymaterial such as vaginalswabs, semen stains, andcrime scene blood stains

• FIDM - One referencechallenge (blood stain) andone challenge formitochondrial DNA analysis(hair or nails)


Forensic Sciences

800-323-4040 | 847-832-7000 Option 1 | cap.org 253

Forensic Sciences

20

Forensic Pathology FR/FR1Procedure Program Code Challenges/Shipment

FR/FR1

Forensic pathology cases z 6

Additional Information• Cases may include or reflect anthropologic materials, ballistics, dental identification,

DNA identification, environmental pathology, forensic evidence, injury pattern,natural death, medicolegal issues, toxicology, and trace evidence.

• FR/FR1 is for hospital-based pathologists, forensic pathologists, residents, fellows,and medical examiners/coroners. This educational program is also designed forinvestigators, analysts, and technicians/technologists.

Program Information• FR - One CD-ROM containing

six case studies illustratinggross and/or microscopicslides and questions related tomedicolegal decision making;one individual response form

• FR1 - Additional pathologist orinvestigator (within the sameinstitution) reporting option withCME or CE credit; must orderin conjunction with Survey FR

• Pathologists can earn amaximum of 12 CME credits(AMA PRA Category 1 Credits™)for completion of an entire year


• Members of the AmericanBoard of Medicolegal DeathInvestigators, analysts, andtechnologists can earn amaximum of 12 CE credits forcompletion of an entire year


Vitreous Fluid, Postmortem VFAnalyte Program Code Challenges/Shipment

VF

Acetone z 3

Chloride z 3

Creatinine z 3

Ethanol z 3

Glucose z 3

Potassium z 3

Sodium z 3

Vitreous urea nitrogen z 3


vitreous fluid specimens


Forensic Sciences


Fore

nsic

Sci

ence

s

20Refer to Section 8, Toxicology, for a more comprehensive selection of toxicology offerings.

Forensic Toxicology, Criminalistics FTCAnalyte Program Code Challenges/Shipment

FTC


The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Survey FTC.


specimens and one 20.0-mLsynthetic urine specimen



7-aminoclonazepam


Acetaminophen


Alprazolam

Amitriptyline

Amphetamine

Benzoylecgonine

Butalbital

Carisoprodol

Chlorpheniramine

Clonazepam

Cocaethylene

Cocaine

Codeine

Cyclobenzaprine*

Delta-9-THC

Delta-9-THC-COOH

Desipramine

Desmethylcyclobenzaprine

Diazepam

Diphenhydramine

Doxepin



Ephedrine

Fentanyl*

Fluoxetine

Flurazepam*

Gamma-hydroxybutyrate (GHB)

Hydrocodone

Hydromorphone

Imipramine

Ketamine

Lorazepam

Lysergic acid diethylamide (LSD)

Meperidine*

Meprobamate

Methadone

Methadone metabolite (EDDP)

Methamphetamine

Methylenedioxyamphetamine (MDA)


Morphine*

N-desmethyltramadol

Nordiazepam

Nordoxepin

Norfluoxetine

Norketamine

Norpropoxyphene

Norsertraline

Nortriptyline

Oxazepam

Oxycodone

Oxymorphone

Paroxetine

Phencyclidine

Phenethylamine

Phenobarbital

Phentermine

Phenytoin

Propoxyphene

Pseudoephedrine

Secobarbital

Sertraline

Temazepam

Tramadol*

Trazodone

Zolpidem

*and/or metabolite(s)

FTC Drug ListingChallenges will include a mix of drugs from the list below.

Analyte/Procedure

Index

21

21 | Analyte/Procedure Index

“The CAP's Surveys analyte listings arecomprehensive—so when you're looking atnew tests you can go to the index to see acrossthe spectrum and it helps you pick what youmight want.”

Analyte/Procedure Index


Ana

lyte

/Pro

cedu

reIn

dex

21

Analyte/Procedure IndexThe following Analyte/Procedure Index is a comprehensive listing of analytes and corresponding CAP program options.

Analytes/procedures in bold type whose corresponding program codes are bold are regulated for proficiency testing by theCenters for Medicare & Medicaid Services (CMS).

Laboratories must perform five challenges three times per year (as noted by boldface) for analytes that are regulated by the CMS.

The X in the LAP ENR column denotes the CAP programs that can be used to fulfill the proficiency testing enrollmentrequirements for CAP-accredited laboratories. Refer to the program description in this catalog to determine compatibilitywith your specific methodologies.

Analyte/Procedure LAP

ENR

Program

Code

Description Pg

1,5-anhydroglucitol AG 1,5-Anhydroglucitol 641,25 dihydroxyVitamin D

BMV1 Bone Markers andVitamins

77

3-methoxytyramines N/NX Urine Chemistry,Special

62

5-hydroxyindoleaceticacid, qualitative

N/NX Urine Chemistry,Special

62

5-hydroxyindoleaceticacid, quantitative

X N/NX Urine Chemistry,Special

62

6-acetylmorphine(6-AM)

DMPM Drug Monitoring forPain Management

95

FTC Forensic Toxicology,Criminalistics

93

OFD Oral Fluid for Drugs ofAbuse

90

T Toxicology 86UDC Forensic Urine Drug

Testing, Confirmatory89

UT Urine Toxicology 867-aminoclonazepam DMPM Drug Monitoring for

Pain Management95


93

T Toxicology 86UT Urine Toxicology 86

7-aminoflunitrazepam FTC Forensic Toxicology,Criminalistics

93


10q (PTEN) deletion GLI Glioma 22411-dehydrothromboxaneB2

TBX 11-Dehydro-thromboxane B2

149

11-deoxycortisol Y/YY Ligand Assay, Special 7517-hydroxycorticosteroids N/NX Urine Chemistry,

Special62

17-hydroxyprogesterone X Y/YY Ligand Assay, Special 7517-ketosteroids N/NX Urine Chemistry,

Special62

25-OH vitamin D X ABVD Accuracy-BasedVitamin D

76


ENR

Program

Code

Description Pg

25-OH vitamin D (cont.) LN40 Vitamin D Cal Ver/Lin 116X VITD 25-OH Vitamin D 76

50:50 mixing study,APTT

CGE/CGEX Coagulation, Extended 144

CGS1 Coag Special, Series 1 14550:50 mixing study, PT CGE/CGEX Coagulation, Extended 144

CGS1 Coag Special, Series 1 145ABO grouping X ABO HLA Serologic Typing 207

X J, J1 Transfusion Medicine 192X JAT Transfusion Medicine,

Automated192

JATE1 Transfusion Medicine,Automated, Educational

193

TMCA Transfusion Medicine,Competency Assessment

194

Acetaminophen X CZ, CZ2X,CZX, Z

Chemistry and TDM 50-52

CZQ Quality Cross Check,Chemistry and TDM

53


93

LN3 TDM Cal Ver/Lin 107X SDS Serum Drug Screen 91

T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86

Acetone X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles

91

X AL2 Serum Alcohol/EthyleneGlycol/Volatiles

91

SDS Serum Drug Screen 91VF Vitreous Fluid, Post-

mortem90

Acid-fast smear X E Mycobacteriology 163X E1 Mycobacteriology, Ltd 163

Acid phosphatase X C3, C3X,CZ, CZ2X,CZX



800-323-4040 | 847-832-7000 Option 1 | cap.org 257

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Acid phosphatase (cont.) CZQ Quality Cross Check,Chemistry and TDM

53

Activated clotting time X CT, CT1,CT2, CT3,CT5

ACT 146

POC14,POC15,POC16

Competency ActivatedClotting Time

45

Activated partialthromboplastin time


X CGL Coagulation, Ltd 144CGS1 Coag Special, Series 1 145CGS3 Coag Special, Series 3 145CGS4 Coag Special, Series 4 145DBGN Anticoagulant

Monitoring, Dabigatran146

FNPX AnticoagulantMonitoring,Fondaparinux

146

RVBN AnticoagulantMonitoring,Rivaroxaban

146

Activated protein Cresistance


CGS2 Coag Special, Series 2 145Acylcarnitine BGL Biochemical Genetics 215Adenovirus ID2 Nucleic Acid Amp,

Respiratory176

IDR Infectious DiseaseRespiratory Panel

177

VLS2 Viral Load 173X VR1 Virology Culture 171X VR2 Viral Antigen by DFA 171X VR4 Viral Antigen by EIA

and Latex172

Adenovirus 40/41 SP, SPN Stool Pathogen 161Adjustable micropipetteCal V/L

I Instrumentation 118

Adrenocorticotropichormone (ACTH)

X TM/TMX Tumor Markers 80

Alanine aminotrans-ferase (ALT/SGPT)

X C1, C3, C3X,CZ, CZ2X,CZX



53

IFS Interfering Substances 119LN2 Chemistry, Lipid,

Enzyme Cal Ver/Lin106

LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin

106


ENR

Program

Code

Description Pg

Albumin X C1, C3, C3X,CZ, CZ2X,CZX



53

FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,



106

SPE Protein Electrophoresis 68Albumin, CSF X M, OLI CSF Chemistry and

Oligoclonal Bands66

Albumin, urine ABU Accuracy-Based Urine 99LN20 Urine Albumin 112

X U Urine Chemistry,General

61

Albumin: creatinine ratio ABU Accuracy-Based Urine 99LN20 Urine Albumin Cal

Ver/Lin112

U Urine Chemistry,General

61

UMC Urine AlbuminCreatinine

138

Alcohol, serum X AL2 Serum Alcohol/EthyleneGlycol/Volatiles

91

LN11 Serum Ethanol CalVer/Lin

110

Alcohol, whole blood X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles

91

LN14 Whole Blood EthanolCal Ver/Lin

111

Aldolase ADL Aldolase 64Aldosterone, serum X RAP Renin and Aldosterone 79Aldosterone, urine X N/NX Urine Chemistry,

Special62

ALK PM5 ImmunohistochemistryTMA

238

Alkaline phosphatase(ALP)




53

FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,



106



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Allele detection PGX, PGX1,PGX2

Pharmacogenetics 219

Allergens (specific) SE Diagnostic Allergy 185Alpha-1 antitrypsin X IG/IGX Immunology, General 180

LN7 Immunology Cal Ver/Lin 109Alpha-1 antitrypsingenotyping

AAT Alpha-1 antitrypsingenotyping

216

Alpha1 globulin SPE Protein electrophoresis 68Alpha2 globulin SPE Protein electrophoresis 68Alpha-2-antiplasmin CGE/CGEX Coagulation, Extended 144Alpha-fetoprotein (AFP),amniotic fluid

X FP/FPX Maternal Screen 78

Alpha-fetoprotein (AFP),serum


X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal

Ver/Lin108

LN5S Ligand Assay, SiemensCal Ver/Lin

108



95


93



UT Urine Toxicology 86Alpha-PVP (a-Pyrrolidino-pentiophenone)

SCDD Synthetic Cannabinoid/Designer Drug

94

Alpha-thalassemia HGM Hemoglobinopathies,Molecular Methods

216

Alprazolam DMPM Drug Monitoring forPain Management

95


93


Aluminum X R Trace Metals 70TMU Trace Metals, Urine 92

AM-2201 N-(4-hydroxypentyl) metabolite

SCDD Synthetic Cannabinoid/Designer Drug

94

Amikacin X CZ, CZ2X,CZX, Z



53

LN3 TDM Cal Ver/Lin 107Amino acids, qualitative X BGL Biochemical Genetics 215Amino acids,quantitative

BGL Biochemical Genetics 215

Amitriptyline FTC Forensic Toxicology,Criminalistics

93


ENR

Program

Code

Description Pg

Amitriptyline (cont.) T Toxicology 86UT Urine Toxicology 86

X ZT, ZZT TDM, Special 54Ammonia C3, C3X,

CZ, CZ2X,CZX



53

LN32 Ammonia Cal Ver/Lin 115Amniotic fluid leakage(nitrazine)

AFL Amniotic Fluid Leakage 134

Amphetamine DMPM Drug Monitoring forPain Management

95


93


90



UT Urine Toxicology 86UDS, UDS6 Urine Drug Screen 88

Amphetamine group DMPM Drug Monitoring forPain Management

95


90


Amylase X C1, C3, C3X,CZ, CZ2X,CZX



53




106

Amylase, pancreatic X C1, C3, C3X,CZ, CZ2X,CZX



53

Amylase, urine LN6 Urine Chemistry CalVer/Lin

108


61

Analytical balance I Instrumentation 118


800-323-4040 | 847-832-7000 Option 1 | cap.org 259

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Anaplasmaphagocytophilum

TTD Antibody Detection-Tick-Transmitted Diseases

178

Androstenedione X Y/YY Ligand Assay, Special 75Angiotensin convertingenzyme

ACE Angiotensin ConvertingEnzyme

64

Anti-A titer ABT, ABT1 Antibody Titer 196Anti-B titer ABT3 Antibody Titer 196Anti-beta-2-glycoprotein CGE/CGEX Coagulation, Extended 144Antibody detection X J, JAT Transfusion Medicine 192


193

X PS Platelet Serology 199TMCA Transfusion Medicine,

Competency Assessment194

Antibody detection/identification (HLA)

X MX1B,MX1C,MX1E, MXB,MXC

HLA Analysis, Class I 206-207


HLA Analysis, Class II 206-207

Antibody identification ETME1 Expanded TransfusionMedicine Exercises

193

X J, JAT Transfusion Medicine 192JATE1 Transfusion Medicine,

Automated, Educational193


194

Antibody screen (HLA) MX1B,MX1C,MX1E, MXB,MXC


MX2B,MX2C,MX2E, MXB,MXC


Anticardiolipin IgA,qualitative

ACL, APS AntiphospholipidAntibody

183

Anticardiolipin IgA,quantitative


183

Anticardiolipin IgG,IgM, polyclonal;qualitative

X ACL, APS AntiphospholipidAntibody

183

Anticardiolipin IgG,IgM, polyclonal;quantitative


183

Anti-CCP CCP Cyclic CitrullinatedPeptide Antibody

184

Anticentromere antibody S2 Immunology Special 181Antichromatin Antibody ACA Antichromatin Antibody 182


ENR

Program

Code

Description Pg

Anti-CMV, total X VM3 Viral Markers-Series 3 201X VR3 Infectious Disease

Serology178

Anti-CMV, IgG, IgM X VR3 Infectious DiseaseSerology

178

Anti-D titer ABT, ABT2 Antibody Titer 196Anti-DNA (ds) antibody,qualitative

X S2, S4 Immunology, Special 181

Anti-DNA (ds) antibody,quantitative

S2, S4 Immunology, Special 181

Anti-DNA topoisom-erase (Scl-70)

RDS Rheumatic DiseaseSpecial Serologies

186

Antiendomysial antibodyIgA, qualitative

X CES Celiac Serology 184

Antiendomysial antibodyIgA, quantitative

CES Celiac Serology 184

Antiendomysial antibodyIgG, qualitative


Antiendomysial antibodyIgG, quantitative


Antifungal susceptibilitytesting

X F Mycology 164

X F1 Yeast 164Antigen detection,bacterial

X D Bacteriology 152

X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156X D8 Group B Strep 156X D9 Rapid Group A Strep,

Waived156

X HC1 C. trachomatis by DFA 159X HC3 C. trachomatis by EIA 159X LBAS Legionella pneumophila 157X SBAS Streptococcus

pneumoniae157

X VS Vaginitis Screen 162Antigen detection, viral X HC2 HSV by DFA 172

X VR2 Viral Antigen Detectionby DFA

171

X VR4 Viral Antigen Detectionby EIA and Latex

172

Antigliadin antibodyIgA, IgG, qualitative


Antigliadin antibodyIgA, IgG, quantitative


Antideamidated gliadinpeptide antibody, IgA,IgG, qual


Antideamidated gliadinpeptide antibody, IgA,IgG, quant




Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Antideamidated gliadinpeptide antibody screen,IgA, IgG


Antideamidatedgliadin peptide/tissuetransglutaminaseantibody screen, IgA, IgG


Antifilamentous actinIgG Antibody

FCN Antifilamentous ActinAntibody

182

Antiglomerular basementmembrane, qualitative

X S2 Immunology, Special 181

Antiglomerular basementmembrane, quantitative

S2 Immunology, Special 181

Anti-HAV, IgM X VM5 Viral Markers-Series 5 202Anti-HAV, total X VM1 Viral Markers-Series 1 201Anti-HBc, IgM X VM5 Viral Markers-Series 5 202Anti-HBc, total X VM1 Viral Markers-Series 1 201Anti-HBe X VM2 Viral Markers-Series 2 201Anti-HBs X VM1 Viral Markers-Series 1 201Anti-HCV RHCVW Anti-HCV, Rapid

Methods, Wavied202

X VM1 Viral Markers-Series 1 201Antihistidyl t-RNAsynthetase (Jo-1)


186

Antihistone antibody AHT Antihistone Antibody 182Anti-HIV-1 X AHIV Anti-HIV Rapid

Methods202

X AHIVW Anti-HIV RapidMethods

202

X VM1 Viral Markers-Series 1 201Anti-HIV-2 X VM1 Viral Markers-Series 1 201

X AHIV Anti-HIV RapidMethods

202

Anti-HIV-1/2 X AHIV Anti-HIV RapidMethods

202

X AHIVW Anti-HIV RapidMethods

202

X VM1 Viral Markers-Series 1 201Anti-HIV 1/2, HIV-1p24 antigen

X VM6 Viral Markers-Series 6 202

Anti-HTLV-I/II X VM3 Viral Markers-Series 3 201Anti-Jo-1(antihistidylt-RNA synthetase)


186

Anti-LKM LKM Liver-KidneyMicrosomal Antibody

186

Antimicrobialsusceptibility testing


X D2 Urine Cultures 154X D4 Bacteriology, Ltd 154X D7 Throat, Urine Cultures 154


ENR

Program

Code

Description Pg

Antimicrobialsusceptibility testing(cont.)

MBT Microbiology BenchTools Competency

153

Antimitochondrialantibody, qualitative


Antimitochondrial M2antibody

H Antimitochondrial M2Antibody

182

Anti-MPO S2 Immunology, Special 181Antimüllerian Hormone AMH Antimüllerian Hormone 76Antimycobacterialsusceptibility testing

X E Mycobacteriology 163

MTBR Molecular MTBDetection andResistance

163

Antineutrophilcytoplasmic antibody(ANCA)


Antinuclear antibody(ANA)

X ANA, IL Immunology 180

Antiparietal cellantibody

APC Antiparietal CellAntibody

182

Antiphospholipidantibody

ACL AntiphospholipidAntibody

183

CGE/CGEX Coagulation, Extended 144Antiphosphatidylserineantibodies (IgG, IgMand IgA)

APS AntiphosphatidylserineAntibodies

183

Anti-PR3 S2 Immunology, Special 181Antiribosomal PAntibody

ARP Antiribosomal PAntibody

183

Anti-RNP antibody,qualitative


Anti-RNP antibody,quantitative


Anti-Saccharomycescerevisiae antibody

ASC Anti-Saccharomycescerevisiae Antibody

183

Anti-Scl-70 (anti-DNAtopoisomerase)


186

Anti-Sm antibody,qualitative


Anti-Sm antibody,quantitative


Anti-Sm/RNP antibody,qualitative


Anti-Sm/RNP antibody,quantitative


Antismooth muscleantibody


Antisperm antibody IgG X ASA Semen Analysis 140Anti-SSA antibody,qualitative



800-323-4040 | 847-832-7000 Option 1 | cap.org 261

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Anti-SSA antibody,quantitative


Anti-SSB antibody,qualitative


Anti-SSB antibody,quantitative


Anti-SSA/SSB antibody,qualitative


Anti-SSA/SSB antibody,quantitative


Antistreptolysin O (ASO) X ASO, IL Immunology 180Antithrombin (Activity, Ag) CGE/CGEX Coagulation, Extended 144

CGS2 Coag Special, Series 2 145LN35 Thrombophilia Cal

Ver/Lin116

Antithyroglobulinantibody, qualitative


Antithyroglobulinantibody, quantitative


Antithyroid microsomal,qualitative


Antithyroid microsomal,quantitative


Antithyroid peroxidase,qualitative


Antithyroid peroxidase,quantitative


Antitissue transgluta-minase antibody IgA,qualitative


Antitissue transgluta-minase antibody IgA,quantitative


Antitissue transgluta-minase antibody IgGqualitative


Antitissue transgluta-minase antibody IgGquantitative


Anti-Trypanosoma cruzi VM4 Viral Markers-Series 4 202Apolipoprotein A1 X ABL Accuracy-Based Lipids 98

X C3, C3X,CZ, CZ2X,CZX



53

Apolipoprotein B X ABL Accuracy-Based Lipids 98X C3, C3X,

CZ, CZ2X,CZX



53


ENR

Program

Code

Description Pg

Apolipoprotein E(APOE) genotyping

APOE Apolipoprotein E(APOE) genotyping

216

Arsenic, urine TMU Trace Metals, Urine 92Arthropod identification TMO Ticks, Mites, and Other

Arthropods169

Aspartate aminotrans-ferase (AST/SGOT)




53




106

Atenolol T Toxicology 86UT Urine Toxicology 86

Atropine T Toxicology 86UT Urine Toxicology 86

Automated WBCdifferential

X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P

Hematology, Auto Diff 125

FH3Q,FH4Q,FH6Q,FH9Q

Quality Cross Check ,Automated HematologySeries

126

Autopsy pathology AUCD/AUCD1

Autopsy Pathology,CD-ROM

240

B-type natriuretic peptides X BNP B-Type NatriureticPeptides, 2 Chall

55

X BNP5 B-Type NatriureticPeptides, 5 Chall

55

BNPQ Quality Cross Check,B-Type NatriureticPeptides

55

LN30 B-Type NatriureticPeptides Cal Ver/Lin

114

X PCARM,PCARMX

Plasma CardiacMarkers

59

POC12 Competency PlasmaCardiac Markers

45

Babesia microti TTD Antibody Detectionof Tick-TransmittedDiseases

178

Bacterial antigendetection


X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Bacterial antigendetection (cont.)

X HC1 C. trachomatis by DFA 159

X HC3 C. trachomatis by EIA 159X LBAS Legionella Antigen

Detection157

POC4 POC Strep ScreenCompetency

44

X SBAS S. pneumoniae AntigenDetection

157

X VS Vaginitis Screen 162Bacterial detection inplatelets

BDP, BDPV Bacterial detection,platelets

197

X BDP5,BDPV5

Bacterial detection,platelets

197

Bacterial identification X D Bacteriology 152X D1, D2, D3,

D7Throat, Urine, GCCultures

154

X D4 Bacteriology, Ltd 154X D8 Group B Strep 156

DEX Expanded Bacteriology 153X HC6/HC6X C. trachomatis/GC by

Nucleic Acid Amp174

X HC7 C. trachomatis/GCDNA by NAA

174

MBT Microbiology BenchTools Competency

153

MRS Methicillin-ResistantStaphylococcus aureusScreen

160

X MRS5 Methicillin-ResistantStaphylococcus aureusScreen

160

Bacterial strain typing BSTE Bacterial Strain Typing-Enterococcus

175

BSTN Bacterial Strain Typing-Gram-negative

175

BSTS Bacterial Strain Typing-Staphylococcus

175

Bacterial vaginosisscreen

BV Bacterial Vaginosis 161

VS2 Vaginitis Screen, VirtualGram Stain

162

Barbiturate group DMPM Drug Monitoring forPain Management

95

SDS Serum Drug Screen 91T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86

BCR/ABL1 p190 X MRD1 Minimal ResidualDisease

225


ENR

Program

Code

Description Pg

BCR/ABL1 p210 X MRD Minimal ResidualDisease

225

Bence Jones protein UBJP Urinary Bence JonesProtein

68

Benzodiazepine group DMPM Drug Monitoring forPain Management

95

SDS Serum Drug Screen 91T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86

Benzoylecgonine DMPM Drug Monitoring forPain Management

95


93


90



UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86UTCO Urine Toxicology

Carryover120

Beta-2-glycoprotein I ACL, APS AntiphospholipidAntibody

183

Beta-2-microglobulin,serum

X TM/TMX Tumor Markers 80

Beta-2-microglobulin,urine

CD Cadmium 92

Beta-hydroxybutyrate X KET Ketones 58Beta globulin SPE Serum Electrophoresis 68Beta-thalassemia HGM Hemoglobinopathies,

Molecular Methods216

Bile crystal identification BCR Bile Crystals 135Bilirubin, confirmatoryurine

DSC Dipstick Confirmatory 135

Bilirubin, direct X C1, C3,C3X, CZ,CZ2X, CZX



53

LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin

106


106

X NB, NB2 Neonatal Bilirubin 58Bilirubin, total X C1, C3, C3X,

CZ, CZ2X,CZX



800-323-4040 | 847-832-7000 Option 1 | cap.org 263

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Bilirubin, total (cont.) CZQ Quality Cross Check,Chemistry and TDM

53

FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LM1 Lung Maturity 68LN2 Chemistry, Lipid,



106

X NB, NB2 Neonatal Bilirubin 58Bilirubin, urine X CMP, CMP1 Clinical Microscopy 133

DSC Dipstick Confirmatory 135POC3 POC Urine Dipstick

Competency44

Bioavailable testosterone DY Ligand Assay, Special 75Biochemical genetics BGL, BGL1 Biochemical Genetics 215Bioterrorism agents LPX Laboratory

Preparedness Exercise159

BK virus ID1T Nucleic Acid Amp, JCand BK

176

VLS, VLS2 Viral Load 173Blood cell identification X BCP Blood Cell Identification 124

EHE1 Expanded VirtualPeripheral Blood Smear

131

X FH1P-FH4P,FH6P, FH9P-FH12P


X HEP Basic Hematology 124VPBS Virtual Peripheral Blood

Smear130

Blood cell identification-body fluid

VBF Virtual Body Fluid 134

Blood culture X BCS Blood Culture 157GNBC Gram-Negative Blood

Culture Panel158

GPBC Gram-Positive BloodCulture Panel

158

Blood cultureStaphylococcus aureus

BCS1 Blood CultureStaphylococcus aureus

157

Blood parasite X BP Blood Parasite 168X P Parasitology 167

Blood parasite, rapid RMAL Rapid Malaria 168Bloom syndrome X MGL4 Molecular Genetics 217Bocavirus IDR Infectious Disease

Respiratory Panel177

Body fluid (cell count) ABF1, ABF2,ABF3

Automated Body Fluid 134

X HFC, HFCI HemocytometerFluid Count

136

Body fluid (chemistry) FLD, FLD2 Body Fluid 65


ENR

Program

Code

Description Pg

Body fluid (crystals) BFC Crystals 135Body fluid photographs CMP, CMP1 Clinical Microscopy 133Bone marrow celldifferential

BMD Bone Marrow CellDifferential

128

Bone marrow cellidentification


128

Bone specific alkalinephosphatase


77

Bordetella parapertussis IDN, IDO Nucleic Acid Amp,Organisms

175

Bordetella pertussis IDN, IDO Nucleic Acid Amp,Organisms

175

Borrelia burgdorferi TTD Antibody Detectionof Tick-TransmittedDiseases

178

BRAF BRAF Mutation testing 224MTP Multigene Tumor Panel 224

BRCA1/2 X MGL3 Molecular Genetics 217Brain tissue by FISH CYJ Fluorescence In Situ

Hybrid, Brain/GliomaTissue

213

Brightfield in situhybridization

X ISH2 In Situ Hybridization 222

Brompheniramine FTC Forensic Toxicology,Criminalistics

93


Buprenorphine DMPM Drug Monitoring forPain Management

95



UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86

Bupropion T Toxicology 86UT Urine Toxicology 86

Butalbital DMPM Drug Monitoring forPain Management

95


93



UT Urine Toxicology 86C. difficile X D Bacteriology-Antigen

Detection152

GIP Gastrointestinal Panel 177SP, SPN Stool Pathogens- Rapid

and Molecular161

CA 15-3 LN34 Tumor Markers CalVer/Lin

115



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

CA 15-3 (cont.) X TM/TMX Tumor Markers 80CA 19-9 FLD Body Fluid 65

LN34 Tumor Markers CalVer/Lin

115

X TM/TMX Tumor Markers 80CA 27.29 X TM/TMX Tumor Markers 80CA 72-4 X TM/TMX Tumor Markers 80CA 125 LN34 Tumor Markers Cal

Ver/Lin115

X TM/TMX Tumor Markers 80Cadmium, urine X CD Cadmium 92Cadmium, whole blood X CD Cadmium 92Caffeine X CZ2X, CZX,

CZ, ZChemistry and TDM 50-52


53

Calcitonin X TM/TMX Tumor Markers 80Calcium ABS Accuracy-Based

Testosterone andEstradiol

99




53




106

Calcium, urine ABU Accuracy-Based Urine 99LN6 Urine Chemistry Cal

Ver/Lin108


61

Calcium, ionized X AQ, AQ2,AQ3, AQ4

Aqueous Blood Gas 82

AQQ,AQ2Q,AQ3Q,AQ4Q

Quality Cross Check,Critical Care AqueousBlood Gas Series

83




53

LN13C Blood Gas Cal Ver/Lin 111


ENR

Program

Code

Description Pg

Calcium, ionized (cont.) POC10,POC11

POC Competency BloodGases

45

Calcofluor white FSM Fungal Smear 165Campylobacter CAMP Campylobacter 158

GIP Gastrointestinal Panel 177Canavan X MGL4 Molecular Genetics 217Candida culture X F3 Candida culture 165Candida sp., DNA probe X VS Vaginitis Screen 162Cannabinoids See Delta-9-THC-

COOH and Delta-9-THC

Carbamazepine X CZ, CZ2X,CZX, Z



53

LN3 TDM Cal Ver/Lin 107T Toxicology 86UT Urine Toxicology 86

Carbamazepine-10,11-epoxide

T Toxicology 86

UT Urine Toxicology 86Carbamazepine, free X CZ, CZ2X,

CZX, ZChemistry and TDM 50-52


53

Carboxyhemoglobin X SO Blood Oximetry 84SOQ Quality Cross Check,

Blood Oximetry84

Carisoprodol DMPM Drug Monitoring forPain Management

95


93


Carnitine BGL1 Biochemical Genetics 215Casts, urine UAA, UAA1 Automated Urinalysis 135CD1a RFAV1 Rare Flow Antigen

Validation CD1a190

CD3 X FL, FL1 Lymphocyte subsetimmunophenotyping

188

LN22 Flow Cytometry CalVer/Lin

113

SCP Stem Cell Processing 198CD4 X FL, FL1 Lymphocyte subset

immunophenotyping188


113

CD8 X FL, FL1 Lymphocyte subsetimmunophenotyping

188


113


800-323-4040 | 847-832-7000 Option 1 | cap.org 265

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

CD20 PM3 Immunohistochemistry 237CD34 CBT Cord Blood Testing 198

X FL4 Flow Cytometry CD34+ 189SCP Stem Cell Processing 198

CD45 CBT Cord Blood Testing 198X FL, FL1 Lymphocyte subset

immunophenotyping188

FL4 Flow Cytometry CD34+ 189SCP Stem Cell Processing 198

CD117 (c-kit) PM1 Immunohistochemistry 237CEA FLD Body Fluid 65


Ver/Lin108


108

Ceruloplasmin X S2, S4 Immunology, Special 181CFU-GM SCP Stem Cell Processing 198CH50 CH50 Total Hemolytic

complement186

CH100 CH50 CH100 186Chlamydia trachomatis X HC1 C. trachomatis by DFA 159

X HC3 C. trachomatis by EIA 159X HC6, HC6X C. trachomatis/GC by

Nucleic Acid Amp174


174

VR1 Virology Culture 171Chlamydiophilapneumoniae

IDN, IDO Nucleic Acid Amp,Organisms

175

Chlordiazepoxide T Toxicology 86UT Urine Toxicology 86

Chloride X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83




53




106



ENR

Program

Code

Description Pg

Chloride (cont.) POC10,POC11


45

Chloride, sweat X SW1, SW2,SW3, SW4

Sweat Analysis Series 71

Chloride, urine LN6 Urine Chemistry CalVer/Lin

108


61

Chloride, vitreous fluid VF Vitreous Fluid, Post-mortem

90

Chlorpheniramine FTC Forensic Toxicology,Criminalistics

93


Chlorpromazine T Toxicology 86UT Urine Toxicology 86

Cholesterol ABL Accuracy-Based Lipids 98X C1, C3, C3X,

CZ, CZ2X,CZX



53

FLD Body Fluid 65X LCW Ltd Chem, Waived 58


106


106

Chromium X R Trace Metals 70Chromium, urine TMU Trace Metals, Urine 92Chromosomalabnormalities

X CY, CYBK Cytogenetics 212

Citalopram T Toxicology 86UT Urine Toxicology 86

CK isoenzymes X CRTI Cardiac Markers 56CK-MB(immunochemical)

X CRT, CRTI Cardiac Markers 56




106

X PCARM,PCARMX


59


45

CK2 (MB) IFS Interfering Substances 119LN2 Chemistry, Lipid,




Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

CK2 (MB) (cont.) LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin

106

Clinical PathologyImprovement Program

CPIP/CPIP1 Quality Management(Education)

16

Clomipramine T Toxicology 86UT Urine Toxicology 86

Clonazepam DMPM Drug Monitoring forPain Management

95


93


Clostridium difficile X D Bacteriology-AntigenDetection

152

GIP Gastrointestinal Panel 177SP, SPN Stool Pathogens- Rapid

and Molecular161

Clozapine T Toxicology 86UT Urine Toxicology 86ZE Therapeutic Drug

Monitoring, Extended54

CMV ID1 Nucleic Acid Amp,Viruses

176

LN38 CMV Viral Load CalVer/Lin

116

VLS, VLS2 Viral Load 173X VM3 Viral Markers-Series 3 201X VR1 Virology Culture 171X VR2 Viral Antigen Detection

by DFA171

X VR3 Infectious DiseaseSerology

178

CO2 X C3, C3X,CZ, CZ2X,CZX



53




106

Cobalt TMU Trace Metals, Urine 92Cocaethylene FTC Forensic Toxicology,

Criminalistics93


Cocaine DMPM Drug Monitoring forPain Management

95


ENR

Program

Code

Description Pg

Cocaine (cont.) FTC Forensic Toxicology,Criminalistics

93


90


Codeine DMPM Drug Monitoring forPain Management

95


93


90



UT Urine Toxicology 86Compatibility testing X J, JAT Transfusion Medicine 192

JATE1 Transfusion MedicineAutomated, Educational

193


194

Complement C3 X IG/IGX Immunology, General 180LN7 Immunology Cal Ver/Lin 109

Complement C4 X IG/IGX Immunology, General 180LN7 Immunology Cal Ver/Lin 109

Complexed PSA X K/KK Ligand Assay, General 74Conductivity, sweat X SW1, SW2,

SW3, SW4Sweat Analysis Series 71

Connexin-26 X MGL3 Molecular Genetics 217Copper X R Trace Metals 70Copper, urine TMU Trace Metals, Urine 92Coproporphyrins X N/NX Urine Chemistry, Special 62Coronavirus ID2 Nucleic Acid Amp,

Respiratory176

IDR Infectious Disease,Respiratory Panel

177

Cortisol ABS Accuracy-BasedTestosterone andEstradiol

99




53


Ver/Lin108


108

Cortisol, salivary SALC Salivary Cortisol 69


800-323-4040 | 847-832-7000 Option 1 | cap.org 267

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Cortisol, urinary free X N/NX Urine Chemistry,Special

62

Cotinine T Toxicology 86UT Urine Toxicology 86

C-peptide X ING Insulin, Gastrin,C-Peptide, PTH

78

C-reactive protein (CRP) X CRP, IL Immunology 180LN12 C-Reactive Protein Cal

Ver/Lin110

C-reactive protein, high-sensitivity (hsCRP)

X HSCRP High-Sensitivity C-Reactive Protein

57

LN21 High-SensitivityC-Reactive Protein CalVer/Lin

113

Creatine kinase (CK) X C1, C3, C3X,CZ, CZ2X,CZX



53




106

Creatinine X AQ2, AQ4 Aqueous Blood Gas 82AQ2Q,AQ4Q


83




53




106

LN24 Creatinine AccuracyCal Ver/Lin

114

SCO Serum Carryover 120Creatinine, urine ABU Accuracy-Based Urine 99

X BU Bone and Mineral,Urine

77

X CD Cadmium 92DAI Urine Drug Adulterant/

Integrity Testing88


ENR

Program

Code

Description Pg

Creatinine, urine (cont.) LN6 Urine Chemistry CalVer/Lin

108

LN20 Urine Albumin CalVer/Lin

112


61

UDC Forensic Urine DrugTesting, Confirmatory

89

X UMC Urine Albumin/Creatinine

138

Creatinine, vitreous fluid VF Vitreous Fluid, Post-mortem

90

Crossmatching EXM, EXM2 Electronic Crossmatch 195X J, JAT Transfusion Medicine 192X MX1B,

MX1C, MXB,MXC


X MX2B,MX2C, MXB,MXC

HLA Analysis Class II 206-207


194

Cryptococcal antigendetection

X F Mycology 164

X F1 Yeast 164Cryptosporidium GIP Gastrointestinal Panel 177Cryptosporidiumimmunoassay,preserved specimen

X P, P3, P4, P5 Parasitology 167

Crystals BFC Body Fluid Crystals 135UAA Automated Urinalysis 135URC Urine Crystals 135

CSF antigen detection X D Bacteriology 152C-telopeptide (CTX) BMV5 Bone Markers and

Vitamin77

BU Bone and Mineral,Urine

77

Cyclic citrullinatedpeptide antibody

CCP Anti-cyclic citrullinatedpeptide antibody

184

Cyclobenzaprine FTC Forensic Toxicology,Criminalistics

93


Cyclosporine X CS ImmunosuppressiveDrugs

53

LN31 ImmunosuppressiveDrugs Cal Ver/Lin

115

CYP2C9 PGX Pharmacogenetics 219CYP2C19 PGX Pharmacogenetics 219CYP2D6 PGX Pharmacogenetics 219Cystatin C CYS Cystatin C 66



Ana

lyte

/Pro

cedu

re In

dex

21


ENR

Program

Code

Description Pg

Cystic fibrosis X MGL2, MGL5

Molecular Genetics 217

Cytogenomic microarray CYCGH Cytogenomic Microarray Analysis

213

Cytology proficiency testing

See Cytopathology GYN proficiency testing

Cytomegalovirus (CMV) ID1 Nucleic Acid Amp, Viruses

176

LN38 CMV Viral Load Cal Ver/Lin

116

VLS, VLS2 Viral Load 173X VM3 Viral Markers- Series 3 201X VR1 Virology Culture 171X VR2 Virology by DFA 171X VR3 Infectious Disease

Serology178

Cytopathology GYN education

APEDK PAP Edu, Online, Indiv., SurePath

244

APEDL PAP Edu, Online, Indiv., Combination

244

APEDM PAP Edu, Online, Indiv., ThinPrep

244

FOVK/FOVK1

Fields of View SurePath 246

FOVM/FOVM1

Fields of View ThinPrep 246

PAPCE1 PAP Edu, Conventional 245PAPJE1 PAP Edu, All

Technologies245

PAPKE1 PAP Edu, SurePath 245PAPME1 PAP Edu, ThinPrep 245PEDK PAP Edu, Online, Lab,

SurePath244

PEDL PAP Edu, Online, Lab, Combination

244

PEDM PAP Edu, Online, Lab, ThinPrep

244

Cytopathology GYN proficiency testing

PAPCPT PAP PT, Conventional 243

PAPJPT PAP PT, Combination 243PAPKPT PAP PT, SurePath 243PAPLPT PAP PT, Combination 243PAPMPT PAP PT, ThinPrep 243PTGDK PAP PT, Sure Path 242PTGDM PAP PT, Thin Prep 242PTGDL PAP PT, Combination 242

Cytopathology, nongynecologic

FNA/FNA1 Fine- Needle Aspiration- online

249

FNAG/FNAG1

Fine- Needle Aspiration- glass

250


ENR

Program

Code

Description Pg

Cytopathology, nongynecologic (cont.)

NGC/NGC1 Nongynecologic Cytopath Edu Prgm

248

Cytopreparation differential

HFC Hemocytometer Fluid Count

136

Dabigatran DBGN Anticoagulant Monitoring, Dabigatran

146

D- dimer, qualitative CGDF Coagulation, D- dimer/FDP

144

CGL Coagulation, Ltd 144WBDD Whole Blood D- dimer 149

D- dimer, quantitative X CGDF Coagulation, D- dimer/FDP

144

X CGL Coagulation, Ltd 144LN42 D- dimer Cal Ver/Lin 117

X PCARM, PCARMX

Plasma Cardiac Markers

59

POC12 Competency Plasma Cardiac Markers

45

Delta- 9- THC FTC Forensic Toxicology, Criminalistics

93

OFD Oral Fluid for Drugs of Abuse

90


Delta- 9- THC- COOH DMPM Drug Monitoring for Pain Management

95

FTC Forensic Toxicology, Criminalistics

93

OFD Oral Fluid for Drugs of Abuse

90




Carryover120

Deoxypyridinoline (DPD) BU Bone and Mineral, Urine

77

Dermatopathology DPATH/DPATH1

Online Digital Slide Program

231

Dermatophyte identification

X F Mycology 164

Desalkylflurazepam T Toxicology 86UT Urine Toxicology 86

Desipramine FTC Forensic Toxicology, Criminalistics

93


X ZT, ZZT TDM, Special 54Desmethylclomipramine T Toxicology 86

Discontinued

Discontinued

Discontinued


800-323-4040 | 847-832-7000 Option 1 | cap.org 269

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Desmethylclomipramine(cont.)

UT Urine Toxicology 86

Desmethylcycloben-zaprine


93

Dextromethorphan T Toxicology 86UT Urine Toxicology 86

DHEA sulfate X Y/YY Ligand Assay, Special 75DIA (Dimeric inhibin A) X FP/FPX Maternal Screen 78Diazepam FTC Forensic Toxicology,

Criminalistics93


Differential, automated X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P


FH3Q,FH4Q,FH6Q,FH9Q

Quality Cross Check,Automated HematologySeries

126

Differential, manual BMD Bone Marrow CellDifferential

128

HFC, HFCI HemocytometerFluid Count

136

Digital slide program infine-needle aspiration,online

FNA/FNA1 Online Digital SlideProgram

249

Digoxin X CZ, CZ2X,CZX, Z



53

LN3 TDM Cal Ver/Lin 107Digoxin, free X CZ, CZ2X,

CZX, ZChemistry and TDM 50-52


53

Dihydrocodeine T Toxicology 86UT Urine Toxicology 86

Diltiazem T Toxicology 86UT Urine Toxicology 86

Dilute prothrombin time CGE/CGEX Coagulation, Extended 144Dilute Russell’s vipervenom time


Dimeric inhibin A (DIA) X FP, FPX Maternal Screen 78Diphenhydramine FTC Forensic Toxicology,

Criminalistics93


Diphenylhydantoin See Phenytoin


ENR

Program

Code

Description Pg

Direct antiglobulintesting

X DAT Direct AntiglobulinTesting

198

TMCAD Transfusion Medicine,Competency Assessment

194

Direct bilirubin X C1, C3,C3X, CZ,CZ2X, CZX



53


106


106

X NB, NB2 Neonatal Bilirubin 58Disease Association/Drug Risk

DADR1,DADR2

Disease Associate/Drug Risk

209

Disopyramide X CZ, CZ2X,CZX, Z



53

DMD/Becker X MGL2 Molecular Genetics 217DNA analysis X DL, DML HLA Molecular Typing 207

DNA, DNAF DNA Database 252FID, FIDM Forensic Identity 252

X ML HLA Molecular Typing 207MHO Molecular Oncology 225

X PARF Parentage/Relationship 204DNA content/cell cycleanalysis

FL, FL2 Flow Cytometry 188

DNA database DNA, DNAF DNA Database 252DNA extraction andamplification

MHO5 Molecular OncologyHematologic

225

DNA fingerprinting IDN, IDO Nucelic Acid Amp,Organisms

175

DNA Mismatch Repair MMR DNA Mismatch Repair 237DNA sequencing SEC, SEC1 DNA Sequencing 218Dopamine X N/NX Urine Chemistry,

Special62

Doxepin FTC Forensic Toxicology,Criminalistics

93


Doxylamine T Toxicology 86UT Urine Toxicology 86

Duloxetine T Toxicology 86UT Urine Toxicology 86

Ecgonine ethyl ester FTC Forensic Toxicology,Criminalistics

93




Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Ecgonine methyl ester FTC Forensic Toxicology,Criminalistics

93


E. coli O157 GIP Gastrointestinal Panel 177EGFR-Epidermal growthfactor receptor

EGFR Mutation testing 224

MTP Multigene Tumor Panel 224eGFR LN24 Creatinine Accuracy

CalVer/Lin114

Electronic crossmatch EXM, EXM2 Electronic Crossmatch 195Electrophoresis X HG Hemoglobinopathy 128

X LPE LipoproteinElectrophoresis

68

X M, OLI CSF Chemistry andOligoclonal Bands

66

X SPE Protein Electrophoresis 68UBJP Urinary Bence Jones

Protein68

Elution, antibody ELU Eluate 199TMCAE Eluate Competency

Assessment194

Embryology EMB Embryology 141Enterotoxigenic E. coli(ETEC)

GIP Gastrointestinal Panel 177

Enterovirus ID1 Nucleic Acid Amp,Viruses

176


177

X VR1 Virology Culture 171Eosinophils, urine SCM2 Special Clinical

Microscopy137

Ephedrine FTC Forensic Toxicology,Criminalistics

93


Epidermal growth factorreceptor (EGFR)

EGFR Mutation testing 224

Epinephrine N/NX Urine Chemistry,Special

62

Epithelial cells, urine UAA1 Automated Urinalysis 135Epstein-Barr virus (EBV) ID1 Nucleic Acid Amp,

Viruses176

ISH In Situ Hybridization 222VLS, VLS2 Viral Load 173VR3 Antibody Detection-

Infectious DiseaseSerology

178

ER, PgR byimmunohistochemistry

X PM2 ER, PgR byimmunohistochemistry

239


ENR

Program

Code

Description Pg

Erythrocytesedimentation rate

ESR, ESR1,ESR2, ESR3

ErythrocyteSedimentation Rate

124

Erythropoietin EPO Erythropoietin 77Escherichia coli O157 GIP Gastrointestinal Panel 177Estradiol ABS Accuracy-Based

Testosterone andEstradiol

99

LN8 ReproductiveEndocrinology CalVer/Lin

109

X Y/YY Ligand Assay, Special 75Estimated glomerularfiltration rate (eGFR)

LN24 Creatinine AccuracyCal Ver/Lin

114

Estriol, unconjugated(uE3)


X Y/YY Ligand Assay, Special 75Estrogen receptors byimmunohistochemistry

X PM2 ER, PgR byImmunohistochemistry

239

Ethanol X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles

91


91

LN11 Serum Ethanol CalVer/Lin

110

LN14 Whole Blood EthanolCal Ver/Lin

111

UDS, UDS6 Urine Drug Screen 88Ethanol, vitreous fluid VF Vitreous Fluid, Post-

mortem90

ETEC(Enterotoxigenic E. coli)


Ethosuximide X CZ, CZ2X,CZX, Z



53

Ethylene glycol AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles

91

AL2 Serum Alcohol/EthyleneGlycol/Volatiles

91

Ethyl glucuronide (EtG) ETB Ethanol Biomarkers 91Ethyl sulfate (EtS) ETB Ethanol Biomarkers 91Euglobulin Test CGE/CGEX Coagulation, Extended 144Everolimus EV Everolimus 53Factor II CGE/CGEX Coagulation, Extended 144Factor II mutation TPM Thrombophilia

Mutations219

Factor V CGE/CGEX Coagulation, Extended 144Factor V Leiden mutation X MGL1 Molecular Genetics 217

TPM ThrombophiliaMutations

219

Factor VII CGE/CGEX Coagulation, Extended 144


800-323-4040 | 847-832-7000 Option 1 | cap.org 271


21


ENR

Program

Code

Description Pg

Factor VIII X CGE/CGEX Coagulation, Extended 144X CGS3 Coag Special, Series 3 145

Factor VIII Inhibitor CGE/CGEX Coagulation, Extended 144Factor IX CGE/CGEX Coagulation, Extended 144Factor X CGE/CGEX Coagulation, Extended 144Factor XI CGE/CGEX Coagulation, Extended 144Factor XII CGE/CGEX Coagulation, Extended 144Factor XIII CGE/CGEX Coagulation, Extended 144Familial dysautonomia X MGL4 Molecular Genetics 217Fanconi anemia X MGL4 Molecular Genetics 217Fecal fat, qualitative FCFS Fecal Fat 67Fecal lactoferrin FLAC Fecal Lactoferrin 159Fentanyl DMPM Drug Monitoring for

Pain Management95

FTC Forensic Toxicology, Criminalistics

93


Fern test X CMMP Clinical Microscopy, Misc

133

Ferritin X C3, C3X, CZ, CZ2X, CZX


CZQ Quality Cross Check, Chemistry and TDM

53


Ver/Lin108

LN5S Ligand Assay, Siemens Cal Ver/Lin

108

Fetal fibronectin X FF Fetal Fibronectin 77Fetal hemoglobin (gastric fluid)

APT Fetal Hemoglobin 136

Fetal hemoglobin identification

X HG Hemoglobinopathy 128

Fetal lung maturity X LM, LM1 Lung Maturity 68Fetal membrane rupture ROM1 Rupture of Fetal

Membrane137

Fetal red cell quantitation

X HBF Fetal Red Cell Detection 199

TMCAF Transfusion Medicine, Competency Assessment

194

Fetal screen (Rosette testing)

X HBF Fetal Red Cell Detection 199

TMCAF Transfusion Medicine, Competency Assessment

194

Fibrin monomer CGE/CGEX Coagulation, Extended 144Fibrinogen X CGL Coagulation, Ltd 144Fibrinogen antigen CGE/CGEX Coagulation, Extended 144


ENR

Program

Code

Description Pg

Fibrinogen degradation products, plasma

CGDF Coagulation, D- dimer/FDP

144

CGL Coagulation, Ltd 144Fibrinogen degradation products, serum

CGDF Coagulation, D- dimer/FDP

144

Fibrinogen degradation products, serum

CGL Coagulation, Ltd 144

Fields of view FOVK/FOVK1

Fields of View SurePath 246

FOVM/FOVM1

Fields of View ThinPrep 246

Fine- needle aspiration, digital slide program

FNA/FNA1 Online Digital Slide Program

249

Fine- needle aspiration, glass slides

FNAG/FNAG1

Fine- Needle Aspiration 250

FISH for breast carcinoma hybridization and interpretation on site (HER2 gene amplification)

X CYH Fluorescence In Situ Hybridization- Breast Cancer

213

FISH for brain/glioma CYJ Fluorescence In Situ Hybridization, Brain/Glioma Tissue

213

FISH for constitutional and hematologic disorders

CYF Fluorescence In Situ Hybridization

212

FISH for lymphoma CYL Fluorescence In Situ Hybridization, Lymphoma

213

FISH for paraffin- embedded tissue

CYH Fluorescence In Situ Hybridization- Breast Cancer

213

CYJ Fluorescence In Situ Hybridization, Brain/Glioma Tissue

213

CYK Fluorescence In Situ Hybridization, Sarcoma Tissue or Pediatric Neoplasm

213

CYL Fluorescence In Situ Hybridization, Lymphoma

213

FISH for sarcoma CYK Fluorescence In Situ Hybridization, Sarcoma Tissue or Pediatric Neoplasm

213

FISH for urothelial carcinoma hybridization and interpretation on- site

X CYI Fluorescence In Situ Hybridization, Urothelial Carcinoma

212

Flunitrazepam T Toxicology 86UT Urine Toxicology 86



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Fluorescent microscopecheck


Fluorescent polarizationassay

X LM, LM1 Lung Maturity 68

Fluoxetine FTC Forensic Toxicology,Criminalistics

93


Flurazepam FTC Forensic Toxicology,Criminalistics

93


Folate, RBC X FOL RBC Folate 79Folate, serum X K/KK Ligand Assay, General 74

LN5 Ligand Assay CalVer/Lin

108


108

Follicle-stimulatinghormone (FSH)


109

X Y/YY Ligand Assay, Special 75Fondaparinux FNPX Anticoagulant

Monitoring,Fondaparinux

146

Forensic identity (DNA) FID, FIDM Forensic Identity 252Forensic pathology FR/FR1 Forensic Pathology 253Forensic toxicology FTC Forensic Toxicology,

Criminalistics93

Fragile X X MGL1 Molecular Genetics 217Free Beta hCG FP1B First Trimester Maternal

Screening, Free Beta78

Free testosterone X DY Ligand Assay, Special 75Friedreich ataxia X MGL2 Molecular Genetics 217Fructosamine FT Fructosamine 67Fungal culture CBT Cord Blood Testing 198

SCP Stem Cell Processing 198Fungal serology FSER Fungal Serology 165Fungus identification X F Mycology 164

X F1 Yeast 164X F3 Candida culture 165

Gabapentin ZE Therapeutic DrugMonitoring, Extended

54

Galactomannan FGAL Galactomannan 165Gamma globulin M, OL1 CSF Chemistry 66

SPE Serum Electrophoresis 68Gamma glutamyltransferase (GGT)




53


ENR

Program

Code

Description Pg

Gamma glutamyltransferase (GGT) (cont.)

IFS Interfering Substances 119


106


106

Gamma hydroxybutyrate FTC Forensic Toxicology,Criminalistics

93

Gardnerella vaginalis,DNA Probe

X VS Vaginitis Screen 162

Gastric occult blood GOCB Gastric Occult Blood 136Gastric pH GOCB Gastric Occult Blood 136Gastrin X ING Insulin, Gastrin,

C-Peptide, PTH78

GATA3 PM5 ImmunohistochemistryTMA

238

Gaucher disease X MGL4 Molecular Genetics 217Genomic copy numberarray

CYCGH CytogenomicMicroarray Analysis

213

Gentamicin X CZ, CZ2X,CZX, Z



53

LN3 TDM Cal Ver/Lin 107Giardia GIP Gastrointestinal Panel 177Giardia immunoassay,preserved specimen

X P, P3, P4, P5 Parasitology 167

Giemsa stain X BP Blood Parasite 168X P Parasitology 167

Glioma by FISH CYJ Fluorescence In SituHybridization,Brain/Glioma Tissue

213

Glucose X AQ2, AQ4 Aqueous Blood Gas 82AQ2Q,AQ4Q


83




53




106



800-323-4040 | 847-832-7000 Option 1 | cap.org 273

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Glucose, CSF X M, OLI CSF Chemistry andOligoclonal Bands

66

Glucose, urine X CMP, CMP1 Clinical Microscopy 133LN6 Urine Chemistry Cal

Ver/Lin108

POC3 POC Urine DipstickCompetency

44


61

Glucose, vitreous fluid VF Vitreous Fluid, Post-mortem

90

Glucose, whole blood X HCC Waived Combination 59X LCW Ltd Chem, Waived 58

LN17 Whole Blood GlucoseCal Ver/Lin

112

POC2 POC GlucoseCompetency

44

POC7 POC/Waived Glucoseand HemoglobinCompetency

44

X WB2 Whole Blood Glucose,3 challenges

59

X WBG Whole Blood Glucose 59Glucose-6-phosphatedehydrogenase

G6PDS Glucose-6 PhosphateDehydrogenase

67

Glutaraldehyde, urine DAI Urine Drug Adulterant/Integrity Testing

88

Glycated Serum albumin GSA Glycated SerumAlbumin

57

Glycogen storagedisease type 1A

X MGL4 Molecular Genetics 217

Glycohemoglobin X GH2, GH5,GH5I

Hemoglobin A1c 57

LN15 Hemoglobin A1c CalVer/Lin

111

Glycosaminoglycans(mucopolysaccharides)


Gram stain X D Bacteriology 152X D2, D3, D7 Throat, Urine, GC

Cultures154

X D4 Bacteriology, Ltd 154X D5 Gram Stain 155

VGS1 Virtual Gram StainBasic

155

VGS2 Virtual Gram StainAdvanced

155

VS2 Vaginitis Screen, VirtualGram stain

162

Group A Streptococcusantigen detection


X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156


ENR

Program

Code

Description Pg

Group A Streptococcusantigen detection (cont.)

X D9 Rapid Group A Strep,Waived

156

POC4 POC Strep ScreenCompetency

44

Group B Streptococcus X D8 Group B Strep 156Growth hormone X Y/YY Ligand Assay, Special 75Gyn cytopathology See Cytopathology

GYN proficiency testingGyn cytopathologyeducation

See CytopathologyGYN education

Haptoglobin X IG/IGX Immunology, General 180X S2/S4 Immunology, Special 181

HBeAg X VM2 Viral Markers-Series 2 201HBsAg X VM1 Viral Markers-Series 1 201HBV HBVL, HBVL5 Hepatitis Viral Load 173

X NAT Nucleic Acid Testing 203HCV HCVN,

HCV2Hepatitis Viral Load,Genotyping andQualitative

173

X NAT Nucleic Acid Testing 203HDL cholesterol ABL Accuracy-Based Lipid 98




53

X LCW Ltd Chem, Waived 58LN2 Chemistry, Lipid,



106

Heavy Chain/LightChain Analysis

HCA Heavy Chain/LightChain Analysis

185

Helicobacter pylori X HPS H. pylori Antigen, Stool 159X S2, S4 H. pylori IgG Antibody 181X S5 H. pylori IgG Antibody 181X VR3 H. pylori IgG Antibody 178

Hematocrit X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83

CBT Cord Blood Testing 198X FH1-FH4,

FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P




Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Hematocrit (cont.) FH3Q,FH4Q,FH6Q,FH9Q


126

X HE, HEP Basic Hematology 124POC10,POC11


45

SCP Stem Cell Processing 198X SO Blood Oximetry 84

SOQ Quality Cross Check,Blood Oximetry

84

Hematology case studies EHE1 Expanded VirtualPeripheral Blood Smear

131


128

VPBS Virtual Periperal BloodSmear

130

HematopathologyOnline Education

HPATH,HPATH1

HematopathologyOnline Education

132

Hemochromatosis X MGL1 Molecular Genetics 217Hemocytometerfluid count

X HFC, HFCI HemocytometerFluid Count

136

Hemoglobin CBT Cord Blood Testing 198X FH1-FH4,



FH3Q,FH4Q,FH6Q,FH9Q


126

X HCC Waived Combination 59X HE, HEP Basic Hematology 124

LN9 Hematology Cal Ver/Lin 110POC7 POC/Waived Glucose

and HemoglobinCompetency

44

SCP Stem Cell Processing 198X SO Blood Oximetry 84

SOQ Quality Cross Check,Blood Oximetry

84

Hemoglobinelectrophoresis

X HG Hemoglobinopathy 128

Hemoglobin, estimated X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83


ENR

Program

Code

Description Pg

Hemoglobin, estimated(cont.)

POC10,POC11


45

Hemoglobin, plasma PHG Plasma Hemoglobin 69Hemoglobin, urine X CMP, CMP1 Clinical Microscopy 133


44

Hemoglobin A1c X GH2 57X GH5, GH5I Hemoglobin A1c 57


111

Hemoglobin A2 X HG Hemoglobinopathy 128Hemoglobin F X HG Hemoglobinopathy 128

SCS Sickle Cell Screen 129Hemoglobin S/C HGM Hemoglobinopathies

Genotyping216

MGL2 Molecular Genetics 217Hemolytic complement,total

CH50 Total HemolyticComplement

186

Hemosiderin, urine SCM1 Special ClinicalMicroscopy

137

Heparin assay CGS4 Coag Special, Series 4 145Heparin-inducedthrombocytopenia


CGS5 Coag, Special, HIT 145CGS6 Coagulation Special 145

Heparin, low molecularweight

LN36 Heparin Cal Ver/Lin 116

Heparin, unfractionated LN36 Heparin Cal/Ver Lin 116Heparin/platelet FactorIV

CGS5 Coag, Special, HIT 145

CGS6 Coagulation Special 145Hepatitis B virus HBVL, HBVL5 Hepatitis Viral Load 173Hepatitis C virus HCVN,

HCV2Hepatitis Viral Load,Genotyping andQualitative

173

HER2, gastric GHER2 Gastric HER2 239HER2 gene amplificationby ISH

X ISH2 In Situ Hybridization 222

HER2 gene amplificationby FISH, hybridizationand interpretation on site

X CYH Fluorescence In SituHybridization-BreastCancer

213

HER2 byimmunohistochemistry

X HER2 HER2 byImmunohistochemistry

239

Herpes simplex virus(HSV)

X HC2 HSV by DFA 172

X HC4 HSV Culture 172ID1 Nucleic Acid Amp,

Viruses176

X VR1 Virology Culture 171X VR2 Viral Antigen by DFA 171


800-323-4040 | 847-832-7000 Option 1 | cap.org 275

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Herpes simplex virus(HSV) (cont.)

X VR3 Antibody Detection-Infectious DiseaseSerology

178

HHV6 ID1 Nucleic Acid Amp,Viruses

176

VLS2 Viral Load 173HHV8 ID1 Nucleic Acid Amp,

Viruses176

High molecular weightkininogen


High-sensitivityC-reactive protein

X HSCRP hsCRP 57


113

Histotechnology qualityimprovement

HQIP,HQIPBX,HQBX1,HQBX2,HQBX3,HQIHC

HistoQIP 234-236

HIV X HIV, HV2 HIV Viral Load 173LN39 HIV Viral Load Cal

Ver/Lin116

X NAT Nucleic Acid Testing 203HIV genotyping HIVG HIV Viral Genotyping 173HIV-1 p24 antigen X VM3 Viral Markers-Series 3 201HIV-1 p24 antigen,Anti HIV 1/2

X VM6 Viral Markers-Series 6 202

HLA-A,B,C antibodyidentification





HLA-(Class I/II)crossmatching





HLA-(Class I/II) antibodyscreen

MX1B,MX1C,MX1E,MX2B,MX2C,MX2E, MXB,MXC

HLA Analysis, Class I/II 206-207


ENR

Program

Code

Description Pg

HLA-A,B,C typing(serologic)

X HLAS,HLAS1

HLA Serologic Typing 207

HLA-B27 typing X B27 HLA-B27 Typing 208HLA-B*57:01 PGX2 Pharmacogenetics 219

DADR1 Disease Association,Drug Risk

209

HLA-B*57:01 DADR1 Disease Association,Drug Risk

209

HLA-B*58:01 DADR1 Disease Association,Drug Risk

209

HLA-DQA1*03/DQB1*03:02


209

HLA-DQA1*05/DQB1*02


209

HLA-DR, DQ typing(serologic)

X HLAS HLA Serologic Typing 207

HLA molecular typing X DL, DML, ML HLA Molecular Typing 207Homocysteine X HMS Homocysteine 58

LN16 Homocysteine CalVer/Lin

112

Homovanillic acid X N/NX Urine Chemistry,Special

62

HPV (cytology), high-risk

X CHPVD Digene SpecimenTransport Medium

246

X CHPVJ Mixed Medium 246X CHPVK SurePath Preservative

Fluid Transport Medium246

X CHPVM ThinPrep PreservCytTransport Medium

246

X HPV Digene Hybrid CaptureTechnology Only

174

ISH In Situ Hybridization 222HSV X HC2 HSV by DFA 172

X HC4 HSV Culture 172ID1 Nucleic Acid Amp,

Viruses176

X VR1 Virology Culture 171X VR2 Viral Antigen by DFA 171X VR3 Antibody Detection-

Infectious DiseaseSerology

178

Human chorionicgonadotropin (hCG),serum




53

X FP/FPX,FP1T

Maternal Screen 78

X HCG, IL Immunology 180X K/KK Ligand Assay, General 74


108



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Human chorionicgonadotropin (hCG),serum (cont.)


108


109

SCO Serum Carryover 120Human chorionicgonadotropin (hCG),urine

X CMP, CMP1 Clinical Microscopy 133

POC1 POC hCG Competency 44POC3 POC Urine Dipstick

Competency44

Human herpesvirus 6 ID1 Nucleic Acid Amp,Viruses

176

VLS2 Viral Load 173Human herpesvirus 8 ID1 Nucleic Acid Amp,

Viruses176

Human immuno-deficiency virus (HIV)

X HIV, HV2 HIV Viral Load 173

HIVG HIV Genotyping 173LN39 HIV Viral Load Cal

Ver/Lin116

Humanmetapneumovirus

ID2 Nucleic Acid Amp,Respiratory

176


177

Human papillomavirus(cytology) high-risk

X CHPVD Digene SpecimenTransport Medium

246

X CHPVJ Mixed Medium 246X CHPVK SurePath Preservative


X CHPVM ThinPrep PreservCytTransport Medium

246

X HPV Digene Hybrid CaptureTechnology Only

174

ISH In Situ Hybridization 222Human papillomavirus(cytology) high-riskgenotyping

CHPVD Digene SpecimenTransport Medium

246

CHPVJ Mixed Medium 246CHPVK SurePath Preservative


CHPVM ThinPrep PreservCytTransport Medium

246

Huntington disease X MGL2 Molecular Genetics 217Hydrocodone DMPM Drug Monitoring for

Pain Management95


93


90


ENR

Program

Code

Description Pg

Hydrocodone (cont.) T Toxicology 86UDC Forensic Urine Drug


UT Urine Toxicology 86Hydromorphone DMPM Drug Monitoring for

Pain Management95


93


90



UT Urine Toxicology 86Hydroxyzine T Toxicology 86

UT Urine Toxicology 86Ibuprofen T Toxicology 86

UT Urine Toxicology 86IDH1 GLI Glioma 224IDH2 GLI Glioma 224IgA X IG/IGX Immunology, General 180

LN7 Immunology Cal Ver/Lin 109X SPE Protein Electrophoresis 68

IgA kappa and lambda HL Heavy Chain/LightChain Analysis

IgD S2, S4 Immunology, Special 181IgE X IG/IGX Immunology, General 180

X K/KK Ligand Assay, General 74X SE Diagnostic Allergy 185

IgE allergen-specific,quantitative

SE Diagnostic Allergy 185

IgE multi-allergen screen X SE Diagnostic Allergy 185IGF-1 (somatomedin C) X BGS Bone and Growth 76

X Y/YY Ligand Assay, Special 75IgG X IG/IGX Immunology, General 180

LN7 Immunology Cal Ver/Lin 109S2, S4 Immunology, Special 181

X SPE Protein Electrophoresis 68IgG, CSF X M, OLI CSF Chemistry and

Oligoclonal Bands66

IgG subclass proteins S2, S4 Immunology, Special 181IgM X IG/IGX Immunology, General 180

LN7 Immunology Cal Ver/Lin 109X SPE Protein Electrophoresis 68

IL-2 CTKN Cytokines 184IL-6 CTKN Cytokines 184IL-8 CTKN Cytokines 184IL-10 CTKN Cytokines 184IL28B PGX1 Pharmacogenetics 219Imipramine FTC Forensic Toxicology,

Criminalistics93


800-323-4040 | 847-832-7000 Option 1 | cap.org 277

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Imipramine (cont.) T Toxicology 86UT Urine Toxicology 86

X ZT, ZZT TDM, Special 54Immature granulocyteparameter

FH9, FH9P Hematology, Auto Diff 125

Immunohistochemistry GHER2 Gastric HER2 239X HER2 HER2 by

Immunohistochemistry239

MK Immunohistochemistry 237MMR DNA Mismatch Repair 237PM1 CD117 by


X PM2 ER, PR byImmunohistochemistry

239

PM3 CD20 byImmunohistochemistry

237

PM5 ImmunohistochemistryTMA

238

India ink IND India Ink 166Infectiousmononucleosis (IM)

X IL, IM Immunology 180

X IMW InfectiousMononucleosis, Waived

181

Influenza virus ID2 Nucleic Acid Amp,Resp

176


177

POC8 POC Influenza A/B Ag 44X VR1 Virology Culture 171X VR2 Viral Antigen Detection

by DFA171


172

In situ hybridization X ISH In Situ Hybridization 222X ISH2 In Situ Hybridization

HER2222

Instrument function I Instrumentation 118Instrument linearity I Instrumentation 118


106


106

LN3 TDM Cal Ver/Lin 107LN5 Ligand Assay Cal

Ver/Lin108


108

LN6 Urine Chemistry CalVer/Lin

108

LN7 Immunology Cal Ver/Lin 109


ENR

Program

Code

Description Pg

Instrument linearity(cont.)


109

LN9 Hematology Cal Ver/Lin 110LN11 Serum Ethanol Cal

Ver/Lin110

LN12 C-Reactive Protein CalVer/Lin

110

LN13 Blood Gas Cal Ver/Lin 111LN13C Blood Gas Cal Ver/Lin 111LN14 Whole Blood Ethanol

Cal Ver/Lin111


111

LN16 Homocysteine CalVer/Lin

112

LN17 Whole Blood GlucoseCal Ver/Lin

112

LN18, LN19 Reticulocyte Cal Ver/Lin 112LN20 Urine Albumin Cal

Ver/Lin112


113


113

LN23 PSA Cal Ver/Lin 113LN24 Creatinine Accuracy

Cal Ver/Lin114

LN25 Troponin I Cal Ver/Lin 114LN27 Troponin T Cal Ver/Lin 114LN30 BNP Cal Ver/Lin 114LN31 Immunosuppressive

Drugs Cal Ver/Lin115

LN32 Ammonia Cal Ver/Lin 115LN33 Serum Myoglobin Cal

Ver/Lin115

LN34 Tumor Markers CalVer/Lin

115

LN35 Thrombophilia CalVer/Lin

116

LN36 Heparin Cal Ver/Lin 116LN37 von Willebrand Factor

Ag Cal Ver/Lin116

LN38 CMV viral load CalVer/Lin

116

LN39 HIV Viral Load CalVer/Lin

116

LN40 Vitamin D Cal Ver/Lin 116LN41 Procalcitonin Cal

Ver/Lin117



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Instrument linearity(cont.)

LN42 D-Dimer Cal Ver/Lin 117

Insulin X ING Insulin, Gastrin,C-Peptide, PTH

78

Interferon (IFN) gamma CTKN Cytokines 184Interleukin (IL)-1 beta CTKN Cytokines 184International normalizedratio (INR)

X CGL Coagulation, Ltd 144

CGS1 Coag Special, Series 1 145CGS4 Coag Special, Series 4 145POC5 POC PT/INR, i-STAT 44POC6 POC PT/INR,

CoaguChek XS Plus44

X WP3, WP4,WP6, WP9

Whole BloodCoagulation

148

X WP10 Whole BloodCoagulation

148

Ionized calcium X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83

X C3, CZ, CZX Chemistry and TDM 50-52POC10,POC11


45

LN13C Blood Gas Cal Ver/Lin 111Iron X C1, C3, C3X,

CZ, CZ2X,CZX



53




106

Isopropanol X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles

91


91

JC virus ID1T Nucleic Acid Amp, JCand BK

176

Jo-1 (antihistidyl t-RNAsynthetase)

RDS Rheumatic DiseaseSpecial

186

JWH-018 N-(4-hydroxypentyl)metabolite

SCDD Synthetic Cannabinoid/Designer Drugs

94



94


ENR

Program

Code

Description Pg

JWH-018 N-PentanoicAcid


94

JWH-073 N-(3-hydroxybutyl) metabolite


94

JWH-073 N-(4-hydroxybutyl) metabolite


94

JWH-073 N-ButanoicAcid


94



94



94

Kaolin activated APTT CGE/CGEX Coagluation, Extended 144Kaolin activated CT CGE/CGEX Coagluation, Extended 144Kappa/lambda X ISH In Situ Hybridization 222Kappa/lambda ratio IG/IGX Immunology, General 180

S2, S4 Immunology, Special 181Free Kappa/Lambdaratio

SFLC Serum Free LightChains

187

Karyotype nomenclature X CY, CYBK Cytogenetics 212Kearns-Sayre syndrome IMD1 Mitochondrial DNA

Deletion Syndromes218

Ketamine FTC Forensic Toxicology,Criminalistics

93


Ketones, serum KET Ketones 58Ketones, urine X CMP, CMP1 Clinical Microscopy 133


44

Kidney stone assessment KSA Kidney StoneAssessment

62

KIT/PDGFRA KIT KIT/PDGFRA 224KOH prep X CMMP Clinical Microscopy,

Misc133

FSM Fungal Smear 165KRAS KRAS Colorectal Cancer

Mutation224

MTP Multigene Tumor Panel 224Laboratory PreparednessExercise

LPX LaboratoryPreparedness Exercise

159

Lactate X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83


800-323-4040 | 847-832-7000 Option 1 | cap.org 279

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Lactate (cont.) X C3, C3X,CZ, CZ2X,CZX



53

FLD Body Fluid 65POC10,POC11


45

LN13C Blood Gas Cal Ver/Lin 111Lactate, CSF X M, OLI CSF Chemistry and

Oligoclonal Bands66

Lactate dehydrogenase(LD)




53




106

SCO Serum Carryover 120Lactate dehydrogenase(LD), CSF

X M, OLI CSF Chemistry andOligclonal Bands

66

Lamellar body count LBC Lamellar Body Count 137Lamotrigine T Toxicology 86

UT Urine Toxicology 86ZE Therapeutic Drug


Large unclassified cells(LUC)

FH4, FH4P Hematology, Auto Diff 125

LD isoenzymes X CRTI Cardiac Markers 56LD1/LD2 ratio X CRTI Cardiac Markers 56LDL cholesterol ABL Accuracy-Based Lipid 98LDL cholesterol,calculated

C1, C3,C3X, CZ,CZ2X, CZX



53

LDL cholesterol,measured

X C1, C3,C3X, CZ,CZ2X, CZX



53

LDL cholesterol, waived X LCW Ltd Chem, Waived 58Lead (blood) X BL Blood Lead 92Lead, urine TMU Trace Metals, Urine 92Leber hereditary opticneuropathy

IMD3 Mitochondrialcytopathies

218


ENR

Program

Code

Description Pg

Lecithin:sphingomyelin(L:S) ratio

LM, LM1 Lung Maturity 68

Legionella pneumophila IDN, IDO Nucleic Acid Amp,Organisms

175

Legionella X LBAS Legionella Ag 157Leigh syndrome IMD1 Mitochondrial DNA

Deletion Syndromes218

Leukemia/lymphomaimmunophenotype

FL3, FL3CD Flow Cytometry 188

Leukemia/lymphomainterpretation only

FL5 Flow CytometryInterpretation Only

189

Leukocyte esterase, urine X CMP, CMP1 Clinical Microscopy 133POC3 POC Urine Dipstick

Competency44

Leukocyte-reducedplatelets

TRC Transfusion-Related CellCount

200

Leukocyte-reduced RBC TRC Transfusion-Related CellCount

200

Leukocyte, stool, Wright-Giemsa

X CMMP Clinical Microscopy,Misc

133

Levetiracetam ZE Therapeutic DrugMonitoring, Extended

54

Lidocaine X CZ, CZ2X,CZX, Z



53


Lipase X C3, C3X,CZ, CZ2X,CZX



53




106

Lipids ABL Accuracy-Based Lipid 98X C1, C3, C3X,

CZ, CZ2X,CZX



53


106


106



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Lipoprotein (a) X ABL Accuracy-Based Lipid 98X C1, C3,

C3X, CZ,CZ2X, CZX



53

Lipoprotein-associatedphospholipase

PLA Lp-PLA2 67

Lipoproteinelectrophoresis

LPE LipoproteinElectrophoresis

68

Lithium X C1, C3, C3X,CZ, CZ2X,CZX, Z



53

LN3 TDM Cal Ver/Lin 107Liver-kidney microsomalantibody

LKM Liver-KidneyMicrosomal Antibody

186

Lorazepam DMPM Drug Monitoring forPain Management

95


93



UT Urine Toxicology 86Lorazepam glucuronide DMPM Drug Monitoring for

Pain Management95

Lupus anticoagulant(screen, conf)


CGS1 Coag Special, Series 1 145Luteinizing hormone (LH) LN8 Reproductive

Endocrinology CalVer/Lin

109

X Y/YY Ligand Assay, Special 75Lyme disease TTD Tick-Transmitted

Disease178

Lymphocyteimmunophenotyping

X FL, FL1 Flow Cytometry 188

Lymphoma by FISH CYL Fluorescence InSitu Hybridization,Lymphoma

213

Lysergic aciddiethylamide (LSD)


93


Magnesium X C1, C3, C3X,CZ, CZ2X,CZX



ENR

Program

Code

Description Pg

Magnesium (cont.) CZQ Quality Cross Check,Chemistry and TDM

53




106

Magnesium, ionized X AQ, AQ2 Aqueous Blood Gas 82AQQ,AQ2Q


83

LN13C Blood Gas Cal Ver/Lin 111POC10,POC11


45

Magnesium, urine X U Urine Chemistry,General

61

Malaria RMAL Rapid Malaria 168Manganese R Trace Metals 70

TMU Trace Metals, Urine 92Maprotiline T Toxicology 86

UT Urine Toxicology 86MCAD IMD2 MCAD 218MCH FH1-FH4,



FH3Q,FH4Q,FH6Q,FH9Q


126

MCHC FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P


FH3Q,FH4Q,FH6Q,FH9Q

Quality Cross Check ,Automated HematologySeries

126

MCV FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P



800-323-4040 | 847-832-7000 Option 1 | cap.org 281

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

MCV (cont.) FH3Q,FH4Q,FH6Q,FH9Q


126

MECP2 genotyping RETT RETT SyndromeGenotyping

219

Mercury, urine TMU Trace Metals, Urine 92MEN2 X MGL3 Molecular Genetics 217Meperidine DMPM Drug Monitoring for

Pain Management95


93


Mephedrone SCDD Synthetic Cannabinoid/Designer Drugs

94


Meprobamate DMPM Drug Monitoring forPain Management

95


93


Metabolic disease testing BGL Biochemical Genetics 215Metanephrine X N/NX Urine Chemistry,

Special62

Methadone DMPM Drug Monitoring forPain Management

95


93


90




Methadone metabolite(EDDP)


95


93




Methamphetamine DMPM Drug Monitoring forPain Management

95


93


ENR

Program

Code

Description Pg

Methamphetamine(cont.)


90




Methanol X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles

91


91

Methaqualone UDC Forensic Urine DrugTesting, Confirmatory

89

UDS, UDS6 Urine Drug Screen 88Methicillin-resistantStaphylococcus aureus(MRSA)


157


175

X MRS, MRS5 Methicillin-ResistantS. aureus

160

Methemoglobin X SO Blood Oximetry 84SOQ Quality Cross Check,

Blood Oximetry84

Methotrexate X CZ, CZ2X,CZX, Z



53

Methotrimeprazine T Toxicology 86UT Urine Toxicology 86

Methylenedioxy-amphetamine (MDA)


95


93


90



UT Urine Toxicology 86Methylenedioxyethyl-amphetamine (MDEA)


89

Methylenedioxymeth-amphetamine (MDMA)


95


93


90





Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Methylenedioxymeth-amphetamine (MDMA)(cont.)

UDS, UDS6 Urine Drug Screen 88

UT Urine Toxicology 86Methylenedioxy-pyrovalerone (MDPV)


94


Methylenetetra-hydrofolate reductase(MTHFR)


Methylone SCDD Synthetic Cannabinoid/Designer Drugs

94

Methylphenidate T Toxicology 86UT Urine Toxicology 86

Metoprolol T Toxicology 86UT Urine Toxicology 86

MGMT GLI Glioma 224Microalbumin, urine LN20 Urine AlbuminCal

Ver/Lin112

X U Urine Chemistry 61X UMC Urine Albumin

(Microalbumin)/Creatinine

138

Microsatellite instability MSI Microsatellite Instability 222Microtiter plate readerlinearity


Minimal residual disease X MRD Minimal ResidualDisease, BCR/ABL1p210

225

X MRD1 Minimal ResidualDisease, BCR/ABL1p190

225

MRD2 Minimal ResidualDisease, PML/RARA

225

Mirtazapine T Toxicology 86UT Urine Toxicology 86

Mite identification TMO Ticks, Mites, and OtherArthropods

169

Mitochondrial DNA,forensic

DNA, DNAF DNA Database 252

FIDM Forensic Identity 252Mixing studies, PT CGE/CGEX Coagulation, Extended 144Mixing studies, APTT CGE/CGEX Coagulation, Extended 144

CGS1 Coag Special, Series 1 145Modified acid-fast stain X P, P3, P4, P5 Parasitology 167Mold identification X F Mycology 164


ENR

Program

Code

Description Pg

Molecular genetics X MGL1,MGL2,MGL3,MGL4,MGL5

Molecular Genetics 217

Molecular HLA typing X DL, DML, ML HLA Molecular Typing 207Molecular hematologiconcology

MHO,MHO1,MHO2,MHO3,MHO5

Molecular HematologicOncology

225

Molecular typing IDN, IDO Nucleic Acid Amp,Organisms

175

Monitoring engraftment X ME Monitoring Engraftment 208Mononuclear cell count CBT Cord Blood Testing 198

SCP Stem Cell Processing 198Morphine DMPM Drug Monitoring for

Pain Management95


93


90



UT Urine Toxicology 86M-protein (paraprotein)identification

X SPE Protein Electrophoresis 68

MRSA BCS1 Blood CultureStaphylococcus aureus

157


175


160

Mucolipidosis IV X MGL4 Molecular Genetics 217Mucopolysaccharide(Glycosaminoglycan)

X BGL Biochemical Genetics 215

Multiple endocrineneoplasia type 2 (MEN2)


Mumps-IgG VR3M Virology 178Mycobacterial culture X E1 Mycobacteriology, Ltd 163Mycobacterialidentification

X E Mycobacteriology 163

Mycobacteriumtuberculosis

IDO Nucleic Acid Amp,Organisms

175

Mycobacteriumtuberculosis antibodydetection

QF M. tuberculosis InfectionDetection

186

Mycobacteriumtuberculosisidentification andresistance detection

MTBR Molecular MTBIdentification andResistance Detection

163


800-323-4040 | 847-832-7000 Option 1 | cap.org 283

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Mycophenolic acid X MPA Mycophenolic Acid 53Mycoplasmapneumoniae


175

VR3 Antibody Detection-Infectious DiseaseSerology

178

Myoclonus epilepsywith ragged red fibers(MERRF)

IMD3 Mitochondrialcytopathies

218

Myoglobin X CRT, CRTI Cardiac Markers 56LN33 Serum Myoglobin Cal

Ver/Lin115

X PCARM,PCARMX


59


45

Myoglobin, urine MYG Myoglobin, Urine 62Myotonic dystrophy X MGL2 Molecular Genetics 217N-acetylprocainamide(NAPA)

X CZ, CZ2X,CZX, Z



53

LN3 TDM Cal Ver/Lin 107N-desmethyltramadol DMPM Drug Monitoring for

Pain Management95


93


Naproxen T Toxicology 86UT Urine Toxicology 86

Nasal smears,eosinophil

X CMMP Clinical Microscopy,Misc.

133

Neisseria gonorrhoeae X D3 GC Cultures 154X D4 Bacteriology, Ltd 154X HC6/HC6X C. trachomatis/GC by

Nucleic Acid Amp174


174

Neoplastic cellularity NEO Neoplastic Cellularity 223Neoplastic disorder byFISH

CYF Fluorescence In SituHybridization

212

Neuropathology NP/NP1 NeuropathologyProgram

241

Neutral fats FCFS Fecal Fat 67Next-GenerationSequencing

NGS Next-GenerationSequencing

221

Nicotine T Toxicology 86UT Urine Toxicology 86

Niemann-Pick disease X MGL4 Molecular Genetics 217Nitrite, urine X CMP, CMP1 Clinical Microscopy 133


ENR

Program

Code

Description Pg

Nitrite, urine (cont.) DAI Urine Drug Adulterant/Integrity Testing

88


44

Nitrogen, total, urine U Urine Chemistry,General

61

Nongynecologiccytopathology

FNA/FNA1 Fine-NeedleAspiration-Digital

249

FNAG/FNAG1

Fine-NeedleAspiration-Glass

250

NGC/NGC1 NongynecologicCytopathologyEducation Program

248

Norbuprenorphine DMPM Drug Monitoring forPain Management

95



UT Urine Toxicology 86Norchlordiazepoxide T Toxicology 86

UT Urine Toxicology 86Norcodeine T Toxicology 86

UT Urine Toxicology 86Norcyclobenzaprine T Toxicology 86

UT Urine Toxicology 86Nordiazepam DMPM Drug Monitoring for

Pain Management95


93



UT Urine Toxicology 86Nordoxepin FTC Forensic Toxicology,

Criminalistics93


Norepinephrine X N/NX Urine Chemistry,Special

62

Norfentanyl DMPM Drug Monitoring forPain Management

95


Norfluoxetine FTC Forensic Toxicology,Criminalistics

93


Norketamine FTC Forensic Toxicology,Criminalistics

93




Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Normeperidine DMPM Drug Monitoring forPain Management

95


Normetanephrine X N/NX Urine Chemistry Special 62Norovirus GIP Gastrointestinal Panel 177

SP1 Stool Pathogens 161Noroxycodone DMPM Drug Monitoring for

Pain Management95

Noroxymorphone DMPM Drug Monitoring forPain Management

95

Norpropoxyphene DMPM Drug Monitoring forPain Management

95


93



UT Urine Toxicology 86Norsertraline FTC Forensic Toxicology,

Criminalistics93


Nortrimipramine T Toxicology 86UT Urine Toxicology 86

Nortriptyline FTC Forensic Toxicology,Criminalistics

93


X ZT, ZZT TDM, Special 54Norverapamil T Toxicology 86

UT Urine Toxicology 86NRAS MTP Multigene Tumor Panel 224nRBC FH3, FH3P,

FH9, FH9PHematology, Auto Diff 125

NT-pro B-type natriureticpeptides

X BNP B-Type NatriureticPeptides, 2 Chall

55


55


55

LN30 BNP Cal Ver/Lin 114N-telopeptide (NTX) BMV6 Bone Markers and

Vitamin77

X BU Bone and Mineral,Urine

77

Nucleated cells, total CBT Cord Blood Testing 198SCP Stem Cell Processing 198

Nucleated red cells, total ABF3 Automated Body Fluid 134CBT Cord Blood Testing 198


ENR

Program

Code

Description Pg

Nucleated red cells, total(cont.)

SCP Stem Cell Processing 198

Nucleated red blood cellcount

FH3, FH3P,FH9, FH9P


Nucleic acidamplification

BSTE Bacterial Strain TypingEnterococcus

175

BSTN Bacterial Strain TypingGram-NegativeOrganisms

125

BSTS Bacterial Strain TypingStaphylococcus

175

HBVL, HBVL5HCVN,HCV2

Hepatitis Viral Load 173

X HC6/HC6X C. trachomatis/GC byNucleic Acid Amp

174


174

X HIV, HV2 HIV Viral Load 173IDN, IDO Nucleic Acid Amp,

Organisms175

ID1, ID1T Nucleic Acid Amp,Viruses

176


176


160

SP, SPN, SP1 Stool Pathogens 161VLS, VLS2 Viral Load 173VRE Vancomycin-Resistant

Enterococcus162

Nucleic acid testing X NAT Nucleic Acid Testing 203O-desmethyltramadol T Toxicology 86

UT Urine Toxicology 86Occult blood OCB Occult Blood 137

POC9 POC Fecal Occult Blood 44Occult blood, gastric GOCB Gastric Occult Blood 136Ocular micrometer check I Instrumentation 118Olanzapine T Toxicology 86

UT Urine Toxicology 86Oligoclonal bands X OLI Oligoclonal Bands 66Opiate group DMPM Drug Monitoring for

Pain Management95


90

T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86UTCO Urine Toxicology

Carryover120


800-323-4040 | 847-832-7000 Option 1 | cap.org 285

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Organic acids, urinequalitative

X BGL Biochemical Genetics 215

Organic acids, urinequantitative


Osmolality, measured X C3, C3X,CZ, CZ2X,CZX



53




106

Osmolality, sweat X SW1, SW2,SW3, SW4


Osmolality, urine X CMP, CMP1 Clinical Microscopy 133LN6 Urine Chemistry Cal

Ver/Lin108


44


61

Osmometer check I Instrumentation 118Osteocalcin BGS Bone and Growth 76Oxazepam DMPM Drug Monitoring for

Pain Management95


93



UT Urine Toxicology 86Oxcarbazepinemetabolite

ZE Therapeutic DrugMonitoring, Extended

54

Oxidants, urine DAI Urine Drug Adulterant/Integrity Testing

88

Oxycodone DMPM Drug Monitoring forPain Management

95


93


90




Oxyhemoglobin X SO Blood Oximetry 84


ENR

Program

Code

Description Pg

Oxyhemoglobin (cont.) SOQ Quality Cross Check,Blood Oximetry

84

Oxymorphone DMPM Drug Monitoring forPain Management

95


93


90



UT Urine Toxicology 86Pancreatic amylase X C1, C3, C3X,

CZ, CZ2X,CZX



53

PAPP-A FP1B First Trimester MaternalScreening, Free Beta

78

FP1T First Trimester MaternalScreening, Total hCG

78

Parainfluenza virus ID2 Nucleic Acid Amp,Respiratory

176


177

X VR1 Virology Culture 171X VR2 Viral Antigen Detection

by DFA171

Paraproteinidentification


Parasite identification X BP Blood Parasite 168X P, P3, P4, P5 Parasitology 167

Parathyroid hormone(PTH)

X ING Insulin, Gastrin,C-Peptide, PTH

78

Parentage/relationshiptesting

X PARF Parentage/Relationship 204

Paroxetine FTC Forensic Toxicology,Criminalistics

93


Parvovirus B19 ID1 Nucleic Acid Amp,Viruses

176

PCO2 X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83

POC10,POC11


45



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

PCO2 (cont.) LN13,LN13C

Blood Gas Cal Ver/Lin 111

Pearson syndrome IMD1 Mitochondrial DNADeletion Syndromes

218

PerformanceImprovement Program inSurgical Pathology

PIP/PIP1,PIPW/PIPW1

PerformanceImprovement Programin Surgical Pathology

228-229

Peripheral blood smear,virtual

VPBS Virtual Peripheral BloodSmear

130

pH AFL Amniotic Fluid Leakage 134X AQ, AQ2,

AQ3, AQ4Aqueous Blood Gas 82

AQQ,AQ2Q,AQ3Q,AQ4Q


83

FLD Body Fluid 65GOCB Gastric Occult Blood 136POC10,POC11


45

LN13,LN13C


pH, urine X CMP, CMP1 Clinical Microscopy 133DAI Urine Drug Adulterant/

Integrity Testing88


44


89

pH meters I Instrumentation 118Phencyclidine FTC Forensic Toxicology,

Criminalistics93


90




Phenethylamine FTC Forensic Toxicology,Criminalistics

93


Pheniramines T Toxicology 86UT Urine Toxicology 86

Phenobarbital X CZ, CZ2X,CZX, Z



53


93


ENR

Program

Code

Description Pg

Phenobarbital (cont.) LN3 TDM Cal Ver/Lin 107T Toxicology 86UDC Forensic Urine Drug


UT Urine Toxicology 86Phentermine FTC Forensic Toxicology,

Criminalistics93


Phenylephrine T Toxicology 86UT Urine Toxicology 86

Phenylpropanolamine T Toxicology 86UT Urine Toxicology 86

Phenytoin X CZ, CZ2X,CZX, Z



53


93

LN3 TDM Cal Ver/Lin 107SCO Serum Carryover 120T Toxicology 86UT Urine Toxicology 86

Phenytoin, free X CZ, CZ2X,CZX, Z



53

Phosphatidylglycerol(PG)

X LM, LM1 Lung Maturity 68

Phosphorus X C3, C3X,CZ, CZX,CZ2X



53




106

Phosphorus, urine LN6 Urine Chemistry CalVer/Lin

108


61

PIK3CA MTP Multigene Tumor Panel 224Pinworm prep X CMMP Clinical Microscopy,

Misc133

Pipette calibration-gravimetric


Plasma hemogloblin PHG Plasma Hemoglobin 69Plasminogen antigen CGE/CGEX Coagulation, Extended 144


800-323-4040 | 847-832-7000 Option 1 | cap.org 287

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Plasminogen activatorinhibitor


Plasminogen activatorinhibitor (PAI)-1

MGL1 Molecular Genetics 217

Platelet aggregation PF Platelet Function 147Platelet calculator TRC Transfusion-Related Cell

Count200

Platelet inducedaggregation

PIA Platelet Function 149

Platelet antibodydetection

X PS Platelet Serology 199

Platelet count X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P


FH3Q,FH4Q,FH6Q,FH9Q


126

X HE, HEP Basic Hematology 124LN9 Hematology Cal Ver/Lin 110

Platelet count (Platelet-rich plasma)

X TRC Transfusion-Related CellCount

200

Platelet crossmatch PS Platelet Serology 199Platelet function PF1 Platelet Function 147Platelet mapping PLTM Platelet Mapping 149Platelet morphology EHE1 Expanded Virtual

Peripheral Blood Smear131

PML/RARA MRD2 Minimal ResidualDisease

225

PNA FISH-Enterococcus PNA3 PNA FISH forEnterococcus

158

PNA FISH-Gram-Negative Rods

PNA4 PNA FISH for Gram-Negative Rods

158

PNA FISH-Staphylococcus

PNA1 PNA FISH forStaphylococcus

158

PNA FISH-Yeast PNA2 PNA FISH for Yeast 158Pneumocystis detection PCP1 Pneumocystis jiroveci,

Calcofluor White Stain166

PCP2 Pneumocystis jiroveci,DFA Stain

166

PCP3 Pneumocystis jiroveci,Giemsa Stain

166

PCP4 Pneumocystis jiroveci,GMS Stain

166

PNH immunophenotype PNH Paroxysmal NocturnalHemoglobinuria, RBC

189

PO2 X AQ, AQ2,AQ3, AQ4



ENR

Program

Code

Description Pg

PO2 (cont.) AQQ,AQ2Q,AQ3Q,AQ4Q


83

LN13,LN13C


POC10,POC11


45

Porphobilinogen, Urine UPBG Porphobilinogen, Urine 63Postanalytical DNAsequencing

SEC DNA Sequencing Count 218

Postvasectomy spermcount

X PV Postvasectomy SpermCount

140

Potassium X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83

X C1, C3, C3X,CZ, CZX,CZ2X



53




106



45

Potassium, urine LN6 Urine Chemistry CalVer/Lin

108


61

Potassium, vitreous fluid VF Vitreous Fluid, Post-mortem

90

PRA MX1B,MX1C,MX1E, MXB,MXC


MX2B,MX2C,MX2E, MXB,MXC


Prader-Willi/AngelmanSyndrome




Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Prealbumin(transthyretin)

X C3, C3X,CZ, CZX,CZ2X



53

X S2, S4 Immunology, Special 181Prekallikrein CGE/CGEX Coagulation, Extended 144Predictive markers byimmunohistochemistry

X HER2 HER2 byImmunohistochemistry

239

GHER2 Gastric HER2 239PM1 CD117 by



239

PM3 CD20 byImmunohistochemistry

237

PM5 ImmunohistochemistryTMA

238

Primidone X CZ, CZX,CZ2X, Z



53

LN3 TDM Cal Ver/Lin 107Pro B-type natriureticpeptides

X BNP B-Type NatriureticPeptides, 2 Chall

55


55


55

Procainamide X CZ, CZX,CZ2X, Z



53

LN3 TDM Cal Ver/Lin 107Procalcitonin LN41 Procalcitonin Cal

Ver/Lin117

PCT Procalcitonin 69Progesterone LN8 Reproductive

Endocrinology CalVer/Lin

109

X Y/YY Ligand Assay, Special 75Progesterone receptorsby immunohistochemistry


239

Prolactin LN8 ReproductiveEndocrinology CalVer/Lin

109

X Y/YY Ligand Assay, Special 75Propoxyphene DMPM Drug Monitoring for

Pain Management95


ENR

Program

Code

Description Pg

Propoxyphene (cont.) FTC Forensic Toxicology,Criminalistics

93




Carryover120

Propranolol T Toxicology 86UT Urine Toxicology 86

Prostate-specific antigen(PSA)

X K/KK Ligand Assay, General 74

LN23 PSA Cal Ver/Lin 113Prostate-specific antigen,complexed (cPSA)


Prostate-specific antigen,free (PSA, free)


Prostatic acidphosphatase (PAP)


Protein electrophoresis,serum, interpretation


Protein C CGE/CGEX Coagulation, Extended 144CGS2 Coag Special, Series 2 145LN35 Thrombophilia Cal

Ver/Lin116

Protein S CGE/CGEX Coagulation, Extended 144CGS2 Coag Special, Series 2 145

Protein, total X C1, C3, C3X,CZ, CZX,CZ2X



53




106

SPE Lipoprotein and ProteinElectrophoresis

68

Protein, CSF X M, OLI CSF Chemistry andOligoclonal Bands

66

Protein, urine X CMP, CMP1 Clinical Microscopy 133DSC Dipstick Confirmatory 135LN6 Urine Chemistry Cal

Ver/Lin108


44


800-323-4040 | 847-832-7000 Option 1 | cap.org 289

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Protein, urine (cont.) X U Urine Chemistry,General

61

Prothrombin mutation X MGL1 Molecular Genetics 217TPM Thrombophilia

Mutations219

Prothrombin fragment1.2


Prothrombin time X CGL Coagulation, Ltd 144CGS1 Coag Special, Series 1 145CGS4 Coag Special, Series 4 145DBGN Anticoagulant

Monitoring, Dabigatran146

FNPX AnticoagulantMonitoring,Fondaparinux

146

POC5 POC PT/INR, i-STAT 44POC6 POC PT/INR,

CoaguChek XS Plus44

RVBN AnticoagulantMonitoringRivaroxaban

146

X WP3, WP4,WP6, WP9

Whole BloodCoagulation

148

Prothrombin time, dilute CGE/CGEX Coagulation, Extended 144Provider-performedmicroscopy

X CMMP Clinical Microscopy,Misc

133

Pseudocholinesterase X C7 Pseudocholinesterase 69Pseudoephedrine FTC Forensic Toxicology,

Criminalistics93


Pyridinoline (PYD) BU Bone and Mineral,Urine

77

Q-MONITORS QM1 Quality ManagementTools

42

Q-PROBES QP151 Quality ManagementTools

27

QP152 Quality ManagementTools

28


29


30

Q-TRACKS QT1-5 Quality ManagementTools

33-34,39

QT7, 8, 10 Quality ManagementTools

35-36

QT15-17,19

Quality ManagementTools

37-38,40

Quetiapine T Toxicology 86UT Urine Toxicology 86


ENR

Program

Code

Description Pg

Quinidine X CZ, CZX,CZ2X, Z



53


Quinine T Toxicology 86UT Urine Toxicology 86

Ranitidine T Toxicology 86UT Urine Toxicology 86

Rapamycin (sirolimus) X CS ImmunosuppressiveDrugs

53

Rapid Group A Strep X D Bacteriology 152X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156X D9 Rapid Group A Strep,

Waived156

RBC count ABF1, ABF2,ABF3




FH3Q,FH4Q,FH6Q,FH9Q


126

X HE, HEP Basic Hematology 124X HFC, HFCI Hemocytometer

Fluid Count136

LN9 Hematology Cal Ver/Lin 110RBC count, urine UAA, UAA1 Automated Urinalysis 135RBC folate X FOL RBC Folate 79RBC morphology EHE1 Expanded Virtual

Peripheral Blood Smear131

RDW H1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P


FH3Q,FH4Q,FH6Q,FH9Q


126

HE, HEP Basic Hematology 124



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Red blood cell antigendetection

J, J1 Transfusion Medicine 192

Red blood cell antigengenotyping

RAG Red blood cell antigengenotyping

199

Red blood cell antigentyping

RBCAT Red blood cell antigentyping

200

Reducing substance,urine



44

Refractometer check I Instrumentation 118Renin X RAP Renin and Aldosterone 79Reptilase time CGE/CGEX Coagulation, Extended 144Respiratory syncytialvirus (RSV)


176


177


by DFA171

X VR4 Virology AntigenDetection by EIA andLatex

172

Reticulocyte count,percent

LN18, LN19 Reticulocyte Cal Ver/Lin 112

X RT, RT2, RT3,RT4

Reticulocyte 129

Reticulocyte count,absolute

X RT, RT2, RT3,RT4

Reticulocyte 129

RETT Syndrome RETT RETT SyndromeGenotyping

219

RhD X MGL2 Molecular Genetics 217RhD typing X J, J1 Transfusion Medicine 192

X JAT Transfusion Medicine,Automated

192


193


194

Rheumatoid factor X IL, RF/RFX Immunology 180Rhinovirus ID2 Nucleic Acid Amp,

Respiratory176


177

Rotavirus GIP Gastrointestinal Panel 177SP, SPN Stool Pathogens 161


172

RSV ID2 Nucleic Acid Amp,Respiratory

176

X VR1 Virology Culture 171


ENR

Program

Code

Description Pg

RSV (cont.) X VR2 Viral Antigen Detectionby DFA

171


172

Rubella antibody, IgG X IL, RUB/RUBX

Immunology 180

Rubeola antibody(English measles)


178

Rupture of FetalMembranes

ROM1 Rupture of FetalMembranes

137

Russell’s viper venomtime, dilute


Salicylate X CZ, CZX,CZ2X, Z



53

LN3 TDM Cal Ver/Lin 107X SDS Serum Drug Screen 91


Salmonella GIP Gastrointestinal Panel 177Sarcoma by FISH CYK Fluorescence In Situ

Hybridization213

Sarcoma translocation SARC Sarcoma Translocation 223Scl-70 (anti-DNAtopoisomerase)

RDS Rheumatic DiseaseSpecial

186

Secobarbital FTC Forensic Toxicology,Criminalistics

93


89

Selenium X R Trace Metals 70Selenium, urine TMU Trace Metals, Urine 71Semen analysis X ASA, SC,

SV, PVSemen Analysis 140

SC1, SM Semen Analysis 140SMCD,SM1CD,SM2CD

Semen Analysis,CD-ROM

140

Sertraline FTC Forensic Toxicology,Criminalistics

93


Serum free light chains SFLC Serum Free LightChains

187

Sex hormone-bindingglobulin (SHBG)

X DY Ligand Assay, Special 75

Shiga toxin SP Stool Pathogens-Rapidand Molecular

161

ST Shiga Toxin 161


800-323-4040 | 847-832-7000 Option 1 | cap.org 291

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Shiga-like toxinproducing E. coli (STEC)


Shigella GIP Gastrointestinal Panel 177Sickle cell screen X HG Hemoglobinopathy 128

X SCS Sickle Cell Screen 129Sirolimus (Rapamycin) X CS Immunosuppressive

Drugs53

Sodium X AQ, AQ2,AQ3, AQ4


AQQ,AQ2Q,AQ3Q,AQ4Q


83




53




106



45

Sodium, sweat X SW1, SW2,SW3, SW4


Sodium, urine LN6 Urine Chemistry CalVer/Lin

108


61

Sodium, vitreous fluid VF Vitreous Fluid, Post-mortem

90

Soluble transferrinreceptor

STFR Soluble TransferrinReceptor

72

Somatomedin C (IGF-1) X Y, YY Ligand Assay, Special 75Specific gravity X CMP, CMP1 Clinical Microscopy 133

DAI Urine Drug Adulterant/Integrity Testing

88


44


89

Spectrophotometerlinearity


Sperm count X SMCD Semen Analysis,CD-ROM

140

Sperm count, automated SC1 Semen Analysis 140


ENR

Program

Code

Description Pg

Sperm count, manual X SC Semen Analysis 140X PV Postvasectomy Sperm

Count140

Sperm morphology SM Semen Analysis 140SM1CD Semen Analysis,

CD-ROM140

Sperm motility SMCD Semen Analysis,CD-ROM

140

Sperm viability SM2CD Semen Analysis,CD-ROM

140

X SV Semen Analysis 140Spinal fluid meningitispanel


Spinal muscular atrophy X MGL2 Molecular Genetics 217Spinocerebellar ataxia X MGL2 Molecular Genetics 217Split fats FCFS Fecal Fat 67Staphylococcus aureus-blood culture


157

STEC (Shiga-like toxinproducing E. coli)


Strep screen POC4 POC/Waived StrepScreen Competency

44

Streptococcusagalactiae

X D8 Group B Strep 156

Streptococcuspneumoniae

X SBAS S. pneumoniae AgDetection

157

Streptococcus pyogenes X D Bacteriology 152X D1, D7 Throat, Urine Cultures 154X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156X D9 Rapid Group A Strep,

Waived156

Strychnine T Toxicology 86UT Urine Toxicology 86

Sulfosalicylic acid (SSA) DSC Dipstick Confirmatory 135Surgical pathology DPATH/

DPATH1Online Digital SlideProgram

231

PIP/PIP1,PIPW/PIPW1

PerformanceImprovement Programin Surgical Pathology

228-229

PCSP, PCSP1 Practicum in CancerSurgical Pathology

233

VBP/VBP1 Online Virtual BiopsiesProgram

230

Synthetic Cannabinoid/Designer Drugs


94

Syphilis X G Syphilis Serology 186T3, free(triiodothyronine)

ABTH Harmonized Thyroid 100



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

T3, free(triiodothyronine) (cont.)




53

X K/KK Ligand Assay, General 74T3, total(triiodothyronine)





53


Ver/Lin108


108

T3 uptake & relatedtests




53

X K/KK Ligand Assay, General 74T4, free (thyroxine, free) ABTH Harmonized Thyroid 100




53

X K/KK Ligand Assay, General 74T4, total (thyroxine,total)





53


Ver/Lin108


108

Tacrolimus X CS ImmunosuppressiveDrugs

53

LN31 ImmunosuppressiveDrugs Cal Ver/Lin

115

Tay Sachs X MGL4 Molecular Genetics 217tCO2 AQ, AQ2,

AQ3, AQ4Aqueous Blood Gas 82


ENR

Program

Code

Description Pg

tCO2 (cont.) AQQ,AQ2Q,AQ3Q,AQ4Q


83

POC10,POC11


45

Temazepam DMPM Drug Monitoring forPain Management

95


93



UT Urine Toxicology 86Teriflunomide ZE Therapeutic Drug


Testosterone ABS Accuracy-BasedTestosterone andEstradiol

99


109

X Y/YY Ligand Assay, Special 75Testosterone,bioavailable

DY Ligand Assay, Special 75

Testosterone, free X DY Ligand Assay, Special 75Thallium, urine TMU Trace Metals, Urine 71Theophylline X CZ, CZX,

CZ2X, ZChemistry and TDM 50-52


53

LN3 TDM Cal Ver/Lin 107Throat culture X D1, D7 Throat, Urine Cultures 154

X D4 Bacteriology, Ltd 154Thrombin time CGE/CGEX Coagulation, Extended 144

CGS4 Coag Special, Series 4 145DBGN Dabigatran 146

Thrombin-antithrombin CGE/CGEX Coagulation, Extended 144Thromboelastogram TEG Thromboelastogram 147Thrombophilia Mutations TPM Thrombophilia

Mutations219

Thyroglobulin X TM/TMX Tumor Markers 80Thyroid-stimulatinghormone (TSH)

ABS Accuracy-BasedTestosterone andEstradiol

99

ABTH Harmonized Thyroid 100X C1, C3, C3X,

CZ, CZX,CZ2X



53


800-323-4040 | 847-832-7000 Option 1 | cap.org 293

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

Thyroid-stimulatinghormone (TSH) (cont.)



108


108

Thyroxine, free ABTH Harmonized Thyroid 100X C1, C3, C3X,

CZ, CZX,CZ2X



53

X K/KK Ligand Assay, General 74Thyroxine, total ABTH Harmonized Thyroid 100




53


Ver/Lin108


108

Tick identification TMO Ticks, Mites, and OtherArthropods

169

Tissue parasiteidentification

X BP Blood Parasite 168

X P Parasitology 167Tissue plasminogenactivator


Tobramycin X CZ, CZX,CZ2X, Z



53

LN3 TDM Cal Ver/Lin 107Total bile acids TBLA Total Bile Acid 70Total bilirubin X C1, C3, C3X,

CZ, CZX,CZ2X



53

FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LM1 Lung Maturity 68LN2 Chemistry, Lipid,



106

X NB, NB2 Neonatal Bilirubin 58


ENR

Program

Code

Description Pg

Total bilirubin, urine X CMP, CMP1 Clinical Microscopy 133DSC Dipstick Confirmatory 135

Total free fatty acids FCFS Fecal Fat 67Total hCG X FP1T First Trimester Maternal

Screening, Total hCG78

Total hemolyticcomplement

CH50 Total HemolyticComplement

186

Total iron bindingcapacity, measured and% saturation

X C3, C3X, CZCZX, CZ2X



53

Total nitrogen, urine U Urine Chemistry,General

61

Total nucleated cells CBT Cord Blood Testing 198SCP Stem Cell Processing 198

Total nucleated red cells CBT Cord Blood Testing 198SCP Stem Cell Processing 198

Total protein X C1, C3, C3X,CZ, CZX,CZ2X



53




106

SPE Protein Electrophoresis 68Total protein, CSF X M, OLI CSF Chemistry and

Oligoclonal Bands66

Total protein, urine LN6 Urine Chemistry CalVer/Lin

108


61

Total tricyclics X SDS Serum Drug Screen 91X ZT, ZZT TDM, Special 54

Touch imprint/Crushprep

TICP, TICP1 Touch Imprint/CrushPrep

247

Toxicology, serum,qualitative

X SDS Serum Drug Screen 91

X T Toxicology 86Toxicology, urine,qualitative

X T Toxicology 86

X UDS, UDS6 Urine Drug Screen 88X UT Urine Toxicology 86

Toxicology, urine,qualitative/quantitative

X UDC Forensic Urine DrugTesting, Confirmatory

89



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Toxoplasma gondii X VR3 Antibody Detection-Infectious DiseaseSerology

178

Tramadol DMPM Drug Monitoring forPain Management

95


93


Transferrin X C3, C3X,CZ, CZX,CZ2X



53

LN7 Immunology Cal Ver/Lin 109X S2, S4 Immunology, Special 181

Transfusion medicine ETME1 Expanded TransfusionMedicine Exercises

193

EXM, EXM2 Electronic Crossmatch 195X J, J1 Transfusion Medicine 192X JAT Transfusion Medicine,

Automated192

JATE1 Transfusion Medicine,Automated

193

JE1 Transfusion Medicine,Education

192


194

TMCAD Transfusion Medicine,Competency Assessment

194

TMCAE Transfusion Medicine,Competency Assessment

194

TMCAF Transfusion Medicine,Competency Assessment

194

X TRC Transfusion-Related CellCount

200

Trazodone FTC Forensic Toxicology,Criminalistics

93


Treponema pallidum X G Syphilis Serology 186Trichomonas vaginalis X VS, VS1 Vaginitis Screen 162Tricyclic group T Toxicology 86


Tricyclics, total X SDS Serum Drug Screen 91X ZT, ZZT TDM, Special 54

Triglycerides ABL Accuracy-Based Lipid 98X C1, C3, C3X,

CZ, CZX,CZ2X



ENR

Program

Code

Description Pg

Triglycerides (cont.) CZQ Quality Cross Check,Chemistry and TDM

53

FCFS Fecal Fat 67FLD Body Fluid 65

X LCW Ltd Chem, Waived 58LN2 Chemistry, Lipid,



106

Triiodothyronine (T3) ABTH Harmonized Thyroid 100X C1, C3, C3X,

CZ, CZX,CZ2X



53


Ver/Lin108


108

Triiodothyronine (T3),Free





53

X K/KK Ligand Assay, General 74Trimipramine T Toxicology 86

UT Urine Toxicology 86Troponin I, plasma X PCARM,

PCARMXPlasma CardiacMarkers

59


45

Troponin I, serum X CRT, CRTI Cardiac Markers 56LN25 Troponin I Cal Ver/Lin 114

Troponin T, serum LN27 Troponin T Cal Ver/Lin 114TNT Troponin T 56

X TNT5 Troponin T, 5 challenge 56Tumor necrosis factor(TNF)-alpha

CTKN Cytokines 184

UGT1A1 PGX Pharmacogenetics 219Unsaturated iron bindingcapacity, measured

X C3, C3X,CZ, CZX,CZ2X



53

UR-144 N-(4-hydroxypentyl)metabolite

SCDD Synthetic Cannabinoid/Designer Stimulant

94


800-323-4040 | 847-832-7000 Option 1 | cap.org 295

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

UR-144 N-(5-hydroxypentyl)metabolite


94

UR-144 N-pentanoicacid metabolite


94

Urea nitrogen X AQ2, AQ4 Aqueous Blood Gas 82AQ2Q,AQ4Q


83




53




106

Urea nitrogen, urine LN6 Urine Chemistry CalVer/Lin

108


61

Urea nitrogen, vitreousfluid

VF Vitreous Fluid, Post-mortem

90

Urease X RUR Rapid Urease 160Uric acid X C1, C3, C3X,

CZ, CZX,CZ2X



53




106

Uric acid, urine LN6 Urine Chemistry CalVer/Lin

108


61

Urine albumin LN20 Urine albumin Cal Ver/Lin

112


61

X UMC Urine AlbuminCreatinine

138

Urine albumin:creatinine ratio

ABU Accuracy-Based Urine 99


ENR

Program

Code

Description Pg

Urine albumin:creatinine ratio (cont.)

U Urine Chemistry,General

61

UMC Urine AlbuminCreatinine

138

Urine crystals UAA Automated Urinalysis 135URC Crystals 135

Urine culture X D2, D7 Throat, Urine Cultures 154X D4 Bacteriology, Ltd 154

Urine dipstick POC3 POC/Waived UrineDipstick Competency

44

Urine drug screen X UDS, UDS6 Urine Drug Screen 88Urine sediment, colorphotographs


Urobilinogen X CMP, CMP1 Clinical Microscopy 133POC3 POC Urine Dipstick

Competency44

Uroporphyrin X N/NX Urine Chemistry,Special

62

Urothelial carcinoma byFISH, hybridization andinterpretation on-site

X CYI Fluorescence InSitu Hybridization,Urothelial Carcinoma

212

Vaginal wetpreparations

X CMMP Clinical Microscopy,Misc.

133

Vaginitis screen BV Bacterial Vaginosis 161X VS BD Affirm VP III Antigen

Detection162

X VS1 Genzyme OSOMTrichomonas

162

VS2 Vaginitis Screen, VirtualGram Stain

162

Valproic acid X CZ, CZX,CZ2X, Z



53


Valproic acid, free X CZ, CZX,CZ2X, Z



53

Vancomycin X CZ, CZX,CZ2X, Z



53

LN3 TDM Cal Ver/Lin 107Vancomycin-resistantEnterococcus


175

VRE Vancomycin-resistantEnterococcus

162



Ana

lyte

/Pro

cedu

reIn

dex

21


ENR

Program

Code

Description Pg

Vanillylmandelic acid X N/NX Urine Chemistry,Special

62

Varicella-zoster virus(VZV)

ID1 Nucleic AcidAmplification

176


by DFA171


178

Vascular endothelialgrowth factor (VEGF)

CTKN Cytokines 184

Venlafaxine T Toxicology 86UT Urine Toxicology 86

Verapamil T Toxicology 86UT Urine Toxicology 86

Viability CBT Cord Blood Testing 198SCP Stem Cell Processing 198

Viral antigen detection X HC2 HSV by DFA 172POC8 POC Influenza A/B Ag 44

X VR2 Viral Antigen Detectionby DFA

171


172

Viral isolation/identification

X HC4 HSV Culture 172

X VR1 Virology Culture 171Virtual biopsy program,online

VBP/VBP1 Online Virtual BiopsiesProgram

230

Virtual Gram Stain VGS1 Virtual Gram StainBasic

155

VGS2 Virtual Gram StainAdvanced

155

Virtual peripheral bloodsmear


130

Viscosity V Viscosity 187Vitamin A BMV3 Bone Markers and

Vitamins77

Vitamin B12 X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal

Ver/Lin108


108

Vitamin D, 25-OH X ABVD Accuracy-BasedVitamin D

76

LN40 Vitamin D Cal Ver/Lin 116X VITD 25-OH Vitamin D 76

Vitamin D, 1, 25Dihydroxy


77

Vitamin E BMV4 Bone Markers andVitamins

77


ENR

Program

Code

Description Pg

VKORC1 PGX Pharmacogenetics 219Volatiles X AL1 Whole Blood Alcohol/

Ethylene Glycol/Volatiles91


91

von Willebrand factor CGE/CGEX Coagulation, Extended 144CGS3 Coag Special, Series 3 145LN37 von Willebrand Factor

Ag Cal Ver/Lin116

VZV ID1 Nucleic AcidAmplification

176


by DFA171


178

Wavelength andphotometric calibration


WBC count ABF1, ABF2,ABF3


CBT Cord Blood Testing 198X FH1-FH4,



FH3Q,FH4Q,FH6Q,FH9Q


126

FL4 Flow Cytometry CD34+ 189X HE, HEP Basic Hematology 124X HFC, HFCI Hemocytometer

Fluid Count136

LN9 Hematology Cal Ver/Lin 110X RWBC Rapid Total White

Blood Cell Count130

SCP Stem Cell Processing 198UAA, UAA1 Automated Urinalysis 135

WBC count (leukocyte-reduced platelets)


200

WBC count (leukocyte-reduced RBCs)


200

WBC differential EHE1 Expanded VirtualPeripheral Blood Smear

131


130


800-323-4040 | 847-832-7000 Option 1 | cap.org 297

Analyte/Procedure

Index

21


ENR

Program

Code

Description Pg

WBC differential,automated



FH3Q,FH4Q,FH6Q,FH9Q


126

WBC differential-bodyfluid

VBF Virtual Body Fluid 134

WBC morphology EHE1 Expanded VirtualPeripheral Blood Smear

131

West Nile virus X NAT Nucleic Acid Testing 203Worm identification WID Worm Identification 169Yeast identification X F Mycology 164

X F1 Yeast 164X F3 Candida culture 165

ZAP-70 ZAP70 ZAP-70 Analysis byFlow Cytometry

190

Zinc X R Trace Metals 70Zinc, urine TMU Trace Metals, Urine 71Zolpidem FTC Forensic Toxicology,

Criminalistics93


Zonisamide ZE Therapeutic DrugMonitoring, Extended

54

Deliver the best in patient care when youintegrate the CAP’s proficiency testing,accreditation, and education programs• Provide comprehensive, scientifically endorsed laboratory

standards, proficiency testing/EQA, and educational programs• Offer a comprehensive view of the laboratory for ongoing

monitoring of quality performance• Educate laboratory staff with a complete offering of programs

supported by peer groups and scientific leaders that provide aunique balance of regulatory and educational coaching

• Take the guesswork out of laboratory compliance• Gain global quality recognition• Reduce the risk of inaccurate and unreliable test results

CAP accreditation programs customized to meet your patient careneeds include:• Laboratory Accreditation• Reproductive Laboratory Accreditation• Forensic Drug Testing Accreditation• Biorepository Accreditation• CAP 15189™ Accreditation

To learn more, visit cap.org and choose the LaboratoryImprovement Programs tab.

“Participating in CAPLaboratory ImprovementPrograms, which aredeveloped by leadingexperts, provides confidencethat your laboratory is doingthe right thing. The CAPaccreditation checklistsystem is an incredibleresource for keeping up withdaily management, newCLIA and CAP requirements,and ensuring that you’reperforming high qualitytesting. No other proficiencytesting provider developsprograms for the newesttechnologies as rapidly andeffectively as the CAP.”

Elizabeth Wagar, MD, FCAPProfessor & Chair,Department ofLaboratory MedicineThe University of Texas MDAnderson Cancer Center

Accreditation ProficiencyTesting/EQA

CAP Education

22 | Program Code Page Index

ProgramCode

PageIndex

22

“What we really like it is the span of the programsthat the CAP offers. Within each of these areas wecan see how we can become more efficient.”

Program Code Page IndexPr

ogra

m C

ode

Page

Inde

x

22


Program Code Pg

APTGDM 242AQ 82AQ2 82AQ2Q 83AQ3 82AQ3Q 83AQ4 82AQ4Q 83AQQ 83ARP 183ASA 140ASC 183ASO 180AUCD 240AUCD1 240B27 208BCP 124BCR 135BCS 157BCS1 157BDP 197BDP5 197BDPV 197BDPV5 197BFBRG 131BFC 135BGL 215BGL1 215BGS 76BL 92BLM 96BMD 128BMV1 77BMV2 77BMV3 77BMV4 77BMV5 77BMV6 77BNP 55BNP5 55BNPQ 55BP 168BRAF 224BSTE 175BSTN 175BSTS 175BU 77

Program Code Page Index

Program Code Pg

AAT 216ABF1 134ABF2 134ABF3 134ABL 98ABO 207ABS 99ABT 196ABT1 196ABT2 196ABT3 196ABTH 100ABU 99ABVD 76ACA 182ACE 64ACL 183ADL 64AFL 134AG 64AHIV 202AHIVW 202AHT 182AL1 91AL2 91AL2M 96AMH 76ANA 180APAPCE 245APAPCPT 243APAPJE 245APAPJPT 243APAPKE 245APAPKPT 243APAPLE 245APAPLPT 243APAPME 245APAPMPT 243APC 182APEDK 244APEDL 244APEDM 244APOE 216APS 183APT 136APTGDK 242APTGDL 242

Program Code Pg

BV 161C1 50–52C3 50–52C3X 50–52C7 69CAMP 158CBT 198CCP 184CD 92CES 184CGDF 144CGE 144CGEX 144CGL 144CGM 150CGS1 145CGS2 145CGS3 145CGS4 145CGS5 145CGS6 145CH50 186CHPVD 246CHPVJ 246CHPVK 246CHPVM 246CMMP 133CMP 133CMP1 133CPIP 16CPIP1 16CRP 180CRT 56CRTI 56CS 53CT 146CT1 146CT2 146CT3 146CT5 146CTKN 184CY 212CYBK 212CYCGH 213CYF 212CYH 213CYI 212

Program Code Pg

CYJ 213CYK 213CYL 213CYM 214CYS 66CZ 50–52CZ2X 50–52CZQ 53CZVM 60CZX 50–52D 152D1 154D2 154D3 154D4 154D5 155D6 156D7 154D8 156D9 156DADR1 209DADR2 209DAI 88DAT 198DBGN 146DEX 153DL 207DML 207DMPM 95DNA 252DNAF 252DPATH 231DPATH1 231DSC 135DY 75E 163E1 163EGFR 224EHE1 131ELU 199EMB 141EPO 77ESR 124ESR1 124ESR2 124ESR3 124ETB 91

Program Code Pg

ETME1 193EV 53EXM 195EXM2 195F 164F1 164F3 165FCFS 67FCN 182FF 77FGAL 165FH1 125FH1P 125FH2 125FH2P 125FH3 125FH3P 125FH3Q 126FH4 125FH4P 125FH4Q 126FH5 125FH5P 125FH6 125FH6P 125FH6Q 126FH7 125FH7P 125FH8 125FH8P 125FH9 125FH9P 125FH9Q 126FH10 125FH10P 125FH11 125FH11P 125FH12 125FH12P 125FID 252FIDM 252FL 188FL1 188FL2 188FL3 188FL3CD 188FL4 189

Discontinued

Discontinued

Discontinued

Program Code Page IndexProgram

Code Page Index

22

800-323-4040 | 847-832-7000 Option 1 | cap.org 301

Program Code Pg

FL5 189FLAC 159FLD 65FLD2 65FNA 249FNA1 249FNAG 250FNAG1 250FNPX 146FOL 79FOVK 246FOVK1 246FOVM 246FOVM1 246FP 78FP1B 78FP1T 78FPX 78FR 253FR1 253FSER 165FSM 165FT 67FTC 93G 186G6PDS 67GH2 57GH5 57GH5I 57GHER2 239GIP 177GLI 224GNBC 158GOCB 136GPBC 158GSA 57H 182HBF 199HBRG 125HBVL 173HBVL5 173HC1 159HC2 172HC3 159HC4 172HC6 174HC6X 174HC7 174HCA 185HCC 59

Program Code Pg

HCG 180HCV2 173HCVN 173HE 124HEP 124HER2 239HFC 136HFCi 136HG 128HGM 216HIV 173HIVG 173HLAS 207HLAS1 207HMS 58HPATH 132HPATH1 132HPS 159HPV 174HQBX1 236HQBX2 236HQBX3 236HQIHC 235HQIP 234HQIPBX 235HSCRP 57HV2 173I 118ID1 176ID1T 176ID2 176IDN 175IDO 175IDR 177IFS 119IG 180IGX 180IL 180IM 180IMD1 218IMD2 218IMD3 218IMW 181IND 166ING 78ISH 222ISH2 222J 192J1 192JAT 192

Program Code Pg

JATE1 193JE1 192K 74KET 58KIT 224KK 74KRAS 224KSA 62KVM 80LBAS 157LBC 137LCW 58LDM 121LKM 186LLM 121LM 68LM1 68LN2 106LN2BV 106LN2VM 121LN2VM1 121LN3 107LN5 108LN5S 108LN6 108LN7 109LN8 109LN9 110LN11 110LN12 110LN13 111LN13C 111LN14 111LN15 111LN16 112LN17 112LN18 112LN19 112LN20 112LN21 113LN22 113LN23 113LN24 114LN25 114LN27 114LN30 114LN31 115LN32 115LN33 115LN34 115

Program Code Pg

LN35 116LN36 116LN37 116LN38 116LN39 116LN40 116LN41 117LN42 117LPE 68LPX 159LUM 121M 66MBRG 166MBT 153ME 208MGL1 217MGL2 217MGL3 217MGL4 217MGL5 217MHO 225MHO1 225MHO2 225MHO3 225MHO5 225MK 237ML 207MMR 237MPA 53MRD 225MRD1 225MRD2 225MRS 160MRS5 160MSI 222MTBR 163MTP 224MVM 72MX1B 206MX1C 206MX1E 206MX2B 206MX2C 206MX2E 206MXB 207MXC 207MYG 62N 62NAT 203NB 58

Program Code Pg

NB2 58NEO 223NGC 248NGC1 248NGS 221NP 241NP1 241NVM 63NX 62OCB 137OFD 90OLI 66P 167P3 167P4 167P5 167PAPCE 245PAPCPT 243PAPJE 245PAPJPT 243PAPKE 245PAPKPT 243PAPLE 245PAPLPT 243PAPME 245PAPMPT 243PARF 204PBRG 168PCARM 59PCARMX 59PCP1 166PCP2 166PCP3 166PCP4 166PCSP 233PCSP1 233PCT 69PEDK 244PEDL 244PEDM 244PF 147PF1 147PGX 219PGX1 219PGX2 219PHG 69PIA 149PIP 228PIP1 228PIPW 229

Discontinued

Program Code Page IndexPr

ogra

m C

ode

Page

Inde

x

22


Program Code Pg

PIPW1 229PLA 67PLTM 149PM1 237PM2 239PM3 237PM5 238PNA1 158PNA2 158PNA3 158PNA4 158PNH 189POC1 44POC2 44POC3 44POC4 44POC5 44POC6 44POC7 44POC8 44POC9 44POC10 45POC11 45POC12 45POC14 45POC15 45POC16 45PS 199PTGDK 242PTGDL 242PTGDM 242PV 140QF 186QM 42QP151 27QP152 28QP153 29QP154 30QT1 33QT2 33QT3 34QT4 34QT5 39QT7 35QT8 35QT10 36QT15 37QT16 37QT17 38QT19 40

Program Code Pg

R 70RAG 199RAP 79RBCAT 200RDS 186RETT 219RF 180RFAV1 190RFX 180RHCVW 202RMAL 168ROM1 137RT 129RT2 129RT3 129RT4 129RUB 180RUBX 180RUR 160RVBN 146RWBC 130S2 181S4 181S5 181SALC 69SARC 223SBAS 157SC 140SC1 140SCDD 94SCM1 137SCM2 137SCO 120SCP 198SCS 129SDS 91SE 185SEC 218SEC1 218SFLC 187SM 140SM1CD 140SM2CD 140SMCD 140SO 84SOQ 84SP 161SP1 161SPE 68SPN 161

Program Code Pg

ST 161STFR 72SV 140SW1 71SW2 71SW3 71SW4 71T 86TBLA 70TBX 149TEG 147TICP 247TICP1 247TM 80TMCA 194TMCAD 194TMCAE 194TMCAF 194TMO 169TMU 92TMX 80TNT 56TNT5 56TPM 219TRC 200TTD 178U 61UAA 135UAA1 135UABRG 138UBJP 68UDC 89UDS 88UDS6 88UDSM 96UMC 138UPBG 63URC 135UT 86UTCO 120UVM 63V 187VBF 134VBP 230VBP1 230VF 90VGS1 155VGS2 155VITD 76VLS 173

Program Code Pg

VLS2 173VM1 201VM2 201VM3 201VM4 202VM5 202VM6 202VPBS 130VR1 171VR2 171VR3 178VR3M 178VR4 172VRE 162VS 162VS1 162VS2 162WB2 59WBDD 149WBG 59WID 169WP3 148WP4 148WP6 148WP9 148WP10 148Y 75YVM 80YY 75Z 50–52ZAP70 190ZE 54ZT 54ZZT 54

Discontinued

Notes

800-323-4040 | 847-832-7000 Option 1 | cap.org 303

Notes

Notes


Notes

2015 surveys catalog web, rev. 1/26/15

Documents